
<html lang="en"     class="pb-page"  data-request-id="b19cd95d-14ae-4cd3-bc22-d063a2d72a7e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.9b02001;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?" /></meta><meta name="dc.Creator" content="Maxime  Liberelle" /></meta><meta name="dc.Creator" content="Nicolas  Jonckheere" /></meta><meta name="dc.Creator" content="Patricia  Melnyk" /></meta><meta name="dc.Creator" content="Isabelle  Van Seuningen" /></meta><meta name="dc.Creator" content="Nicolas  Lebègue" /></meta><meta name="dc.Description" content="Membrane-bound mucins belong to a heterogeneous family of large O-glycoproteins involved in numerous cancers and inflammatory diseases of the epithelium. Some of them are also involved in protein–p..." /></meta><meta name="Description" content="Membrane-bound mucins belong to a heterogeneous family of large O-glycoproteins involved in numerous cancers and inflammatory diseases of the epithelium. Some of them are also involved in protein–p..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 6, 2020" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02001" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02001" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02001" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02001" /></link>
        
    
    

<title>EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02001" /></meta><meta property="og:title" content="EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0010.jpeg" /></meta><meta property="og:description" content="Membrane-bound mucins belong to a heterogeneous family of large O-glycoproteins involved in numerous cancers and inflammatory diseases of the epithelium. Some of them are also involved in protein–protein interactions, with receptor tyrosine kinase ErbB2, and fundamental and clinical data showed that these complexes have a detrimental impact on cancer outcome, thus raising interest in therapeutic targeting. This paper aims to demonstrate that MUC3, MUC4, MUC12, MUC13, and MUC17 have a common evolutionary origin and share a common structural organization with EGF-like and SEA domains. Theoretical structure–function relationship analysis of the conserved domains indicated that the studied membrane-bound mucins share common biological properties along with potential specific functions. Finally, the potential druggability of these complexes is discussed, revealing ErbB2-related pathways of cell signaling to be targeted." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02001"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02001">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02001&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02001&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02001&amp;href=/doi/10.1021/acs.jmedchem.9b02001" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 5074-5088</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01701" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.9b01743" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Maxime Liberelle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Maxime Liberelle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm CHU Lille, UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000 Lille, France</div><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, UMR-S 1172-LiNC-Lille Neuroscience & Cognition, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Maxime++Liberelle">Maxime Liberelle</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nicolas Jonckheere</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas Jonckheere</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm CHU Lille, UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000 Lille, France</div><div class="loa-info-affiliations-info">Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR-S 1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Jonckheere">Nicolas Jonckheere</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patricia Melnyk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patricia Melnyk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm CHU Lille, UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000 Lille, France</div><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, UMR-S 1172-LiNC-Lille Neuroscience & Cognition, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patricia++Melnyk">Patricia Melnyk</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Isabelle Van Seuningen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Isabelle Van Seuningen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm CHU Lille, UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000 Lille, France</div><div class="loa-info-affiliations-info">Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-UMR-S 1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Isabelle++Van+Seuningen">Isabelle Van Seuningen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Nicolas Lebègue</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nicolas Lebègue</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Lille, Inserm CHU Lille, UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, F-59000 Lille, France</div><div class="loa-info-affiliations-info">Univ. Lille, Inserm, CHU Lille, UMR-S 1172-LiNC-Lille Neuroscience & Cognition, F-59000 Lille, France</div></div><span class="conrtib-corresp"><strong>*</strong>Inserm UMR-S 1172/LiNC, Faculté de Pharmacie, 3 rue du Pr. Laguesse, 59045 Lille, France. Phone: +33 3 20 96 49 77. Email: <a href="/cdn-cgi/l/email-protection#c1afa8a2aeada0b2efada4a3a4a6b4a481b4afa8b7ecada8adada4efa7b3"><span class="__cf_email__" data-cfemail="1f71767c70737e6c31737a7d7a786a7a5f6a71766932737673737a31796d">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Leb%C3%A8gue">Nicolas Lebègue</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4245-2833" title="Orcid link">http://orcid.org/0000-0003-4245-2833</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02001&amp;href=/doi/10.1021%2Facs.jmedchem.9b02001" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 5074–5088</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 6, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 December 2019</li><li><span class="item_label"><b>Published</b> online</span>6 February 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02001" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02001</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5074%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMaxime%2BLiberelle%252C%2BNicolas%2BJonckheere%252C%2BPatricia%2BMelnyk%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D10%26contentID%3Dacs.jmedchem.9b02001%26title%3DEGF-Containing%2BMembrane-Bound%2BMucins%253A%2BA%2BHidden%2BErbB2%2BTargeting%2BPathway%253F%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5088%26publicationDate%3DMay%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02001"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">557</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02001" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;EGF-Containing Membrane-Bound Mucins: A Hidden ErbB2 Targeting Pathway?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Maxime&quot;,&quot;last_name&quot;:&quot;Liberelle&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Jonckheere&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;Melnyk&quot;},{&quot;first_name&quot;:&quot;Isabelle&quot;,&quot;last_name&quot;:&quot;Van Seuningen&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Lebègue&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;5074-5088&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02001&quot;},&quot;abstract&quot;:&quot;Membrane-bound mucins belong to a heterogeneous family of large O-glycoproteins involved in numerous cancers and inflammatory diseases of the epithelium. Some of them are also involved in protein–protein interactions, with receptor tyrosine kinase ErbB2, and fundamental and clinical data showed that these complexes have a detrimental impact on cancer outcome, thus raising interest in therapeutic targeting. This paper aims to demonstrate that MUC3, MUC4, MUC12, MUC13, and MUC17 have a common evolutionary origin and share a common structural organization with EGF-like and SEA domains. Theoretical structure–function relationship analysis of the conserved domains indicated that the studied membrane-bound mucins share common biological properties along with potential specific functions. Finally, the potential druggability of these complexes is discussed, revealing ErbB2-related pathways of cell signaling to be targeted.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02001&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02001" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02001&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02001" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02001&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02001" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02001&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02001&amp;href=/doi/10.1021/acs.jmedchem.9b02001" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02001" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02001" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02001%26sid%3Dliteratum%253Aachs%26pmid%3D32027502%26genre%3Darticle%26aulast%3DLiberelle%26date%3D2020%26atitle%3DEGF-Containing%2BMembrane-Bound%2BMucins%253A%2BA%2BHidden%2BErbB2%2BTargeting%2BPathway%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D10%26spage%3D5074%26epage%3D5088%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292544" title="Targeting">Targeting</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/jmcmar.2020.63.issue-10/20200528/jmcmar.2020.63.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Membrane-bound mucins belong to a heterogeneous family of large O-glycoproteins involved in numerous cancers and inflammatory diseases of the epithelium. Some of them are also involved in protein–protein interactions, with receptor tyrosine kinase ErbB2, and fundamental and clinical data showed that these complexes have a detrimental impact on cancer outcome, thus raising interest in therapeutic targeting. This paper aims to demonstrate that MUC3, MUC4, MUC12, MUC13, and MUC17 have a common evolutionary origin and share a common structural organization with EGF-like and SEA domains. Theoretical structure–function relationship analysis of the conserved domains indicated that the studied membrane-bound mucins share common biological properties along with potential specific functions. Finally, the potential druggability of these complexes is discussed, revealing ErbB2-related pathways of cell signaling to be targeted.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">I.  Context</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mucins form a family of large gel-forming O-glycoproteins synthesized by epithelial cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Arising from heterogeneous evolutionary origins,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> they are organized into a peptidic chain called apomucin and a heavily glycosylated serine/threonine rich region. In addition to this O-glycosylation, which represents up to 50–80% of the total molecular weight of the molecule, N-glycosylation occurs to a lesser extent.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Mucins play a role in lubrication, transduction of the signal, cell–cell or cell–extracellular matrix communication, and barrier formations because of their abilities to filter compounds and ions and retain factors and water molecules.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Twenty-two mucin genes that encode two subfamilies of mucins have been described:<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> membrane-bound and secretory mucins. Herein, we focus on the membrane-bound mucins or transmembrane (TM) mucins that are typically localized at the apical surface of normal epithelial cells.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> This subfamily includes MUC1, MUC3A/3B, MUC4, MUC12, MUC13, MUC15–MUC17, and MUC20–MUC22. They share common structural features. The N-terminal (Nt) part of the apomucin is composed of amino acid (aa) tandem repeats or pseudorepeated aa sequences, rich in serine and threonine residues, that are extensively glycosylated followed by a less glycosylated part of variable length. This extracellular part of the TM mucin may contain one or several structural and functional domains. This Nt part is noncovalently associated with the C-terminal (Ct) part that is composed of a single transmembrane helix followed by a cytoplasmic tail of approximately 70–80 residues, shorter for MUC4 (23 amino acids) and MUC16 (35 amino acids). While MUC15 and MUC20–MUC22 are almost exclusively composed of the O-glycosylated part directly followed by the transmembrane domain, the other TM mucins contain either epidermal growth factor (EGF)-like domains (MUC4) or a sperm protein, enterokinase and agrin (SEA) domain (MUC1 and MUC16), or both (MUC3A/3B, MUC12, MUC13, and MUC17). All mucins are post-transcriptionally cleaved at a site in the SEA domain, except for MUC4, which is cleaved at the consensus GDPH sequence.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> MUC4 also contains several unique domains not found in other mucins (AMOP, NIDO, and VWD)<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic view of EGF-containing TM mucins. Schematic representation of the non-proline/serine/threonine rich domain (PTS) part of TM mucin family members. Asserted cleavage sites are marked with red lines. All of the mucins have at least two epidermal growth factor (EGF) domains. MUC4 exhibits three unique domains: NIDO, AMOP, and von Willebrand factor D (VWD). All of the other mucins except MUC4 have a SEA domain involved in their cleavage.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This review will focus on MUC3, MUC4, MUC12, MUC13, and MUC17 TM mucins. Herein, we will thus focus on the mucins containing EGF domains and discuss their evolution, their structure, and their function. Other TM mucins will not be discussed for the following reasons. MUC1, which is evolutionary related with soluble mucins,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> interacts with the EGFR pathway via its cytoplasmic tail and does not have an EGF domain. MUC16, which has a unique structure with its SEA repeat domains,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> appears to come from distinct ancestors. MUC15 and MUC20–MUC22 do not have an extended apomucin part. Most of the reviews describing TM mucins are essentially focusing on their O-glycan part, on cleavage function, on the regulation of their expression at the genomic level, or on their role associated with resistance to apoptosis and resistance to chemotherapy.<a onclick="showRef(event, 'ref8 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref8 ref11 ref12">(8,11,12)</a></div><div class="NLM_p">Apart from their structure, TM mucins have common implications in pathological disorders, at the edge between inflammation and cancer,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and recently, some of them have attracted interest as potential and promising therapeutic targets.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> We will discuss the links between their structures and biological properties, leading to a hypothesis about a new ErbB pathway to study and to target in therapeutic approaches. The EGFR/ErbB receptor family consists of a type I transmembrane growth factor receptor that comprised EGFR/HER/ErbB1, HER2/ErbB2 (derived from erythroblastic leukemia viral oncogene), HER3/ErbB3, and HER4/ErbB4.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p last">In this work, we want to establish a new paradigm where EGF-like domain-containing TM mucins may be regarded as sharing common structural properties producing similar biological functions. This postulate should enable us to consider biological properties for each mucin as being relevant for others until specific functions have been elucidated. Moreover, considering the potential implication of ErbB family members, this will lead to a potential breakthrough for the design of new therapeutic strategies.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">II.  Physiological and Pathological Aspects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41705" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41705" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4">II.A.  Healthy Tissue Distribution and Function</h3><div class="NLM_p last">In a normal situation, TM mucins are commonly expressed and co-expressed<a onclick="showRef(event, 'ref11 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref11 ref17 ref18 ref19 ref20 ref21 ref22">(11,17−22)</a> in tissues at the interface with the environment with potentially harmful conditions such as gastrointestinal, respiratory, and reproductive tracts but also in middle ear epithelium or eyes.<a onclick="showRef(event, 'ref19 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref22 ref23">(19,22,23)</a> MUC4 is abundant in the normal respiratory tract, particularly in the trachea, and is also the main TM mucin component of the stomach. MUC3 is broadly expressed and quite abundant in the small intestine, while MUC12 and MUC17 are predominant in the colon. MUC3 is also noticeably present in the heart, liver, and thymus. MUC13 is expressed in the large and small intestine, stomach, esophagus, and kidney.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The main function of those TM mucins, in combination with secreted mucin layers, is to contribute to the development of a mucosal glycocalyx protection for epithelial cells against external aggression. They form a barrier against harsh physicochemical (pH, salinity, and temperature) or biological (enzymes, bacteria, parasites, and viruses) conditions.<a onclick="showRef(event, 'ref4 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref7">(4,7)</a> Because of the presence of a cleavage site, TM mucins also exist in soluble forms to help lubrication of the lumens.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The noncovalent association of subunits may lead to a resistance to physical damage, the rupture of the tight link allowing the release of the energy without breaking the cell membrane.<a onclick="showRef(event, 'ref7 ref22'); return false;" href="javascript:void(0);" class="ref ref7 ref22">(7,22)</a> Most TM mucins can be phosphorylated on their intracellular tails and connected to signal transduction in response to either shedding or modification of the molecules associated with their glycocalyx.<a onclick="showRef(event, 'ref7 ref24'); return false;" href="javascript:void(0);" class="ref ref7 ref24">(7,24)</a> They may also be activated in response to ligand binding or protein association.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> By interacting directly or indirectly with adhesion-associated proteins such as lectins, selectins, or integrins, they could regulate cell trafficking (cell–cell adhesion, cell–cell communication, and cell–matrix interaction).<a onclick="showRef(event, 'ref4 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref4 ref25 ref26">(4,25,26)</a> Finally, they are also involved in the regulation of the cell cycle because they can induce proliferation, differentiation, or migration.<a onclick="showRef(event, 'ref4 ref7 ref22'); return false;" href="javascript:void(0);" class="ref ref4 ref7 ref22">(4,7,22)</a> Among all of these functions, most are carried out by the glycans of the O-glycosylated subunit. Nevertheless, the EGF-containing mucins are involved in cell signaling and regulation processes,<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33 ref34 ref35">(27−35)</a> in healthy conditions, from tissue regeneration, wound healing,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and embryogenesis and fetus development.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">II.B.  Pathological Distribution</h3><div class="NLM_p last">Mucins, and in particular TM mucins, because they have a dual function between barrier formation and signal transduction, are involved in cancer and inflammatory pathologies.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> They are often overexpressed in epithelial cancers.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Noticeably, MUC4 is not expressed in healthy pancreas, whereas it is neoexpressed in the early neoplastic stage of this cancer.<a onclick="showRef(event, 'ref17 ref19 ref28 ref34'); return false;" href="javascript:void(0);" class="ref ref17 ref19 ref28 ref34">(17,19,28,34)</a> In contrast, the downregulation of TM mucins may be observed in inflammatory pathologies and leads to adverse effects such as the decrease in the epithelium protective barrier<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> that can promote cancer development.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> With regard to carcinogenesis, the implication of TM mucins is dual in the aberrant behavior of malignant cells. The proliferative and anti-apoptotic effects involve the extracellular apomucin and the cytoplasmic tail, while the invasive and anti-adhesive effects are due to the glycosylated extracellular part of the mucin.<a onclick="showRef(event, 'ref7 ref38'); return false;" href="javascript:void(0);" class="ref ref7 ref38">(7,38)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">III.  Molecular Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">III.A.  Sequence Level</h3><div class="NLM_p">Sequence data and domain assignments were retrieved from Uniprot or the literature.<a onclick="showRef(event, 'ref17 ref20 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref17 ref20 ref39 ref40 ref41">(17,20,39−41)</a> The consensus sequences described for the EGF-like domains end after the sixth cysteine residue. The main structure of EGF-like domains is a major two-stranded β-sheet (Nt) followed by a loop to a minor Ct, two-stranded β-sheet. The minor sheet needs at least four residues following the last cysteine to be folded. Thus, we chose to extend our considered consensus sequences to this length.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">MUC3 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was first described as a unique gene but was later separated in two, MUC3A and MUC3B.<a onclick="showRef(event, 'ref40 ref43'); return false;" href="javascript:void(0);" class="ref ref40 ref43">(40,43)</a> MUC3B has a glycosylated subunit that is longer than that of MUC3A. With regard to their apomucin parts, they are almost identical, with only nine nonconserved residues of 369. They both consist of two EGF-like domains separated by a SEA domain that is cleaved at the GSIVV motif, right after the serine, leading to two noncovalently associated subunits. The cytoplasmic tail contains 13 serine/threonine residues and only one tyrosine that can be potentially phosphorylated on MUC3A. Finally, five potential N-glycosylated sites were characterized by an N-X-S/T motif.</div><div class="NLM_p">MUC4 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) displays the largest apomucin, with notably three unique domains, NIDO, AMOP, and VWD from Nt to Ct. Two EGF-like domains are also described, named EGF1 and EGF2. EGF3 was later identified<a onclick="showRef(event, 'ref18 ref28'); return false;" href="javascript:void(0);" class="ref ref18 ref28">(18,28)</a> with the six cysteine residues correctly spaced in the Nt part following EGF1. MUC4 may also be post-transcriptionally cleaved into two tightly associated subunits. This cleavage occurs at the Asp–Pro bond of the autocatalytic acid sensitive GDPH motif located at the Nt part of the VWD. Finally, MUC4 exhibits a really short cytoplasmic tail of 23 residues, with two serine residues and one tyrosine residue and 22 potential N-glycosylated sites.</div><div class="NLM_p">MUC12 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is highly homologous to MUC3, with two EGF-like domains separated by a SEA domain that displays a cleavage motif at the Ser–Ile bond of the GSIVV motif. MUC12 has only two putative N-glycosylated sites and 11 serine/threonine and two tyrosine residues (potential phosphorylation sites) within its cytoplasmic tail.</div><div class="NLM_p">MUC13 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is the shortest overall TM mucin considering its O-glycosylated subunit. The apomucin is described with three EGF-like domains, EGF1–EGF3 from Nt to Ct, with a SEA domain between EGF1 and EGF2. MUC13 is cleaved at an unknown site into two noncovalently associated subunits. The cleavage may occur at a homologous but degenerated GSVVV site as it is described for the classical SEA domain.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> As seen for MUC3, five putative sites for N-glycosylation are reported and the cytoplasmic tail contains 13 serine/threonine residues, two tyrosines, and a protein kinase C phosphorylation motif.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p last">Finally, MUC17 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) is another MUC3 homologue because it displays two EGF-like domains and one SEA domain, with cleavage at the GSVVV motif.<a onclick="showRef(event, 'ref17 ref44'); return false;" href="javascript:void(0);" class="ref ref17 ref44">(17,44)</a> MUC17 has five potential N-glycosylated sites and 12 serine/threonine and three tyrosine residues in its cytoplasmic tail.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">III.B.  Common Features</h3><div class="NLM_p">All of the TM mucins discussed here display at least two EGF-like domains in their structure, including conserved cysteine residues that form disulfide bonds within each domain. We previously observed that the EGF topology is conserved in the predicted structures of EGF-like domains of MUC3, MUC4, MUC12, MUC13, MUC16, and MUC17.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Except these conserved cysteines, EGF domains are not strongly homologous, with only the presence on the C-loop of at least one aromatic, one positive, and one negative residue.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Despite a low degree of overall sequence homology, previous works on the EGF–EGFR complex have shown that only a few residues of an EGF-like domain are critical for the affinity.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Furthermore, ErbB specificity came from distant residues located in the Ct linear region.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">The SEA module is a 120-amino acid domain found in many membrane-associated proteins at the cell surface.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Except for MUC4, TM mucins usually contain a SEA module with a modest degree of sequence homology but a highly conserved GSXVV motif responsible for the cleavage of pro-mucins into mature mucins composed of two subunits.<a onclick="showRef(event, 'ref44 ref49'); return false;" href="javascript:void(0);" class="ref ref44 ref49">(44,49)</a> No clear consensus sequence emerges from sequence alignment, because SEA domains are formed by successive helices and stranded β-sheets. Multiple N-glycosylation and O-glycosylation sites are also found in SEA domains.</div><div class="NLM_p">MUC4, in this regard, is described as the only TM mucin without a SEA domain. However, MUC4 possesses between EGF1 and EGF2 domains an uncharacterized domain entitled the intermediate domain (ID) that is possibly homologous with the SEA domain following sequence alignments (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S1</a>). However, this alignment did not allow us to confidently state the SEA nature of the intermediate domain.</div><div class="NLM_p">To confirm the possibility of SEA domain homology in MUC4, we analyzed sequence conservation among various and distant MUC4 orthologs (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S2</a>). A map of the conserved and nonconserved regions of MUC4 was built with this alignment. Highly conserved regions (>80% conservation over all of the found orthologs) are highlighted in purple (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S3</a>). Totally nonconserved regions, where large insertions, deletions, and/or mutations were found, are highlighted in orange. Highly conserved residues can be identified either to be part of an interaction domain or to be involved in protein folding. Residues that participate in the formation of interactions with protein partners tend to co-evolve and thus exhibit a moderate variability. Our analysis of data shows that all of the most conserved residues in the Ct part of MUC4 from the CR to the EGF2 domain (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S3</a>), especially the hydrophobic residues included in the ID region, exhibited characteristic patterns of helices and stranded β-sheets common to canonical and noncanonical SEA domains.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> With this pattern, we produced an alignment of a large part of the ID of MUC4 consistent with the SEA domain. We used the characterized noncanonical SEA domain [Protein Data Bank (PDB) entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WIQ">4WIQ</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a>] displaying the best homology with MUC4 as a pattern. We were able to produce a homology model by molecular modeling using this alignment (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). This model has an insertion where cleavage is usually found and exhibits a supplementary β-strand as its template. Moreover, MUC4 was shown to be proteolytically cleaved to produce a soluble form<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> in a locus other than the GDPH and within a region flanked by the two EGF-like domains. Considering this common cleavage feature, and the high probability of sequential and structural homology with canonical SEA domains, we will then consider the ID of MUC4 as a highly degenerated but still potent SEA-like domain.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeling of the SEA-like domain of MUC4 by homology. Sequence alignment between MUC4 and a less canonical but crystallized SEA domain (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WIQ">4WIQ</a>). With 15.6% identical and 33.6% homologous sequences, a potential structure model of the putative MUC4 SEA domain was built.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">III.C.  Evolutionary Track</h3><div class="NLM_p">Our last hypothesis raises the question of a potential common evolutionary origin of these mucins. Indeed, MUC4 seems to have all of the domains (EGF and SEA-like) commonly found in other mucins. Moreover, previous works have agreed on at least three distinct origins for mucins.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">Except for MUC4 and MUC16 that have been found to come from convergent evolution, MUC1, MUC3, MUC12, MUC13, and MUC17 are linked with the basement membrane-specific heparan sulfate proteoglycan core protein (HSPG2).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> This work relied on the sequence alignment and gene homology of common domains by comparison of SEA domains of mucins and other proteins, which allowed us to link them (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S4</a>). MUC4 that does not contain a classical SEA domain could not be linked with the other mucins or with HSPG2. Its NIDO–AMOP–VWD unique domains were considered and compared to the Nidogen ancestor and Susd2 as origin proteins. Another group performed evolutionary analysis by aligning the sequences of ErbB receptor natural ligands and observed a clustering of the ligands depending on their receptor specificity.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Our sequence analysis from EGF-containing proteins, in particular mucins, showed that MUC3, MUC4, MUC12, and MUC17 clustered together with potential ErbB2 ligands. Indeed, this study showed that EGF domains of these mucins displayed a splice site between the fourth and fifth cysteines and close to transmembrane domains. From SEA domain amino acid sequence alignment (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S4</a>), we constructed a phylogenetic tree that was found to be inconclusive considering the divergence of MUC4 regarding the SEA-like domain relative to the other mucins. However, MUC1, MUC3, MUC12, and MUC17 seemed to evolve from a HSPG2 common ancestor as described previously.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> We then explored the evolution of the only common domain among all of the proteins of interest, the EGF-like domain. It was previously described that HSPG2 could be the progenitor of the EGF domain in TM mucins by the same way as the SEA domain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">We performed the alignment of all mucin EGF-like domains with several soluble EGF ligands and protein-containing EGF domains from putative ancestors<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S5</a>). The 63 kDa sperm urchin membrane protein (63sp) was also included in this analysis. 63sp is one of the first proteins in which a SEA domain was observed, and its structure looks homologous to TM mucins (with an EGF–SEA–EGF module). Our analysis revealed a segregation between the differently positioned EGFs relative to the SEA domain with “EGF1” (Nt from the SEA domain) clustering together, as well as “EGF2” (Ct from the SEA domain). The EGF-like domains from HSPG2 or NIDO are probably linked, but we could not reach a conclusion about the ancestral character of those proteins (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Moreover, none of these two proteins have an EGF domain next to a SEA domain so we could not link them further in our analysis. We generated a phylogenic tree focused only on an EGF-like domain from mucins that indicates that MUC13 seemed to be the oldest of the EGF-containing mucins with MUC4 considered as the first to have diverged. Another hypothesis could be a divergence of the MUC4/MUC13 progenitor from a common ancestor of MUC3, MUC12, and MUC17 (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S6</a>). From this tree, we can also conclude that duplication produced the supplementary EGF domains (EGF3 for both MUC4 and MUC13). We noticed that the EGF3 domain of MUC4 diverges from the MUC4 EGF1 domain as well as EGF3 of MUC13, which seems to be derived from its EGF2 domain. MUC4 also possesses a fourth putative cysteine rich EGF domain, composed of six close cysteine residues that could form another EGF-like domain. This alignment suggests that it is not linked with the other EGF-like domain of MUC4 and should have a distinct origin.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Phylogenic tree based on EGF-like domain alignment with clustering. The tree was built with the Blosum62 matrix by Average Distance on Jalview. Several clusters could be observed, and EGF-like domains of mucins are not mixed with domains from NIDO or HSPG2. MUC13 appears to be the most primitive mucin, being furthermore the closest to 63sp. Mucins are grouped together, with the EGF1 and EGF2 domains clearly separated. The fourth possible EGF domain of MUC4 (CR) exhibits no tight relationship with the others and thus may arise from a distinct origin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We generated a last tree from sequence alignments of SEA domain-containing mucins, including both surrounding EGF domains, to ensure that this larger homologous sequence would make our results more accurate (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The ancestral character of MUC13 was confirmed as well as the position of MUC4 as the first to have diverged, despite its SEA domain degeneration. The position of both <i>MUC13</i> and <i>MUC4</i> genes on the same chromosome 3 and on the same cluster<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> strengthens this conclusion. Finally, an evolutionary study showed that genes encoding <i>Muc13</i> were identified in zebrafish and chicken while the <i>MUC4</i> homologous gene was found only in chicken.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Mucin genes localized on chromosome 7 as <i>MUC3</i>, <i>MUC12</i>, and <i>MUC17</i> seem to be missing in chicken as well as in fish and might therefore reflect a more recent development in vertebrates.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> These results confirm our hypothesis that MUC13 is the oldest mucin protein and that all others are linked due to later duplications.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Alignment and phylogenic tree of EGF-containing TM mucins with clustering based on the full EGF–SEA–EGF module. Using ClustalO and Blosum62 with correction focused on the cysteine residues for the EGF domains and on the hydrophobic residues for the SEA domain, an alignment and a tree were built showing MUC4 as a member of only one mucin subfamily that includes MUC13, MUC12, MUC17, and MUC3A/3B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To refine even more this evolutionary sequence, a closer look at the EGF1 domain is needed. MUC13 has a classical EGF domain (six cysteine residues forming three disulfide bridges) when MUC4 has a fourth disulfide bridge.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It was postulated that the common ancestor of every EGF domain was a four-disulfide-bridged structure in which a bridge was shared among two consecutive domains.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Therefore, <i>MUC13</i> and <i>MUC4</i> are expected to have segregated after gene duplication, both from an integrin-like EGF domain by the loss of an extra cysteine for <i>MUC13</i> and from a disulfide capture of the lone half-cysteine by a new mutated one for <i>MUC4</i>.</div><div class="NLM_p">The ancestral MUC13 or ancestral MUC4 from which the MUC3-related mucins were derived is not clear. MUC3, MUC4, MUC12, and MUC17 display only one EGF domain close to the membrane, whereas MUC13 and its orthologs exhibit a second EGF domain in this Ct part (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Therefore, the MUC3-related mucins of a common ancestor probably seem to be closer to MUC4 than MUC13. Moreover, the Nt extended EGF1 domains of MUC3 and MUC17 share strong sequence homology. The sequence encompassing the first four cysteine residues of MUC3 closely resembles the sequence encompassing the four last cysteines (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). These observations led to the hypothesis that the common ancestor of the MUC3-related mucins resembles MUC17 that lost two cysteine residues and provided the EGF1 domain of MUC12 and MUC3. The four remaining cysteine domains were then duplicated to produce the eight cysteine domains found in both MUC3A and MUC3B. By considering the whole sequence of interest for each mucin (from the first EGF domain to the cytosolic tail), we found the same order for each mucin in the evolution of their family and undoubtedly linking MUC4 with the others (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S7</a>). We also found a strong homology between MUC13 and HEG1 (another human protein with an EGF–SEA–EGF module), Mua3, MUP4 (two proteins that are found as homologues of sp63 from blast), and sp63 of sea urchin, potentially indicating a common origin with the TM mucins (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S8</a>). These proteins from distant species are even closer to MUC13 than MUC4, indicating the ancestral character of MUC13 was conserved throughout evolution.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Focus on the EGF1 domain of MUC3A/3B. Comparison of sequences of the first four cysteines and the last four of MUC3-EGF1, leading to 33.6% identical and >50% homologous sequences. This argues for the presence of two repetitive EGF-like domains with only four cysteines instead of one containing eight cysteines. Moreover, alignment of all of the homologous cysteines with this hypothesis leads to a coherent tree.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">III.D.  Peculiar Features</h3><div class="NLM_p">In addition to sharing high degrees of homology and a common structure, the TM mucins also exhibit some unique structural features. The main and common characteristics in EGF-containing proteins are the extra cysteines that tend to arise from duplicates in the EGF domain sequences. MUC13 displays an extra consensual EGF domain, directly following its EGF2 domain and preceding the transmembrane helix. Moreover, this third EGF domain contains in theory another paired cysteine occurring in the last Ct loop. The combination of these paired cysteines leading to a disulfide bridge is unknown, nor do we know how they link together or with which other cysteines present in the sequence they interact. Two of the most probable connections of the paired cysteines are 1–3, 2–4, 5–6, and 7–8 with cysteines 7 and 8 forming another loop in a manner similar to that of cysteines 5 and 6, or 1–3, 2–4, 5–8, and 6–7, with cysteines 5–8 stabilizing a large loop with two disulfide bridges (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Schematic representation of cysteine connections for the EGF2 domain of MUC13. Two connections are envisaged for the extra cysteines of MUC13, with (A) the two extra cysteines forming another loop and (B) the two extra cysteines stabilizing a large loop with two disulfide bridges. This last hypothesis results in a structure homologous to the formal structure of EGF but with a more rigid Ct part.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The MUC4 EGF1 domain also contains another paired cysteine for which the connectivity has yet to be elucidated. From our simulation, two main possibilities exist: 1–5, 2–4, 3–6, and 7–8, with the second cysteine of EGF1 being homologous to the first consensus cysteine from hEGF, or 1–4, 2–5, 3–6, and 7–8, with the first cysteine being homologous to the first one from hEGF (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). In both cases, an extra bridge is formed, on the B-loop, rigidifying the whole Nt and central structure.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representation and molecular modeling of two possible structures of the MUC4 EGF1 domain. Two possible structures for EGF1, modeled (A) according to the alignment of hypothesis 1 and (B) according to the alignment of hypothesis 2. Virtually no difference is found in the residues that should be involved in the interaction with ErbB2. Nevertheless, hypothesis 2 leads to a more rigid structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The MUC12 EGF1 domain encloses in its sequence only four cysteines but is still referenced as an EGF-like domain. The structure of this domain, to compensate for the loss of the disulfide bridges, is unknown, but domains structurally equivalent to EGF with only two disulfide bridges have already been elucidated (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AUT">1AUT</a><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E8D">5E8D</a><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a>).</div><div class="NLM_p">Both MUC3A and MUC3B have extra paired cysteines in the Nt position of EGF1, but the combination is not elucidated. As postulated, the sequence enclosed by the cysteines at positions 1–4 strongly resembles that found for the four last at positions 5–8. We hypothesize that a duplication event followed by the loss of cysteines produced this EGF-like domain with eight cysteines. Another possibility could be to consider those eight cysteines not as one but as two EGF domains.</div><div class="NLM_p">In all mucins except MUC13, the EGF2 domains display another cysteine at position <i>n</i> – 4 from the first disulfide bridge and between <i>n</i> – 22 and <i>n</i> – 27 at the Nt part. MUC3-related mucins display also extra paired cysteines immediately following the Ct part of the SEA domain. Once again, the hypothetical establishment of disulfide bridges within these cysteines is unknown, as iw whether they belong to an extended EGF domain or to the SEA domain.</div><div class="NLM_p last">Finally, MUC4 is the only TM mucin with extra and unique domains. First, 12 cysteines were noticed before the EGF1 domain with the six closest described as probably forming another EGF-like domain.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The six others could also theoretically form one, as well. Nevertheless, they both exhibited structural particularities that raise the question of whether they are functional or degenerate EGF domains. In addition, MUC4 has three unique domains, NIDO, AMOP, and VWD, which are highly conserved among different species, suggesting they have biological functions.<a onclick="showRef(event, 'ref9 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref9 ref56 ref57">(9,56,57)</a></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">III.E.  Structure–Function Relationship</h3><div class="NLM_p">The SEA domain was first identified in highly O-glycosylated proteins and was first regarded as being involved in post-transcriptional modifications like glycosylation.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> This domain has been identified in proteins that undergo proteolysis and more exactly by autoproteolysis mechanisms as for MUC1 or as presumed for the other SEA-containing mucins.<a onclick="showRef(event, 'ref44 ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref44 ref49 ref50">(44,49,50)</a> The cleavage occurs between the glycine and the serine of a retained sequence GSφφφ (where φ is an aliphatic hydrophobic residue) resulting from conformational strain.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> All of the SEA domains exhibit the same structure, with a ferredoxin-like fold consisting of a succession of β-strands and α helices, with a sequential βαββαβ arrangement.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Divergent SEA domains were recently identified, with nonconserved sequences but appropriate folding.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> It appears that SEA domains are quite tolerant to sequence divergence. The β-strands can keep up a small addition of a unique residue. Helices are tolerant to medium insertion that induces a twist. Finally, the interloops are tolerant to long insertions.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The autoproteolytic pattern is not necessarily conserved but sometimes is replaced by a specific protease recognition site, maintaining its ability to be cleaved. Residues other than those involved in the autoproteolysis were found to have an impact on the stabilization of the noncovalent subunit interaction<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and on the level of N-glycosylation whose modifications disrupt mucin functions.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><div class="NLM_p">All TM mucins of interest exhibit the canonical SEA domain except MUC4. Nevertheless, as previously demonstrated, the DI located between EGF1 and EGF2 domains can be considered as a degenerate SEA-like domain. The main role of the SEA domain in TM mucins seems to be its cleavage into two subunits that noncovalently reassociated.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This mechanism would allow the release of the soluble form of the mucin, which could then act to form mucus, or as a ligand in a paracrine or exocrine process. However, inhibition of the cleavage potency of the SEA domain has abolished the whole function of the mucins regarding proliferation and migration.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> There is also evidence of a second cleavage site in several mucins,<a onclick="showRef(event, 'ref51 ref59'); return false;" href="javascript:void(0);" class="ref ref51 ref59">(51,59)</a> which would involve the release of a full soluble extracellular subunit and a free cytoplasmic subunit leading to transduction of the signal to the nucleus.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">Another role for this SEA domain could be to form a ligand–receptor combination from a unique gene.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Wreschner et al. postulated that both subunits resulting from SEA cleavage act as a ligand–receptor couple, with dynamic association/dissociation.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Both events would then induce modification of the transmembrane part, leading to signal transduction, regulation of cell–cell interaction or immune cell recognition, and detection of bacteria.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> This mechanism could also protect the cell against physical rupture by breaking. Indeed, when a cell faces an external force that could lead to the rupture of the membrane, this force can be dissipated by the cleavage of mucins at the level of their SEA domain, safeguarding the cell membrane.</div><div class="NLM_p">EGF domains are structurally well-defined and widespread domains, as they are found in almost all living organisms and viruses.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> EGF domains are considered as ancestral proteins derived from the first tertiary structures that proteins have adopted. Several subclasses of EGF domains exist, with differences in loop length or cysteine number or positioning. They almost all share at least five homologous cysteines and one found to be topologically homologous that form three highly conserved disulfide bridges. These bridges lead to the canonic structure of the EGF domains and can be described as follows. The Nt part whose structure is EGF domain-dependent is followed by the A-loop. Then two β-strands separated from each other by the B-loop shape a major β-sheet followed by the C-loop, a very short minor stranded β-sheet, and finally the Ct part.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Apart from these disulfide bridges, EGF domains exhibit very little to no sequence conservation. We can still notice some exceptions. The presence of hydrophobic residues located just next to the first two cysteines is needed to ensure a correct folding<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> as well as some conserved glycine residues whose mutation leads to the unfolded domain.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div><div class="NLM_p last">EGF domains are involved in a wide range of functions such as serving as ligands for cell signaling or coagulation or in protein–protein interactions (PPIs). They were also found as spacers in large clusters of repetitive duplicated domains or in a mosaic assembly with other domains.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> We will focus on a particular functional subclass of EGF domains, those acting as ErbB receptor ligands. A dozen soluble EGF domains have been described as ligands for a member of the ErbB family such as ErbB1 (EGFR), ErbB3, or ErbB4 but none for ErbB2. Close comparison at the sequence level did not lead to a clear consensus conserved pattern. A conserved hydrophobic region was found around the second cysteine, but only the arginine located just before the last cysteine seems to be crucial for ErbB affinity.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> This arginine can be replaced with a polar ionic residue but with a loss of affinity for the ErbB receptor.<a onclick="showRef(event, 'ref52 ref64 ref66'); return false;" href="javascript:void(0);" class="ref ref52 ref64 ref66">(52,64,66)</a> In addition to these aa clusters, other residues are important for the specificity of receptor recognition by negative constraints, especially in both of the terminal linear regions.<a onclick="showRef(event, 'ref47 ref67'); return false;" href="javascript:void(0);" class="ref ref47 ref67">(47,67)</a> It was indeed demonstrated that a pan-ErbB ligand, noted panerbin, could be produced with the sequence of EGF fused with the terminal region of neuregulin. Therefore, specificity seems to be more a result of negative regulation from those terminal regions than from sequence hot spots. Finally, other common criteria allow us to discern ErbB receptor ligands, like the presence of a splicing site between the fourth and fifth cysteines and membrane proximity.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Currently, three of the five mucins cited (MUC4, MUC13, and MUC17) have been shown to interact with ErbB2, a member of the ErbB family without identified soluble ligands, and this has consequences for proliferation, migration, and differentiation in normal and cancer cells.<a onclick="showRef(event, 'ref25 ref28 ref29 ref33'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref29 ref33">(25,28,29,33)</a></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">IV.  MUC/ErbB2 Complexes</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">ErbB2 belongs to the ErbB family, which incudes EGFR (ErbB1), ErbB3, and ErbB4.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> ErbB2 is a receptor tyrosine kinase (RTK) but with many unique features compared to its close homologues. The three other ErbB receptors exist in a tethered monomeric inactive conformation and can bind several specific soluble ligands to shift toward an extended conformation that have a propensity to form active homo- and heterodimers.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> No soluble ligand is known for ErbB2, which, moreover, does not expose a tethered conformation and seems to be constitutively in an active pro-dimeric conformation. Due to the absence of ligand regulation, it is also believed to be “poised” to interact and form heterodimers and act as the preferential partner for the other ErbBs.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><div class="NLM_p">A computational study of ErbB2 led to a slightly different conclusion.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The authors compared the crystallographic structure of ErbB2 with that of <i>Drosophila</i> EGFR (dEGFR). They could observe striking similarities between both crystallographic data, with dEGFR not having a tethered conformation. dEGFR exists in an autoinhibited conformation that relies on interaction between domains I and III of the extracellular part of the receptor, instead of domains II and IV found in other mammalian ErbBs. This conformation closes the binding pocket in the absence of a ligand in a manner similar to that of the conformation adopted by free ErbB2. Therefore, ErbB2 seems to be the closest homologue relative to the ErbB invertebrate family. Nevertheless, dEGFR has four soluble ligands that need to be palmitoylated to be active and consequently associated with the membrane, like MUC4, the membrane-bound partner of ErbB2.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The authors conclude that far from being always in an open unregulated conformation, ErbB2 would exhibit an autoinhibited conformation with a larger buried surface and a more restrictive regulation than for the other ErbBs.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> In light of these conclusions, the implication of the TM mucins as ligands<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> or membrane partners for ErbB2 opens a totally new field in the ErbB2 targeting pathway.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13">IV.A.  Which Mucin?</h3><div class="NLM_p last">Every EGF-containing TM mucin has been involved in carcinogenesis, by either up- or downregulation mechanisms,<a onclick="showRef(event, 'ref8 ref19 ref34 ref35 ref70 ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref8 ref19 ref34 ref35 ref70 ref71 ref72">(8,19,34,35,70−72)</a> and some of them were described as interfering with the ErbB2 pathway. The most studied is MUC4 and its rat and mouse orthologs, which have been proven to interact directly with ErbB2.<a onclick="showRef(event, 'ref25 ref28 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref25 ref28 ref73 ref74">(25,28,73,74)</a> Recently, a mirror function has been found for MUC13.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In another study that focused on the autoproteolytic function of the SEA domain of rMUC3 (now described as the homologue of the human MUC17 ortholog), the authors found that rMUC3 promoted proliferation depending on its interaction with ErbB2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> From the five members of the EGF-containing TM mucin family of interest in this review, three have already been shown to be partners of ErbB2. We can then strongly postulate that all of the mucins of this subfamily could interact with ErbB2 or another ErbB family member. Unlike most membrane-bound mucins, MUC1 lacks EGF-like domains. Despite this, MUC1 interacts with EGFR at the plasma membrane.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> This interaction is weakened when MUC1 lacks its cytoplasmic tail.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> MUC1 also regulates EGFR trafficking and nuclear accumulation and chromatin binding regardless of the exogenous ligand.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> An indirect interaction of MUC1 and EGFR has also been demonstrated in different works<a onclick="showRef(event, 'ref78 ref79'); return false;" href="javascript:void(0);" class="ref ref78 ref79">(78,79)</a> and implies galectin-3 that anchors the bridge between glycosylated Asn36-MUC1 and EGFR.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> MUC1 also physically binds with ErbB2, ErbB3, and ErbB4 following heregulin stimulation.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">IV.B.  With Whom?</h3><div class="NLM_p">MUC4 is involved in the induction of proliferation and migration via direct interaction with ErbB2. The main partner of ErbB2 and its own ligands, ErbB3 and the neuregulins (Neu), respectively, must also be considered. The ErbB2/ErbB3/Neu complex is described as being strongly oncogenic and involved in tumorigenesis. In a normal polarized cell, there is segregation of the members of the MUC4/ErbB2/ErbB3/NRG complex.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> In a polarized cell without MUC4, ErbB2 and ErbB3 are on the basolateral pole but the ligands of ErbB3 are available only at the apical level, avoiding the formation of the heterodimer. In the presence of MUC4, ErbB2 is relocated at the apical level, allowing complexation of both proteins but prohibiting the complexation with ErbB3 because it is still basolateral. Following loss of cell polarity, which occurs frequently in cancer cells, the association of MUC4 with ErbB2 induces partial phosphorylation of ErbB2 on two sites, Tyr1139 and Tyr1248.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> When ErbB3/Neu is added to the complex, the phosphorylation of ErbB2 is extended to ErbB3 allowing activation of two major signaling pathways involved in cell proliferation and differentiation as PI3K/AKt and p38, respectively.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> MUC4 seems to induce extended and robust phosphorylation of both ErbBs by stabilizing the four-partner complex at the cell membrane and relocating both ErbBs from the intracellular compartment to the membrane.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Furthermore, this complex is associated with resistance to apoptosis and also resistance to chemotherapy.<a onclick="showRef(event, 'ref27 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref27 ref83 ref84">(27,83,84)</a> All of these results point to an overactivation of the ErbB2 pathway following interaction with MUC4, linking the experimental evidence with human cancer pathogenesis. The same mechanism is drawn for the protein complex between MUC13 and ErbB2 leading to cell proliferation, migration, invasion, and resistance to apoptosis.<a onclick="showRef(event, 'ref29 ref34 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref29 ref34 ref85 ref86">(29,34,85,86)</a> rMUC3, strongly homologous to MUC17, also promotes proliferation, migration, and resistance to apoptosis<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> that could be directly linked to ErbB2.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Nevertheless, its proliferative aspect is considered here as a possibility for healing intestinal ulcers, emphasizing the dual aspect between aberrant proliferation encountered in cancer cells and its protective aspect in terms of inflammatory diseases.</div><div class="NLM_p last">Recently, a new involvement of ErbB3 was discovered because in the absence of ErbB2, a direct interaction between MUC4 and ErbB3 could be observed, with oncogenic effects.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> MUC4, and the other TM mucins, with their multiple EGFs domains, could therefore activate several different pathways depending on the cellular context, making them even more of a pivot to target to inhibit several oncogenic pathways.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">IV.C.  How?</h3><div class="NLM_p">The physical interaction between EGF-containing TM mucins and ErbB2 needs to be elucidated to design and propose new therapeutics in the clinical setting. While the three-dimensional structure of the ErbB2 receptor has been determined well (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WLW">3WLW</a><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a>), no structural data for TM mucins are available. The understanding of the mechanisms of interaction must then rely on homology modeling and the following hypotheses.</div><div class="NLM_p">First, we have supposed that interaction between TM mucins and ErbB receptors is mediated by the EGF-like domains forming a complex homologous to that described for EGFR–EGF<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> or dEGFR–spitz.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The crucial role played by the EGF–SEA–EGF module<a onclick="showRef(event, 'ref28 ref35 ref90'); return false;" href="javascript:void(0);" class="ref ref28 ref35 ref90">(28,35,90)</a> argues in favor of such a case and was further demonstrated by our work. Indeed, we have shown that the truncated mutant encompassing only the EGF domains of MUC4 was necessary to provide efficient interaction with ErbB2.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Data on MUC13 have shown that only the EGF domains surrounding the SEA domain were active and the deletion of EGF3, the EGF domain closest to the membrane, did not disturb interaction.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">While various EGF-containing TM mucins were able to bind to the same ErbB receptor, no common structural features have been identified between the constitutive EGF-like domains of these mucins. The first hypothesis suggested that isolated EGF domains were not sufficient to interact with ErbB2 or were considered as ErbB2 ligands with low affinity. Similar to the case for the dEGFR ligands, they may be required to be membrane-bound to exhibit their full biological activity. As previously described, EGF-containing TM mucins consist of a central core extended in the Nt and Ct parts by regulatory regions. While the central core would be responsible for the ErbB activation, the regulatory regions could be involved in receptor specificity. Indeed, as detailed previously, both of the terminal regions are critical for the receptor specificity, providing a negative regulation. Specificity of TM mucins for ErbB2 may then come from an outer region, with the SEA domain being the most probable candidate that is common to all TM mucins.</div><div class="NLM_p">Another hypothesis would be to consider that a wider interface is needed. The SEA domain, shared by all of the EGF-containing TM mucins, could be part of the interaction with ErbB2 either by performing the correct folding of the EGF domains or by acting as a chaperone protein. The SEA domain could also interact with ErbB2 in a recognition site, positioning the EGF domains close to their binding sites or modifying the folding of ErbB2 by supplying the required energy leading to its open state. Evidence that the SEA domain is involved in the interaction with ErbB2 was demonstrated by the inhibition of both half-protein activity resulting from a chemical bond breaking in the SEA domain of rMUC3.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Those data strongly suggest that EGF-containing TM mucins need the full length EGF–SEA–EGF module to confer their biological activity. Indeed, modification of the SEA domain, impairment of its autocatalytic function, or the SEA domain alone did not demonstrate any biological activity.<a onclick="showRef(event, 'ref33 ref90'); return false;" href="javascript:void(0);" class="ref ref33 ref90">(33,90)</a> The overall hypothesis remains contested because MUC13 was described to need only one EGF domain to have the full biological activity<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> or only the EGF1 domain of MUC4 was sufficient to observe co-immunoprecipitation.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a></div><div class="NLM_p last">These results suggest a dual mechanism for each mucin, with an activity carried by only the EGF domains and another carried by a larger interface leading to the formation of a larger complex and enhancing the cellular response. Regardless, a tight link seems to exist between the EGF domains and the adjacent SEA domain. Our hypothesis is that both EGF and SEA domains have achieved co-evolution until they become a single module, with functions different from those of the isolated domains.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The fact that SEA domains were not found to be able to exchange among the various mucins<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> reinforces the hypothesis suggesting the importance of EGF and SEA domain folding or of a more complex tertiary folding with a common interface, including intrachain interactions. This extended ligand interface could have co-evolved with ErbB2<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> to avoid cross-interaction with other EGF/ErbBs.</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">V.  Perspectives</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">V.A.  EGF and Human Pathophysiology</h3><div class="NLM_p">A large number of questions still need to be answered about the EGF-containing TM mucins. From a molecular biology point of view, elucidation of the structure and insight into the interplay between EGF and SEA domains may lead to a better understanding of their exact role. From these differences, specificities and unique functions could be discovered. Their function as an ErbB2 partner opens an entire new therapeutic field about this RTK that is often overexpressed in cancer. However, this partnership could also be exploited for its powerful regenerative properties, in inflammatory diseases as well as in degenerative pathologies, by selectively activating the appropriate array of ErbB2 signaling pathway.</div><div class="NLM_p last">MUC4 and MUC13 are described as well-validated targets for cancer therapy, in particular for pancreatic adenocarcinoma. Both mucins are not expressed in healthy pancreas but are overexpressed in pancreatic adenocarcinoma,<a onclick="showRef(event, 'ref34 ref93'); return false;" href="javascript:void(0);" class="ref ref34 ref93">(34,93)</a> in which they drive the aggressiveness of cancer cells in an ErbB2-dependent way that can be reverted by silencing.<a onclick="showRef(event, 'ref34 ref94'); return false;" href="javascript:void(0);" class="ref ref34 ref94">(34,94)</a> Furthermore, a proof of concept of the strategy targeting those mucins has already been demonstrated. miRNA as a negative regulator for both has been shown to be a tumor suppressor in pancreatic cancer.<a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95,96)</a> Those results pave the way for the development of therapeutics targeting the mucin–ErbB complex in cancers.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">V.B.  TM Mucins as Promising Therapeutic Targets</h3><div class="NLM_p">We have revealed in this review that EGF-containing TM mucins, involved in the deleterious process of cancer or inflammatory diseases, were membrane partners of the oncogenic receptor ErbB2. We have also exposed a large body of evidence on their structural convergence, as well as solid hypotheses about the implications of EGF and SEA domains for the interaction with ErbB2. Disturbance or inhibition of the interaction between TM mucins and ErbB receptors represents a new potential therapeutic area in the treatment of epithelium-derived pathologies. Targeting an EGF-like domain, mostly globular, with drugs constitutes a challenging task. The involvement of the SEA domain as well as the evidence for a tight relationship between SEA and EGF domains in the formation of a unique module could reveal a more druggable interface. In a similar way, studies of rMUC3/MUC17 have shown that modification of the SEA domain could impair the activity of the mucin. Altogether, this review highlights several potential sites on EGF-containing TM mucins to be targeted (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). (1) The direct inhibition targeting the EGF domains by an antibody strategy. If different EGFs induce various cell responses or activate the formation of different dimers, this could help to ensure specific inhibition. (2) Targeting of an allosteric site by small organic molecules. The SEA domain is larger and more adaptable than an EGF domain. Therefore, a putative druggable binding site could be targeted, leading to misfolding of the protein and disruption of the interaction with the ErbB2 receptor. (3) Inhibition of MUC-ErbB2 PPI. Both EGF and SEA domains seem to interact together with ErbB2 forming a delocalized and dual epitope as the binding interface. Both epitopes can be contiguous and form a broader druggable interface that could be targeted by PPI inhibitors. (4) Stabilizing the autocatalytic loop involved in the cleavage of the SEA domain. As disruption of the cleavage of the SEA domain can presumably abolish the activity of the mucins, this strategy could lead to a proper inhibition of the mucin-induced pathways. (5) Disruption or stabilization of the noncovalent intramolecular interactions of the SEA domain. Following the hypothesis of a dual receptor–ligand generated by the SEA domain,<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> this strategy could modulate the activity of the mucin, provided that the existence and biological significance of this hypothesis are validated. (6) Inhibition of SEA–EGF domain PPI. We raised the hypothesis that there could be a binding interface between one EGF domain and part of the SEA domain. Disruption of this interaction with PPI inhibitors could impair the proper folding of this module and then the formation of the MUC–ErbB2 complex.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Schematic representation of the possible targetable interfaces on mucins to impair their complexes with ErbB receptors. Several targetable assumed protein interfaces in the ErbB2–mucin pathways can be identified, either to directly impair binding of this mucin to the ErbB receptor or to modulate this interaction by allosteric means. (1) Targeting an EGF domain on an EGF–ErbB interface. (2) Targeting the SEA domain on an EGF–ErbB interface. (3) Targeting an interface that includes a partial combination of the two previous ones or targeting both at the same time with a dual ligand. (4) Stabilizing the autocatalytic loop involved in the cleavage of the SEA domain. (5) Impairing the intra-SEA domain interaction. (6) Targeting allosteric interfaces, possibly disrupting the interface between the SEA and EGF domains.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">V.C.  ErbB2 PPI Interface as a Promising Therapeutic Target</h3><div class="NLM_p last">ErbB2 targeting by antibodies or catalytic tyrosine kinase inhibitors suffers from a lack of efficiency in some cancers, like in pancreatic adenocarcinoma or breast cancer, and often triggers resistance mechanisms.<a onclick="showRef(event, 'ref83 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref83 ref97 ref98">(83,97,98)</a> Due to its partnership with the EGF-containing TM mucins, ErbB2 exhibits increased pro-oncogenic properties. We propose two new and promising pathways for disrupting the deleterious effect of ErbB2 oncogenic signaling: (1) targeting specific interfaces on ErbB2 binding sites involved in interaction with EGF-containing TM mucins, focusing on epitopes different from those currently targeted using antibodies, and (2) stabilizing the closed conformation of ErbB2 to prevent any interaction with a possible partner. The second option presents several advantages. ErbB2 RTK is a key regulator leading to multiple intracellular signaling pathways. Drugs that block or attenuate RTK activity by targeting its extracellular epitope would reduce the possibility of resistance involving parallel bypass signaling pathways. Second, targeting ErbB2 could produce a pan-mucin inhibition that would avoid a shift from one mucin to another (redundancy), as in pancreatic adenocarcinoma in which both MUC4 and MUC13 are overexpressed. Finally, inhibition of the TM mucin–ErbB2 complex will only lower the oncogenicity of ErbB2 and not abolish it totally, as ErbB2 should still be able to heterodimerize with other ErbB domains. Only the overaggressiveness of the adjunction of mucins with ErbB2 would be suppressed. This strategy should induce less stress in the cancer cells and presumably reduce the possibility of the occurrence of resistance. Indeed, therapies targeting ErbB2 met many resistance mechanisms despite good therapeutic results, often with the emergence of bypass signaling pathways or target alterations.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> In this regard, targeting mucins would only eliminate the detrimental effect of the overexpression of the mucins without altering the normal functionality of ErbB2 or other RTK domains. Moreover, this strategy may allow the use of ErbB2-targeted therapy with a synergistic outcome.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">V.D.  Concluding Remarks: Just the Tip of the Iceberg</h3><div class="NLM_p">This review has identified the EGF–SEA–EGF module as a common module shared among a class of TM mucins. Moreover, this module was also found in a protein from sea urchin. It was also found in two proteins from <i>Caenorhabditis elegans</i>, MUP4 and Mua3. Two <i>Drosophila</i> homologues were also identified. In humans, several possible homologues could also be found, some with the full motif, like HEG1 or UROL, and some with only a SEA–EGF module. Among those, one (NGC) is already characterized to bind ErbB3, and another, HEG1, is potentially a partner of ErbB2. A rootless tree built with these modules shows strong evidence of an evolutionary link among all of these proteins (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Phylogenetic relationship of Ct regions of several proteins from humans and invertebrates with EGF–SEA–EGF or SEA–EGF modules. Alignment was performed with the ClustalO algorithm, adding to the previously studied mucins, several human proteins all having EGF domains listed as potential ligands and having in addition a SEA domain (uromudulin-like, UROL1 and UROL2; chondroitin sulfate proteoglycan 5, NGC; interphotoreceptor matrix proteoglycans 1 and 2, IMPG1 and IMPG2, respectively; heart development protein with EGF-like domains 1, HEG1), two proteins of <i>Drosophila megalonaster</i> (muc-like1 and muc-like2), two proteins of <i>C. elegans</i> (Mua3 and MUP4), and a sea urchin protein (63sp). A rootless maximum likelihood tree was constructed from this alignment using MegaX. As expected, human proteins are separated from invertebrate proteins and appear to be linked. HEG1 appears to be strongly related to MUC13 and more closely related to invertebrate proteins than to other mucins of its family, enforcing its ancestral characteristic. From this tree, an outer group is composed of MEP and NGC, in which no SEA domain can be found.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A systematic alignment of EGF ligands and EGF domains associated with SEA from invertebrate or human proteins showed a common feature. The soluble ligands clustered with the EGF juxtamembrane domain (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">Figure S9</a>). This clustering exists from invertebrates to humans, despite differences in the clade or numbers of receptor/ligand couples. It raises the hypothesis that the soluble EGF could be more recent than the TM mucins with the EGF–SEA–EGF module. The partnership between TM mucins and ErbB could be then an ancestral feature and now be frequent and represent a complete set of modulators for ErbB/RTK signaling. This could be a whole shadow pathway of transient signaling, potentially responsible for some resistance phenomena with cancer therapies.</div><div class="NLM_p last">In summary, we have identified a new subfamily of TM mucins containing EGF and SEA domains potentially sharing common structure–function relationships. This subfamily of SEA- and EGF-containing TM mucins (SEA–EGF TM mucins) demonstrated its capacity to be a membrane partner of the ErbB receptor, in particular with ErbB2, which has yet to have an identified ligand. Interest in targeting the SEA–EGF TM mucin–ErbB complex has already been partially demonstrated for MUC4 and MUC13 with ErbB2. Here, we present several strategies for targeting SEA–EGF TM mucin–ErbB complexes in cancer that should lead to a major breakthrough in the future.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02001" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02001?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02001</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Multiple-sequence alignments of EGF domains, SEA domains, and combined EGF and SEA domains and resultant phylogenic trees (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf">jm9b02001_si_001.pdf (4.1 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02001" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Lebègue</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm CHU Lille,
UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences
et Cancer, F-59000 Lille, France</span>; 
    <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille,
UMR-S 1172-LiNC-Lille Neuroscience & Cognition, F-59000 Lille, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4245-2833" title="Orcid link">http://orcid.org/0000-0003-4245-2833</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3c52555f53505d4f1250595e595b49597c4952554a115055505059125a4e"><span class="__cf_email__" data-cfemail="d5bbbcb6bab9b4a6fbb9b0b7b0b2a0b095a0bbbca3f8b9bcb9b9b0fbb3a7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maxime Liberelle</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm CHU Lille,
UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences
et Cancer, F-59000 Lille, France</span>; 
    <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille,
UMR-S 1172-LiNC-Lille Neuroscience & Cognition, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Jonckheere</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm CHU Lille,
UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences
et Cancer, F-59000 Lille, France</span>; 
    <span class="hlFld-Affiliation affiliation">Univ.
Lille, CNRS, Inserm, CHU
Lille, UMR9020-UMR-S 1277-Canther-Cancer Heterogeneity, Plasticity
and Resistance to Therapies, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia Melnyk</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm CHU Lille,
UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences
et Cancer, F-59000 Lille, France</span>; 
    <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm, CHU Lille,
UMR-S 1172-LiNC-Lille Neuroscience & Cognition, F-59000 Lille, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isabelle Van Seuningen</span> - <span class="hlFld-Affiliation affiliation">Univ.
Lille, Inserm CHU Lille,
UMR-S1172-JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences
et Cancer, F-59000 Lille, France</span>; 
    <span class="hlFld-Affiliation affiliation">Univ.
Lille, CNRS, Inserm, CHU
Lille, UMR9020-UMR-S 1277-Canther-Cancer Heterogeneity, Plasticity
and Resistance to Therapies, F-59000 Lille, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>M.L. conceived and designed the work. M.L., N.L., and I.V.S. wrote and edited the paper. All authors have revised and given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55844" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55844" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Maxime Liberelle</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=BIO-d7e1189-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Maxime Liberelle</b> earned his Master’s degree in drug design and discovery from the University of Lille in 2015. He obtained his Ph.D. in structural biochemistry (2019) under the supervision of Pr. N. Lebègue at the University of Lille in the Jean-Pierre Aubert Research Center (JPArc, Inserm UMR-S1172). His Ph.D. research focused on the characterization, structure–function relationships, and therapeutic targeting of the MUC4–ErbB2 oncogenic complex. He joined the medicinal chemistry research group (CMFA) of the Louvain Drug Research Institute (LDRI, Brussels, Belgium) in a postdoctoral position under the supervision of Pr. R. Frédérick. His research topic focuses on the protein–protein interaction field, from characterization to targeting.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Nicolas Jonckheere</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=BIO-d7e1194-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nicolas Jonckheere</b> is an Inserm researcher at CANcer Heterogeneity, Plasticity and Resistance to THERapies (CANTHER, UMR9020 CNRS UMR-S1277 Inserm), earned his Ph.D. in MUC4 transcriptional regulation at the University of Lille (2004), conducted research at the University California (Irvine, CA), and was recruited as a tenure researcher at Inserm UMR-S1172/JPARC. He is a molecular and cellular biologist who has worked on mucins for 20 years and is particularly interested in the membrane-bound O-glycoprotein MUC4 in pancreatic cancer. The research of his team aims to understand the roles of MUC4 membrane-bound mucin and its partner, the oncogenic receptor ErbB2, and the underlying cellular mechanisms (cell signaling and miRNA). The group is using a threefold (in vitro, in vivo, and ex vivo) approach to decipher their roles in the initiation of pancreatic carcinogenesis and in the resistance to chemotherapy.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Patricia Melnyk</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=BIO-d7e1199-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Patricia Melnyk</b> earned her degree in chemical engineering from Chimie ParisTech and a Ph.D. in organic chemistry from Paris 6 University. After two postdoctoral positions, she became Project Manager and then Combinatorial Chemistry Group Leader (Cerep, France). She is Professor of Chemistry (Faculty of Pharmacy, University of Lille) and heads the “Brain Biology and Chemistry” team in the Lille Neuroscience & Cognition Research Center (Inserm UMR-S1172). Her major research interests focus on medicinal chemistry in the area of neurodegenerative diseases and cancer. She has published more than 80 articles and presented at more than 100 conferences. She has been a co-inventor on 12 international patents. She is at the origin of the discovery of AZP2006, a drug candidate in clinical phase II trials, and co-founded AlzProtect Co.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Isabelle Van Seuningen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=BIO-d7e1204-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Isabelle Van Seuningen</b> is an expert on epithelial mucins in human pathophysiology, especially in cancers and inflammatory diseases. She started her career by studying the protease–antiprotease balance in the respiratory tract before dedicating most of her research to mucins. She has extensively worked on transcriptional and epigenetic regulation of human and mouse mucin genes in cancer and inflammatory diseases of both the respiratory and intestinal tracts. She is also known for her extensive work on the human MUC4 mucin that was discovered in the Lille laboratory beginning of the 1990s. She is part of the French national panel of experts for pancreatic cancer. She is currently the director of the Canther laboratory that is studying the heterogeneity, plasticity, and resistance of cancers to therapies.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Nicolas Lebègue</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=BIO-d7e1209-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Nicolas Lebègue</b> obtained his Master’s degree in organic and macromolecular chemistry at the University of Lille, followed by a Ph.D. in medicinal chemistry at the Faculty of Pharmacy of the University of Lille. He has more than 20 years of expertise in drug discovery and held the position of Principal Research Investigator in the development of new antimitotics and PPAR ligands in collaboration with Servier Laboratories (Paris, France). Currently, he is a Professor of Medicinal Chemistry, and his research focuses on two main fields: (1) deciphering the mechanisms and quantifying the binding affinities of PPIs involved in cancer and neurodegenerative diseases and (2) structure-based design and synthesis of small-molecule protein–protein interaction modulators.</p></figure></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">63sp</td><td class="NLM_def"><p class="first last">63 kDa sperm urchin membrane protein</p></td></tr><tr><td class="NLM_term">aa</td><td class="NLM_def"><p class="first last">amino acid</p></td></tr><tr><td class="NLM_term">Ct</td><td class="NLM_def"><p class="first last">C-terminal</p></td></tr><tr><td class="NLM_term">EGF</td><td class="NLM_def"><p class="first last">epidermal growth factor</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">HEG1</td><td class="NLM_def"><p class="first last">heart development protein with EGF-like domains 1</p></td></tr><tr><td class="NLM_term">HSPG2</td><td class="NLM_def"><p class="first last">heparan sulfate proteoglycan 2</p></td></tr><tr><td class="NLM_term">ID</td><td class="NLM_def"><p class="first last">intermediate domain</p></td></tr><tr><td class="NLM_term">IMPG</td><td class="NLM_def"><p class="first last">interphotoreceptor matrix proteoglycan</p></td></tr><tr><td class="NLM_term">MEP</td><td class="NLM_def"><p class="first last">Meprin A subunit</p></td></tr><tr><td class="NLM_term">NGC</td><td class="NLM_def"><p class="first last">chondroitin sulfate proteoglycan 5</p></td></tr><tr><td class="NLM_term">Neu</td><td class="NLM_def"><p class="first last">neuregulin</p></td></tr><tr><td class="NLM_term">Nt</td><td class="NLM_def"><p class="first last">N-terminal</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">RTK</td><td class="NLM_def"><p class="first last">receptor tyrosine kinase</p></td></tr><tr><td class="NLM_term">SEA</td><td class="NLM_def"><p class="first last">sperm protein, enterokinase, and agrin</p></td></tr><tr><td class="NLM_term">TM</td><td class="NLM_def"><p class="first last">transmembrane</p></td></tr><tr><td class="NLM_term">UROL</td><td class="NLM_def"><p class="first last">uromudulin-like</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 100 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker-Nasir, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoessli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakoori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasir ud, D.</span></span> <span> </span><span class="NLM_article-title">Mucin Glycoproteins</span>. <i>Proc. Pak. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=205-232&author=E.+Walker-Nasirauthor=I.+Ahmadauthor=D.+Hoessliauthor=A.+Shakooriauthor=D.+Nasir+ud&title=Mucin+Glycoproteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin glycoproteins</span></div><div class="casAuthors">Walker-Nasir, Evelyne; Ahmad, Ishtiaq; Hoessli, Daniel C.; Shakoori, A. R.; Nasir-ud-Din</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Pakistan Academy of Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-232</span>CODEN:
                <span class="NLM_cas:coden">PKSPAW</span>;
        ISSN:<span class="NLM_cas:issn">0377-2969</span>.
    
            (<span class="NLM_cas:orgname">Pakistan Academy of Sciences</span>)
        </div><div class="casAbstract">A review discusses mucin glycoproteins, their classification, phys. and biochem. properties, gene expression and regulation, biosynthesis, and their role in normal physiol. and in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVI5zO0W0I2rVg90H21EOLACvtfcHk0lhSy_hurepFvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFyntw%253D%253D&md5=9a9d79271e467ab275eefd0c1da000f5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker-Nasir%26aufirst%3DE.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DHoessli%26aufirst%3DD.%26aulast%3DShakoori%26aufirst%3DA.%26aulast%3DNasir%2Bud%26aufirst%3DD.%26atitle%3DMucin%2520Glycoproteins%26jtitle%3DProc.%2520Pak.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D40%26spage%3D205%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">Distinct Evolution of the Human Carcinoma-Associated Transmembrane Mucins, MUC1, MUC4 AND MUC16</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2005.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.gene.2005.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=16500040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2006&pages=28-34&author=S.+Duraisamyauthor=S.+Ramasamyauthor=S.+Kharbandaauthor=D.+Kufe&title=Distinct+Evolution+of+the+Human+Carcinoma-Associated+Transmembrane+Mucins%2C+MUC1%2C+MUC4+AND+MUC16&doi=10.1016%2Fj.gene.2005.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 and MUC16</span></div><div class="casAuthors">Duraisamy, Sekhar; Ramasamy, Selvi; Kharbanda, Surender; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28-34</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The MUC family of mucins consists of secreted and membrane-bound forms.  Overexpression of the membrane-bound family members, MUC1 (CA15-3), MUC4 and MUC16 (CA125), is found in diverse human carcinomas.  However, despite being classified in the same family, little is known about the genetic origins of the carcinoma-assocd. mucins.  The present results show that MUC1 homologs are restricted to mammalian species.  MUC1 has no sequence similarity with the other membrane-bound mucins, except for the presence of a sea urchin sperm protein-enterokinase-agrin (SEA) domain.  The results indicate that the MUC1 SEA domain originated from heparin sulfate proteoglycan of basement membrane (HSPG2; perlecan), an inducer of tumor cell growth.  MUC4 has no SEA domain, but does have (i) a NIDO domain that evolved from an ancestor common to nidogen, and (ii) AMOP and VWD domains that originated from an ancestor common to the Sushi-domain contg. protein.  MUC16 contains multiple SEA domains that are found in a chicken gene and were subsequently repeated through duplication events.  The SEA domains in MUC16 appear to have evolved from agrin before the divergence of birds and mammals.  These findings indicate that MUC1, MUC4 and MUC16 evolved from distinct ancestors and that the membrane-bound mucins consist of different subgroups based on their genetic backgrounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDizS-jtQ-fbVg90H21EOLACvtfcHk0lhSy_hurepFvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaqu7w%253D&md5=61372ada19695f06903e5eb795e762a0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2005.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2005.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DDistinct%2520Evolution%2520of%2520the%2520Human%2520Carcinoma-Associated%2520Transmembrane%2520Mucins%252C%2520MUC1%252C%2520MUC4%2520AND%2520MUC16%26jtitle%3DGene%26date%3D2006%26volume%3D373%26spage%3D28%26epage%3D34%26doi%3D10.1016%2Fj.gene.2005.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corfield, A. P.</span></span> <span> </span><span class="NLM_article-title">Mucins: a Biologically Relevant Glycan Barrier in Mucosal Protection</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1850</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.bbagen.2014.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24821013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOltbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1850&publication_year=2015&pages=236-252&author=A.+P.+Corfield&title=Mucins%3A+a+Biologically+Relevant+Glycan+Barrier+in+Mucosal+Protection&doi=10.1016%2Fj.bbagen.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins: A biologically relevant glycan barrier in mucosal protection</span></div><div class="casAuthors">Corfield, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1850</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">236-252</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mucins found as components of mucus gel layers at mucosal surfaces throughout the body play roles in protection as part of the defensive barrier on an organ and tissue specific basis.  The human MUC gene family codes up to 20 known proteins, which can be divided into secreted and membrane-assocd. forms each with a typical protein domain structure.  The secreted mucins are adapted to cross link in order to allow formation of the extended mucin networks found in the secreted mucus gels.  The membrane-assocd. mucins possess membrane specific domains which enable their various biol. functions as part of the glycocalyx.  All mucins are highly O-glycosylated and this is tissue specific and linked with specific biol. functions at these locations.  Mucin biol. is dynamic and the processes of degrdn. and turnover are well integrated with biosynthesis to maintain a continuous mucosal protection against all external aggressive forces.  Interaction of mucins with microflora plays an important role in normal function.  Mucins are modified in a variety of diseases and this may be due to abberant mucin peptide or glycosylation.  Mucins represent a family of glycoprotein having fundamental roles in mucosal protection and communication with external environment.  The review emphasizes the nature of mucins as glycoproteins and their role in presenting an array of glycan structures at the mucosal cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-E-3BmX8E3bVg90H21EOLACvtfcHk0li2wmTLbBqqEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOltbzL&md5=c30f2b809562ef2945cb3e3a13a72b1c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DCorfield%26aufirst%3DA.%2BP.%26atitle%3DMucins%253A%2520a%2520Biologically%2520Relevant%2520Glycan%2520Barrier%2520in%2520Mucosal%2520Protection%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2015%26volume%3D1850%26spage%3D236%26epage%3D252%26doi%3D10.1016%2Fj.bbagen.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, B. J.</span></span> <span> </span><span class="NLM_article-title">Mucins in Cancer: Protection and Control of the Cell Surface</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1038/nrc1251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fnrc1251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=14681689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVGnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=45-60&author=M.+A.+Hollingsworthauthor=B.+J.+Swanson&title=Mucins+in+Cancer%3A+Protection+and+Control+of+the+Cell+Surface&doi=10.1038%2Fnrc1251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins in cancer: protection and control of the cell surface</span></div><div class="casAuthors">Hollingsworth, Michael A.; Swanson, Benjamin J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-60</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mucins - large extracellular proteins that are heavily glycosylated with complex oligosaccharides - establish a selective mol. barrier at the epithelial surface and engage in morphogenetic signal transduction.  Alterations in mucin expression or glycosylation accompany the development of cancer and influence cellular growth, differentiation, transformation, adhesion, invasion and immune surveillance.  Mucins are used as diagnostic markers in cancer, and are under investigation as therapeutic targets for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCTyd5l3B-TLVg90H21EOLACvtfcHk0li2wmTLbBqqEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVGnu7w%253D&md5=26a6f24250cb21c6cd2a707c3b9f9790</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1251%26sid%3Dliteratum%253Aachs%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DSwanson%26aufirst%3DB.%2BJ.%26atitle%3DMucins%2520in%2520Cancer%253A%2520Protection%2520and%2520Control%2520of%2520the%2520Cell%2520Surface%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D45%26epage%3D60%26doi%3D10.1038%2Fnrc1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisine, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niehans, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toribara, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. B.</span></span> <span> </span><span class="NLM_article-title">The MUC6 Secretory Mucin Gene is Expressed in a Wide Variety ofEpithelial Tissues</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-9896(199812)186:4<398::AID-PATH192>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10209489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVyisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=1998&pages=398-405&author=A.+E.+Bartmanauthor=M.+P.+Buisineauthor=J.+P.+Aubertauthor=G.+A.+Niehansauthor=N.+W.+Toribaraauthor=Y.+S.+Kimauthor=E.+J.+Kellyauthor=J.+E.+Crabtreeauthor=S.+B.+Ho&title=The+MUC6+Secretory+Mucin+Gene+is+Expressed+in+a+Wide+Variety+ofEpithelial+Tissues&doi=10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues</span></div><div class="casAuthors">Bartman, Allen E.; Buisine, Marie-Pierre; Aubert, Jean-Pierre; Niehans, Gloria A.; Toribara, Neil W.; Kim, Young S.; Kelly, Eric J.; Crabtree, Jean E.; Ho, Samuel B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">398-405</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Secretory mucins play an important role in the cytoprotection of epithelial surfaces and are used as tumor markers in a variety of cancers.  The MUC6 secretory mucin was originally isolated from a gastric cDNA library.  The aim was to det. the specific type and location of MUC6 mucin gene expression in a wide range of human adult and fetal epithelial tissues.  In situ hybridization, RNA anal., and immunohistochem. were used to quantify and localize mucin gene expression.  The data obtained show that MUC6 is highly expressed in gastric mucosa, duodenal Brunner's glands, gall bladder, seminal vesicle, pancreatic centroacinar cells and ducts, and periductal glands of the common bile duct; focal expression is seen in basal endometrial and endocervical glands.  MUC6 epitopes were also highly expressed in 7/10 pancreatic cancers and 7/10 cholangiocarcinomas and focally expressed in 4/10 endocervical adenocarcinomas.  Expression of MUC6 occurs early in fetal development and was obsd. in Brunner's glands and pancreatic ducts at 18-19 wk and in gastric glands at 20 wk' gestation.  The tissue distribution of the MUC6 secretory mucin indicates that it may function to protect epithelial tissues from a wide range of substances.  Expression of MUC6 is frequently preserved in pancreatic and bile duct adenocarcinomas, but it is only sparsely expressed in endocervical carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMb7P2h1Yt87Vg90H21EOLACvtfcHk0li2wmTLbBqqEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVyisg%253D%253D&md5=a4a42b210261a58f91de2d5332ae43ae</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9896%2528199812%2529186%253A4%253C398%253A%253AAID-PATH192%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBartman%26aufirst%3DA.%2BE.%26aulast%3DBuisine%26aufirst%3DM.%2BP.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26aulast%3DNiehans%26aufirst%3DG.%2BA.%26aulast%3DToribara%26aufirst%3DN.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKelly%26aufirst%3DE.%2BJ.%26aulast%3DCrabtree%26aufirst%3DJ.%2BE.%26aulast%3DHo%26aufirst%3DS.%2BB.%26atitle%3DThe%2520MUC6%2520Secretory%2520Mucin%2520Gene%2520is%2520Expressed%2520in%2520a%2520Wide%2520Variety%2520ofEpithelial%2520Tissues%26jtitle%3DJ.%2520Pathol.%26date%3D1998%26volume%3D186%26spage%3D398%26epage%3D405%26doi%3D10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">Intestinal Mucins in Health and Disease</span>. <i>Digestion</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1159/000198115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1159%2F000198115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=234-263&author=J.+F.+Forstner&title=Intestinal+Mucins+in+Health+and+Disease&doi=10.1159%2F000198115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000198115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000198115%26sid%3Dliteratum%253Aachs%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DIntestinal%2520Mucins%2520in%2520Health%2520and%2520Disease%26jtitle%3DDigestion%26date%3D2004%26volume%3D17%26spage%3D234%26epage%3D263%26doi%3D10.1159%2F000198115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Putten, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strijbis, K.</span></span> <span> </span><span class="NLM_article-title">Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer</span>. <i>J. Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1159/000453594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1159%2F000453594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28052300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFeisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=281-299&author=J.+P.+M.+van%0APuttenauthor=K.+Strijbis&title=Transmembrane+Mucins%3A+Signaling+Receptors+at+the+Intersection+of+Inflammation+and+Cancer&doi=10.1159%2F000453594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer</span></div><div class="casAuthors">van Putten, Jos P. M.; Strijbis, Karin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Innate Immunity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-299</span>CODEN:
                <span class="NLM_cas:coden">JIIOB2</span>;
        ISSN:<span class="NLM_cas:issn">1662-811X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Mucosal surfaces line our body cavities and provide the interaction surface between commensal and pathogenic microbiota and the host.  The barrier function of the mucosal layer is largely maintained by gel-forming mucin proteins that are secreted by goblet cells.  In addn., mucosal epithelial cells express cell-bound mucins that have both barrier and signaling functions.  The family of transmembrane mucins consists of diverse members that share a few characteristics.  The highly glycosylated extracellular mucin domains inhibit invasion by pathogenic bacteria and can form a tight mesh structure that protects cells in harmful conditions.  The intracellular tails of transmembrane mucins can be phosphorylated and connect to signaling pathways that regulate inflammation, cell-cell interactions, differentiation, and apoptosis.  Transmembrane mucins play important roles in preventing infection at mucosal surfaces, but are also renowned for their contributions to the development, progression, and metastasis of adenocarcinomas.  In general, transmembrane mucins seem to have evolved to monitor and repair damaged epithelia, but these functions can be highjacked by cancer cells to yield a survival advantage.  This review presents an overview of the current knowledge of the functions of transmembrane mucins in inflammatory processes and carcinogenesis in order to better understand the diverse functions of these multifunctional proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppBljisk5Z6LVg90H21EOLACvtfcHk0ljQ8UsGszMLVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFeisbo%253D&md5=d38d559090bd6d2e3ef174d7f1254edf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1159%2F000453594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000453594%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BPutten%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DStrijbis%26aufirst%3DK.%26atitle%3DTransmembrane%2520Mucins%253A%2520Signaling%2520Receptors%2520at%2520the%2520Intersection%2520of%2520Inflammation%2520and%2520Cancer%26jtitle%3DJ.%2520Innate%2520Immun.%26date%3D2017%26volume%3D9%26spage%3D281%26epage%3D299%26doi%3D10.1159%2F000453594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Membrane-Bound Mucin Modular Domains: from Structure to Function</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2012.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.biochi.2012.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=23178705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslynu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2013&pages=1077-1086&author=N.+Jonckheereauthor=N.+Skrypekauthor=F.+Frenoisauthor=I.+Van+Seuningen&title=Membrane-Bound+Mucin+Modular+Domains%3A+from+Structure+to+Function&doi=10.1016%2Fj.biochi.2012.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-bound mucin modular domains: From structure to function</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Frenois, Frederic; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1077-1086</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Mucins belong to a heterogeneous family of large O-glycoproteins composed of a long peptidic chain called apomucin on which are linked hundreds of oligosaccharidic chains.  Among mucins, membrane-bound mucins are modular proteins and have a structural organization usually contg. Pro/Thr/Ser-rich O-glycosylated domains (PTS), EGF-like and SEA domains.  Via these modular domains, the membrane-bound mucins participate in cell signaling and cell interaction with their environment in normal and pathol. conditions.  Moreover, the recent knowledge of these domains and their biol. activities led to the development of new therapeutic approaches involving mucins.  In this review, we show 3D structures of EGF and SEA domains.  We also describe the functional features of the evolutionary conserved domains of membrane-bound mucins and discuss consequences of splice events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX6h5d5eX1wrVg90H21EOLACvtfcHk0ljQ8UsGszMLVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslynu7nM&md5=8d88b659cf4fba257cd8d70bbbc40690</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2012.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2012.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DFrenois%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DMembrane-Bound%2520Mucin%2520Modular%2520Domains%253A%2520from%2520Structure%2520to%2520Function%26jtitle%3DBiochimie%26date%3D2013%26volume%3D95%26spage%3D1077%26epage%3D1086%26doi%3D10.1016%2Fj.biochi.2012.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, K.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Y.</span></span> <span> </span><span class="NLM_article-title">NIDO, AMOP and Vwd Domains of MUC4 Play Synergic Role in MUC4 Mediated Signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">10385</span>– <span class="NLM_lpage">10399</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.14420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.14420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28060749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC1c7jtVOmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=10385-10399&author=Y.+Zhuauthor=J.-J.+Zhangauthor=Y.-P.+Pengauthor=X.+Liuauthor=K.-L.+Xieauthor=J.+Tangauthor=K.-R.+Jiangauthor=W.-T.+Gaoauthor=L.+Tianauthor=K.+Zhangauthor=Z.-K.+Xuauthor=Y.+Miao&title=NIDO%2C+AMOP+and+Vwd+Domains+of+MUC4+Play+Synergic+Role+in+MUC4+Mediated+Signaling&doi=10.18632%2Foncotarget.14420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling</span></div><div class="casAuthors">Zhu Yi; Zhang Jing-Jing; Peng Yun-Peng; Liu Xian; Jiang Kui-Rong; Gao Wen-Tao; Tian Lei; Zhang Kai; Miao Yi; Zhu Yi; Zhang Jing-Jing; Peng Yun-Peng; Liu Xian; Jiang Kui-Rong; Gao Wen-Tao; Tian Lei; Zhang Kai; Miao Yi; Zhu Yi; Zhang Jing-Jing; Peng Yun-Peng; Liu Xian; Xie Kun-Ling; Tang Jie; Jiang Kui-Rong; Gao Wen-Tao; Tian Lei; Zhang Kai; Xu Ze-Kuan; Miao Yi; Xie Kun-Ling; Tang Jie</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">10385-10399</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MUC4 mucin is well known as an important potential target to overcome pancreatic cancer.  Three unique domains (NIDO, AMOP, and vWD) with unclear roles only present in MUC4 but are not found in other membrane-bound mucins.  Our previous studies first reported that its splice variant, MUC4/Y can be a model of MUC4 (MUC4 gene fragment is more than 30KB, too huge to clone and eukaryotic express) in pancreatic cancer.  More importantly, based on MUC4/Y with the appropriate length of gene sequence, it is easy to construct the unique domain-lacking models of MUC4/Y (MUC4) for research.  The present study focuses on investigation of the respective role of the unique NIDO, AMOP, and vWD domain or their synergistic effect on MUC4(MUC4/Y)-mediated functions and mechanisms by series of in vitro assays, sequence-based transcriptome analysis, validation of qRT-PCR & Western blot, and systematic comparative analysis.  Our results demonstrate: 1) NIDO, AMOP, and vWD domain or their synergy play significant roles on MUC4/Y-mediated malignant function of pancreatic cancer, downstream of molecule mechanisms, particularly MUC4/Y-triggered malignancy-related positive feedback loops, respectively. 2) The synergistic roles of three unique domains on MUC4/Y-mediated functions and mechanisms are more prominent than the respective domain because the synergy of three domain plays the more remarkable effects on MUC4/Y-mediated signaling hub.  Thus, to improve reversed effects of domain-lacking and break the synergism of domains will contribute to block MUC4/Y(MUC4) triggering various oncogenic signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRr6PjoGs2VCu2mnZh2OgS0fW6udTcc2easfGBUr8P8fLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7jtVOmug%253D%253D&md5=30def6751b6cd7fd6d22524f69f7721e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.14420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.14420%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.-J.%26aulast%3DPeng%26aufirst%3DY.-P.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DK.-L.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DK.-R.%26aulast%3DGao%26aufirst%3DW.-T.%26aulast%3DTian%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DZ.-K.%26aulast%3DMiao%26aufirst%3DY.%26atitle%3DNIDO%252C%2520AMOP%2520and%2520Vwd%2520Domains%2520of%2520MUC4%2520Play%2520Synergic%2520Role%2520in%2520MUC4%2520Mediated%2520Signaling%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D10385%26epage%3D10399%26doi%3D10.18632%2Foncotarget.14420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">Evolution of the Human MUC1 Oncoprotein</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.3892/ijo.31.3.671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.3892%2Fijo.31.3.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17671696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=671-677&author=S.+Duraisamyauthor=T.+Kufeauthor=S.+Ramasamyauthor=D.+Kufe&title=Evolution+of+the+Human+MUC1+Oncoprotein&doi=10.3892%2Fijo.31.3.671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of the human MUC1 oncoprotein</span></div><div class="casAuthors">Duraisamy, Sekhar; Kufe, Turner; Ramasamy, Selvi; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">671-677</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">The mucin (MUC) family consists of secreted and membrane-bound forms.  The transmembrane mucin 1 (MUC1) is a heterodimer that is aberrantly overexpressed by diverse human carcinomas and certain hematol. malignancies.  The MUC1 N-terminal (MUC1-N) and C-terminal (MUC1-C) subunits are generated by autocleavage within a SEA domain.  The MUC1 cytoplasmic domain (MUC 1-CD) located downstream of the SEA domain is sufficient for the induction of anchorage-independent growth and tumorigenicity; however, no information is available regarding the origin of these transforming sequences.  Previous work demonstrated that, except for the SEA domain, MUC1 has no sequence homol. with other membrane-bound mucins.  The present results demonstrate that MUC 1-CD evolved from repeat regions in the MUC5B secreted mucin.  We also show that MUC1 sequences upstream to the SEA domain emerged from MUC5B.  These findings indicate that both the MUC1-N and MUC1-C subunits evolved from secreted gel-forming mucins and that the MUC 1-CD oncogenic function emerged by diversification after evolution from MUC5B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWinU9uWTx-LVg90H21EOLACvtfcHk0li2Du-c2YQxjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnF&md5=4b59c367d8685388d60c5d576675aa55</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3892%2Fijo.31.3.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.31.3.671%26sid%3Dliteratum%253Aachs%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DT.%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DEvolution%2520of%2520the%2520Human%2520MUC1%2520Oncoprotein%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2007%26volume%3D31%26spage%3D671%26epage%3D677%26doi%3D10.3892%2Fijo.31.3.671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Mucins and Pancreatic Cancer</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1794</span>– <span class="NLM_lpage">1812</span>, <span class="refDoi"> DOI: 10.3390/cancers2041794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.3390%2Fcancers2041794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24281201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1794-1812&author=N.+Jonckheereauthor=N.+Skrypekauthor=I.+Van+Seuningen&title=Mucins+and+Pancreatic+Cancer&doi=10.3390%2Fcancers2041794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins and Pancreatic cancer</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1794-1812</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is characterized by an often dramatic outcome (five year survival <5%) related to a late diagnosis and a lack of efficient therapy.  Therefore, clinicians desperately need new biomarkers and new therapeutic tools to develop new efficient therapies.  Mucins belong to an ever increasing family of O-glycoproteins.  Secreted mucins are the main component of mucus protecting the epithelia whereas membrane-bound mucins are thought to play important biol. roles in cell-cell and cell-matrix interactions, in cell signaling and in modulating biol. properties of cancer cells.  In this review, we will focus on the altered expression pattern of mucins in pancreatic cancer, from the early neoplastic lesion Pancreatic Intraepithelial Neoplasia (PanIN) to invasive pancreatic carcinomas, and the mol. mechanisms (including genetic and epigenetic regulation) and signaling pathways known to control their expression.  Moreover, we will discuss the recent advances about the biol. of both secreted and membrane-bound mucins and their key roles in pancreatic carcinogenesis and resistance to therapy.  Finally, we will discuss exciting opportunities that mucins offer as potential therapeutic targets in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGQ7BWDwTvZrVg90H21EOLACvtfcHk0li2Du-c2YQxjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWksrnL&md5=f3e8517a154d4f38d63112fbb0584155</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fcancers2041794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers2041794%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DMucins%2520and%2520Pancreatic%2520Cancer%26jtitle%3DCancers%26date%3D2010%26volume%3D2%26spage%3D1794%26epage%3D1812%26doi%3D10.3390%2Fcancers2041794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Mucins and Tumor Resistance to Chemotherapeutic Drugs</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1846</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2014.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.bbcan.2014.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24785432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Oqsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=142-151&author=N.+Jonckheereauthor=N.+Skrypekauthor=I.+Van+Seuningen&title=Mucins+and+Tumor+Resistance+to+Chemotherapeutic+Drugs&doi=10.1016%2Fj.bbcan.2014.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins and tumor resistance to chemotherapeutic drugs</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-151</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Epithelial cancer patients not considered eligible for surgical resection frequently benefit from chemotherapy.  Chemotherapy is the treatment of cancer with one or combination of cytotoxic or cytostatic drugs.  Recent advances in chemotherapy allowed a great no. of cancer patients to receive treatment with significant results.  Unfortunately, resistance to chemotherapeutic drug treatment is a major challenge for clinicians in the majority of epithelial cancers because it is responsible for the inefficiency of therapies.  Mucins belong to a heterogeneous group of large O-glycoproteins that can be either secreted or membrane-bound.  Implications of mucins have been described in relation to cancer cell behavior and cell signaling pathways assocd. with epithelial tumorigenesis.  Because of the frequent alteration of the pattern of mucin expression in cancers as well as their structural and functional characteristics, mucins are thought to also be involved in response to therapies.  In this report, we review the roles of mucins in chemoresistance and the assocd. underlying mol. mechanisms (phys. barrier, resistance to apoptosis, drug metab., cell stemness, epithelial-mesenchymal transition) and discuss the therapeutic tools/strategies and/or prognosis biomarkers for personalized chemotherapy that could be proposed from these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0lu7CzPacrVg90H21EOLACvtfcHk0li2Du-c2YQxjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Oqsr3I&md5=982babca9b26013312bb7755fa077530</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DMucins%2520and%2520Tumor%2520Resistance%2520to%2520Chemotherapeutic%2520Drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2014%26volume%3D1846%26spage%3D142%26epage%3D151%26doi%3D10.1016%2Fj.bbcan.2014.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourgholami, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, D. L.</span></span> <span> </span><span class="NLM_article-title">MUC1 as a Potential Target in Anticancer Therapies</span>. <i>Am. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1097/COC.0b013e31828f5a07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1097%2FCOC.0b013e31828f5a07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=23608828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs12ktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2015&pages=108-118&author=K.+Pillaiauthor=M.+H.+Pourgholamiauthor=T.+C.+Chuaauthor=D.+L.+Morris&title=MUC1+as+a+Potential+Target+in+Anticancer+Therapies&doi=10.1097%2FCOC.0b013e31828f5a07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 as a Potential Target in Anticancer Therapies</span></div><div class="casAuthors">Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-118</span>CODEN:
                <span class="NLM_cas:coden">AJCODI</span>;
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">MUC1 is a glycoprotein that is overexpressed in tumor cells.  In normal cells it forms a protective layer against microbes and toxic chems., besides providing lubrication on ductal surfaces.  Oversecretion of MUC1 provide cancer cells with invasiveness, metastasis, and resistance to death induced by reactive oxygen species.  MUC1 is made up of 2 heterodimers, MUC1-N and MUC1-C.  MUC1-N is heavily glycosylated at 5 regions of the variable N-tandem repeats.  MUC1-C is divisible into extracellular, intracellular, and cytoplasmic domain (MUC1-C/CD).  The extracellular domain serves as a docking site for epidermal growth factor receptors and other receptor kinases; the transmembrane domain serves to relay messages from extracellular to MUC1-C/CD.  The MUC1-C/CD has 5 phosphorylating sites that on interacting with the SH2 domain of specific proteins can stimulate tumor growth.  Therapies targeting MUC1 consists of monoclonal antibodies (MAb), vaccines, or small mols. (aptamers).  MAb therapies are mainly aimed at MUC1-N with little success, however, new generation of MAb are being developed for MUC1-C.  Vaccines (peptide, carbohydrate, glycopeptide, DNA, and dendritic cell) have been developed that recognizes the aberrant glycosylated region of the variable N-tandem repeats in MUC1-N, whereas new generation vaccines are aimed at the cytoplasmic region of MUC1-C.  Aptamers (peptides that resemble DNA, RNA) have been used for blocking the dimerization of CQC region and the 5 phosphorylating region of MUC1-C.  In addn., aptamers have been used as cytotoxic drug carriers.  However, none of the therapies for MUC1 are currently in clin. application, as they need further refinement and evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqetDDOl6c_RLVg90H21EOLACvtfcHk0lhI8rMOx_u8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs12ktbk%253D&md5=a446f5365795baab0f3d4b6e53c99d86</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2FCOC.0b013e31828f5a07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOC.0b013e31828f5a07%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DK.%26aulast%3DPourgholami%26aufirst%3DM.%2BH.%26aulast%3DChua%26aufirst%3DT.%2BC.%26aulast%3DMorris%26aufirst%3DD.%2BL.%26atitle%3DMUC1%2520as%2520a%2520Potential%2520Target%2520in%2520Anticancer%2520Therapies%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D38%26spage%3D108%26epage%3D118%26doi%3D10.1097%2FCOC.0b013e31828f5a07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahdaoui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Targeting MUC4 in Pancreatic Cancer: miRNAs</span>. <i>Oncoscience</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.18632/oncoscience.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncoscience.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26682251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC28rivVWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=799-800&author=N.+Jonckheereauthor=F.+Lahdaouiauthor=I.+Van+Seuningen&title=Targeting+MUC4+in+Pancreatic+Cancer%3A+miRNAs&doi=10.18632%2Foncoscience.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MUC4 in pancreatic cancer: miRNAs</span></div><div class="casAuthors">Jonckheere Nicolas; Lahdaoui Fatima; Van Seuningen Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Oncoscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">799-800</span>
        ISSN:<span class="NLM_cas:issn">2331-4737</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF3fV9CLD7bEEksK8CslK8fW6udTcc2eaOSCm3kkqpf7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rivVWqtg%253D%253D&md5=d575441f9ffa3d90c4687016b59ccf46</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.18632%2Foncoscience.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncoscience.249%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DLahdaoui%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DTargeting%2520MUC4%2520in%2520Pancreatic%2520Cancer%253A%2520miRNAs%26jtitle%3DOncoscience%26date%3D2015%26volume%3D2%26spage%3D799%26epage%3D800%26doi%3D10.18632%2Foncoscience.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Setua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doxtater, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">miR-145: Revival of a Dragon in Pancreatic Cancer</span>. <i>J. Nat. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28616589" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&author=S.+Setuaauthor=S.+hanauthor=K.+Doxtaterauthor=M.+M.+Yallapuauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=miR-145%3A+Revival+of+a+Dragon+in+Pancreatic+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetua%26aufirst%3DS.%26aulast%3Dhan%26aufirst%3DS.%26aulast%3DDoxtater%26aufirst%3DK.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DmiR-145%253A%2520Revival%2520of%2520a%2520Dragon%2520in%2520Pancreatic%2520Cancer%26jtitle%3DJ.%2520Nat.%2520Sci.%26date%3D2017%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olayioye, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, N. E.</span></span> <span> </span><span class="NLM_article-title">The ErbB Signaling Network: Receptor Heterodimerization in Development and Cancer</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3159</span>– <span class="NLM_lpage">3167</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.13.3159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1093%2Femboj%2F19.13.3159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10880430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1ajtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=3159-3167&author=M.+A.+Olayioyeauthor=R.+M.+Neveauthor=H.+A.+Laneauthor=N.+E.+Hynes&title=The+ErbB+Signaling+Network%3A+Receptor+Heterodimerization+in+Development+and+Cancer&doi=10.1093%2Femboj%2F19.13.3159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The ErbB signaling network: receptor heterodimerization in development and cancer</span></div><div class="casAuthors">Olayioye, Monilola A.; Neve, Richard M.; Lane, Heidi A.; Hynes, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3159-3167</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review, with ∼126 refs., on individual ErbB receptors and their signaling pot. and examples of specific ErbB heterodimers in signaling and development.  The authors particular emphasis is on their role in mammary gland biol. , an organ in which the ErbB family and its ligands are critically involved in development, differentiation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr03qEN815kibVg90H21EOLACvtfcHk0lhI8rMOx_u8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1ajtLY%253D&md5=3e70478dda68f1cfd5ab5bdb910e96a2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.13.3159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.13.3159%26sid%3Dliteratum%253Aachs%26aulast%3DOlayioye%26aufirst%3DM.%2BA.%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DHynes%26aufirst%3DN.%2BE.%26atitle%3DThe%2520ErbB%2520Signaling%2520Network%253A%2520Receptor%2520Heterodimerization%2520in%2520Development%2520and%2520Cancer%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26spage%3D3159%26epage%3D3167%26doi%3D10.1093%2Femboj%2F19.13.3159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymkowski, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">MUC17, a Novel Membrane-Tethered Mucin</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2002.6475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1006%2Fbbrc.2002.6475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11855812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlGmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2002&pages=466-475&author=J.+R.+Gumauthor=S.+C.+Crawleyauthor=J.+W.+Hicksauthor=D.+E.+Szymkowskiauthor=Y.+S.+Kim&title=MUC17%2C+a+Novel+Membrane-Tethered+Mucin&doi=10.1006%2Fbbrc.2002.6475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MUC17, a Novel Membrane-Tethered Mucin</span></div><div class="casAuthors">Gum, James R., Jr.; Crawley, Suzanne C.; Hicks, James W.; Szymkowski, David E.; Kim, Young S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-475</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Membrane mucins have several functions in epithelial cells including cytoprotection, extravasation during metastases, maintenance of luminal structure, and signal transduction.  In this paper we describe a large membrane mucin expressed in the normal intestine.  This novel mucin, designated MUC17, contains an extended, repetitive extracellular glycosylation domain and a carboxyl terminus with two EGF-like domains, a SEA module domain, a transmembrane domain, and a cytoplasmic domain with potential serine and tyrosine phosphorylation sites.  RNA blot anal. and in situ hybridization indicates that MUC17 is expressed in select pancreatic and colon cancer cell lines and in intestinal absorptive cells.  Radiation hybrid mapping localized MUC17 to chromosome 7q22 where it resides in close proximity with three other membrane mucin genes, MUC3A, MUC3B, and MUC12.  Thus, these membrane mucins reside together in a gene cluster, but are expressed in different tissues and are likely to have different functions as well.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBHXjqsqOkKLVg90H21EOLACvtfcHk0lgScOKzJIf_0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlGmtLw%253D&md5=27d9ff1bee3f4e22da2bec5420c05576</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2002.6475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2002.6475%26sid%3Dliteratum%253Aachs%26aulast%3DGum%26aufirst%3DJ.%2BR.%26aulast%3DCrawley%26aufirst%3DS.%2BC.%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DSzymkowski%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DMUC17%252C%2520a%2520Novel%2520Membrane-Tethered%2520Mucin%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D291%26spage%3D466%26epage%3D475%26doi%3D10.1006%2Fbbrc.2002.6475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">Structural Organization and Classification of the Human Mucin Genes</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">D1192</span>– <span class="NLM_lpage">D1206</span>, <span class="refDoi"> DOI: 10.2741/Moniaux</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.2741%2FMoniaux" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11578969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFCgt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=D1192-D1206&author=N.+Moniauxauthor=F.+Escandeauthor=N.+Porchetauthor=J.+P.+Aubertauthor=S.+K.+Batra&title=Structural+Organization+and+Classification+of+the+Human+Mucin+Genes&doi=10.2741%2FMoniaux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural organization and classification of the human mucin genes</span></div><div class="casAuthors">Moniaux, Nicolas; Escande, Fabienne; Porcher, Nicole; Aubert, Jean-Pierre; Batra, Surinder K.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience [online computer file]</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">D1192-D1206</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review with refs.  The cells of living organisms in contact with the external environment are const. attacked by different kinds of substances such as micro-organisms, toxins, and pollutants.  With evolution, defense mechanisms, such as the secretion of mucus has been developed.  Mucins are the main components of mucus.  They are synthesized and secreted by specialized cells of the epithelium and in some case, by non mucin-secreting cells.  Little was known about the structure of mucins until a decade ago.  This is principally due to heavy glycosylation of mucins, which complicated their anal.  With the application of mol. biol. methods, structures of the mucin core peptides (apomucins) are beginning to be elucidated.  A total of eleven human mucin (MUC) genes have been identified and numbered in chronol. order of their description: MUC1-4, MUC5Ac, MUC5B, MUC6-8, and MUC11-12.  Of these, the complete cDNA sequence are published only for six mucins MUC1, MUC2, MUC4, MUC5B, MUC5AC, and MUC7.  Human mucin genes, in general, show three common features: (I) a nucleotide tandem repeat domain; (II) a predicted peptide domain contg. a high percentage of serines and threonines; (III) complex RNA expression.  The tandem repeats in mucins make up the majority of the backbone.  Related to their structure, mucins can be classified in three distinct subfamilies: gel-forming, sol., and membrane-bound.  Each member from one family possesses common characteristics and probably specific functions.  For a long time, they were thought to have the unique function of protecting and lubricating the epithelial surfaces.  The study of the mucins structure as well as the relationship between structure and function show that mucins also possess other important functions, such as growth, direct implication in the fetal development, the epithelial renewal and differentiation, the epithelial integrity, carcinogenesis, and metastasis.  This review presents the actual knowledge of the mucins structure and the best-characterized function related to their structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7aAAizjakLVg90H21EOLACvtfcHk0lgScOKzJIf_0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFCgt7o%253D&md5=9e384d8b1d380e1a32c5f390bd9eda73</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2741%2FMoniaux&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252FMoniaux%26sid%3Dliteratum%253Aachs%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DEscande%26aufirst%3DF.%26aulast%3DPorchet%26aufirst%3DN.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DStructural%2520Organization%2520and%2520Classification%2520of%2520the%2520Human%2520Mucin%2520Genes%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2001%26volume%3D6%26spage%3DD1192%26epage%3DD1206%26doi%3D10.2741%2FMoniaux" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Packer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuckin, M. A.</span></span> <span> </span><span class="NLM_article-title">Expression of the Cell Surface Mucin Gene Family in Adenocarcinomas</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15375564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1119-1126&author=L.+M.+Packerauthor=S.+J.+Williamsauthor=S.+Callaghanauthor=D.+C.+Gotleyauthor=M.+A.+McGuckin&title=Expression+of+the+Cell+Surface+Mucin+Gene+Family+in+Adenocarcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the cell surface mucin gene family in adenocarcinomas</span></div><div class="casAuthors">Packer, Leisl M.; Williams, Stephanie J.; Callaghan, Shirley; Gotley, David C.; McGuckin, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1119-1126</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Cell surface mucins are complex glycoproteins expressed on the apical membrane surface of mucosal epithelial cells.  In malignant epithelial cells they are thought to influence cell adhesion, and are clin. targets for tumor immunotherapy and serum tumor marker assays.  The authors have compared expression of MUC1, MUC3, MUC4, MUC11, MUC12 and MUC13 mRNA in epithelial cancers and/or cell lines with non-malignant tissues.  In non-malignant tissues, MUC3, 4, 11, 12 and 13 were expressed at highest levels in gastrointestinal tissues, whereas MUC1 was more widely distributed.  Significant down-regulation of the MUC4, MUC12 and MUC13 genes was obsd. in colonic cancers compared with normal tissue, whereas MUC1 was upregulated.  In rectal cancers, levels of all 6 mucin genes were not significantly different to those in normal rectal tissues.  Both MUC1 and MUC4 were down-regulated in gastric cancers, whereas cancer and normal tissue levels were similar for MUC3, 11, 12 and 13.  In esophageal cancers there was a general trend toward higher levels than in normal tissue for MUC1, 3, 12 and 13.  In ovarian cancers MUC1 levels were very high, whereas only low levels of all other mucins were obsd.  The authors also report expression in renal cell carcinomas, bladder carcinomas and breast cancer cell lines.  The reported expression profiles of the cell surface mucin gene family will help direct biol. and clin. studies of these mols. in mucosal biol., and in malignant and inflammatory diseases of epithelial tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVTdk2bWbNbVg90H21EOLACvtfcHk0lgScOKzJIf_0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFWkt74%253D&md5=c7a30eafb15cf99a660901824b0237d9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DL.%2BM.%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DCallaghan%26aufirst%3DS.%26aulast%3DGotley%26aufirst%3DD.%2BC.%26aulast%3DMcGuckin%26aufirst%3DM.%2BA.%26atitle%3DExpression%2520of%2520the%2520Cell%2520Surface%2520Mucin%2520Gene%2520Family%2520in%2520Adenocarcinomas%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2004%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuckin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyre, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antalis, T. M.</span></span> <span> </span><span class="NLM_article-title">Two Novel Mucin Genes Down-Regulated in Colorectal Cancer Identified by Differential Display</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4083</span>– <span class="NLM_lpage">4089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10463611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4083-4089&author=S.+J.+Williamsauthor=M.+A.+McGuckinauthor=D.+C.+Gotleyauthor=H.+J.+Eyreauthor=G.+R.+Sutherlandauthor=T.+M.+Antalis&title=Two+Novel+Mucin+Genes+Down-Regulated+in+Colorectal+Cancer+Identified+by+Differential+Display"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel mucin genes down-regulated in colorectal cancer identified by differential display</span></div><div class="casAuthors">Williams, Stephanie J.; McGuckin, Michael A.; Gotley, David C.; Eyre, Helen J.; Sutherland, Grant R.; Antalis, Toni M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4083-4089</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Epithelial mucins are large, secreted and cell surface glycoproteins involved in epithelial cell protection, adhesion modulation, and signaling.  Using differential display, the authors have identified two novel mucin cDNAs (dd34 and dd29), hereafter designated MUC11 and MUC12, resp., that are down-regulated in colorectal cancers.  Northern blots demonstrated polydisperse signals characteristic of mucin transcripts in RNA from normal colon that were absent in colorectal cancer.  Both cDNAs were mapped by fluorescence in situ hybridization to chromosome band 7q22, the location of the MUC3 mucin gene, thus suggesting that there may be a cluster of mucin genes at this locus.  The sequences of both differential display clones were extended by a combination of screening libraries and PCR.  The 2.8-kb MUC11 cDNA composite encoded 35 serine/threonine-rich, mucin-like degenerate 28 amino acid tandem repeats.  The MUC12 cDNA composite encoded a putative transmembrane mucin contg. two extracellular cysteine-rich, EGF-like domains, a coiled-coil region, and a mucin-like domain consisting of 28 amino acid degenerate tandem repeats.  Distinct patterns of expression of MUC11, MUC12, and MUC3 mRNAs were obsd. in a range of normal human tissues.  MUC12 mRNA was not expressed in any of six colorectal cancer cell lines examd. and was down-regulated or absent in 6 of 15 (40%) tumors compared with matched normal colonic tissue.  In contrast, MUC11 showed a different pattern of mRNA expression, with four of these lines showing low levels and the other two lines showing relatively high levels of MUC11 transcripts.  Expression of MUC11 was down-regulated in the tumors of 12 of 15 (80%) paired samples.  Structural homol. of MUC12 with rat, mouse, and human MUC3 and human and rat MUC4/ASGP2 indicate that there is a distinct subfamily of transmembrane mucins with conserved epidermal growth factor domains.  The homol. of MUC12 with epidermal growth factor-like growth factors and its down-regulation in colorectal cancers, together with known interactions between rat MUC4 and c-erbB-2 growth factor receptors, suggests that MUC12 may be involved in epithelial cell growth regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-kQoBC9zYYrVg90H21EOLACvtfcHk0lgScOKzJIf_0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOlurw%253D&md5=9ed3c916d0e3741b066bbe43a438ce96</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DMcGuckin%26aufirst%3DM.%2BA.%26aulast%3DGotley%26aufirst%3DD.%2BC.%26aulast%3DEyre%26aufirst%3DH.%2BJ.%26aulast%3DSutherland%26aufirst%3DG.%2BR.%26aulast%3DAntalis%26aufirst%3DT.%2BM.%26atitle%3DTwo%2520Novel%2520Mucin%2520Genes%2520Down-Regulated%2520in%2520Colorectal%2520Cancer%2520Identified%2520by%2520Differential%2520Display%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4083%26epage%3D4089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wreschner, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyre, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuckin, M. A.</span></span> <span> </span><span class="NLM_article-title">Muc13, a Novel Human Cell Surface Mucin Expressed by Epithelial and Hemopoietic Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">18327</span>– <span class="NLM_lpage">18336</span>, <span class="refDoi"> DOI: 10.1074/jbc.M008850200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M008850200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11278439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFWmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=18327-18336&author=S.+J.+Williamsauthor=D.+H.+Wreschnerauthor=M.+Tranauthor=H.+J.+Eyreauthor=G.+R.+Sutherlandauthor=M.+A.+McGuckin&title=Muc13%2C+a+Novel+Human+Cell+Surface+Mucin+Expressed+by+Epithelial+and+Hemopoietic+Cells&doi=10.1074%2Fjbc.M008850200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">MUC13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells</span></div><div class="casAuthors">Williams, Stephanie J.; Wreschner, Daniel H.; Tran, Mai; Eyre, Helen J.; Sutherland, Grant R.; McGuckin, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">18327-18336</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Transmembrane mucins are glycoproteins involved in barrier function in epithelial tissues.  To identify novel transmembrane mucin genes, we performed a tblastn search of the GenBank EST data bases with a serine/threonine-rich search string, and a rodent gene expressed in bone marrow was identified.  We detd. the cDNA sequence of the human orthologue of this gene, MUC13, which localizes to chromosome band 3q13.3 and generates 3.2-kilobase pair transcripts encoding a 512-amino acid protein comprised of an N-terminal mucin repeat domain, three epidermal growth factor-like sequences, a SEA module, a transmembrane domain, and a cytoplasmic tail (GenBank accession no. AF286113).  MUC13 mRNA is expressed most highly in the large intestine and trachea, and at moderate levels in the kidney, small intestine, appendix, and stomach.  In situ hybridization in murine tissues revealed expression in intestinal epithelial and lymphoid cells.  Immunohistochem. demonstrated the human MUC13 protein on the apical membrane of both columnar and goblet cells in the gastrointestinal tract, as well as within goblet cell thecae, indicative of secretion in addn. to presence on the cell surface.  MUC13 is cleaved, and the β-subunit contg. the cytoplasmic tail undergoes homodimerization.  Including MUC13, there are at least five cell surface mucins expressed in the gastrointestinal tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9mVDySvfUQbVg90H21EOLACvtfcHk0ljWAmz39X1O0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFWmtrc%253D&md5=a0aeccbe883586e922260da9456dbbe4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M008850200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M008850200%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DWreschner%26aufirst%3DD.%2BH.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DEyre%26aufirst%3DH.%2BJ.%26aulast%3DSutherland%26aufirst%3DG.%2BR.%26aulast%3DMcGuckin%26aufirst%3DM.%2BA.%26atitle%3DMuc13%252C%2520a%2520Novel%2520Human%2520Cell%2520Surface%2520Mucin%2520Expressed%2520by%2520Epithelial%2520and%2520Hemopoietic%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D18327%26epage%3D18336%26doi%3D10.1074%2Fjbc.M008850200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behera, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praharaj, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negi, S.</span></span> <span> </span><span class="NLM_article-title">Exploring the Role and Diversity of Mucins in Health and Disease with Special Insight into Non-Communicable Diseases</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1007/s10719-015-9606-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs10719-015-9606-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26239922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yrsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=575-613&author=S.+K.+Beheraauthor=A.+B.+Praharajauthor=B.+Dehuryauthor=S.+Negi&title=Exploring+the+Role+and+Diversity+of+Mucins+in+Health+and+Disease+with+Special+Insight+into+Non-Communicable+Diseases&doi=10.1007%2Fs10719-015-9606-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases</span></div><div class="casAuthors">Behera, Santosh Kumar; Praharaj, Ardhendu Bhusan; Dehury, Budheswar; Negi, Sapna</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">575-613</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mucins are major glycoprotein components of the mucus that coats the surfaces of cells lining the respiratory, digestive, gastrointestinal and urogenital tracts.  They function to protect epithelial cells from infection, dehydration and phys. or chem. injury, as well as to aid the passage of materials through a tract i.e., lubrication.  They are also implicated in the pathogenesis of benign and malignant diseases of secretory epithelial cells.  In Human there are two types of mucins, membrane-bound and secreted that are originated from mucous producing goblet cells localized in the epithelial cell layer or in mucous producing glands and encoded by MUC gene.  Mucins belong to a heterogeneous family of high mol. wt. proteins composed of a long peptidic chain with a large no. of tandem repeats that form the so-called mucin domain.  The mol. wt. is generally high, ranging between 0.2 and 10 million Dalton and all mucins contain one or more domains which are highly glycosylated.  The size and no. of repeats vary between mucins and the genetic polymorphism represents no. of repeats (VNTR polymorphisms), which means the size of individual mucins can differ substantially between individuals which can be used as markers.  In human it is only MUC1 and MUC7 that have mucin domains with less than 40 % serine and threonine which in turn could reduce no. of PTS domains.  Mucins can be considered as powerful two-edged sword, as its normal function protects from unwanted substances and organisms at an arm's length while, malfunction of mucus may be an important factor in human diseases.  In this review we have unearthed the current status of different mucin proteins in understanding its role and function in various non-communicable diseases in human with special ref. to its organ specific locations.  The findings described in this review may be of direct relevance to the major research area in biomedicine with ref. to mucin and mucin assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHWImBD_UyPrVg90H21EOLACvtfcHk0ljWAmz39X1O0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yrsbfI&md5=4bee3b7b9620462c8347ec87264fbe91</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs10719-015-9606-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-015-9606-6%26sid%3Dliteratum%253Aachs%26aulast%3DBehera%26aufirst%3DS.%2BK.%26aulast%3DPraharaj%26aufirst%3DA.%2BB.%26aulast%3DDehury%26aufirst%3DB.%26aulast%3DNegi%26aufirst%3DS.%26atitle%3DExploring%2520the%2520Role%2520and%2520Diversity%2520of%2520Mucins%2520in%2520Health%2520and%2520Disease%2520with%2520Special%2520Insight%2520into%2520Non-Communicable%2520Diseases%26jtitle%3DGlycoconjugate%2520J.%26date%3D2015%26volume%3D32%26spage%3D575%26epage%3D613%26doi%3D10.1007%2Fs10719-015-9606-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span> <span> </span><span class="NLM_article-title">MUC genes: mucin or not mucin? That is the question</span>. <i>Med. Sci. (Paris)</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1051/medsci/2004205569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1051%2Fmedsci%2F2004205569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15190477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ovFGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2004&pages=569-574&author=N.+Porchetauthor=J.+P.+Aubert&title=MUC+genes%3A+mucin+or+not+mucin%3F+That+is+the+question&doi=10.1051%2Fmedsci%2F2004205569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">MUC genes: mucin or not mucin? That is the question</span></div><div class="casAuthors">Porchet Nicole; Aubert Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Medecine sciences : M/S</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">569-74</span>
        ISSN:<span class="NLM_cas:issn">0767-0974</span>.
    </div><div class="casAbstract">Mucins are macromolecules lying the cells in contact with external environment and protect the epithelium against constant attacks such as digestive fluids, microorganisms, pollutants, and toxins.  Mucins are the main components of mucus and are synthesized and secreted by specialized cells of the epithelium (goblet cells, cells of mucous glands) or non mucin-secreting cells.  Human mucin genes show common features: large size of their mRNAs, large nucleotide tandem repeat domains, complex expression both at tissular and cellular level.  Since 1987, 21 MUC symbols have been used to designate genes encoding O-glycoproteins containing tandem repeat domains rich in serine, threonine and proline.  Some of these genes encode true mucins while others encode non mucin adhesion O-glycoproteins.  In this paper, we propose a classification based on sequence similarities and expression areas.  Two main families can be distinguished: secreted mucins or gel-forming mucins (MUC2, MUC5AC, MUC5B, MUC6), and membrane-bound mucins (MUC1, MUC3, MUC4, MUC12, MUC17).  Muc-deficient mice will provide important models in the study of functional relationships between these two mucin families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRWSA7JRbXU0NoizSOkG_FfW6udTcc2eZlXf-c9AZLeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ovFGnug%253D%253D&md5=f7803fe7b8483a0cb8fbbda80aa44b61</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1051%2Fmedsci%2F2004205569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fmedsci%252F2004205569%26sid%3Dliteratum%253Aachs%26aulast%3DPorchet%26aufirst%3DN.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26atitle%3DMUC%2520genes%253A%2520mucin%2520or%2520not%2520mucin%253F%2520That%2520is%2520the%2520question%26jtitle%3DMed.%2520Sci.%2520%2528Paris%2529%26date%3D2004%26volume%3D20%26spage%3D569%26epage%3D574%26doi%3D10.1051%2Fmedsci%2F2004205569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Abad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arike, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelaseyed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, G. C.</span></span> <span> </span><span class="NLM_article-title">The Human Transmembrane Mucin MUC17 Responds to Tnfα by Increased Presentation at the Plasma Membrane</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>476</i></span>,  <span class="NLM_fpage">2281</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1042/BCJ20190180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2FBCJ20190180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=31387973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCnurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=476&publication_year=2019&pages=2281-2295&author=H.+Schneiderauthor=E.+Bergerauthor=B.+Dolanauthor=B.+Martinez-Abadauthor=L.+Arikeauthor=T.+Pelaseyedauthor=G.+C.+Hansson&title=The+Human+Transmembrane+Mucin+MUC17+Responds+to+Tnf%CE%B1+by+Increased+Presentation+at+the+Plasma+Membrane&doi=10.1042%2FBCJ20190180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane</span></div><div class="casAuthors">Schneider, Hannah; Berger, Evelin; Dolan, Brendan; Martinez-Abad, Beatriz; Arike, Liisa; Pelaseyed, Thaher; Hansson, Gunnar C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">476</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2281-2295</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Here, we identified two unknown phosphorylated serine residues, S4428 and S4492, in the cytoplasmic tail of human MUC17.  We have previously demonstrated that MUC17 is anchored to the apical membrane domain via an interaction with the scaffolding protein PDZK1.  S4492, localized in the C-terminal PDZ binding motif of MUC17, was mutated to generate phosphomimetic and phosphodeficient variants of MUC17.  Using Caco-2 cells as a model system, we found that induction of an inflammatory state by long-term stimulation with the proinflammatory cytokine TNFα resulted in an increase of MUC17 protein levels and enhanced insertion of MUC17 and its two phospho-variants into apical membranes.  Up-regulation and apical insertion of MUC17 was followed by shedding of MUC17-contg. vesicles.  Transmembrane mucins have previously been shown to play a role in the prevention of bacterial colonization by acting as sheddable decoys for encroaching bacteria.  Overexpression and increased presentation at the plasma membrane of wild-type MUC17 and its phosphodeficient variant MUC17 S-4492A protected Caco-2 cells against adhesion of enteropathogenic Escherichia coli, indicating that C-terminal phosphorylation of MUC17 may play a functional role in epithelial cell protection.  We propose a new function for MUC17 in inflammation, where MUC17 acts as a second line of defense by preventing attachment of bacteria to the epithelial cell glycocalyx in the small intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRzvER6zG8W7Vg90H21EOLACvtfcHk0ljWAmz39X1O0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCnurrP&md5=e9aecaf30ceb530b6619e979ab366baf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2FBCJ20190180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBCJ20190180%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DE.%26aulast%3DDolan%26aufirst%3DB.%26aulast%3DMartinez-Abad%26aufirst%3DB.%26aulast%3DArike%26aufirst%3DL.%26aulast%3DPelaseyed%26aufirst%3DT.%26aulast%3DHansson%26aufirst%3DG.%2BC.%26atitle%3DThe%2520Human%2520Transmembrane%2520Mucin%2520MUC17%2520Responds%2520to%2520Tnf%25CE%25B1%2520by%2520Increased%2520Presentation%2520at%2520the%2520Plasma%2520Membrane%26jtitle%3DBiochem.%2520J.%26date%3D2019%26volume%3D476%26spage%3D2281%26epage%3D2295%26doi%3D10.1042%2FBCJ20190180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bafna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">MUC4Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2070</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-6041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F0008-5472.CAN-07-6041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=18381409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2065-2070&author=P.+Chaturvediauthor=A.+P.+Singhauthor=S.+Chakrabortyauthor=S.+C.+Chauhanauthor=S.+Bafnaauthor=J.+L.+Mezaauthor=P.+K.+Singhauthor=M.+A.+Hollingsworthauthor=P.+P.+Mehtaauthor=S.+K.+Batra&title=MUC4Mucin+Interacts+with+and+Stabilizes+the+HER2+Oncoprotein+in+Human+Pancreatic+Cancer+Cells&doi=10.1158%2F0008-5472.CAN-07-6041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4 Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells</span></div><div class="casAuthors">Chaturvedi, Pallavi; Singh, Ajay P.; Chakraborty, Subhankar; Chauhan, Subhash C.; Bafna, Sangeeta; Meza, Jane L.; Singh, Pankaj K.; Hollingsworth, Michael A.; Mehta, Parmender P.; Batra, Surinder K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2065-2070</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MUC4, a high-mol. wt. transmembrane glycoprotein, is overexpressed in pancreatic cancer and is implicated in its pathogenesis.  It is a heterodimeric protein contg. a large extracellular, heavily glycosylated subunit, MUC4α, and a transmembrane growth factor-like subunit, MUC4β.  In the present study, we have shown the interaction of human MUC4 with the receptor tyrosine kinase HER2 in pancreatic adenocarcinoma cells by reciprocal coimmunopptn. and cocapping studies.  MUC4 colocalized with HER2 at the cell surface and in the cytoplasm.  Silencing of MUC4 by transient or stable expression of MUC4-targeted short-interfering RNA led to the down-regulation of HER2 with a concomitant decrease in its phosphorylated form (pY1248-HER2).  Further analyses revealed that the MUC4-knockdown-mediated decrease in HER2 expression occurred due to the drop in the stability of the receptor.  In MUC4-knockdown pancreatic cancer cells, we also obsd. a reduced phosphorylation of the focal adhesion kinase and p42/44 mitogen-activated protein kinase, which are downstream effector proteins in HER2 signaling.  Our findings add a new dimension to MUC4 function as a modulator of cell signaling and provide mechanistic evidence for its role in pancreatic cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbz1l8961rMLVg90H21EOLACvtfcHk0lgfDqYdtSRy6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb8%253D&md5=97c108255745915d2a50825ccc25a733</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-6041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-6041%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DA.%2BP.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DBafna%26aufirst%3DS.%26aulast%3DMeza%26aufirst%3DJ.%2BL.%26aulast%3DSingh%26aufirst%3DP.%2BK.%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DMUC4Mucin%2520Interacts%2520with%2520and%2520Stabilizes%2520the%2520HER2%2520Oncoprotein%2520in%2520Human%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2065%26epage%3D2070%26doi%3D10.1158%2F0008-5472.CAN-07-6041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lodish, H.</span>; <span class="NLM_string-name">Berk, A.</span>; <span class="NLM_string-name">Zipursky, S. L.</span>; <span class="NLM_string-name">Mastsudaira, P.</span>; <span class="NLM_string-name">Baltimore, D.</span>; <span class="NLM_string-name">Darnell, J.</span></span> <i>Molecular and Cellular Biology</i>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">W. H. Freeman</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=H.+Lodish&author=A.+Berk&author=S.+L.+Zipursky&author=P.+Mastsudaira&author=D.+Baltimore&author=J.+Darnell&title=Molecular+and+Cellular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLodish%26aufirst%3DH.%26btitle%3DMolecular%2520and%2520Cellular%2520Biology%26pub%3DW.%2520H.%2520Freeman%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span>; <span class="NLM_string-name">Farooq, A.</span>; <span class="NLM_string-name">Carothers Carraway, C. A.</span></span> <span> </span><span class="NLM_article-title">The Membrane Mucin Muc4 as a Modulator for the Receptor Tyrosine Kinase Erbb2</span>. In  <i>Recent Progress in Cancer Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. K.</span></span>, Ed.; <span class="NLM_publisher-name">Transworld Research Network</span>: <span class="NLM_publisher-loc">Kerala, India</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">75</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=59-75&author=K.+L.+Carraway&author=A.+Farooq&author=C.+A.+Carothers+Carrawayauthor=C.+K.+Tang&title=Recent+Progress+in+Cancer+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DThe%2520Membrane%2520Mucin%2520Muc4%2520as%2520a%2520Modulator%2520for%2520the%2520Receptor%2520Tyrosine%2520Kinase%2520Erbb2%26btitle%3DRecent%2520Progress%2520in%2520Cancer%2520Research%26aulast%3DTang%26aufirst%3DC.%2BK.%26pub%3DTransworld%2520Research%2520Network%26date%3D2007%26spage%3D59%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessein, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">The Mucin MUC4 and its Membrane Partner Erbb2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e32232</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0032232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1371%2Fjournal.pone.0032232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22393391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=N.+Jonckheereauthor=N.+Skrypekauthor=J.+Merlinauthor=A.+F.+Desseinauthor=P.+Dumontauthor=E.+Leteurtreauthor=A.+Harrisauthor=J.+Desseynauthor=C.+Susiniauthor=F.+Frenoisauthor=I.+Van+Seuningen&title=The+Mucin+MUC4+and+its+Membrane+Partner+Erbb2+Regulate+Biological+Properties+of+Human+CAPAN-2+Pancreatic+Cancer+Cells+via+Different+Signalling+Pathways&doi=10.1371%2Fjournal.pone.0032232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Dumont, Patrick; Leteurtre, Emmanuelle; Harris, Ann; Desseyn, Jean-Luc; Susini, Christiane; Frenois, Frederic; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e32232</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mucin MUC4 and its membrane partner the ErbB2 oncogenic receptor are potential interacting partners in human pancreatic tumor development.  However, the way they function is still largely unknown.  In this work, we aimed to identify the cellular mechanisms and the intracellular signalling pathways under the control of both ErbB2 and MUC4 in a human pancreatic adenocarcinomatous cell line.  Using co-immunopptn. and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 via the EGF domains of MUC4.  Stable cell clones were generated in which either MUC4 or ErbB2 were knocked down (KD) by a shRNA approach.  Biol. properties of these cells were then studied in vitro and in vivo.  Our results show that ErbB2-KD cells are more apoptotic and less proliferative (decreased cyclin D1 and increased p27kip1 expression) while migration and invasive properties were not altered.  MUC4-KD clones were less proliferative with decreased cyclin D1 expression, G1 cell cycle arrest and altered ErbB2/ErbB3 expression.  Their migration properties were reduced whereas invasive properties were increased.  Importantly, inhibition of ErbB2 and MUC4 expression did not impair the same signalling pathways (inhibition of MUC4 expression affected the JNK pathway whereas that of ErbB2 altered the MAPK pathway).  Finally, ErbB2-KD and MUC4-KD cells showed impaired tumor growth in vivo.  Our results show that ErbB2 and MUC4, which interact phys., activate different intracellular signalling pathways to regulate biol. properties of CAPAN-2 pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraoUloWRMMlrVg90H21EOLACvtfcHk0lgfDqYdtSRy6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D&md5=656b500d070b2e9b6d64ee65a37aa624</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0032232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0032232%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DMerlin%26aufirst%3DJ.%26aulast%3DDessein%26aufirst%3DA.%2BF.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DDesseyn%26aufirst%3DJ.%26aulast%3DSusini%26aufirst%3DC.%26aulast%3DFrenois%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DThe%2520Mucin%2520MUC4%2520and%2520its%2520Membrane%2520Partner%2520Erbb2%2520Regulate%2520Biological%2520Properties%2520of%2520Human%2520CAPAN-2%2520Pancreatic%2520Cancer%2520Cells%2520via%2520Different%2520Signalling%2520Pathways%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0032232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafeez, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ise, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrman, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghimire, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span> <span> </span><span class="NLM_article-title">MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">491</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2016.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=27321183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=491&author=S.+Khanauthor=M.+Sikanderauthor=M.+C.+Ebelingauthor=A.+Ganjuauthor=S.+Kumariauthor=M.+M.+Yallapuauthor=B.+B.+Hafeezauthor=T.+Iseauthor=S.+Nagataauthor=N.+Zafarauthor=S.+W.+Behrmanauthor=J.+Y.+Wanauthor=H.+M.+Ghimireauthor=P.+Sahayauthor=P.+Pradhanauthor=S.+C.+Chauhanauthor=M.+Jaggi&title=MUC13+Interaction+with+Receptor+Tyrosine+Kinase+HER2+Drives+Pancreatic+Ductal+Adenocarcinoma+Progression&doi=10.1038%2Fonc.2016.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression</span></div><div class="casAuthors">Khan, S.; Sikander, M.; Ebeling, M. C.; Ganju, A.; Kumari, S.; Yallapu, M. M.; Hafeez, B. B.; Ise, T.; Nagata, S.; Zafar, N.; Behrman, S. W.; Wan, J. Y.; Ghimire, H. M.; Sahay, P.; Pradhan, P.; Chauhan, S. C.; Jaggi, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-500</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although MUC13, a transmembrane mucin, is aberrantly expressed in pancreatic ductal adenocarcinoma (PDAC) and generally correlates with increased expression of HER2, the underlying mechanism remains poorly understood.  Herein, we found that MUC13 co-localizes and interacts with HER2 in PDAC cells (reciprocal co-immunopptn., immunofluorescence, proximity ligation, co-capping assays) and tissues (immunohistofluorescence).  The results from this study demonstrate that MUC13 functionally interacts and activates HER2 at p1248 in PDAC cells, leading to stimulation of HER2 signaling cascade, including ERK1/2, FAK, AKT and PAK1 as well as regulation of the growth, cytoskeleton remodeling and motility, invasion of PDAC cells-all collectively contributing to PDAC progression.  Interestingly, all of these phenotypic effects of MUC13-HER2 co-localization could be effectively compromised by depleting MUC13 and mediated by the first and second EGF-like domains of MUC13.  Further, MUC13-HER2 co-localization also holds true in PDAC tissues with a strong functional correlation with events contributing to increased degree of disorder and cancer aggressiveness.  In brief, findings presented here provide compelling evidence of a functional ramification of MUC13-HER2: this interaction could be potentially exploited for targeted therapeutics in a subset of patients harboring an aggressive form of PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoapvPnMZTrQrVg90H21EOLACvtfcHk0lhxTkitjgKJgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrsLbL&md5=8bea92c022d6054cbced6eafb44c8720</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.218%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DSikander%26aufirst%3DM.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DGanju%26aufirst%3DA.%26aulast%3DKumari%26aufirst%3DS.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DHafeez%26aufirst%3DB.%2BB.%26aulast%3DIse%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DZafar%26aufirst%3DN.%26aulast%3DBehrman%26aufirst%3DS.%2BW.%26aulast%3DWan%26aufirst%3DJ.%2BY.%26aulast%3DGhimire%26aufirst%3DH.%2BM.%26aulast%3DSahay%26aufirst%3DP.%26aulast%3DPradhan%26aufirst%3DP.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DJaggi%26aufirst%3DM.%26atitle%3DMUC13%2520Interaction%2520with%2520Receptor%2520Tyrosine%2520Kinase%2520HER2%2520Drives%2520Pancreatic%2520Ductal%2520Adenocarcinoma%2520Progression%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D491%26doi%3D10.1038%2Fonc.2016.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">C-Terminal Domain of Rodent Intestinal Mucin Muc3 is Proteolytically Cleaved in the Endoplasmic Reticulum to Generate Extracellular and Membrane Components</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1042/bj20020289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20020289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12027806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFGltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2002&pages=623-631&author=R.+Wangauthor=I.+A.+Khatriauthor=J.+F.+Forstner&title=C-Terminal+Domain+of+Rodent+Intestinal+Mucin+Muc3+is+Proteolytically+Cleaved+in+the+Endoplasmic+Reticulum+to+Generate+Extracellular+and+Membrane+Components&doi=10.1042%2Fbj20020289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components</span></div><div class="casAuthors">Wang, Rongquan; Khatri, Ismat A.; Forstner, Janet F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">623-631</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Although human MUC3 and rodent Muc3 are both membrane-assocd. intestinal mucins, the present study has explored the possibility that rodent Muc3 might exist in sol. as well as membrane forms.  No evidence was obtained for the existence of sol. splice variants; however, expts. with heterologous cells transfected with cDNA encoding the 381-residue C-terminal domain of rodent Muc3 showed that a definitive proteolytic cleavage occurs during processing in the endoplasmic reticulum.  The products consisted of a V5-tagged 30 kDa extracellular glycopeptide and a Myc-tagged 49 kDa membrane-assocd. glycopeptide.  Throughout their cellular transport to the plasma membrane, the two fragments remained assocd. by noncovalent SDS-sensitive interactions.  Site-specific mutagenesis pinpointed the need for glycine and serine residues in the cleavage sequence Leu-Ser-Lys-Gly-Ser-Ile-Val-Val, which is localized between the two epidermal-growth-factor-like motifs of the mucin.  A similar cleavage sequence (Phe-Arg-Pro-Gly ↓ Ser-Val-Val-Val, where ↓ signifies the cleavage site) has been reported in human MUC1 and analogous sites are present in human MUC3, MUC12 and MUC17.  Thus early proteolytic cleavage may be a conserved characteristic of many membrane-assocd. mucins, possibly as a prelude to later release of their large extracellular domains at cell surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Q77ZPGCwTbVg90H21EOLACvtfcHk0lhxTkitjgKJgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFGltbk%253D&md5=6d96ba89e3c08417a52eeee46241c13f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2Fbj20020289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20020289%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DKhatri%26aufirst%3DI.%2BA.%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DC-Terminal%2520Domain%2520of%2520Rodent%2520Intestinal%2520Mucin%2520Muc3%2520is%2520Proteolytically%2520Cleaved%2520in%2520the%2520Endoplasmic%2520Reticulum%2520to%2520Generate%2520Extracellular%2520and%2520Membrane%2520Components%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D366%26spage%3D623%26epage%3D631%26doi%3D10.1042%2Fbj20020289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Contribution of the Conservative Cleavage Motif to Posttranslational Processing of the Carboxyl Terminal Domain of Rodent Muc3</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1007/s11010-008-9753-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs11010-008-9753-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=18401557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlSru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2008&pages=155-166&author=Y.+Liauthor=Z.+Pengauthor=Y.+Heauthor=W.+Chenauthor=X.+Bianauthor=D.+Fangauthor=R.+Wang&title=Contribution+of+the+Conservative+Cleavage+Motif+to+Posttranslational+Processing+of+the+Carboxyl+Terminal+Domain+of+Rodent+Muc3&doi=10.1007%2Fs11010-008-9753-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of the conservative cleavage motif to posttranslational processing of the carboxyl terminal domain of rodent Muc3</span></div><div class="casAuthors">Li, Yicheng; Peng, Zhihong; He, Yonghong; Chen, Wensheng; Bian, Xiuwu; Fang, Dianchun; Wang, Rongquan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">155-166</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In previous work, we showed by transient expression studies in COS-1 cells that the C-terminal domain of rat intestinal membrane mucin (rMuc3) that was cloned in the pSecTag2 plasmid (named as p20) is posttranslationally cleaved twice.  One location is between the glycine and the serine within a LS1KGS2IV1V2 motif, and the other is in the 49-kDa membrane-tethered fragment at an undefined site.  The SEA (sea urchin sperm protein, enterokinase and agrin) module of rMuc3 is responsible for the cleavage and assocn. of the cleaved fragments.  The present study demonstrates how the conservative cleavage motif LS1KGS2IV1V2 contributes to posttranslational processing through mutagenesis of each residue in the LS1KGS2IV1V2 motif.  Mutation of S2 to alanine (p20s2/a) completely prevented cleavage.  While p20k/a (in this construct the K is replaced by A) and p20s1/a (in this construct the S1 is replaced by A) (6 and 3%) showed almost the same result as the wild-type p20 transfectant (4%), 79, 39, 22, 17, and 14% of the products from p20g/a (in this construct the G is replaced by A), p20i/a (in this construct the I is replaced by A), p20l/a (in this construct the L is replaced by A), p20v2/a (in this construct the V2 is replaced by A), and p20v1/a (in this construct the V1 is replaced by A) remained uncleaved.  The cleaved N-terminal fragment of the p20s1/a transfectant was 26-kDa, but the N-terminal fragments from p20, p20g/a, p20l/a, p20k/a, p20i/a, p20v1/a, and p20v2/a were 30-kDa.  The S1 residue was possibly O-glycosylated, which was supported by deglycosylation with O-cocktail (a mixt. of glycosidases).  The N-terminal fragment of p20s1/a-transfected cells was present at high levels in the spent media.  Thus, the S2, G, I, L, V2, and V1 residues within the conserved cleavage motif, LS1KGS2IV1V2, are important for cleavage and contribute to the structural formation and conformational stress of the small loop between the β2 and the β3 strands.  The S1 residue is possibly O-glycosylated, and mutation of S1 residue to alanine does not affect the cleavage of the LS1KGS2IV1V2 motif, but it is important for the dissocn. and further release of the cleaved N-terminal fragment from the cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJSuhCZ08LbVg90H21EOLACvtfcHk0lh_LdNMgWaprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlSru7w%253D&md5=5fe652b625a6d762df34fff662040eca</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11010-008-9753-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-008-9753-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBian%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DContribution%2520of%2520the%2520Conservative%2520Cleavage%2520Motif%2520to%2520Posttranslational%2520Processing%2520of%2520the%2520Carboxyl%2520Terminal%2520Domain%2520of%2520Rodent%2520Muc3%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D313%26spage%3D155%26epage%3D166%26doi%3D10.1007%2Fs11010-008-9753-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Role of N-glycosylation of the SEA Module of Rodent Muc3 in Posttranslational Processing of its Carboxy-Terminal Domain</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1102</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwp095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1093%2Fglycob%2Fcwp095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19561031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2ks77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1094-1102&author=Y.+Heauthor=Y.+Liauthor=Z.+Pengauthor=H.+Yuauthor=X.+Zhangauthor=L.+Chenauthor=Q.+Jiauthor=W.+Chenauthor=R.+Wang&title=Role+of+N-glycosylation+of+the+SEA+Module+of+Rodent+Muc3+in+Posttranslational+Processing+of+its+Carboxy-Terminal+Domain&doi=10.1093%2Fglycob%2Fcwp095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Role of N-glycosylation of the SEA module of rodent Muc3 in posttranslational processing of its carboxy-terminal domain</span></div><div class="casAuthors">He, Yonghong; Li, Yicheng; Peng, Zhihong; Yu, Hao; Zhang, Xin; Chen, Lei; Ji, Qing; Chen, Wensheng; Wang, Rongquan</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1094-1102</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A prominent feature of the rodent Muc3 SEA module is the precursor cleavage event that segregates the O-glycosylated N-terminal fragment and transmembrane domain into the noncovalently attached heterodimer.  There are seven potential N-glycosylation sites that occur in a cluster in the SEA module of Muc3.  However, it is unknown if these sites are modified or what the function of these N-glycans may be in the SEA module.  Our data show that the proteolytic cleavage of the rodent Muc3 SEA module was partially prevented by treatment with tunicamycin, an inhibitor of N-glycosylation.  Each single mutant of the seven N-glycosylation sites (N1A, N2A, N3A, N4A, N5A, N6A, and N7A) and multiple mutants, including double (N34A) and triple (N345A) mutants, and mutants with four (N3457A), five (N34567A), six (N134567A and N234567A), seven (N1234567A) mutations, confirmed that all seven of these potential sites are N-glycosylated simultaneously.  The proteolytic cleavage of the SEA module was not affected when it lacked only one, two, or three N-glycans, but was partially inhibited when lacking four, five, and six N-glycans.  In all, 2%, 48%, 85%, and 73% of the products from N3457A, N34567A, N134567A, and N234567A transfectants, resp., remained uncleaved.  The proteolytic cleavage was completely prevented in the N1234567A transfectant, which eliminated all seven N-glycans in the SEA module.  The interaction of the heterodimer was independent of the N-glycans within the rodent Muc3 SEA module.  Thus, the N-glycosylation pattern constituted a control point for the modulation of the proteolytic cleavage of the SEA module.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreEWFBaBwgnLVg90H21EOLACvtfcHk0lh_LdNMgWaprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2ks77M&md5=06d79e5f9899acbd45c809d3f1f811b6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwp095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwp095%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DRole%2520of%2520N-glycosylation%2520of%2520the%2520SEA%2520Module%2520of%2520Rodent%2520Muc3%2520in%2520Posttranslational%2520Processing%2520of%2520its%2520Carboxy-Terminal%2520Domain%26jtitle%3DGlycobiology%26date%3D2009%26volume%3D19%26spage%3D1094%26epage%3D1102%26doi%3D10.1093%2Fglycob%2Fcwp095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Autoproteolysis of the SEA Module of Rmuc3 C-Terminal Domain Modulate its Functional Composition</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.abb.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20727344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2010&pages=238-247&author=Z.+Pengauthor=Y.+Heauthor=Y.+Yangauthor=R.+Zhuauthor=J.+Baiauthor=Y.+Liauthor=H.+Yuauthor=X.+Zhangauthor=L.+Chenauthor=W.+Chenauthor=D.+Fangauthor=R.+Wang&title=Autoproteolysis+of+the+SEA+Module+of+Rmuc3+C-Terminal+Domain+Modulate+its+Functional+Composition&doi=10.1016%2Fj.abb.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Autoproteolysis of the SEA module of rMuc3 C-terminal domain modulates its functional composition</span></div><div class="casAuthors">Peng, Zhihong; He, Yonghong; Yang, Yongtao; Zhu, Rong; Bai, Jianying; Li, Yicheng; Yu, Hao; Zhang, Xin; Chen, Lei; Chen, Wensheng; Fang, Dianchun; Wang, Rongquan</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-247</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RMuc3 is a typical transmembrane mucin and contains a 174 amino acid domain called an SEA module in its C-terminal domain which is cleaved in eukaryotic cells.  However, the mechanism by which the rMuc3 SEA module is proteolyzed and its biol. significance has to be elucidated.  In this study, we showed that the rMuc3 C-terminal domain was cleaved at LSKGSIVV motif within SEA module in prokaryotic cells, the time-dependence of the cleavage was found in the purified rMuc3 C-terminal domain carrying a mutated LSKASIVV motif expressed in bacteria.  Thus, the cleavage of rMuc3 SEA module depended on autoproteolysis.  The autoproteolysis of the SEA module of rMuc3 C-terminal domain played a crit. role in the migration and invasion of the LoVo human colon cancer cells with rMuc3 C-terminal domain in vitro.  The rMuc3 C-terminal domain induced a significant activation of HER/ErbB2 phosphorylated form (py1248) in LoVo cells.  Inhibition of the phosphorylation by gefitinib (ZD1839) did attenuate migration and invasion of LoVo cells with rMuc3 C-terminal domain.  Thus, rMuc3 C-terminal domain undergoes autoproteolysis at its SEA module, which maintains its availability for the potentiation of the signaling process that is modulated by HER/ErbB2 phosphorylation to promote the migration and invasion of LoVo cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOtC1zJrckLbVg90H21EOLACvtfcHk0lh_LdNMgWaprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLbE&md5=49df82391362f28f33ea2d808134fd0a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DAutoproteolysis%2520of%2520the%2520SEA%2520Module%2520of%2520Rmuc3%2520C-Terminal%2520Domain%2520Modulate%2520its%2520Functional%2520Composition%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D503%26spage%3D238%26epage%3D247%26doi%3D10.1016%2Fj.abb.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span> <span> </span><span class="NLM_article-title">MUC13 Mucin Augments Pancreatic Tumorigenesis</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F1535-7163.MCT-11-0598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22027689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=24-33&author=S.+C.+Chauhanauthor=M.+C.+Ebelingauthor=D.+M.+Maherauthor=M.+D.+Kochauthor=A.+Watanabeauthor=H.+Aburataniauthor=Y.+Lioauthor=M.+Jaggi&title=MUC13+Mucin+Augments+Pancreatic+Tumorigenesis&doi=10.1158%2F1535-7163.MCT-11-0598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">MUC13 Mucin Augments Pancreatic Tumorigenesis</span></div><div class="casAuthors">Chauhan, Subhash C.; Ebeling, Mara C.; Maher, Diane M.; Koch, Michael D.; Watanabe, Akira; Aburatani, Hiroyuki; Lio, Yuhlong; Jaggi, Meena</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-33</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The high death rate of pancreatic cancer is attributed to the lack of reliable methods for early detection and underlying mol. mechanisms of its aggressive pathogenesis.  Although MUC13, a newly identified transmembrane mucin, is known to be aberrantly expressed in ovarian and gastro-intestinal cancers, its role in pancreatic cancer is unknown.  Herein, we investigated the expression profile and functions of MUC13 in pancreatic cancer progression.  The expression profile of MUC13 in pancreatic cancer was investigated using a recently generated monoclonal antibody (clone PPZ0020) and pancreatic tissue microarrays.  The expression of MUC13 was significantly (P < 0.005) higher in cancer samples compared with normal/nonneoplastic pancreatic tissues.  For functional analyses, full-length MUC13 was expressed in MUC13 null pancreatic cancer cell lines, MiaPaca and Panc1.  MUC13 overexpression caused a significant (P < 0.05) increase in cell motility, invasion, proliferation, and anchorage-dependent or -independent clonogenicity while decreasing cell-cell and cell-substratum adhesion.  Exogenous MUC13 expression significantly (P < 0.05) enhanced pancreatic tumor growth and reduced animal survival in a xenograft mouse model.  These tumorigenic characteristics correlated with the upregulation/phosphorylation of HER2, p21-activated kinase 1 (PAK1), extracellular signal-regulated kinase (ERK), Akt, and metastasin (S100A4), and the suppression of p53.  Conversely, suppression of MUC13 in HPAFII pancreatic cancer cells by short hairpin RNA resulted in suppression of tumorigenic characteristics, repression of HER2, PAK1, ERK, and S100A4, and upregulation of p53.  MUC13 suppression also significantly (P < 0.05) reduced tumor growth and increased animal survival.  These results imply a role of MUC13 in pancreatic cancer and suggest its potential use as a diagnostic and therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJzNhtWxDCObVg90H21EOLACvtfcHk0lh_LdNMgWaprA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWnug%253D%253D&md5=e875631de1d3498829c49510a3a5c0eb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0598%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DMaher%26aufirst%3DD.%2BM.%26aulast%3DKoch%26aufirst%3DM.%2BD.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DLio%26aufirst%3DY.%26aulast%3DJaggi%26aufirst%3DM.%26atitle%3DMUC13%2520Mucin%2520Augments%2520Pancreatic%2520Tumorigenesis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D24%26epage%3D33%26doi%3D10.1158%2F1535-7163.MCT-11-0598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corredor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polk, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekels, L. L.</span></span> <span> </span><span class="NLM_article-title">Cysteine-Rich Domains of Muc3 Intestinal Mucin Promote Cell Migration, Inhibit Apoptosis, and Accelerate Wound Healing</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2006.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1053%2Fj.gastro.2006.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17101324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlantrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=1501-1517&author=S.+B.+Hoauthor=L.+A.+Dvorakauthor=R.+E.+Moorauthor=A.+C.+Jacobsonauthor=M.+R.+Freyauthor=J.+Corredorauthor=D.+B.+Polkauthor=L.+L.+Shekels&title=Cysteine-Rich+Domains+of+Muc3+Intestinal+Mucin+Promote+Cell+Migration%2C+Inhibit+Apoptosis%2C+and+Accelerate+Wound+Healing&doi=10.1053%2Fj.gastro.2006.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine-rich domains of MUC3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing</span></div><div class="casAuthors">Ho, Samuel B.; Dvorak, Leah A.; Moor, Rachel E.; Jacobson, Amanda C.; Frey, Mark R.; Corredor, Julissa; Polk, D. Brent; Shekels, Laurie L.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1501-1517</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Muc3 intestinal mucin contains an extracellular cysteine-rich domain with 2 epidermal growth factor (EGF)-like motifs.  The aim of this study was to det. the functional properties of Muc3 proteins.  Glutathione S-transferase-fusion proteins contg. both Muc3 EGF-like domains (m3EGF1,2) or truncated versions (m3EGF1 and m3EGF2) were purified from Escherichia coli.  Mouse colon (young adult mouse colon) and human A431 and LoVo cells were examd. for migration and tyrosine phosphorylation in response to recombinant proteins.  LoVo cells were transfected with a human MUC3A transmembrane-EGF1,2 construct and a stable clone was isolated (LhM3c14).  Endogenous MUC3A in LoVo was inhibited by specific small interfering RNA transfection.  Apoptosis was quantitated by nuclear morphol. or terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick-end labeling assay.  Colitis was induced in mice by oral 5% dextran sodium sulfate or rectal 5% acetic acid, followed by enema treatments.  m3EGF1,2 stimulated cell migration in all cell lines, but did not induce proliferation.  Migration was inhibited by a tyrosine phosphorylation inhibitor, genistein, but not by the EGF receptor inhibitor, tyrphostin (AG1478).  Inhibition of endogenous MUC3A in LoVo reduced baseline migration.  Tyrosine phosphorylation of ErbB receptors was not obsd. after treatment of cells with m3EGF1,2.  LoVo cells pretreated with m3EGF1,2 and transfected LhM3c14 cells showed reduced apoptosis in response to tumor necrosis factor α or Fas-receptor stimulation.  Administration of m3EGF1,2 per rectum significantly reduced mucosal ulceration and apoptosis in exptl. acute colitis.  Truncated proteins m3EGF1 and m3EGF2 had no effect.  The Muc3 mucin cysteine-rich domain plays an active role in epithelial restitution, and represents a potential novel therapeutic agent for intestinal wound healing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk3i6efVJG87Vg90H21EOLACvtfcHk0lhqZRmz7BXZeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlantrfK&md5=29bcfd935b97c40706b3af00eb8521a6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2006.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2006.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BB.%26aulast%3DDvorak%26aufirst%3DL.%2BA.%26aulast%3DMoor%26aufirst%3DR.%2BE.%26aulast%3DJacobson%26aufirst%3DA.%2BC.%26aulast%3DFrey%26aufirst%3DM.%2BR.%26aulast%3DCorredor%26aufirst%3DJ.%26aulast%3DPolk%26aufirst%3DD.%2BB.%26aulast%3DShekels%26aufirst%3DL.%2BL.%26atitle%3DCysteine-Rich%2520Domains%2520of%2520Muc3%2520Intestinal%2520Mucin%2520Promote%2520Cell%2520Migration%252C%2520Inhibit%2520Apoptosis%252C%2520and%2520Accelerate%2520Wound%2520Healing%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D1501%26epage%3D1517%26doi%3D10.1053%2Fj.gastro.2006.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buisine, M P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devisme, L</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savidge, T C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gespach, C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, B</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J P</span></span> <span> </span><span class="NLM_article-title">Mucin Gene Expression in Human Embryonic and Fetal Intestine</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1136/gut.43.4.519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1136%2Fgut.43.4.519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9824580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADyaK1M%252FntFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=519-524&author=M+P+Buisineauthor=L+Devismeauthor=T+C+Savidgeauthor=C+Gespachauthor=B+Gosselinauthor=N+Porchetauthor=J+P+Aubert&title=Mucin+Gene+Expression+in+Human+Embryonic+and+Fetal+Intestine&doi=10.1136%2Fgut.43.4.519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin gene expression in human embryonic and fetal intestine</span></div><div class="casAuthors">Buisine M P; Devisme L; Savidge T C; Gespach C; Gosselin B; Porchet N; Aubert J P</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">519-24</span>
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    </div><div class="casAbstract">BACKGROUND:  The intestinal epithelium is covered by a continuous layer of mucus which is secreted by well differentiated epithelial cells.  Disregulation of the expression of mucins has been reported to have possible implications in the neoplastic process which affects intestinal mucosae.  It is well known that preneoplastic and neoplastic tissues can express fetal phenotypic characteristics.  AIMS:  To assess whether the expression of mucin genes in the intestinal tract is linked to the stage of cellular differentiation and tissue development, by studying the expression of six mucin genes in human fetal small intestine and colon, and also adult tissues.  METHODS:  In situ hybridisation was used to study mRNA expression of MUC2, MUC3, MUC4, MUC5B, MUC5AC, and MUC6 in 32 human embryos and fetuses (6.5-27 weeks gestation).  Normal adult mucosae were used as controls.  RESULTS:  Three mucin genes, MUC2, MUC4, and MUC5AC, were differently expressed in fetal intestine compared with expression in normal adults.  CONCLUSION:  These differences in mucin gene expression suggest a possible regulatory role for these products in intestinal epithelial cell differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmzg6Bx2Gf7SXXDYhVZBdlfW6udTcc2eb4v5TlfyfdKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FntFahtw%253D%253D&md5=e44b470c30251c1aa000a3c626b82804</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1136%2Fgut.43.4.519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.43.4.519%26sid%3Dliteratum%253Aachs%26aulast%3DBuisine%26aufirst%3DM%2BP%26aulast%3DDevisme%26aufirst%3DL%26aulast%3DSavidge%26aufirst%3DT%2BC%26aulast%3DGespach%26aufirst%3DC%26aulast%3DGosselin%26aufirst%3DB%26aulast%3DPorchet%26aufirst%3DN%26aulast%3DAubert%26aufirst%3DJ%2BP%26atitle%3DMucin%2520Gene%2520Expression%2520in%2520Human%2520Embryonic%2520and%2520Fetal%2520Intestine%26jtitle%3DGut%26date%3D1998%26volume%3D43%26spage%3D519%26epage%3D524%26doi%3D10.1136%2Fgut.43.4.519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Constantinou, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. D.</span></span> <span> </span><span class="NLM_article-title">Transmembrane Mucin Expression and Function in Embryo Implantation and Placentation</span>. <i>Adv. Anat., Embryol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-15856-3_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2F978-3-319-15856-3_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26450494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC28zgsVSjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2015&pages=51-68&author=P.+E.+Constantinouauthor=M.+Morgadoauthor=D.+D.+Carson&title=Transmembrane+Mucin+Expression+and+Function+in+Embryo+Implantation+and+Placentation&doi=10.1007%2F978-3-319-15856-3_4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane Mucin Expression and Function in Embryo Implantation and Placentation</span></div><div class="casAuthors">Constantinou Pamela E; Morgado Micaela; Carson Daniel D; Carson Daniel D</div><div class="citationInfo"><span class="NLM_cas:title">Advances in anatomy, embryology, and cell biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-68</span>
        ISSN:<span class="NLM_cas:issn">0301-5556</span>.
    </div><div class="casAbstract">Transmembrane mucins (TMs) are extremely large, complex glycoproteins that line the apical surfaces of simple epithelia including those of the female reproductive tract.  TMs provide a physical barrier consistent with their role as part of the innate immune system.  This barrier function must be overcome in the context of embryo implantation to permit blastocyst attachment.  Three major TMs have been identified in uterine epithelia of multiple species: MUC1, MUC4, and MUC16.  MUC1 has been found in all species studied to date, whereas expression of MUC4 and MUC16 have been less well studied and may be species specific.  The strategies for removing mucins to permit embryo attachment also vary in a species-specific way and include both hormonal suppression of TM gene expression and membrane clearance via cell surface proteases.  Studies emerging from the cancer literature indicate that TMs can modulate a surprisingly wide variety of signal transduction processes.  Furthermore, various cell surface proteins have been identified that bind either the oligosaccharide or protein motifs of TMs suggesting that these molecules may support cell attachment in some contexts, including trophoblast interactions with cells of the immune system.  The intimate association of TMs at sites of embryo-maternal interaction and the varied functions these complex molecules can play make them key players in embryo implantation and placentation processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRy2yIyExYNymlSCSgBhwJFfW6udTcc2eb4v5TlfyfdKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zgsVSjtg%253D%253D&md5=a96ed918cd17831aa07b18d230715e87</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-15856-3_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-15856-3_4%26sid%3Dliteratum%253Aachs%26aulast%3DConstantinou%26aufirst%3DP.%2BE.%26aulast%3DMorgado%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DD.%2BD.%26atitle%3DTransmembrane%2520Mucin%2520Expression%2520and%2520Function%2520in%2520Embryo%2520Implantation%2520and%2520Placentation%26jtitle%3DAdv.%2520Anat.%252C%2520Embryol.%2520Cell%2520Biol.%26date%3D2015%26volume%3D216%26spage%3D51%26epage%3D68%26doi%3D10.1007%2F978-3-319-15856-3_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichtner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prehn, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. P.</span></span> <span> </span><span class="NLM_article-title">Mucin Glycoproteins Block Apoptosis; Promote Invasion, Proliferation, and Migration; and Cause Chemoresistance through Diverse Pathways in Epithelial Cancers</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1007/s10555-019-09781-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs10555-019-09781-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=30680581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVCjtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=237-257&author=I.+S.+Reynoldsauthor=M.+Fichtnerauthor=D.+A.+McNamaraauthor=E.+W.+Kayauthor=J.+H.+M.+Prehnauthor=J.+P.+Burke&title=Mucin+Glycoproteins+Block+Apoptosis%3B+Promote+Invasion%2C+Proliferation%2C+and+Migration%3B+and+Cause+Chemoresistance+through+Diverse+Pathways+in+Epithelial+Cancers&doi=10.1007%2Fs10555-019-09781-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers</span></div><div class="casAuthors">Reynolds, Ian S.; Fichtner, Michael; McNamara, Deborah A.; Kay, Elaine W.; Prehn, Jochen H. M.; Burke, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">237-257</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Overexpression of mucin glycoproteins has been demonstrated in many epithelial-derived cancers.  The significance of this overexpression remains uncertain.  The aim of this paper was to define the assocn. of mucin glycoproteins with apoptosis, cell growth, invasion, migration, adhesion, and clonogenicity in vitro as well as tumor growth, tumorigenicity, and metastasis in vivo in epithelial-derived cancers by performing a systematic review of all published data.  A systematic review of PubMed, Embase, and the Cochrane Central Register of Controlled Trials was performed to identify all papers that evaluated the assocn. between mucin glycoproteins with apoptosis, cell growth, invasion, migration, adhesion, and clonogenicity in vitro as well as tumor growth, tumorigenicity, and metastasis in vivo in epithelial-derived cancers.  PRISMA guidelines were adhered to.  Results of individual studies were extd. and pooled together based on the organ in which the cancer was derived from.  The initial search revealed 2031 papers, of which 90 were deemed eligible for inclusion in the study.  The studies included details on MUC1, MUC2, MUC4, MUC5AC, MUC5B, MUC13, and MUC16.  The majority of studies evaluated MUC1.  MUC1 overexpression was consistently assocd. with resistance to apoptosis and resistance to chemotherapy.  There was also evidence that overexpression of MUC2, MUC4, MUC5AC, MUC5B, MUC13, and MUC16 conferred resistance to apoptosis in epithelial-derived cancers.  The overexpression of mucin glycoproteins is assocd. with resistance to apoptosis in numerous epithelial cancers.  They cause resistance through diverse signaling pathways.  Targeting the expression of mucin glycoproteins represents a potential therapeutic target in the treatment of epithelial-derived cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK0HgIuw40SrVg90H21EOLACvtfcHk0lgRopSZOtrIUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVCjtLvE&md5=c537ecc850fa0d592311d8f57f3408e8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10555-019-09781-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-019-09781-w%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DI.%2BS.%26aulast%3DFichtner%26aufirst%3DM.%26aulast%3DMcNamara%26aufirst%3DD.%2BA.%26aulast%3DKay%26aufirst%3DE.%2BW.%26aulast%3DPrehn%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26atitle%3DMucin%2520Glycoproteins%2520Block%2520Apoptosis%253B%2520Promote%2520Invasion%252C%2520Proliferation%252C%2520and%2520Migration%253B%2520and%2520Cause%2520Chemoresistance%2520through%2520Diverse%2520Pathways%2520in%2520Epithelial%2520Cancers%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2019%26volume%3D38%26spage%3D237%26epage%3D257%26doi%3D10.1007%2Fs10555-019-09781-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinall, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">MUC3 Human Intestinal Mucin. Analysis of Gene Structure, the Carboxyl Terminus, and a Novel Upstream Repetitive Region</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">26678</span>– <span class="NLM_lpage">26686</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.42.26678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.272.42.26678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9334251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2sXmvV2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=26678-26686&author=J.+R.+Gumauthor=J.+J.+Hoauthor=W.+S.+Prattauthor=J.+W.+Hicksauthor=A.+S.+Hillauthor=L.+E.+Vinallauthor=A.+M.+Robertonauthor=D.+M.+Swallowauthor=Y.+S.+Kim&title=MUC3+Human+Intestinal+Mucin.+Analysis+of+Gene+Structure%2C+the+Carboxyl+Terminus%2C+and+a+Novel+Upstream+Repetitive+Region&doi=10.1074%2Fjbc.272.42.26678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region</span></div><div class="casAuthors">Gum, James R., Jr.; Ho, Jenny J. L.; Pratt, Wendy S.; Hicks, James W.; Hill, Alex S.; Vinall, Lynne E.; Roberton, Anthony M.; Swallow, Dallas M.; Kim, Young S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">26678-26686</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MUC3 is a large mucin glycoprotein expressed by the human intestine and gall bladder.  In this manuscript, we present details of the deduced protein structure of MUC3.  The MUC3 carboxyl-terminal domain is 617 residues in length, including 511 residues of a non-repetitive mucin-like domain (27% Thr, 22% Ser, and 11% Pro) and a 106-residue Cys-rich domain with homol. to the epidermal growth factor (EGF)-like structural motifs found in many proteins.  The region of MUC3 located upstream of the previously described 51-base pair (bp) tandem repeats, which encode a major Ser and Thr-rich domain, consists of a second type of repetitive structure with an imperfect periodicity of approx. 1125 bp.  This domain is also mucin-like and appears to be considerably larger than 2000 residues (6000 bp).  The MUC3 gene itself is large and complex.  Using pulse field gel electrophoresis and blot anal., the smallest fragment found that contained all human genomic DNA hybridizing to the 51-bp tandem repeat probe was 200 kilobases with restriction enzyme SwaI.  Both PvuII and PstI produced two sets of hybridizing fragments that were hypervariable within the human population with a pattern suggestive of both a variation in the no. of tandem repeats (VNTR) and sequence polymorphism.  These fragments varied independently of each other, but no genetic recombination was detected in a study of 40 human families.  Thus, the MUC3 gene encodes a very large glycoprotein with a structure very different from that of any mucin currently described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKsYYDWJqIybVg90H21EOLACvtfcHk0lgRopSZOtrIUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvV2it7g%253D&md5=24908161ac35ce86ddcbadeeb07fe43d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.42.26678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.42.26678%26sid%3Dliteratum%253Aachs%26aulast%3DGum%26aufirst%3DJ.%2BR.%26aulast%3DHo%26aufirst%3DJ.%2BJ.%26aulast%3DPratt%26aufirst%3DW.%2BS.%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DHill%26aufirst%3DA.%2BS.%26aulast%3DVinall%26aufirst%3DL.%2BE.%26aulast%3DRoberton%26aufirst%3DA.%2BM.%26aulast%3DSwallow%26aufirst%3DD.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DMUC3%2520Human%2520Intestinal%2520Mucin.%2520Analysis%2520of%2520Gene%2520Structure%252C%2520the%2520Carboxyl%2520Terminus%252C%2520and%2520a%2520Novel%2520Upstream%2520Repetitive%2520Region%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D26678%26epage%3D26686%26doi%3D10.1074%2Fjbc.272.42.26678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, D. M.</span></span> <span> </span><span class="NLM_article-title">Multiple Transcripts of MUC3: Evidence for Two Genes, MUC3A and MUC3B</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2000.3406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1006%2Fbbrc.2000.3406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10973822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFGltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=916-923&author=W.+S.+Prattauthor=S.+Crawleyauthor=J.+Hicksauthor=J.+Hoauthor=M.+Nashauthor=Y.+S.+Kimauthor=J.+R.+J.+Gumauthor=D.+M.+Swallow&title=Multiple+Transcripts+of+MUC3%3A+Evidence+for+Two+Genes%2C+MUC3A+and+MUC3B&doi=10.1006%2Fbbrc.2000.3406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B</span></div><div class="casAuthors">Pratt, Wendy S.; Crawley, Suzanne; Hicks, Jim; Ho, Jenny; Nash, Matthew; Kim, Young S.; Gum, James R.; Swallow, Dallas M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-923</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The MUC3 gene encodes a transmembrane mucin-type glycoprotein.  A no. of consistent single nucleotide changes were obsd. in different MUC3 cDNAs from a single individual, suggesting the presence of at least three different transcripts per individual.  This transcript heterogeneity is due both to the existence of a second copy of the MUC3 gene and to allelic changes.  Sequencing of the second MUC3 shows that it has the same C-terminal domain and intron/exon structure as the previously described MUC3.  The tandem repeat domain has the same amino acid consensus sequence but shows more substitutions.  The unique exonic sequences range from 94 to 100% identity at the nucleotide level and correspondingly few amino acid changes have been identified.  The introns show around 95% identity.  We propose to name this second gene MUC3B, MUC3A being reserved for the first MUC3 gene.  MUC3B, like MUC3A, is expressed in intestine and Caco-2 cells.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk8ca8l86QmbVg90H21EOLACvtfcHk0lgRopSZOtrIUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFGltrs%253D&md5=c1fe1a9626cbd0688f6c8a8a59725126</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2000.3406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2000.3406%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DW.%2BS.%26aulast%3DCrawley%26aufirst%3DS.%26aulast%3DHicks%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DJ.%26aulast%3DNash%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DGum%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DSwallow%26aufirst%3DD.%2BM.%26atitle%3DMultiple%2520Transcripts%2520of%2520MUC3%253A%2520Evidence%2520for%2520Two%2520Genes%252C%2520MUC3A%2520and%2520MUC3B%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D275%26spage%3D916%26epage%3D923%26doi%3D10.1006%2Fbbrc.2000.3406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nollet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span> <span> </span><span class="NLM_article-title">Complete Sequence of The Human Mucin MUC4: a Putative Cell Membrane-Associated Mucin</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1042/0264-6021:3380325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj3380325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10024507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXitVGks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1999&pages=325-333&author=N.+Moniauxauthor=S.+Nolletauthor=N.+Porchetauthor=P.+Degandauthor=A.+Laineauthor=J.+P.+Aubert&title=Complete+Sequence+of+The+Human+Mucin+MUC4%3A+a+Putative+Cell+Membrane-Associated+Mucin&doi=10.1042%2F0264-6021%3A3380325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin</span></div><div class="casAuthors">Moniaux, Nicolas; Nollet, Severine; Porchet, Nicole; Degand, Pierre; Laine, Anne; Aubert, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-333</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The MUC4 gene, which encodes a human epithelial mucin, is expressed in various epithelial tissues, just as well in adult as in poorly differentiated cells in the embryo and fetus.  Its N-terminus and central sequences have previously been reported as comprising a 27-residue peptide signal, followed by a large domain varying in length from 3285 to 7285 amino acid residues.  The present study establishes the whole coding sequence of MUC4 in which the C-terminus is 1156 amino acid residues long and shares a high degree of similarity with the rat sialomucin complex (SMC).  SMC is a heterodimeric glycoprotein complex composed of mucin (ascites sialoglycoprotein 1, ASGP-1) and transmembrane (ASGP-2) subunits.  The same organization is found in MUC4, where the presence of a GlyAspProHis proteolytic site may cleave the large precursor into two subunits, MUC4α and MUC4β.  Like ASGP-2, which binds the receptor tyrosine kinase p185neu, MUC4β possesses two epidermal growth factor-like domains, a transmembrane sequence and a potential phosphorylated site.  MUC4, the human homolog of rat SMC, may be a heterodimeric bifunctional cell-surface glycoprotein of 2.12 μm.  These results confer a new biol. role for MUC4 as a ligand for ErbB2 in cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBgPHz2KOx17Vg90H21EOLACvtfcHk0lhL84BZ8mxmXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVGks7k%253D&md5=b3fded696fa0312672e1f5e7c8244d83</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1042%2Fbj3380325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3380325%26sid%3Dliteratum%253Aachs%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DNollet%26aufirst%3DS.%26aulast%3DPorchet%26aufirst%3DN.%26aulast%3DDegand%26aufirst%3DP.%26aulast%3DLaine%26aufirst%3DA.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26atitle%3DComplete%2520Sequence%2520of%2520The%2520Human%2520Mucin%2520MUC4%253A%2520a%2520Putative%2520Cell%2520Membrane-Associated%2520Mucin%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D338%26spage%3D325%26epage%3D333%26doi%3D10.1042%2F0264-6021%3A3380325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigoutsos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparrow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunwoodie, S. L.</span></span> <span> </span><span class="NLM_article-title">Evolution of Distinct EGF Domains with Specific Functions</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1110/ps.041207005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1110%2Fps.041207005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15772310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1091-1103&author=M.+A.+Woutersauthor=I.+Rigoutsosauthor=C.+K.+Chuauthor=L.+L.+Fengauthor=D.+B.+Sparrowauthor=S.+L.+Dunwoodie&title=Evolution+of+Distinct+EGF+Domains+with+Specific+Functions&doi=10.1110%2Fps.041207005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of distinct EGF domains with specific functions</span></div><div class="casAuthors">Wouters, Merridee A.; Rigoutsos, Isidore; Chu, Carmen K.; Feng, Lina L.; Sparrow, Duncan B.; Dunwoodie, Sally L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1091-1103</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">EGF domains are extracellular protein modules cross-linked by three intra-domain disulfides.  Past studies suggest the existence of two types of EGF domain with three-disulfides, human EGF-like (hEGF) domains and complement C1r-like (cEGF) domains, but to date no functional information has been related to the two different types, and they are not differentiated in sequence or structure databases.  We have developed new sequence patterns based on the different C-termini to search specifically for the two types of EGF domains in sequence databases.  The exhibited sensitivity and specificity of the new pattern-based method represents a significant advancement over the currently available sequence detection techniques.  We re-annotated EGF sequences in the latest release of Swiss-Prot looking for functional relationships that might correlate with EGF type.  We show that important post-translational modifications of three-disulfide EGFs, including unusual forms of glycosylation and post-translational proteolytic processing, are dependent on EGF subtype.  For example, EGF domains that are shed from the cell surface and mediate intercellular signaling are all hEGFs, as are all human EGF receptor family ligands.  Addnl. exptl. data suggest that functional specialization has accompanied subtype divergence.  Based on our structural anal. of EGF domains with three-disulfide bonds and comparison to laminin and integrin-like EGF domains with an addnl. inter-domain disulfide, we propose that these hEGF and cEGF domains may have arisen from a four-disulfide ancestor by selective loss of different cysteine residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE3REf-ife8LVg90H21EOLACvtfcHk0lhL84BZ8mxmXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislOmsrY%253D&md5=7cff3e1aba722fcdcaf6f998dd4d7b9d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1110%2Fps.041207005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.041207005%26sid%3Dliteratum%253Aachs%26aulast%3DWouters%26aufirst%3DM.%2BA.%26aulast%3DRigoutsos%26aufirst%3DI.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DFeng%26aufirst%3DL.%2BL.%26aulast%3DSparrow%26aufirst%3DD.%2BB.%26aulast%3DDunwoodie%26aufirst%3DS.%2BL.%26atitle%3DEvolution%2520of%2520Distinct%2520EGF%2520Domains%2520with%2520Specific%2520Functions%26jtitle%3DProtein%2520Sci.%26date%3D2005%26volume%3D14%26spage%3D1091%26epage%3D1103%26doi%3D10.1110%2Fps.041207005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">Initiation of Transcription of the MUC3A Human Intestinal Mucin from a TATA-Less Promoter and Comparison with the MUC3B Amino Terminus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">49600</span>– <span class="NLM_lpage">49609</span>, <span class="refDoi"> DOI: 10.1074/jbc.M305769200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M305769200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12958310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49600-49609&author=J.+R.+J.+Gumauthor=J.+W.+Hicksauthor=S.+C.+Crawleyauthor=C.+M.+Dahlauthor=S.+C.+Yangauthor=A.+M.+Robertonauthor=Y.+S.+Kim&title=Initiation+of+Transcription+of+the+MUC3A+Human+Intestinal+Mucin+from+a+TATA-Less+Promoter+and+Comparison+with+the+MUC3B+Amino+Terminus&doi=10.1074%2Fjbc.M305769200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation of Transcription of the MUC3A Human Intestinal Mucin from a TATA-less Promoter and Comparison with the MUC3B Amino Terminus</span></div><div class="casAuthors">Gum, James R., Jr.; Hicks, James W.; Crawley, Suzanne C.; Dahl, Christine M.; Yang, Stacey C.; Roberton, Anthony M.; Kim, Young S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49600-49609</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human intestinal mucin genes MUC3A and MUC3B are members of a membrane mucin gene family residing at chromosome 7q22.  In this paper, we utilized genomic and cDNA cloning to elucidate the sequence of the 5'-region of the MUC3A gene including the gene promoter and the amino terminus coding sequence.  Following its 21-residue signal peptide, the amino terminus of the mucin consists of a 233-residue Thr-, Ser-, and Pro-rich nonrepetitive sequence that is contiguous with its hypervariable domain of 375-residue repeats.  RNase protection anal. and 5'-GeneRacer PCR indicated that MUC3A gene transcripts initiate from multiple start sites along a region spanning ∼180 bases.  The 5'-flanking region of the gene had promoter activity when fused to a luciferase reporter gene in all of the tested cell lines.  This region contained binding sites for several transcription factors, including those implicated in the regulation of intestinal genes, but lacked a cognate TATA box.  These features of the gene promoter may enable the gene to be expressed at variable levels in several cell types with different repertoires of transcription factors.  We also utilized 5'-GeneRacer PCR to det. the sequence of the 5'-terminus of the MUC3B message.  The amino termini of the MUC3A and MUC3B mucins are 91% conserved at the amino acid level.  Thus, MUC3A and MUC3B have highly conserved amino and carboxyl termini, suggesting a recent duplication of the entire ancestral gene.  It remains to be detd. whether other members of the 7q22 membrane mucin gene family have amino-terminal domains similar to MUC3A and MUC3B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9JuJz1tmsbVg90H21EOLACvtfcHk0lhL84BZ8mxmXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrtb8%253D&md5=297fda904bd75ab6f7323307c42ba78e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305769200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305769200%26sid%3Dliteratum%253Aachs%26aulast%3DGum%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DCrawley%26aufirst%3DS.%2BC.%26aulast%3DDahl%26aufirst%3DC.%2BM.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DRoberton%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DInitiation%2520of%2520Transcription%2520of%2520the%2520MUC3A%2520Human%2520Intestinal%2520Mucin%2520from%2520a%2520TATA-Less%2520Promoter%2520and%2520Comparison%2520with%2520the%2520MUC3B%2520Amino%2520Terminus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49600%26epage%3D49609%26doi%3D10.1074%2Fjbc.M305769200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmai-Pallag, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodabukus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinarsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leir, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A.</span></span> <span> </span><span class="NLM_article-title">The Role of the SEA (Sea Urchin Sperm Protein, Enterokinase and Agrin) Module in Cleavage of Membrane-Tethered Mucins</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2911</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2005.04711.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1111%2Fj.1742-4658.2005.04711.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15943821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Cmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2005&pages=2901-2911&author=T.+Palmai-Pallagauthor=N.+Khodabukusauthor=L.+Kinarskyauthor=S.+H.+Leirauthor=S.+Shermanauthor=M.+A.+Hollingsworthauthor=A.+Harris&title=The+Role+of+the+SEA+%28Sea+Urchin+Sperm+Protein%2C+Enterokinase+and+Agrin%29+Module+in+Cleavage+of+Membrane-Tethered+Mucins&doi=10.1111%2Fj.1742-4658.2005.04711.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins</span></div><div class="casAuthors">Palmai-Pallag, Timea; Khodabukus, Naila; Kinarsky, Leo; Leir, Shih-Hsing; Sherman, Simon; Hollingsworth, Michael A.; Harris, Ann</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2901-2911</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The membrane-tethered mucins are cell surface-assocd. dimeric or multimeric mols. with extracellular, transmembrane and cytoplasmic portions, that arise from cleavage of the primary polypeptide chain.  Following the first cleavage, which may be cotranslational, the subunits remain closely assocd. through undefined noncovalent interactions.  These mucins all share a common structural motif, the SEA module that is found in many other membrane-assocd. proteins that are released from the cell surface and has been implicated in both the cleavage events and assocn. of the subunits.  Here we examine the SEA modules of three membrane-tethered mucins, MUC1, MUC3 and MUC12, which have significant sequence homol. within the SEA domain.  We previously identified the primary cleavage site within the MUC1 SEA domain as FRPG/SVVV, a sequence that is highly conserved in MUC3 and MUC12.  We now show by site-directed mutagenesis that the F, G and S residues are important for the efficiency of the cleavage reaction but not indispensable and that amino acids outside this motif are probably important.  These data are consistent with a new model of the MUC1 SEA domain that is based on the soln. structure of the MUC16 SEA module, derived by NMR spectroscopy.  Further, we demonstrate that cleavage of human MUC3 and MUC12 occurs within the SEA domain.  However, the SEA domains of MUC1, MUC3 and MUC12 are not interchangeable, suggesting that either these modules alone are insufficient to mediate efficient cleavage or that the 3D structure of the hybrid mols. does not adequately recreate an accessible cleavage site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGAQm6_LkJ97Vg90H21EOLACvtfcHk0lhL84BZ8mxmXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Cmsrs%253D&md5=5d9a53d3f6e5a1a290aac1c4bd137e4a</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2005.04711.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2005.04711.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalmai-Pallag%26aufirst%3DT.%26aulast%3DKhodabukus%26aufirst%3DN.%26aulast%3DKinarsky%26aufirst%3DL.%26aulast%3DLeir%26aufirst%3DS.%2BH.%26aulast%3DSherman%26aufirst%3DS.%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DHarris%26aufirst%3DA.%26atitle%3DThe%2520Role%2520of%2520the%2520SEA%2520%2528Sea%2520Urchin%2520Sperm%2520Protein%252C%2520Enterokinase%2520and%2520Agrin%2529%2520Module%2520in%2520Cleavage%2520of%2520Membrane-Tethered%2520Mucins%26jtitle%3DFEBS%2520J.%26date%3D2005%26volume%3D272%26spage%3D2901%26epage%3D2911%26doi%3D10.1111%2Fj.1742-4658.2005.04711.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">Mucin 13: Structure, Function, and Potential Roles in Cancer Pathogenesis</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-10-0443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F1541-7786.MCR-10-0443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=21450906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVGlsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=531-537&author=D.+M.+Maherauthor=B.+K.+Guptaauthor=S.+Nagataauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=Mucin+13%3A+Structure%2C+Function%2C+and+Potential+Roles+in+Cancer+Pathogenesis&doi=10.1158%2F1541-7786.MCR-10-0443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin 13: Structure, Function, and Potential Roles in Cancer Pathogenesis</span></div><div class="casAuthors">Maher, Diane M.; Gupta, Brij K.; Nagata, Satoshi; Jaggi, Meena; Chauhan, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">531-537</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Mucin 13 (MUC13) is a high-mol.-wt. transmembrane glycoprotein that is frequently and aberrantly expressed in a variety of epithelial carcinomas, including gastric, colorectal, and ovarian cancers.  On the basis of the high expression of MUC13 in cancer cells as well as recent lab. findings suggesting a malignant phenotype of MUC13-transfected cell lines, the oncogenic potential of MUC13 has emerged.  The various functional domains of MUC13 may confer oncogenic potential to MUC13.  For example, the bulky extracellular domain with extensive modification with glycan chains may prevent cell-cell and cell-extracellular matrix binding whereas the cytoplasmic tail contg. serine and tyrosine residues for potential phosphorylation may participate in cell signaling.  MUC13 exhibits the characteristics suitable as an early marker for cancer screening and presents a promising target for antibody-guided targeted therapy.  Mol Cancer Res; 9(5); 531-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo38FEcWYk_77Vg90H21EOLACvtfcHk0lhRUIdp6NC9jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVGlsb4%253D&md5=72dec84545e4d80f1927fade058f2da7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-10-0443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-10-0443%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DD.%2BM.%26aulast%3DGupta%26aufirst%3DB.%2BK.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DMucin%252013%253A%2520Structure%252C%2520Function%252C%2520and%2520Potential%2520Roles%2520in%2520Cancer%2520Pathogenesis%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D531%26epage%3D537%26doi%3D10.1158%2F1541-7786.MCR-10-0443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogiso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(02)00963-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2FS0092-8674%2802%2900963-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12297050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=775-787&author=H.+Ogisoauthor=R.+Ishitaniauthor=O.+Nurekiauthor=S.+Fukaiauthor=M.+Yamanakaauthor=J.+H.+Kimauthor=K.+Saitoauthor=A.+Sakamotoauthor=M.+Inoueauthor=M.+Shirouzuauthor=S.+Yokoyama&title=Crystal+Structure+of+the+Complex+of+Human+Epidermal+Growth+Factor+and+Receptor+Extracellular+Domains&doi=10.1016%2FS0092-8674%2802%2900963-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains</span></div><div class="casAuthors">Ogiso, Hideo; Ishitani, Ryuichiro; Nureki, Osamu; Fukai, Shuya; Yamanaka, Mari; Kim, Jae-Hoon; Saito, Kazuki; Sakamoto, Ayako; Inoue, Mio; Shirouzu, Mikako; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-787</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Epidermal growth factor (EGF) regulates cell proliferation and differentiation by binding to the EGF receptor (EGFR) extracellular region, comprising domains I-IV, with the resultant dimerization of the receptor tyrosine kinase.  In this study, the crystal structure of a 2:2 complex of human EGF and the EGFR extracellular region has been detd. at 3.3 Å resoln.  EGFR domains I-III are arranged in a C shape, and EGF is docked between domains I and III.  The 1:1 EGF•EGFR complex dimerizes through a direct receptor•receptor interaction, in which a protruding β-hairpin arm of each domain II holds the body of the other.  The unique "receptor-mediated dimerization" was verified by EGFR mutagenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqILejwMfkBaLVg90H21EOLACvtfcHk0lhRUIdp6NC9jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKisL8%253D&md5=f909ae76aad06fb0a8704ee101e76310</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900963-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900963-7%26sid%3Dliteratum%253Aachs%26aulast%3DOgiso%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DNureki%26aufirst%3DO.%26aulast%3DFukai%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Complex%2520of%2520Human%2520Epidermal%2520Growth%2520Factor%2520and%2520Receptor%2520Extracellular%2520Domains%26jtitle%3DCell%26date%3D2002%26volume%3D110%26spage%3D775%26epage%3D787%26doi%3D10.1016%2FS0092-8674%2802%2900963-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Woning, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venselaar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rotterdam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs-Oomen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leeuwen, J. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zoelen, E. J. J.</span></span> <span> </span><span class="NLM_article-title">Role of the C-Terminal Linear Region of EGF-Like Growth Factors in ErbB Specificity</span>. <i>Growth Factors</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1080/08977190902891010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1080%2F08977190902891010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19384683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlagtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=163-172&author=S.+P.+van%0Ader+Woningauthor=H.+Venselaarauthor=W.+van+Rotterdamauthor=S.+Jacobs-Oomenauthor=J.+E.+M.+van+Leeuwenauthor=E.+J.+J.+van+Zoelen&title=Role+of+the+C-Terminal+Linear+Region+of+EGF-Like+Growth+Factors+in+ErbB+Specificity&doi=10.1080%2F08977190902891010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity</span></div><div class="casAuthors">van der Woning, Sebastian P.; Venselaar, Hanka; van Rotterdam, Walter; Jacobs-Oomen, Saskia; van Leeuwen, Jeroen E. M.; van Zoelen, Everardus J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Growth Factors</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">163-172</span>CODEN:
                <span class="NLM_cas:coden">GRFAEC</span>;
        ISSN:<span class="NLM_cas:issn">0897-7194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The epidermal growth factor (EGF)-like growth factors bind their ErbB receptors in a highly selective manner.  Recently, the authors have shown that the sequence YYDLL in the C-terminal linear region is compatible with binding to all ligand-binding ErbB receptors.  In the present study, the authors show that introduction of the YYDLL sequence into the ErbB1 specific ligands EGF and transforming growth factor-α (TGFα) broadened their receptor specificity towards ErbB4.  Upon introduction of the YYDLL sequence into epiregulin, which by itself binds ErbB1 and ErbB4 but not ErbB3, its binding specificity was broadened to ErbB3, concomitant with enhanced affinity for ErbB4.  Introduction of the YYDLL sequence into NRG1β resulted in a 10-fold increase in affinity for ErbB3, without affecting its receptor specificity.  Remarkably, the strongly enhanced affinity for ErbB3 neg. influenced their mitogenic activity towards cells coexpressing ErbB2 and ErbB3.  These observations are discussed in terms of the optimized ErbB affinity, selectivity and mitogenic potential that have taken place during evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz-9GnGuDqlrVg90H21EOLACvtfcHk0lhRUIdp6NC9jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlagtrg%253D&md5=a4b961455018e63a4408a09217fc7972</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1080%2F08977190902891010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08977190902891010%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWoning%26aufirst%3DS.%2BP.%26aulast%3DVenselaar%26aufirst%3DH.%26aulast%3Dvan%2BRotterdam%26aufirst%3DW.%26aulast%3DJacobs-Oomen%26aufirst%3DS.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DJ.%2BE.%2BM.%26aulast%3Dvan%2BZoelen%26aufirst%3DE.%2BJ.%2BJ.%26atitle%3DRole%2520of%2520the%2520C-Terminal%2520Linear%2520Region%2520of%2520EGF-Like%2520Growth%2520Factors%2520in%2520ErbB%2520Specificity%26jtitle%3DGrowth%2520Factors%26date%3D2009%26volume%3D27%26spage%3D163%26epage%3D172%26doi%3D10.1080%2F08977190902891010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bork, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patthy, L.</span></span> <span> </span><span class="NLM_article-title">The SEA Module: a New Extracellular Domain Associated with O-Glycosylation</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1421</span>– <span class="NLM_lpage">1425</span>, <span class="refDoi"> DOI: 10.1002/pro.5560040716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fpro.5560040716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=7670383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=1421-1425&author=P.+Borkauthor=L.+Patthy&title=The+SEA+Module%3A+a+New+Extracellular+Domain+Associated+with+O-Glycosylation&doi=10.1002%2Fpro.5560040716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The SEA module: a new extracellular domain associated with O-glycosylation</span></div><div class="casAuthors">Bork, Peer; Patthy, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1421-5</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Using a variety of homol. search methods and multiple alignments, a new extracellular module was identified in (1) agrin, (2) enterokinase, (3) a 63-kDa sea urchin sperm protein, (4) perlecan, (5) the breast cancer marker MUC1 (episialin), (6) the cell surface antigen 114/A10, and (7/8) two functionally uncharacterized, probably extracellular, Caenorhabditis elegans proteins.  Despite the functional diversity of these adhesive proteins, a common denominator seems to be their existence in heavily glycosylated environments.  In addn., the better characterized proteins mentioned above contain all O-glycosidic-linked carbohydrates such as heparan sulfate that contribute considerably to their mol. masses.  The common module might regulate or assist binding to neighboring carbohydrate moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnywONmeXVM7Vg90H21EOLACvtfcHk0ljKgndkjNTSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D&md5=e9f3b8fcf8a3bcbaaf27588d9aeffede</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560040716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560040716%26sid%3Dliteratum%253Aachs%26aulast%3DBork%26aufirst%3DP.%26aulast%3DPatthy%26aufirst%3DL.%26atitle%3DThe%2520SEA%2520Module%253A%2520a%2520New%2520Extracellular%2520Domain%2520Associated%2520with%2520O-Glycosylation%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D1421%26epage%3D1425%26doi%3D10.1002%2Fpro.5560040716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgotto, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaudin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chissoe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chothia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of the Polycystic Kidney Disease 1 (PKD1) Gene Reveals an Integral Membrane Glycoprotein with Multiple Evolutionary Conserved Domains</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1093/hmg/6.9.1483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1093%2Fhmg%2F6.9.1483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9285785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVGitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1997&pages=1483-1489&author=R.+Sandfordauthor=B.+Sgottoauthor=S.+Aparicioauthor=S.+Brennerauthor=M.+Vaudinauthor=R.+K.+Wilsonauthor=S.+Chissoeauthor=K.+Pepinauthor=A.+Batemanauthor=C.+Chothiaauthor=J.+Hughesauthor=P.+Harris&title=Comparative+Analysis+of+the+Polycystic+Kidney+Disease+1+%28PKD1%29+Gene+Reveals+an+Integral+Membrane+Glycoprotein+with+Multiple+Evolutionary+Conserved+Domains&doi=10.1093%2Fhmg%2F6.9.1483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains</span></div><div class="casAuthors">Sandford, Richard; Sgotto, Barbara; Aparicio, Sam; Brenner, Sydney; Vaudin, Mark; Wilson, Richard K.; Chissoe, Stephanie; Pepin, Kym; Bateman, Alex; Chothia, Cyrus; Hughes, Jim; Harris, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1483-1489</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">PKD1 is the major locus of the common genetic disorder autosomal dominant polycystic kidney disease (ADPKD).  Anal. of the predicted protein sequence of the human PKD1 gene, polycystin, shows a large mol. with a unique arrangement of extracellular domains and multiple putative transmembrane regions.  The precise function of polycystin remains unclear with a paucity of mutations to define key structural and functional domains.  To refine the structure of this protein the authors have cloned the genomic region encoding the Fugu PKD1 gene.  Fugu PKD1 spans 36 kb of genomic DNA and has greater complexity with 54 exons compared with 46 in man.  Comparative anal. of the predicted protein sequences shows a lower level of homol. than in similar studies with identity of 40 and 59% similarity.  However key structural motifs including leucine rich repeats (LRR), a C-type lectin and LDL-A like domains and 16 PKD repeats are maintained.  A region of homol. with the sea urchin REJ protein was also confirmed in Fugu but found to extend over 1000 amino acids.  Several highly conserved intra- and extra-cellular regions, with no known sequence homologies, that are likely to be of functional importance were detected.  The likely structure of the membrane assocd. region has been refined with similarity to the PKD2 protein and voltage gated Ca2+ and Na+ channels highlighted over part of this area.  The overall protein structure has therefore been clarified and this comparative anal. derived structure will form the basis for the functional study of polycystin and its individual domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps1tuih9LFkrVg90H21EOLACvtfcHk0ljKgndkjNTSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVGitrs%253D&md5=7078b5da3e9d29e88ba8e1de8fa5937c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F6.9.1483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F6.9.1483%26sid%3Dliteratum%253Aachs%26aulast%3DSandford%26aufirst%3DR.%26aulast%3DSgotto%26aufirst%3DB.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DVaudin%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26aulast%3DChissoe%26aufirst%3DS.%26aulast%3DPepin%26aufirst%3DK.%26aulast%3DBateman%26aufirst%3DA.%26aulast%3DChothia%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DP.%26atitle%3DComparative%2520Analysis%2520of%2520the%2520Polycystic%2520Kidney%2520Disease%25201%2520%2528PKD1%2529%2520Gene%2520Reveals%2520an%2520Integral%2520Membrane%2520Glycoprotein%2520with%2520Multiple%2520Evolutionary%2520Conserved%2520Domains%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1997%26volume%3D6%26spage%3D1483%26epage%3D1489%26doi%3D10.1093%2Fhmg%2F6.9.1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, N. V.</span></span> <span> </span><span class="NLM_article-title">Expansion of Divergent SEA Domains in Cell Surface Proteins and Nucleoporin 54</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1002/pro.3096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fpro.3096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=27977898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisV2ru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=617-630&author=J.+Peiauthor=N.+V.+Grishin&title=Expansion+of+Divergent+SEA+Domains+in+Cell+Surface+Proteins+and+Nucleoporin+54&doi=10.1002%2Fpro.3096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Expansion of divergent SEA domains in cell surface proteins and nucleoporin 54</span></div><div class="casAuthors">Pei, Jimin; Grishin, Nick V.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">617-630</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">SEA (sea urchin sperm protein, enterokinase, agrin) domains, many of which possess autoproteolysis activity, have been found in a no. of cell surface and secreted proteins.  Despite high sequence divergence, SEA domains were also proposed to be present in dystroglycan based on a conserved autoproteolysis motif and receptor-type protein phosphatase IA-2 based on structural similarity.  The presence of a SEA domain adjacent to the transmembrane segment appears to be a recurring theme in quite a no. of type I transmembrane proteins on the cell surface, such as MUC1, dystroglycan, IA-2, and Notch receptors.  By comparative sequence and structural analyses, we identified dystroglycan-like proteins with SEA domains in Capsaspora owczarzaki of the Filasterea group, one of the closest single-cell relatives of metazoans.  We also detected novel and divergent SEA domains in a variety of cell surface proteins such as EpCAM, α/ε-sarcoglycan, PTPRR, collectrin/Tmem27, amnionless, CD34, KIAA0319, fibrocystin-like protein, and a no. of cadherins.  While these proteins are mostly from metazoans or their single cell relatives such as choanoflagellates and Filasterea, fibrocystin-like proteins with SEA domains were found in several other eukaryotic lineages including green algae, Alveolata, Euglenozoa, and Haptophyta, suggesting an ancient evolutionary origin.  In addn., the intracellular protein Nucleoporin 54 (Nup54) acquired a divergent SEA domain in choanoflagellates and metazoans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fXi3UtZFQ7Vg90H21EOLACvtfcHk0ljKgndkjNTSbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisV2ru74%253D&md5=46694eb3e8caa25827dc7a924ffa2a85</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fpro.3096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3096%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26atitle%3DExpansion%2520of%2520Divergent%2520SEA%2520Domains%2520in%2520Cell%2520Surface%2520Proteins%2520and%2520Nucleoporin%252054%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D617%26epage%3D630%26doi%3D10.1002%2Fpro.3096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Secretion of Muc4/Sialomucin Complex: Implication of Intracellular Proteolysis</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1042/bj20020862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20020862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12186632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVOgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2002&pages=41-48&author=M.+Komatsuauthor=M.+E.+Arangoauthor=K.+L.+Carraway&title=Synthesis+and+Secretion+of+Muc4%2FSialomucin+Complex%3A+Implication+of+Intracellular+Proteolysis&doi=10.1042%2Fbj20020862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis</span></div><div class="casAuthors">Komatsu, Masanobu; Arango, Maria E.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Muc4/sialomucin complex (SMC) is a heterodimeric glycoprotein complex implicated in epithelial protection and overexpressed in some tumors.  It is encoded by a single gene, and the two subunits are produced by proteolytic cleavage at a time before substantial O-glycosylation, near the time of transit from the endoplasmic reticulum to the Golgi.  Although Muc4/SMC is translated as a membrane protein, it is produced as a sol. form in many epithelia.  Transfection expts. using Cos-7, HBL-100 human epithelial, MCF-7 human breast tumor and HC11 mouse mammary cell lines showed that sol. rat Muc4/SMC is produced by a proteolytic cleavage mechanism and released by secretion from multiple cell lines, including both human and mouse normal epithelial cells and tumor cells.  Similar transfection expts. demonstrated the same mechanism for the human analog MUC4.  Gel electrophoresis analyses of deglycosylated membrane and sol. transmembrane subunits and of the membrane-assocd. cleavage fragment indicated a released cleavage product of 25 kDa, resulting from cleavage between two epidermal growth factor-like domains.  Further evidence for this site was obtained from deletion mutants removing this region of the protein, which blocked secretion.  Finally, pulse-chase analyses of Muc4/SMC biosynthesis indicated no kinetic difference between the timing of the cleavage to release the sol. form and that to produce the two subunits, indicating that the sol. form is created early in transit to the cell surface.  These studies provide the first clear evidence that membrane mucins can be released from cells by an intracellular proteolytic mechanism that leads to secretion of the sol. form of the mucin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTdwdfME2jeLVg90H21EOLACvtfcHk0li2d3wnbks7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVOgtbs%253D&md5=092ea987bafd76faa9b7477b82cb8800</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2Fbj20020862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20020862%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DSynthesis%2520and%2520Secretion%2520of%2520Muc4%252FSialomucin%2520Complex%253A%2520Implication%2520of%2520Intracellular%2520Proteolysis%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D368%26spage%3D41%26epage%3D48%26doi%3D10.1042%2Fbj20020862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staros, J. V.</span></span> <span> </span><span class="NLM_article-title">Insights Into the Evolution of the Erbb Receptor Family and Their Ligands from Sequence Analysis</span>. <i>BMC Evol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">79</span>, <span class="refDoi"> DOI: 10.1186/1471-2148-6-79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2F1471-2148-6-79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17026767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD28nhvVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=79&author=R.+A.+Steinauthor=J.+V.+Staros&title=Insights+Into+the+Evolution+of+the+Erbb+Receptor+Family+and+Their+Ligands+from+Sequence+Analysis&doi=10.1186%2F1471-2148-6-79"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis</span></div><div class="casAuthors">Stein Richard A; Staros James V</div><div class="citationInfo"><span class="NLM_cas:title">BMC evolutionary biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  In the time since we presented the first molecular evolutionary study of the ErbB family of receptors and the EGF family of ligands, there has been a dramatic increase in genomic sequences available.  We have utilized this greatly expanded data set in this study of the ErbB family of receptors and their ligands.  RESULTS:  In our previous analysis we postulated that EGF family ligands could be characterized by the presence of a splice site in the coding region between the fourth and fifth cysteines of the EGF module and the placement of that module near the transmembrane domain.  The recent identification of several new ligands for the ErbB receptors supports this characterization of an ErbB ligand; further, applying this characterization to available sequences suggests additional potential ligands for these receptors, the EGF modules from previously identified proteins: interphotoreceptor matrix proteoglycan-2, the alpha and beta subunit of meprin A, and mucins 3, 4, 12, and 17.  The newly available sequences have caused some reorganizations of relationships among the ErbB ligand family, but they add support to the previous conclusion that three gene duplication events gave rise to the present family of four ErbB receptors among the tetrapods.  CONCLUSION:  This study provides strong support for the hypothesis that the presence of an easily identifiable sequence motif can distinguish EGF family ligands from other EGF-like modules and reveals several potential new EGF family ligands.  It also raises interesting questions about the evolution of ErbB2 and ErbB3: Does ErbB2 in teleosts function differently from ErbB2 in tetrapods in terms of ligand binding and intramolecular tethering? When did ErbB3 lose kinase activity, and what is the functional significance of the divergence of its kinase domain among teleosts?</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi1nU8Avu4MGLFM_lbR1VmfW6udTcc2eaQ2t059WcqI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nhvVyhtQ%253D%253D&md5=84e75c48950823330d28c0679b66a8d2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2F1471-2148-6-79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2148-6-79%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BA.%26aulast%3DStaros%26aufirst%3DJ.%2BV.%26atitle%3DInsights%2520Into%2520the%2520Evolution%2520of%2520the%2520Erbb%2520Receptor%2520Family%2520and%2520Their%2520Ligands%2520from%2520Sequence%2520Analysis%26jtitle%3DBMC%2520Evol.%2520Biol.%26date%3D2006%26volume%3D6%26spage%3D79%26doi%3D10.1186%2F1471-2148-6-79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, T.</span></span> <span> </span><span class="NLM_article-title">An Inventory of Mucin Genes in the Chicken Genome Shows that the Mucin Domain of Muc13 is Encoded by Multiple Exons and that Ovomucin is Part of a Locus of Related Gel-Forming Mucins</span>. <i>BMC Genomics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">197</span>, <span class="refDoi"> DOI: 10.1186/1471-2164-7-197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2F1471-2164-7-197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=16887038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD28rgtFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=197&author=T.+Langauthor=G.+C.+Hanssonauthor=T.+Samuelsson&title=An+Inventory+of+Mucin+Genes+in+the+Chicken+Genome+Shows+that+the+Mucin+Domain+of+Muc13+is+Encoded+by+Multiple+Exons+and+that+Ovomucin+is+Part+of+a+Locus+of+Related+Gel-Forming+Mucins&doi=10.1186%2F1471-2164-7-197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins</span></div><div class="casAuthors">Lang Tiange; Hansson Gunnar C; Samuelsson Tore</div><div class="citationInfo"><span class="NLM_cas:title">BMC genomics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Mucins are large glycoproteins that cover epithelial surfaces of the body.  All mucins contain at least one PTS domain, a region rich in proline, threonine and serine.  Mucins are also characterized by von Willebrand D (VWD) domains or SEA domains.  We have developed computational methods to identify mucin genes and proteins based on these properties of the proteins.  Using such methods we are able to characterize different organisms where genome sequence is available with respect to their mucin repertoire.  RESULTS:  We have here made a comprehensive analysis of potential mucins encoded by the chicken (Gallus gallus) genome.  Three transmembrane mucins (Muc4, Muc13, and Muc16) and four gel-forming mucins (Muc6, Muc2, Muc5ac, and Muc5b) were identified.  The gel-forming mucins are encoded within a locus similar to the corresponding human mucins.  However, the chicken has an additional gene inserted between Muc2 and Muc5ac that encodes the the alpha-subunit of ovomucin, a protein similar to Muc2, but it is lacking a PTS domain.  We also show that the beta-subunit of ovomucin is the orthologue of human MUC6.  The transmembrane Muc13 gene is in chicken as well as in mammals adjacent to the HEG (heart of glass) gene.  HEG has PTS, EGF and transmembrane domains like Muc13, suggesting that these two proteins are evolutionary related.  Unlike previously known mucins, the PTS domain of Muc13 is encoded by multiple exons, where each exon encodes a repeat unit of the PTS domain.  CONCLUSION:  We report new mucin homologues in chicken and this information will aid in understanding the evolution of mucins in vertebrates.  The fact that ovomucin, a protein not found in mammals, was located in the same locus as other gel-forming mucins provides strong support that these proteins are evolutionary related.  Furthermore, a relationship of HEG and the transmembrane Muc13 is suggested on the basis of their biochemical properties and their presence in the same locus.  Finally, our finding that the chicken Muc13 is distributed between multiple exons raises the interesting possibility that the length of the PTS domain could be controlled by alternative splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDcsBNFcQGDDAyhZbj3lKdfW6udTcc2eaQ2t059WcqI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rgtFegsA%253D%253D&md5=77a5ca6b6c37c51c5ebefe78b970f091</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1186%2F1471-2164-7-197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2164-7-197%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DT.%26aulast%3DHansson%26aufirst%3DG.%2BC.%26aulast%3DSamuelsson%26aufirst%3DT.%26atitle%3DAn%2520Inventory%2520of%2520Mucin%2520Genes%2520in%2520the%2520Chicken%2520Genome%2520Shows%2520that%2520the%2520Mucin%2520Domain%2520of%2520Muc13%2520is%2520Encoded%2520by%2520Multiple%2520Exons%2520and%2520that%2520Ovomucin%2520is%2520Part%2520of%2520a%2520Locus%2520of%2520Related%2520Gel-Forming%2520Mucins%26jtitle%3DBMC%2520Genomics%26date%3D2006%26volume%3D7%26spage%3D197%26doi%3D10.1186%2F1471-2164-7-197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mather, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oganessyan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foundling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, W.</span></span> <span> </span><span class="NLM_article-title">The 2.8 A Crystal Structure of Gla-Domainless Activated Protein C</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6822</span>– <span class="NLM_lpage">6831</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1996.tb01073.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fj.1460-2075.1996.tb01073.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9003757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2sXosFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=6822-6831&author=T.+Matherauthor=V.+Oganessyanauthor=P.+Hofauthor=R.+Huberauthor=S.+Foundlingauthor=C.+Esmonauthor=W.+Bode&title=The+2.8+A+Crystal+Structure+of+Gla-Domainless+Activated+Protein+C&doi=10.1002%2Fj.1460-2075.1996.tb01073.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.8 Å crystal structure of Gla-domainless activated protein C</span></div><div class="casAuthors">Mather, Timothy; Oganessyan, Vaheh; Hof, Peter; Huber, Robert; Foundling, Steven; Esmon, Charles; Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6822-6831</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The structure of the Gla-domainless form of the human anticoagulant enzyme activated protein C has been solved at 2.8 Å resoln.  The light chain is composed of two domains: an epidermal growth factor (EGF)-like domain modified by a large insert contg. an addnl. disulfide, followed by a typical EGF-like domain.  The arrangement of the long axis of these domains describes an angle of ∼80°.  Disulfide linked to the light chain is the catalytic domain, which is generally trypsin-like but contains a large insertion loop at the edge of the active site, a third helical segment, a prominent cationic patch analogous to the anion binding exosite I of thrombin and a trypsin-like Ca[II] binding site.  The arrangement of loops around the active site partially restricts access to the cleft.  The S2 and S4 subsites are much more polar than in factor Xa and thrombin, and the S2 site is unrestricted.  While quite open and exposed, the active site contains a prominent groove, the surface of which is very polar with evidence for binding sites on the primed side, in addn. to those typical of the trypsin class found on the non-primed side.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkej7gdt0PFLVg90H21EOLACvtfcHk0li2d3wnbks7oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXosFejtw%253D%253D&md5=8ccddc7ab7574d36a707326b5657f09d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb01073.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb01073.x%26sid%3Dliteratum%253Aachs%26aulast%3DMather%26aufirst%3DT.%26aulast%3DOganessyan%26aufirst%3DV.%26aulast%3DHof%26aufirst%3DP.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DFoundling%26aufirst%3DS.%26aulast%3DEsmon%26aufirst%3DC.%26aulast%3DBode%26aufirst%3DW.%26atitle%3DThe%25202.8%2520A%2520Crystal%2520Structure%2520of%2520Gla-Domainless%2520Activated%2520Protein%2520C%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D6822%26epage%3D6831%26doi%3D10.1002%2Fj.1460-2075.1996.tb01073.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kado, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizohata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyafusa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span> <span> </span><span class="NLM_article-title">Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5: Structural, Functional, and Molecular Dynamics Simulation Analyses</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">2319</span>– <span class="NLM_lpage">2330</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.656009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M115.656009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26627827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=2319-2330&author=Y.+Kadoauthor=E.+Mizohataauthor=S.+Nagatoishiauthor=M.+Iijimaauthor=K.+Shinodaauthor=T.+Miyafusaauthor=T.+Nakayamaauthor=T.+Yoshizumiauthor=A.+Sugiyamaauthor=T.+Kawamuraauthor=Y.-H.+Leeauthor=H.+Matsumuraauthor=H.+Doiauthor=H.+Fujitaniauthor=T.+Kodamaauthor=Y.+Shibasakiauthor=K.+Tsumotoauthor=T.+Inoue&title=Epiregulin+Recognition+Mechanisms+by+Anti-epiregulin+Antibody+9E5%3A+Structural%2C+Functional%2C+and+Molecular+Dynamics+Simulation+Analyses&doi=10.1074%2Fjbc.M115.656009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5</span></div><div class="casAuthors">Kado, Yuji; Mizohata, Eiichi; Nagatoishi, Satoru; Iijima, Mariko; Shinoda, Keiko; Miyafusa, Takamitsu; Nakayama, Taisuke; Yoshizumi, Takuma; Sugiyama, Akira; Kawamura, Takeshi; Lee, Young-Hun; Matsumura, Hiroyoshi; Doi, Hirofumi; Fujitani, Hideaki; Kodama, Tatsuhiko; Shibasaki, Yoshikazu; Tsumoto, Kouhei; Inoue, Tsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2319-2330</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Epiregulin (EPR) is a ligand of the epidermal growth factor (EGF) family that upon binding to its epidermal growth factor receptor (EGFR) stimulates proliferative signaling, esp. in colon cancer cells.  Here, we describe the three-dimensional structure of the EPR antibody (the 9E5(Fab) fragment) in the presence and absence of EPR.  Among the six complementarity-detg. regions (CDRs), CDR1-3 in the light chain and CDR2 in the heavy chain predominantly recognize EPR.  In particular, CDR3 in the heavy chain dramatically moves with cis-trans isomerization of Pro103.  A mol. dynamics simulation and mutational analyses revealed that Arg40 in EPR is a key residue for the specific binding of 9E5 IgG.  From isothermal titrn. calorimetry anal., the dissocn. const. was detd. to be 6.5 nm.  Surface plasmon resonance anal. revealed that the dissocn. rate of 9E5 IgG is extremely slow.  The superimposed structure of 9E5(Fab)·EPR on the known complex structure of EGF·EGFR showed that the 9E5(Fab) para-tope overlaps with Domains I and III on the EGFR, which reveals that the 9E5(Fab)·EPR complex could not bind to the EGFR.  The 9E5 antibody will also be useful in medicine as a neutralizing antibody specific for colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob94WIFMCWBLVg90H21EOLACvtfcHk0lhAUkdQebu-2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbg%253D&md5=56461f527bfd11fd88802296a0132b1d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.656009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.656009%26sid%3Dliteratum%253Aachs%26aulast%3DKado%26aufirst%3DY.%26aulast%3DMizohata%26aufirst%3DE.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DIijima%26aufirst%3DM.%26aulast%3DShinoda%26aufirst%3DK.%26aulast%3DMiyafusa%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DSugiyama%26aufirst%3DA.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DY.-H.%26aulast%3DMatsumura%26aufirst%3DH.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DFujitani%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DT.%26atitle%3DEpiregulin%2520Recognition%2520Mechanisms%2520by%2520Anti-epiregulin%2520Antibody%25209E5%253A%2520Structural%252C%2520Functional%252C%2520and%2520Molecular%2520Dynamics%2520Simulation%2520Analyses%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D2319%26epage%3D2330%26doi%3D10.1074%2Fjbc.M115.656009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">The Role of the AMOP Domain of MUC4/Y Promoted Tumor Angiogenesis and Metastasis in Pancreatic Cancer</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">34</span>, <span class="refDoi"> DOI: 10.1186/s13046-016-0369-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2Fs13046-016-0369-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26884069" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=34&author=J.+Tangauthor=Y.+Zhuauthor=K.+Xieauthor=X.+Zhangauthor=X.+Zhiauthor=W.+Wangauthor=Z.+Liauthor=Q.+Zhangauthor=L.+Wangauthor=J.+Wangauthor=Z.+Xu&title=The+Role+of+the+AMOP+Domain+of+MUC4%2FY+Promoted+Tumor+Angiogenesis+and+Metastasis+in+Pancreatic+Cancer&doi=10.1186%2Fs13046-016-0369-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0369-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0369-0%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DThe%2520Role%2520of%2520the%2520AMOP%2520Domain%2520of%2520MUC4%252FY%2520Promoted%2520Tumor%2520Angiogenesis%2520and%2520Metastasis%2520in%2520Pancreatic%2520Cancer%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26spage%3D34%26doi%3D10.1186%2Fs13046-016-0369-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanapragassam, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">Role of MUC4-NIDO Domain in the MUC4-Mediated Metastasis of Pancreatic Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3346</span>– <span class="NLM_lpage">3356</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2011.505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22105367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3346-3356&author=S.+Senapatiauthor=V.+S.+Gnanapragassamauthor=N.+Moniauxauthor=N.+Momiauthor=S.+K.+Batra&title=Role+of+MUC4-NIDO+Domain+in+the+MUC4-Mediated+Metastasis+of+Pancreatic+Cancer+Cells&doi=10.1038%2Fonc.2011.505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells</span></div><div class="casAuthors">Senapati, S.; Gnanapragassam, V. S.; Moniaux, N.; Momi, N.; Batra, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3346-3356</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MUC4 is a large transmembrane type I glycoprotein that is overexpressed in pancreatic cancer (PC) and has been shown to be assocd. with its progression and metastasis.  However, the exact cellular and mol. mechanism(s) through which MUC4 promotes metastasis of PC cells has been sparsely studied.  Here we showed that the nidogen-like (NIDO) domain of MUC4, which is similar to the G1-domain present in the nidogen or entactin (an extracellular matrix protein), contributes to the protein-protein interaction property of MUC4.  By this interaction, MUC4 promotes breaching of basement membrane (BM) integrity, and spreading of cancer cells.  These observations are corroborated with the data from our study using an engineered MUC4 protein without the NIDO domain, which was ectopically expressed in the MiaPaCa PC cells, lacking endogenous MUC4 and nidogen protein.  The in vitro studies demonstrated an enhanced invasiveness of MiaPaCa cells expressing MUC4 (MiaPaCa-MUC4) compared with vector-transfected cells (MiaPaCa-Vec; P=0.003) or cells expressing MUC4 without the NIDO domain (MiaPaCa-MUC4-NIDOΔ; P=0.03).  However, the absence of NIDO-domain has no significant role on cell growth and motility (P=0.93).  In the in vivo studies, all the mice orthotopically implanted with MiPaCa-MUC4 cells developed metastasis to the liver as compared with MiaPaCa-Vec or the MiaPaCa-MUC4-NIDOΔ group, hence, supporting our in vitro observations.  Addnl., a reduced binding (P=0.0004) of MiaPaCa-MUC4-NIDOΔ cells to the fibulin-2 coated plates compared with MiaPaCa-MUC4 cells indicated a possible interaction between the MUC4-NIDO domain and fibulin-2, a nidogen-interacting protein.  Furthermore, in PC tissue samples, MUC4 colocalized with the fibulin-2 present in the BM.  Altogether, our findings demonstrate that the MUC4-NIDO domain significantly contributes to the MUC4-mediated metastasis of PC cells.  This may be partly due to the interaction between the MUC4-NIDO domain and fibulin-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeiyORyYPmRbVg90H21EOLACvtfcHk0lhAUkdQebu-2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrrP&md5=649969f81badd3f3a4c2ca3acfa3f50c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.505%26sid%3Dliteratum%253Aachs%26aulast%3DSenapati%26aufirst%3DS.%26aulast%3DGnanapragassam%26aufirst%3DV.%2BS.%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DMomi%26aufirst%3DN.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DRole%2520of%2520MUC4-NIDO%2520Domain%2520in%2520the%2520MUC4-Mediated%2520Metastasis%2520of%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D3346%26epage%3D3356%26doi%3D10.1038%2Fonc.2011.505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bork, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patthy, L.</span></span> <span> </span><span class="NLM_article-title">The SEA Module: A New Extracellular Domain Associated with O-Glycosylation</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1421</span>– <span class="NLM_lpage">1425</span>, <span class="refDoi"> DOI: 10.1002/pro.5560040716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fpro.5560040716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=7670383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=1421-1425&author=P.+Borkauthor=L.+Patthy&title=The+SEA+Module%3A+A+New+Extracellular+Domain+Associated+with+O-Glycosylation&doi=10.1002%2Fpro.5560040716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The SEA module: a new extracellular domain associated with O-glycosylation</span></div><div class="casAuthors">Bork, Peer; Patthy, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1421-5</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Using a variety of homol. search methods and multiple alignments, a new extracellular module was identified in (1) agrin, (2) enterokinase, (3) a 63-kDa sea urchin sperm protein, (4) perlecan, (5) the breast cancer marker MUC1 (episialin), (6) the cell surface antigen 114/A10, and (7/8) two functionally uncharacterized, probably extracellular, Caenorhabditis elegans proteins.  Despite the functional diversity of these adhesive proteins, a common denominator seems to be their existence in heavily glycosylated environments.  In addn., the better characterized proteins mentioned above contain all O-glycosidic-linked carbohydrates such as heparan sulfate that contribute considerably to their mol. masses.  The common module might regulate or assist binding to neighboring carbohydrate moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnywONmeXVM7Vg90H21EOLACvtfcHk0lh2PzfF2xPLkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D&md5=e9f3b8fcf8a3bcbaaf27588d9aeffede</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560040716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560040716%26sid%3Dliteratum%253Aachs%26aulast%3DBork%26aufirst%3DP.%26aulast%3DPatthy%26aufirst%3DL.%26atitle%3DThe%2520SEA%2520Module%253A%2520A%2520New%2520Extracellular%2520Domain%2520Associated%2520with%2520O-Glycosylation%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D1421%26epage%3D1425%26doi%3D10.1002%2Fpro.5560040716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">Evidence for a Second Peptide Cleavage in the C-Terminal Domain of Rodent Intestinal Mucin Muc3</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1042/bj20030944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20030944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=14572308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlSns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2004&pages=207-212&author=I.+A.+Khatriauthor=R.+Wangauthor=J.+F.+Forstner&title=Evidence+for+a+Second+Peptide+Cleavage+in+the+C-Terminal+Domain+of+Rodent+Intestinal+Mucin+Muc3&doi=10.1042%2Fbj20030944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a second peptide cleavage in the C-terminal domain of rodent intestinal mucin Muc3</span></div><div class="casAuthors">Khatri, Ismat A.; Wang, Rongquan; Forstner, Janet F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-212</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Rat intestinal mucin Muc3 (rMuc3), like its human homolog (MUC3) and several other membrane mucins, contains a C-terminally located SEA (sea urchin sperm protein, enterokinase and agrin) module, with an intrinsic proteolytic site sequence G↓SIVV (where G↓S is the glycine serine cleavage site).  As shown previously, expression of the C-terminal domain of rMuc3 in COS-1 cells yields a V5 epitope-tagged N-terminal glycopeptide of 30 kDa and a Myc- and His epitope-tagged C-terminal glycopeptide of 49 kDa.  The present study shows that the 49 kDa membrane-anchored fragment undergoes a further cleavage reaction which decreases its size to 30 kDa.  Western blotting, pulse-chase metabolic incubations, immunopptn. and deglycosylation with N-glycosidase F were used to detect and identify the proteolytic products.  Both the first and second cleavages are presumed to facilitate solubilization of Muc3 at the apical surface of enterocytes and/or enhance the potential for Muc3 to participate in ligand-receptor and signal transduction events for enterocyte function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRsUFKr-B9xbVg90H21EOLACvtfcHk0lh2PzfF2xPLkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlSns7w%253D&md5=05fc60f3f92f301162529c66e4523f52</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1042%2Fbj20030944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20030944%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DI.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DEvidence%2520for%2520a%2520Second%2520Peptide%2520Cleavage%2520in%2520the%2520C-Terminal%2520Domain%2520of%2520Rodent%2520Intestinal%2520Mucin%2520Muc3%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D378%26spage%3D207%26epage%3D212%26doi%3D10.1042%2Fbj20030944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, P. J.</span></span> <span> </span><span class="NLM_article-title">Post-Translational Regulation of Signaling Mucins</span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.sbi.2011.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.sbi.2011.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=21889329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12rtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=590-596&author=P.+J.+Cullen&title=Post-Translational+Regulation+of+Signaling+Mucins&doi=10.1016%2Fj.sbi.2011.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational regulation of signaling mucins</span></div><div class="casAuthors">Cullen, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">590-596</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Signaling mucins are large transmembrane glycoproteins that regulate signal transduction pathways.  Recent advances have shown that two major types of post-translational modifications, protein glycosylation and proteolytic processing, play important and unexpected roles in regulating signaling mucin function.  New O-glycosyltransferases and proteases have been identified, and the structure of the domain that undergoes auto-proteolysis has been solved.  A picture is beginning to emerge where specific glycosyl modifications and regulated processing control the signaling and adherence properties of signaling glycoproteins and contribute to the routing of signals to specific pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfv1AQ5My24LVg90H21EOLACvtfcHk0lh2PzfF2xPLkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12rtbjO&md5=e713a54fb806de937597039ed26d2dd8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2011.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2011.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DCullen%26aufirst%3DP.%2BJ.%26atitle%3DPost-Translational%2520Regulation%2520of%2520Signaling%2520Mucins%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D590%26epage%3D596%26doi%3D10.1016%2Fj.sbi.2011.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wreschner, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcguckin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baruch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoeli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaretsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smorodinsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keydar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neophytou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span> <span> </span><span class="NLM_article-title">Generation of Ligand–Receptor Alliances by “SEA” Module-Mediated Cleavage of Membrane-Associated Mucin Proteins</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1110/ps.16502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1110%2Fps.16502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11847293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFKnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=698-706&author=D.+H.+Wreschnerauthor=M.+A.+Mcguckinauthor=S.+J.+Williamsauthor=A.+Baruchauthor=M.+Yoeliauthor=R.+Zivauthor=L.+Okunauthor=J.+Zaretskyauthor=N.+Smorodinskyauthor=I.+Keydarauthor=P.+Neophytouauthor=M.+Staceyauthor=H.+Linauthor=S.+Gordon&title=Generation+of+Ligand%E2%80%93Receptor+Alliances+by+%E2%80%9CSEA%E2%80%9D+Module-Mediated+Cleavage+of+Membrane-Associated+Mucin+Proteins&doi=10.1110%2Fps.16502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins</span></div><div class="casAuthors">Wreschner, Daniel H.; McGuckin, Michael A.; Williams, Stefanie J.; Baruch, Amos; Yoeli, Merav; Ziv, Ravit; Okun, Liron; Zaretsky, Joseph; Smorodinsky, Nechama; Keydar, Iafa; Neophytou, Pavlos; Stacey, Martin; Lin, His-Hsien; Gordon, Siamon</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">698-706</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A mechanism is described whereby one and the same gene can encode both a receptor protein as well as its specific ligand.  Generation of this receptor-ligand partnership is effected by proteolytic cleavage within a specific module located in a membrane resident protein.  It is postulated here that the "SEA" module, found in a no. of heavily O-linked glycosylated membrane-assocd. proteins, serves as a site for proteolytic cleavage.  The subunits generated by proteolytic cleavage of the SEA module reassoc., and can subsequently elicit a signaling cascade.  We hypothesize that all membrane resident proteins contg. such a "SEA" module will undergo cleavage, thereby generating a receptor-ligand alliance.  This requires that the protein subunits resulting from the proteolytic cleavage reassoc. with each other in a highly specific fashion.  The same SEA module that serves as the site for proteolytic cleavage, probably also contains the binding sites for reassocn. of the resultant two subunits.  More than one type of module can function as a site for proteolytic cleavage; this can occur not only in one-pass membrane proteins but also in 7-transmembrane proteins and other membrane-assocd. proteins.  The proposal presented here is likely to have significant practical consequences.  It could well lead to the rational design and identification of mols. that, by binding to one of the cleaved partners, will act either as agonists or antagonists, alter signal transduction and, hence, cellular behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzSq8IG_iRLVg90H21EOLACvtfcHk0lh2PzfF2xPLkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFKnu7k%253D&md5=d374ddd38865a307e6bc9f9b96af2934</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1110%2Fps.16502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.16502%26sid%3Dliteratum%253Aachs%26aulast%3DWreschner%26aufirst%3DD.%2BH.%26aulast%3DMcguckin%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DBaruch%26aufirst%3DA.%26aulast%3DYoeli%26aufirst%3DM.%26aulast%3DZiv%26aufirst%3DR.%26aulast%3DOkun%26aufirst%3DL.%26aulast%3DZaretsky%26aufirst%3DJ.%26aulast%3DSmorodinsky%26aufirst%3DN.%26aulast%3DKeydar%26aufirst%3DI.%26aulast%3DNeophytou%26aufirst%3DP.%26aulast%3DStacey%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DGordon%26aufirst%3DS.%26atitle%3DGeneration%2520of%2520Ligand%25E2%2580%2593Receptor%2520Alliances%2520by%2520%25E2%2580%259CSEA%25E2%2580%259D%2520Module-Mediated%2520Cleavage%2520of%2520Membrane-Associated%2520Mucin%2520Proteins%26jtitle%3DProtein%2520Sci.%26date%3D2002%26volume%3D11%26spage%3D698%26epage%3D706%26doi%3D10.1110%2Fps.16502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">SEA (Sea-Urchin Sperm Protein, Enterokinase and Agrin)-Module Cleavage, Association of Fragments and Membrane Targeting of Rat Intestinal Mucin Muc3</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1042/bj20021333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20021333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12605599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2003&pages=263-270&author=I.+A.+Khatriauthor=R.+Wangauthor=J.+F.+Forstner&title=SEA+%28Sea-Urchin+Sperm+Protein%2C+Enterokinase+and+Agrin%29-Module+Cleavage%2C+Association+of+Fragments+and+Membrane+Targeting+of+Rat+Intestinal+Mucin+Muc3&doi=10.1042%2Fbj20021333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">SEA (sea-urchin sperm protein, enterokinase and agrin)-module cleavage, association of fragments and membrane targeting of rat intestinal mucin Muc3</span></div><div class="casAuthors">Khatri, Ismat A.; Wang, Rongquan; Forstner, Janet F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In a previous study we showed, by transient expression studies in COS-1 cells, that the C-terminal domain of rat intestinal membrane mucin Muc3 was cleaved between glycine and serine within a GSIVV (one-letter) amino acid sequence during its residence in the endoplasmic reticulum.  The extracellular domain fragment remained linked to the membrane-assocd. fragment by non-covalent interactions.  The present study demonstrates that cleavage depends not only on the presence of the G/SIVV site (where G/S is the glycine↓serine cleavage site), but also on more distant C-terminal sequences in the SEA (sea-urchin sperm protein, enterokinase and agrin) module.  Inhibition of N-glycosylation by tunicamycin treatment of transfected cells did not prevent re-assocn. of fragments, although cleavage was partially impaired, as some of the non-glycosylated, non-cleaved products were seen to accumulate in cells.  Membrane targeting of the Muc3 domain and its cleavage products occurred in transfected cells and was not impaired in mutants in which the cleavage site was mutated.  Targeting was also not impaired for products devoid of N-linked oligosaccharides.  Our studies thus indicate that (a) cleavage within the SEA module of rat Muc3 requires participation of peptide sequences located C-terminal of and distant from the cleavage site, (b) re-assocn. of the fragments requires the SEA module, but is independent of N-linked oligosaccharides, and (c) membrane targeting of the mucin is independent of the SEA-module-cleavage reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPRwgCV4Vlw7Vg90H21EOLACvtfcHk0lgoC4HYwqxvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFehsr0%253D&md5=eac5cf271ff24de54e223760f5105ded</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2Fbj20021333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021333%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DI.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DSEA%2520%2528Sea-Urchin%2520Sperm%2520Protein%252C%2520Enterokinase%2520and%2520Agrin%2529-Module%2520Cleavage%252C%2520Association%2520of%2520Fragments%2520and%2520Membrane%2520Targeting%2520of%2520Rat%2520Intestinal%2520Mucin%2520Muc3%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D372%26spage%3D263%26epage%3D270%26doi%3D10.1042%2Fbj20021333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kini, R. M.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants in Protein Folding: A Single Conserved Hydrophobic Residue Determines Folding of EGF Domains</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/cb300445a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300445a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=161-169&author=A.+S.+Ngauthor=R.+M.+Kini&title=Structural+Determinants+in+Protein+Folding%3A+A+Single+Conserved+Hydrophobic+Residue+Determines+Folding+of+EGF+Domains&doi=10.1021%2Fcb300445a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants in Protein Folding: A Single Conserved Hydrophobic Residue Determines Folding of EGF Domains</span></div><div class="casAuthors">Ng, A. S. Angie; Kini, R. Manjunatha</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The epidermal growth factor (EGF) domain is evolutionarily conserved despite hypervariability in amino acid sequences.  They fold into a three-looped conformation with a disulfide pairing of C1-C3, C2-C4,and C5-C6.  To elucidate the structural determinants that dictate the EGF fold, we selected the fourth and fifth EGF domains of thrombomodulin (TM) as models; the former domain folds into the canonical conformation, while the latter domain folds with alternate disulfide pairing of C1-C2, C3-C4, and C5-C6.  Since their third disulfide (C5-C6) is conserved, we examd. the folding tendencies of synthetic peptides corresponding to truncated domain four (t-TMEGF4) and five (t-TMEGF5), encompassing the segment C1 to C4.  These peptides fold into their resp. disulfide isoforms indicating that they contain all the required structural determinants.  On the basis of the folding tendencies of these peptides in the absence and presence of 6 M Gn·HCl or 0.5 M NaCl, we detd. that hydrophobic interactions are needed for the canonical EGF fold but not for the noncanonical fold.  Sequence alignment of extant EGF domains and examn. of their three-dimensional structures allowed us to identify a highly conserved hydrophobic residue in intercysteine loop 3 as the key contributor, which nucleates the hydrophobic core and acts as the lynch pin.  When this hydrophobic residue (Tyr25) was substituted with a more hydrophilic Thr, the hydrophobic interactions were disrupted, and t-TMEGF4-Y25T folds similar to t-TMEGF5.  Taken together, our results for the first time demonstrate that a single conserved hydrophobic residue acts as the key determinant in the folding of EGF domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs2VNg2SRlWrVg90H21EOLACvtfcHk0lgoC4HYwqxvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtb%252FF&md5=6b847fda239412e7408f638be2dc8960</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fcb300445a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300445a%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DA.%2BS.%26aulast%3DKini%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520Determinants%2520in%2520Protein%2520Folding%253A%2520A%2520Single%2520Conserved%2520Hydrophobic%2520Residue%2520Determines%2520Folding%2520of%2520EGF%2520Domains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D161%26epage%3D169%26doi%3D10.1021%2Fcb300445a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Zoelen, E. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenferink, A. E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Poll, M. L. M.</span></span> <span> </span><span class="NLM_article-title">The EGF Domain: Requirements for Binding to Receptors of the ErbB Family</span>. <i>Vitam. Horm. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/S0083-6729(00)59005-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2FS0083-6729%2800%2959005-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10714238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVCgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2000&pages=99-131&author=E.+J.+J.+van%0AZoelenauthor=C.+Stortelersauthor=A.+E.+G.+Lenferinkauthor=M.+L.+M.+van+de+Poll&title=The+EGF+Domain%3A+Requirements+for+Binding+to+Receptors+of+the+ErbB+Family&doi=10.1016%2FS0083-6729%2800%2959005-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The EGF domain: requirements for binding to receptors of the ErbB family</span></div><div class="casAuthors">Van Zoelen, Everardus J. J.; Stortelers, Catelijne; Lenferink, Anne E. G.; Van De Poll, Monique L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99-131</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with ∼100 refs.  Epidermal growth factor (EGF) has been the prototype growth-stimulating peptide for many years.  It has a characteristic structure with three disulfide bridges, which is essential for its activity.  However, many other proteins, including both growth factors and proteins with unrelated functions, have similar EGF-like domains.  This indicates that besides a characteristic conformation provided by the EGF-like domain, specific amino acids are required to provide specificity in protein functioning.  Currently, more than 10 different growth factors with an EGF-like domain have been characterized which all exert their action by binding to the four members of the erbB family of receptors.  In this review, studies are described on the structure-function relationship of these EGF-like growth factor mols. in an attempt to analyze the individual amino acids that det. their binding specificity to the individual members of the erbB family.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2VeDIe-OkirVg90H21EOLACvtfcHk0lgoC4HYwqxvLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVCgsbY%253D&md5=4748e7e2e5da7c9312b172d39c686534</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2800%2959005-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252800%252959005-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BZoelen%26aufirst%3DE.%2BJ.%2BJ.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3DLenferink%26aufirst%3DA.%2BE.%2BG.%26aulast%3Dvan%2Bde%2BPoll%26aufirst%3DM.%2BL.%2BM.%26atitle%3DThe%2520EGF%2520Domain%253A%2520Requirements%2520for%2520Binding%2520to%2520Receptors%2520of%2520the%2520ErbB%2520Family%26jtitle%3DVitam.%2520Horm.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2000%26volume%3D59%26spage%3D99%26epage%3D131%26doi%3D10.1016%2FS0083-6729%2800%2959005-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campion, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadaki, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niyogi, S. K.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the Role of Electrostatic Residues in Human Epidermal Growth Factor by Site-Directed Mutagenesis and Chemical Modification</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1002/jcb.240500108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fjcb.240500108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1358899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK38XmsVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1992&pages=35-42&author=S.+R.+Campionauthor=D.+K.+Tadakiauthor=S.+K.+Niyogi&title=Evaluation+of+the+Role+of+Electrostatic+Residues+in+Human+Epidermal+Growth+Factor+by+Site-Directed+Mutagenesis+and+Chemical+Modification&doi=10.1002%2Fjcb.240500108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the role of electrostatic residues in human epidermal growth factor by site-directed mutagenesis and chemical modification</span></div><div class="casAuthors">Campion, Stephen R.; Tadaki, Douglas K.; Niyogi, Salil K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    </div><div class="casAbstract">Four residues in the carboxy-terminal domain of human (h) EGF, glutamate 40, glutamine 43, arginine 45, and aspartate 46 were targeted for site-directed mutagenesis to evaluate their potential role in EGF receptor-ligand interaction.  One or more mutations were generated at each of these sites and the altered recombinant hEGF gene products were purified and evaluated by radioreceptor competition binding assay.  Charge-conservative replacement of glutamate 40 with aspartate resulted in a decrease in receptor binding affinity to 30% relative to wild-type hEGF.  On the other hand, removal of the electrostatic charge by substitution of glutamate 40 with glutamine or alanine resulted in only a slightly greater decrease in receptor binding to 25% relative receptor affinity.  The introduction of a pos. charge upon substitution of glutamine 43 with lysine had no effect on receptor binding.  The substitution of arginine 45 with lysine also showed no effect on receptor binding, unlike the abs. requirement obsd. for the arginine side-chain at position 41 [Engler DA, et al. 1992].  Subsequent elimination of the pos. charge of lysine 45 by reaction with K cyanate showed that the electrostatic property of the residue at this site, as well as that at lysine 28 and lysine 48, was not required for receptor-ligand assocn.  The most highly conserved of the 4 residues studied in this report, aspartate 46, was replaced with alanine, tyrosine, and arginine, resulting in a decrease in relative receptor affinity to 23, 14, and 4%, resp., and suggests the importance of an acidic group at this site of EGF.  The ability to generate sufficient yields of mutant recombinant EGF protein was sensitive to the type of side-chain substitutions generated at the sites described in this report and may indicate a role for these residues in the formation of the EGF structure apparently required for productive yields of EGF proteins in the expression system used in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvgaPMUrav1bVg90H21EOLACvtfcHk0lhCoMRam2hmCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVGksr4%253D&md5=6d801f77d5e225e021c71727964a0ed5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fjcb.240500108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.240500108%26sid%3Dliteratum%253Aachs%26aulast%3DCampion%26aufirst%3DS.%2BR.%26aulast%3DTadaki%26aufirst%3DD.%2BK.%26aulast%3DNiyogi%26aufirst%3DS.%2BK.%26atitle%3DEvaluation%2520of%2520the%2520Role%2520of%2520Electrostatic%2520Residues%2520in%2520Human%2520Epidermal%2520Growth%2520Factor%2520by%2520Site-Directed%2520Mutagenesis%2520and%2520Chemical%2520Modification%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D1992%26volume%3D50%26spage%3D35%26epage%3D42%26doi%3D10.1002%2Fjcb.240500108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staros, J. V.</span></span> <span> </span><span class="NLM_article-title">Evolutionary Analysis of the Erbb Receptor and Ligand Families</span>. <i>J. Mol. Evol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1007/s002390010043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs002390010043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10824084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVGltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2000&pages=397-412&author=R.+A.+Steinauthor=J.+V.+Staros&title=Evolutionary+Analysis+of+the+Erbb+Receptor+and+Ligand+Families&doi=10.1007%2Fs002390010043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary analysis of the ErbB receptor and ligand families</span></div><div class="casAuthors">Stein, Richard A.; Staros, James V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Evolution</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">397-412</span>CODEN:
                <span class="NLM_cas:coden">JMEVAU</span>;
        ISSN:<span class="NLM_cas:issn">0022-2844</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">We have compared all available deduced protein sequences of the ErbB family of receptors and their ligands.  Anal. of the aligned sequences of the receptors indicates that there are some differences in the receptors that are specific to invertebrates.  In addn., comparison of the vertebrate ErbB receptors suggest that a gene duplication event generated two ancestral receptors, the ErbB3/ErbB4 precursor and the ErbB1/ErbB2 precursor.  Subsequent gene duplications of these precursors generated the four receptors present in mammals.  Anal. of the sequences for the known ligands of the ErbB receptors suggests that the vertebrate ligands segregate into the ErbB1 ligands and the ErbB3/ErbB4 ligands, paralleling the evolution of the receptors; however, it is difficult to ascertain any correlation between the invertebrate and the vertebrate ligands.  Even though ErbB3 is kinase-impaired, there is significant conservation of the kinase domain within the vertebrate lineage (human, rat, and Fugu rubripes), suggesting some function for this domain other than kinase activity, such as mediating protein-protein interactions that are involved in receptor dimerization and/or activation of the kinase domain of the heterodimerization partner.  To date, no ligand for ErbB2 has been identified, and comparison of the extracellular domains of ErbB2 reveals two regions that are not conserved across the mammalian species.  These two regions of divergence align with sequences in ErbB1 that have been shown to be proximal to the amino-terminus and to the carboxyl-terminal region, resp., of bound EGF.  Further, one of these regions contains an insertion, relative to the other members of the mammalian ErbB family, which might affect the ligand binding site and provide a structural basis for this receptor's apparent inability to bind ligand independently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGproQ_DD_pbOrVg90H21EOLACvtfcHk0lhCoMRam2hmCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVGltb0%253D&md5=fedca1f34402d5ee3c920559c4b93524</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fs002390010043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002390010043%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BA.%26aulast%3DStaros%26aufirst%3DJ.%2BV.%26atitle%3DEvolutionary%2520Analysis%2520of%2520the%2520Erbb%2520Receptor%2520and%2520Ligand%2520Families%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D2000%26volume%3D50%26spage%3D397%26epage%3D412%26doi%3D10.1007%2Fs002390010043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Woning, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rotterdam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabuurs, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venselaar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs-Oomen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zoelen, E. J. J.</span></span> <span> </span><span class="NLM_article-title">Negative Constraints Underlie the ErbB Specificity of Epidermal Growth Factor-like Ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">40033</span>– <span class="NLM_lpage">40040</span>, <span class="refDoi"> DOI: 10.1074/jbc.M603168200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M603168200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17032651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=40033-40040&author=S.+P.+van%0Ader+Woningauthor=W.+van+Rotterdamauthor=S.+B.+Nabuursauthor=H.+Venselaarauthor=S.+Jacobs-Oomenauthor=M.+Wingensauthor=G.+Vriendauthor=C.+Stortelersauthor=E.+J.+J.+van+Zoelen&title=Negative+Constraints+Underlie+the+ErbB+Specificity+of+Epidermal+Growth+Factor-like+Ligands&doi=10.1074%2Fjbc.M603168200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Negative Constraints Underlie the ErbB Specificity of Epidermal Growth Factor-like Ligands</span></div><div class="casAuthors">van der Woning, Sebastian P.; van Rotterdam, Walter; Nabuurs, Sander B.; Venselaar, Hanka; Jacobs-Oomen, Saskia; Wingens, Miriam; Vriend, Gert; Stortelers, Catelijne; van Zoelen, Everardus J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">40033-40040</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Epidermal growth factor (EGF)-like growth factors bind their ErbB receptors in a highly selective manner, but the mol. basis for this specificity is poorly understood.  We have previously shown that certain residues in human EGF (Ser2-Asp3) and TGFα (Glu26) are not essential for their binding to ErbB1 but prevent binding to ErbB3 and ErbB4.  In the present study, we have used a phage display approach to affinity-optimize the C-terminal linear region of EGF-like growth factors for binding to each ErbB receptor and thereby shown that Arg45 in EGF impairs binding to both ErbB3 and ErbB4.  By omitting all these so-called neg. constraints from EGF, we designed a ligand designated panerbin that binds ErbB1, ErbB3, and ErbB4 with similarly high affinity as their wild-type ligands.  Homol. models, based on the known crystal structure of TGFα-bound ErbB1, showed that panerbin is able to bind ErbB1, ErbB3, and ErbB4 in a highly similar manner with respect to position and no. of interaction sites.  Upon in silico introduction of the exptl. known neg. constraints into panerbin, we found that Arg45 induced local charge repulsion and Glu26 induced steric hindrance in a receptor-specific manner, whereas Ser2-Asp3 impaired binding due to a disordered conformation.  Furthermore, radiolabeled panerbin was used to quantify the level of all three receptors on human breast cancer cells in a single radioreceptor assay.  It is concluded that the ErbB specificity of EGF-like growth factors primarily results from the presence of a limited no. of residues that impair the unintended interaction with other ErbB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3k8RP-SAobrVg90H21EOLACvtfcHk0lhCoMRam2hmCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCrt77K&md5=61885859819aadccf4a5ad433f9966de</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M603168200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M603168200%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWoning%26aufirst%3DS.%2BP.%26aulast%3Dvan%2BRotterdam%26aufirst%3DW.%26aulast%3DNabuurs%26aufirst%3DS.%2BB.%26aulast%3DVenselaar%26aufirst%3DH.%26aulast%3DJacobs-Oomen%26aufirst%3DS.%26aulast%3DWingens%26aufirst%3DM.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3Dvan%2BZoelen%26aufirst%3DE.%2BJ.%2BJ.%26atitle%3DNegative%2520Constraints%2520Underlie%2520the%2520ErbB%2520Specificity%2520of%2520Epidermal%2520Growth%2520Factor-like%2520Ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D40033%26epage%3D40040%26doi%3D10.1074%2Fjbc.M603168200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmon, M. A.</span></span> <span> </span><span class="NLM_article-title">ErbB2 Resembles an Autoinhibited Invertebrate Epidermal Growth Factor Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1038/nature08297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fnature08297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19718021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=287-291&author=D.+Alvaradoauthor=D.+E.+Kleinauthor=M.+A.+Lemmon&title=ErbB2+Resembles+an+Autoinhibited+Invertebrate+Epidermal+Growth+Factor+Receptor&doi=10.1038%2Fnature08297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor</span></div><div class="casAuthors">Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7261</span>),
    <span class="NLM_cas:pages">287-291</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The orphan receptor tyrosine kinase ErbB2 (also known as HER2 or Neu) transforms cells when overexpressed, and it is an important therapeutic target in human cancer.  Structural studies have suggested that the oncogenic (and ligand-independent) signaling properties of ErbB2 result from the absence of a key intramol. 'tether' in the extracellular region that autoinhibits other human ErbB receptors, including the epidermal growth factor (EGF) receptor.  Although ErbB2 is unique among the four human ErbB receptors, here we show that it is the closest structural relative of the single EGF receptor family member in Drosophila melanogaster (dEGFR).  Genetic and biochem. data show that dEGFR is tightly regulated by growth factor ligands, yet a crystal structure shows that it too lacks the intramol. tether seen in human EGFR, ErbB3 and ErbB4.  Instead, a distinct set of autoinhibitory interdomain interactions hold unliganded dEGFR in an inactive state.  All of these interactions are maintained (and even extended) in ErbB2, arguing against the suggestion that ErbB2 lacks autoinhibition.  We therefore suggest that normal and pathogenic ErbB2 signaling may be regulated by ligands in the same way as dEGFR.  Our findings have important implications for ErbB2 regulation in human cancer, and for developing therapeutic approaches that target novel aspects of this orphan receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8HfE12q2H6bVg90H21EOLACvtfcHk0liqP544qmo89Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7rE&md5=defcc42cc5f04104c2aa27a8de600266</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnature08297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08297%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarado%26aufirst%3DD.%26aulast%3DKlein%26aufirst%3DD.%2BE.%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26atitle%3DErbB2%2520Resembles%2520an%2520Autoinhibited%2520Invertebrate%2520Epidermal%2520Growth%2520Factor%2520Receptor%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D287%26epage%3D291%26doi%3D10.1038%2Fnature08297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozloski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carothers Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Mechanistic and Signaling Analysis of Muc4–ErbB2 Signaling Module: New Insights into the Mechanism of Ligand- Independent ErbB2 Activity</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>224</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1002/jcp.22163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fjcp.22163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20432461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2010&pages=649-657&author=G.+A.+Kozloskiauthor=C.+A.+Carothers+Carrawayauthor=K.+L.+Carraway&title=Mechanistic+and+Signaling+Analysis+of+Muc4%E2%80%93ErbB2+Signaling+Module%3A+New+Insights+into+the+Mechanism+of+Ligand-+Independent+ErbB2+Activity&doi=10.1002%2Fjcp.22163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: New insights into the mechanism of ligand-independent ErbB2 activity</span></div><div class="casAuthors">Kozloski, Goldi A.; Carothers-Carraway, Coralie A.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-657</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The membrane mucin Muc4 is aberrantly expressed in numerous epithelial carcinomas and is currently used as a cancer diagnostic and prognostic tool.  Muc4 can also potentiate signal transduction by modulating differential ErbB2 phosphorylation in the absence and in the presence of the ErbB3 sol. ligand heregulin (HRG-β1).  These features of Muc4 suggest that Muc4 is not merely a cancer marker, but an oncogenic factor with a unique-binding/activation relationship with the receptor ErbB2.  In the present study, we examd. the signaling mechanisms that are assocd. with the Muc4-ErbB2 module by analyzing ErbB2 differential signaling in response to Muc4 expression.  Our study was carried out in the A375 human melanoma and BT-474 breast cancer cell lines as our model systems.  Quant. and comparative signaling modulations were evaluated by immunoblot using phospho-specific antibodies, and densitometry anal.  Signaling complex components were identified by chem. crosslinking, fractionation by gel filtration, immunopptn., and immunoblotting.  Activated downstream signaling pathways were analyzed by an antibody microarray screen and immunoblot analyses.  Our results indicate that Muc4 modulates ErbB2 signaling potential significantly by stabilizing and directly interacting with the ErbB2-ErbB3 heterodimer.  Further analyses indicate that Muc4 promotes ErbB2 autocatalysis, but it has no effect on ErbB3 phosphorylation, although the chem. crosslinking data indicated that the signaling module is composed of Muc4, ErbB2, and ErbB3.  Our microarray anal. indicates that Muc4 expression promotes cell migration by increasing the phosphorylation of the focal adhesion kinase and also through an increase in the levels of β-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSHZaHK27N9rVg90H21EOLACvtfcHk0liqP544qmo89Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWnt7g%253D&md5=4edd43e804c4c8fd3c472ec7767d431c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22163%26sid%3Dliteratum%253Aachs%26aulast%3DKozloski%26aufirst%3DG.%2BA.%26aulast%3DCarothers%2BCarraway%26aufirst%3DC.%2BA.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DMechanistic%2520and%2520Signaling%2520Analysis%2520of%2520Muc4%25E2%2580%2593ErbB2%2520Signaling%2520Module%253A%2520New%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Ligand-%2520Independent%2520ErbB2%2520Activity%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2010%26volume%3D224%26spage%3D649%26epage%3D657%26doi%3D10.1002%2Fjcp.22163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Attar, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholefield, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrant, L. G.</span></span> <span> </span><span class="NLM_article-title">The Role of MUC1 and MUC3 in the Biology and Prognosis of Colorectal Cancer</span>. <i>World J. Surg. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi"> DOI: 10.1186/1477-7819-5-31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2F1477-7819-5-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17349047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD2s7nt1Wmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=31&author=T.+J.+Duncanauthor=N.+F.+Watsonauthor=A.+H.+Al-Attarauthor=J.+H.+Scholefieldauthor=L.+G.+Durrant&title=The+Role+of+MUC1+and+MUC3+in+the+Biology+and+Prognosis+of+Colorectal+Cancer&doi=10.1186%2F1477-7819-5-31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer</span></div><div class="casAuthors">Duncan Timothy J; Watson Nicholas F S; Al-Attar Ahmad H; Scholefield John H; Durrant Lindy G</div><div class="citationInfo"><span class="NLM_cas:title">World journal of surgical oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  MUC1 and MUC3 are from a large family of glycoproteins with an aberrant expression profile in various malignancies.  Much interest has been focused on the role of these proteins in the development and progression of colorectal cancer; however, no previous studies have included the highly confounding variable of vascular invasion in their survival analysis.  Using high throughput tissue microarray technology we assessed the prognostic value of MUC1 and MUC3 expression in the largest cohort of colorectal cancer patients to date.  We propose that tumours lacking expression of MUC1 and MUC3 will be more likely to metastasise, due to previously observed loss of cell-cell adhesion, and this will therefore lead to more aggressive cancers with poorer prognosis.  METHODS:  A tissue micro-array was prepared from tumour samples of 462 consecutive patients undergoing resection of a primary colorectal cancer.  A comprehensive prospectively recorded data base with mean follow up of 75 months was collected and included common clinicopathological variables and disease specific survival.  Immunohistochemical analysis of MUC1 and MUC3 expression was performed using antibodies NCL-MUC1 and 1143/B7 respectively, results were correlated with the variables within the database.  RESULTS:  Positive expression of MUC1 and MUC3 was seen in 32% and 74% of tumours respectively.  On univariate analysis no correlation was seen with either MUC1 or MUC3 and any of the clinicopathological variables including tumour grade and stage, vascular invasion and tumour type.  Kaplan-Meier analysis demonstrated a significant reduction in disease specific survival with MUC1 positive tumours (p = 0.038), this was not seen with MUC3 (p = 0.552).  On multivariate analysis, using Cox proportional hazards model, MUC1 expression was shown to be an independent marker of prognosis (HR 1.339, 95%CI 1.002-1.790, p = 0.048).  CONCLUSION:  MUC1 expression in colorectal cancer is an independent marker of poor prognosis, even when vascular invasion is included in the analysis.  These results support previous studies suggesting a role for MUC1 in colorectal cancer development possibly through its effects on cell adhesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtPIDEmh5WI8SzjBFCN0BJfW6udTcc2eZqOSNvHrmAk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7nt1Wmsw%253D%253D&md5=bfeade5cbe689683533a68f96336d091</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1186%2F1477-7819-5-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1477-7819-5-31%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DT.%2BJ.%26aulast%3DWatson%26aufirst%3DN.%2BF.%26aulast%3DAl-Attar%26aufirst%3DA.%2BH.%26aulast%3DScholefield%26aufirst%3DJ.%2BH.%26aulast%3DDurrant%26aufirst%3DL.%2BG.%26atitle%3DThe%2520Role%2520of%2520MUC1%2520and%2520MUC3%2520in%2520the%2520Biology%2520and%2520Prognosis%2520of%2520Colorectal%2520Cancer%26jtitle%3DWorld%2520J.%2520Surg.%2520Oncol.%26date%3D2007%26volume%3D5%26spage%3D31%26doi%3D10.1186%2F1477-7819-5-31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">MUC4Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes xith its Interaction to Extracellular Matrix Proteins</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-06-0353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F1541-7786.MCR-06-0353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17406026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFOksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=309-320&author=P.+Chaturvediauthor=A.+P.+Singhauthor=N.+Moniauxauthor=S.+Senapatiauthor=S.+Chakrabortyauthor=J.+L.+Mezaauthor=S.+K.+Batra&title=MUC4Mucin+Potentiates+Pancreatic+Tumor+Cell+Proliferation%2C+Survival%2C+and+Invasive+Properties+and+Interferes+xith+its+Interaction+to+Extracellular+Matrix+Proteins&doi=10.1158%2F1541-7786.MCR-06-0353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins</span></div><div class="casAuthors">Chaturvedi, Pallavi; Singh, Ajay P.; Moniaux, Nicolas; Senapati, Shantibhushan; Chakraborty, Subhankar; Meza, Jane L.; Batra, Surinder K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-320</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MUC4, a transmembrane mucin, is aberrantly expressed in pancreatic adenocarcinomas while remaining undetectable in the normal pancreas.  Recent studies have shown that the expression of MUC4 is assocd. with the progression of pancreatic cancer and is inversely correlated with the prognosis of pancreatic cancer patients.  In the present study, we have examd. the phenotypic and mol. consequences of MUC4 silencing with an aim of establishing the mechanistic basis for its obsd. role in the pathogenesis of pancreatic cancer.  The silencing of MUC4 expression was achieved by stable expression of a MUC4-specific short hairpin RNA in CD18/HPAF, a highly metastatic pancreatic adenocarcinoma cell line.  A significant decrease in MUC4 expression was detected in MUC4-knockdown (CD18/HPAF-siMUC4) cells compared with the parental and scrambled short interfering RNA-transfected (CD18/HPAF-Scr) control cells by immunoblot anal. and immunofluorescence confocal microscopy.  Consistent with our previous observation, inhibition of MUC4 expression restrained the pancreatic tumor cell growth and metastasis as shown in an orthotopic mouse model.  Our in vitro studies revealed that MUC4-assocd. increase in tumor cell growth resulted from both the enhanced proliferation and reduced cell death.  Furthermore, MUC4 expression was also assocd. with significantly increased invasiveness (P ≤ 0.05) and changes in actin organization.  The presence of MUC4 on the cell surface was shown to interfere with the tumor cell-extracellular matrix interactions, in part, by inhibiting the integrin-mediated cell adhesion.  An altered expression of growth- and metastasis-assocd. genes (LI-cadherin, CEACAM6, RAC1, AnnexinA1, thrombomodulin, epiregulin, S100A4, TP53, TP53BP, caspase-2, caspase-3, caspase-7, plakoglobin, and neuregulin-2) was also obsd. as a consequence of the silencing of MUC4.  In conclusion, our study provides exptl. evidence that supports the functional significance of MUC4 in pancreatic cancer progression and indicates a novel role for MUC4 in cancer cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpahEb7qd8HWLVg90H21EOLACvtfcHk0liqP544qmo89Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFOksLk%253D&md5=82889b3ef6cb08cf1fedeada96c87b39</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-06-0353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-06-0353%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DA.%2BP.%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DSenapati%26aufirst%3DS.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DMeza%26aufirst%3DJ.%2BL.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DMUC4Mucin%2520Potentiates%2520Pancreatic%2520Tumor%2520Cell%2520Proliferation%252C%2520Survival%252C%2520and%2520Invasive%2520Properties%2520and%2520Interferes%2520xith%2520its%2520Interaction%2520to%2520Extracellular%2520Matrix%2520Proteins%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2007%26volume%3D5%26spage%3D309%26epage%3D320%26doi%3D10.1158%2F1541-7786.MCR-06-0353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joe, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maseda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizuka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, H.</span></span> <span> </span><span class="NLM_article-title">Mucin 3 is Involved in Intestinal Epithelial Cell Apoptosis via N-(3-Oxododecanoyl)-L-Homoserine Lactone-Induced Suppression of Akt Phosphorylation</span>. <i>Am. J. Physiol. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">C162</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00271.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1152%2Fajpcell.00271.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24848113" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2014&pages=C162-168&author=R.+Taguchiauthor=S.+Tanakaauthor=G.+H.+Joeauthor=H.+Masedaauthor=N.+Nomuraauthor=J.+Ohnishiauthor=S.+Ishizukaauthor=H.+Shimizuauthor=H.+Miyazaki&title=Mucin+3+is+Involved+in+Intestinal+Epithelial+Cell+Apoptosis+via+N-%283-Oxododecanoyl%29-L-Homoserine+Lactone-Induced+Suppression+of+Akt+Phosphorylation&doi=10.1152%2Fajpcell.00271.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00271.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00271.2013%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DJoe%26aufirst%3DG.%2BH.%26aulast%3DMaseda%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DOhnishi%26aufirst%3DJ.%26aulast%3DIshizuka%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DH.%26atitle%3DMucin%25203%2520is%2520Involved%2520in%2520Intestinal%2520Epithelial%2520Cell%2520Apoptosis%2520via%2520N-%25283-Oxododecanoyl%2529-L-Homoserine%2520Lactone-Induced%2520Suppression%2520of%2520Akt%2520Phosphorylation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell.%2520Physiol.%26date%3D2014%26volume%3D307%26spage%3DC162%26epage%3D168%26doi%3D10.1152%2Fajpcell.00271.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liberelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuru, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencheikh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quenon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucbert, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foulon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebegue, N.</span></span> <span> </span><span class="NLM_article-title">MUC4-ErbB2 Oncogenic Complex: Binding Studies Using Microscale Thermophoresis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">16678</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-53099-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fs41598-019-53099-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=31723153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BB3MjoslyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=16678&author=M.+Liberelleauthor=R.+Magnezauthor=X.+Thuruauthor=Y.+Bencheikhauthor=S.+Ravezauthor=C.+Quenonauthor=A.+S.+Drucbertauthor=C.+Foulonauthor=P.+Melnykauthor=I.+van+Seuningenauthor=N.+Lebegue&title=MUC4-ErbB2+Oncogenic+Complex%3A+Binding+Studies+Using+Microscale+Thermophoresis&doi=10.1038%2Fs41598-019-53099-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis</span></div><div class="casAuthors">Liberelle Maxime; Magnez Romain; Thuru Xavier; Bencheikh Yamina; Ravez Severine; Quenon Camille; Melnyk Patricia; Van Seuningen Isabelle; Lebegue Nicolas; Drucbert Anne-Sophie; Foulon Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16678</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The MUC4 membrane-bound mucin is a large O-glycoprotein involved in epithelial homeostasis.  At the cancer cell surface MUC4 interacts with ErbB2 receptor via EGF domains to promote cell proliferation and migration.  MUC4 is highly regarded as a therapeutic target in pancreatic cancer as it is not expressed in healthy pancreas, while it is neoexpressed in early preneoplastic stages (PanINs).  However, the association/dissociation constant of MUC4-ErbB2 complex is unknown.  Protein-protein interactions (PPIs) have become a major area of research in the past years and the characterization of their interactions, especially by biophysical methods, is intensively used in drug discovery.  To characterize the MUC4-ErbB2 interaction, we used MicroScale Thermophoresis (MST), a powerful method for quantitative protein interaction analysis under challenging conditions.  We worked with CHO cell lysates containing either the transmembrane β subunit of MUC4 (MUC4β) or a truncated mutant encompassing only the EGF domains (MUC4EGF3+1+2).  MST studies have led to the characterization of equilibrium dissociation constants (Kd) for MUC4β-ErbB2 (7-25 nM) and MUC4EGF3+1+2/ErbB2 (65-79 nM) complexes.  This work provides new information regarding the MUC4-ErbB2 interaction at the biophysical level and also confirms that the presence of the three EGF domains of MUC4 is sufficient to provide efficient interaction.  This technological approach will be very useful in the future to validate small molecule binding affinities targeting MUC4-ErbB2 complex for drug discovery development in cancer.  It will also be of high interest for the other known membrane mucins forming oncogenic complexes with ErbBs at the cancer cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRR32oE25Qk82mbXvSEQle5fW6udTcc2eZ1sfqWGsH76Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjoslyitQ%253D%253D&md5=6d446720d0d786b817e653aa12dfd37c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-53099-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-53099-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiberelle%26aufirst%3DM.%26aulast%3DMagnez%26aufirst%3DR.%26aulast%3DThuru%26aufirst%3DX.%26aulast%3DBencheikh%26aufirst%3DY.%26aulast%3DRavez%26aufirst%3DS.%26aulast%3DQuenon%26aufirst%3DC.%26aulast%3DDrucbert%26aufirst%3DA.%2BS.%26aulast%3DFoulon%26aufirst%3DC.%26aulast%3DMelnyk%26aufirst%3DP.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26aulast%3DLebegue%26aufirst%3DN.%26atitle%3DMUC4-ErbB2%2520Oncogenic%2520Complex%253A%2520Binding%2520Studies%2520Using%2520Microscale%2520Thermophoresis%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D16678%26doi%3D10.1038%2Fs41598-019-53099-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsauer, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Muc4/Sialomucin Complex, the Intramembrane Erbb2 Ligand, Translocates Erbb2 to the Apical Surface in Polarized Epithelial Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">30142</span>– <span class="NLM_lpage">30147</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303220200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M303220200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12748185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFOntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=30142-30147&author=V.+P.+Ramsauerauthor=C.+A.+Carrawayauthor=P.+J.+Salasauthor=K.+L.+Carraway&title=Muc4%2FSialomucin+Complex%2C+the+Intramembrane+Erbb2+Ligand%2C+Translocates+Erbb2+to+the+Apical+Surface+in+Polarized+Epithelial+Cells&doi=10.1074%2Fjbc.M303220200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial Cells</span></div><div class="casAuthors">Ramsauer, Victoria P.; Carothers-Carraway, Coralie A.; Salas, Pedro J. I.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">30142-30147</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Muc4/Sialomucin complex (SMC) acts as an intramembrane ligand for the receptor tyrosine kinase ErbB2, inducing a limited phosphorylation of the receptor.  Because Muc4/SMC is found at the apical surfaces of polarized epithelial cells and ErbB2 is often basolateral, the question arises as to whether these components become assocd. in polarized cells.  To address this question, we examd. the localization of these proteins in polarized human colon carcinoma CACO-2 cells.  Dual color immunofluorescence anal. by confocal microscopy demonstrated the basolateral localization of the ErbB2 in these cells; it is primarily co-localized with E-cadherin at adherens junctions.  Expression of apical Muc4/SMC in these cells by transient transfection results in the localization of the ErbB2 at the apical surface.  Twocolor confocal microscopy indicated that ErbB2 is colocalized with Muc4/SMC in the transfected cells but not in untransfected cells in the same culture.  The change of localization of ErbB2 was confirmed by cell surface biotinylation of apical and basolateral proteins, followed by streptavidin pptn. and the subsequent detection of ErbB2 by immunoblotting.  In contrast, Na+/K+-ATPase maintains its basolateral localization in Muc4/SMC-transfected cells, indicating that the translocation of ErbB2 is not the result of depolarization of the cells.  A potential physiol. role for the apical localization of ErbB2 is indicated by the fact that ErbB2 phosphorylated at tyrosine 1248 is found predominantly in Muc4/SMC-transfected cells, but not in untransfected cells, and is co-localized with the apical Muc4/SMC.  The ability of Muc4/SMC to alter the localization of ErbB2, particularly a phosphorylated form of it, in epithelial cells, suggests that it has an important role in regulating ErbB2 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7C5bnjbBBL7Vg90H21EOLACvtfcHk0lhNLe6pIE7KwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFOntLg%253D&md5=2e0745557ae25127c0619fbd006ba9d3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303220200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303220200%26sid%3Dliteratum%253Aachs%26aulast%3DRamsauer%26aufirst%3DV.%2BP.%26aulast%3DCarraway%26aufirst%3DC.%2BA.%26aulast%3DSalas%26aufirst%3DP.%2BJ.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DMuc4%252FSialomucin%2520Complex%252C%2520the%2520Intramembrane%2520Erbb2%2520Ligand%252C%2520Translocates%2520Erbb2%2520to%2520the%2520Apical%2520Surface%2520in%2520Polarized%2520Epithelial%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D30142%26epage%3D30147%26doi%3D10.1074%2Fjbc.M303220200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pochampalli, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">el Bejjani, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J. A.</span></span> <span> </span><span class="NLM_article-title">MUC1 is a Novel Regulator of Erbb1 Receptor Trafficking</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1209976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fsj.onc.1209976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=16983337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVSmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1693-1701&author=M.+R.+Pochampalliauthor=R.+M.+el+Bejjaniauthor=J.+A.+Schroeder&title=MUC1+is+a+Novel+Regulator+of+Erbb1+Receptor+Trafficking&doi=10.1038%2Fsj.onc.1209976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 is a novel regulator of ErbB1 receptor trafficking</span></div><div class="casAuthors">Pochampalli, M. R.; el Bejjani, R. M.; Schroeder, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693-1701</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ErbB receptors are key regulators of cell survival and growth in normal and transformed tissues.  The oncogenic glycoprotein MUC1 is a binding partner and substrate for erbB1 and MUC1 expression can potentiate erbB-dependent signal transduction.  After receptor activation, erbB1 is typically downregulated via an endocytic pathway that results in receptor degrdn. or recycling.  We report here that MUC1 expression inhibits the degrdn. of ligand-activated erbB1.  Through the use of both RNAi-mediated knock down and overexpression constructs of MUC1, we show that MUC1 expression inhibits erbB1 degrdn. after ligand treatment in breast epithelial cells.  This MUC1-mediated protection against erbB1 degrdn. can increase total cellular pools of erbB1 over time.  Biotinylation of surface proteins demonstrates that cell-surface assocd. erbB1 receptor is protected by MUC1 against ligand-induced degrdn., although this is accompanied by an increase in erbB1 internalization.  The MUC1-mediated protection against degrdn. occurs with a decrease in EGF-stimulated ubiquitination of erbB1, and an increase in erbB1 recycling.  These data indicate that MUC1 expression is a potent regulator of erbB1 receptor stability upon activation and may promote transformation through the inhibition of erbB1 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotVbvzuw3MP7Vg90H21EOLACvtfcHk0lj-6rOQHi4GpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVSmtbw%253D&md5=81865b1d612e97b23befe28962504db3</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209976%26sid%3Dliteratum%253Aachs%26aulast%3DPochampalli%26aufirst%3DM.%2BR.%26aulast%3Del%2BBejjani%26aufirst%3DR.%2BM.%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26atitle%3DMUC1%2520is%2520a%2520Novel%2520Regulator%2520of%2520Erbb1%2520Receptor%2520Trafficking%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1693%26epage%3D1701%26doi%3D10.1038%2Fsj.onc.1209976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendler, S. J.</span></span> <span> </span><span class="NLM_article-title">Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-Activated Protein Kinase Activation in the Mouse Mammary Gland</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">13057</span>– <span class="NLM_lpage">13064</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011248200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M011248200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11278868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFyms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=13057-13064&author=J.+A.+Schroederauthor=M.+C.+Thompsonauthor=M.+M.+Gardnerauthor=S.+J.+Gendler&title=Transgenic+MUC1+Interacts+with+Epidermal+Growth+Factor+Receptor+and+Correlates+with+Mitogen-Activated+Protein+Kinase+Activation+in+the+Mouse+Mammary+Gland&doi=10.1074%2Fjbc.M011248200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland</span></div><div class="casAuthors">Schroeder, Joyce A.; Thompson, Melissa C.; Gardner, Melissa Mockensturm; Gendler, Sandra J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">13057-13064</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90% of human breast carcinomas and subsequent metastases.  The precise function of MUC1 over-expression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation.  Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunopptn. of MUC1 with a tyrosine-phosphorylated protein of ∼180 kDa.  We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (ΔCT), or tandem repeat deleted (ΔTR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis.  Immunopptn. expts. revealed that full-length transgenic MUC1 phys. assocs. with all four erbB receptors, and co-localizes with erbB1 in the lactating gland.  Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Muc1 null and wild-type animals.  These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjdmbb-yt3V7Vg90H21EOLACvtfcHk0lj-6rOQHi4GpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFyms7Y%253D&md5=c1c1a53f838efc404e6cfe1ac9ae37b2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011248200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011248200%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26aulast%3DThompson%26aufirst%3DM.%2BC.%26aulast%3DGardner%26aufirst%3DM.%2BM.%26aulast%3DGendler%26aufirst%3DS.%2BJ.%26atitle%3DTransgenic%2520MUC1%2520Interacts%2520with%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520and%2520Correlates%2520with%2520Mitogen-Activated%2520Protein%2520Kinase%2520Activation%2520in%2520the%2520Mouse%2520Mammary%2520Gland%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D13057%26epage%3D13064%26doi%3D10.1074%2Fjbc.M011248200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bitler, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goverdhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J. A.</span></span> <span> </span><span class="NLM_article-title">MUC1 Regulates Nuclear Localization and Function of the Epidermal Growth Factor Receptor</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">1716</span>– <span class="NLM_lpage">1723</span>, <span class="refDoi"> DOI: 10.1242/jcs.062661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1242%2Fjcs.062661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20406885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotFGrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=1716-1723&author=B.+G.+Bitlerauthor=A.+Goverdhanauthor=J.+A.+Schroeder&title=MUC1+Regulates+Nuclear+Localization+and+Function+of+the+Epidermal+Growth+Factor+Receptor&doi=10.1242%2Fjcs.062661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 regulates nuclear localization and function of the epidermal growth factor receptor</span></div><div class="casAuthors">Bitler, Benjamin G.; Goverdhan, Aarthi; Schroeder, Joyce A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1716-1723</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Alteration of protein trafficking and localization is assocd. with several diseases, including cystic fibrosis, breast cancer, colorectal cancer, leukemia and diabetes.  Specifically, aberrant nuclear localization of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, is a poor prognostic indicator in several epithelial carcinomas.  It is now appreciated that in addn. to signaling from the plasma membrane, EGFR also trafficks to the nucleus, and can directly bind the promoter regions of genes encoding cyclin D1 (CCND1) and B-Myb (MYBL2).  We have previously established that loss of MUC1 in an EGFR-dependent transgenic mouse model of breast cancer correlates with the loss of cyclin D1 expression.  Here, we provide evidence for a novel regulatory function of MUC1 in the trafficking and nuclear activity of EGFR.  We found that MUC1 and EGFR interact in the nucleus of breast cancer cells, which promotes the accumulation of chromatin-bound EGFR.  Addnl., the presence of MUC1 results in significant colocalization of EGFR and phosphorylated RNA polymerase II, indicating that MUC1 influences the assocn. of EGFR with transcriptionally active promoter regions.  Importantly, we found that the loss of MUC1 expression resulted in a decrease in the interaction between EGFR and the CCND1 promoter, which translated to a significant decrease in cyclin D1 protein expression.  This data offers insights into a novel regulatory mechanism of EGFR nuclear function and could have important implications for evaluating nuclear localization in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLRAoOWpAsWLVg90H21EOLACvtfcHk0lgOx9AO8gXF_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotFGrsb8%253D&md5=7a8f76141b241b4f1a71dbe16b1d080c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1242%2Fjcs.062661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.062661%26sid%3Dliteratum%253Aachs%26aulast%3DBitler%26aufirst%3DB.%2BG.%26aulast%3DGoverdhan%26aufirst%3DA.%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26atitle%3DMUC1%2520Regulates%2520Nuclear%2520Localization%2520and%2520Function%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26spage%3D1716%26epage%3D1723%26doi%3D10.1242%2Fjcs.062661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stechly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beauce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigny, P.</span></span> <span> </span><span class="NLM_article-title">Galectin-3 Regulates MUC1 and EGFR Cellular Distribution and EGFR Downstream Pathways in Pancreatic Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2514</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2010.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=21258405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1ahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2514-2525&author=J.+Merlinauthor=L.+Stechlyauthor=S.+de+Beauceauthor=D.+Monteauthor=E.+Leteurtreauthor=I.+van+Seuningenauthor=G.+Huetauthor=P.+Pigny&title=Galectin-3+Regulates+MUC1+and+EGFR+Cellular+Distribution+and+EGFR+Downstream+Pathways+in+Pancreatic+Cancer+Cells&doi=10.1038%2Fonc.2010.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells</span></div><div class="casAuthors">Merlin, J.; Stechly, L.; de Beauce, S.; Monte, D.; Leteurtre, E.; van Seuningen, I.; Huet, G.; Pigny, P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2514-2525</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MUC1 is a transmembrane glycoprotein which is typically expressed at the apical membrane of normal epithelial cells.  In cancer cells, the over-expression of MUC1 and its aberrant localization around the cell membrane and in the cytoplasm favors its interaction with different protein partners such as epidermal growth factor receptor (EGFR) and can promote tumor proliferation through the activation of oncogenic signaling pathways.  Our aims were to study the mechanisms inducing MUC1 cytoplasmic localization in pancreatic cancer cells, and to decipher their impact on EGFR cellular localization and activation.  Our results showed that galectin-3, an endogenous lectin, is co-expressed with MUC1 in human pancreatic ductal adenocarcinoma, and that it favors the endocytosis of MUC1 and EGFR.  Depletion of galectin-3 by RNA interference increased the interaction between MUC1 and EGFR, EGFR and ERK-1,2 phosphorylation, and translocation of EGFR to the nucleus.  On the contrary, silencing of galectin-3 led to a decrease of cyclin-D1 levels and of cell proliferation.  The galectin-3-dependent regulation of MUC1/EGFR functions may represent an interesting mechanism modulating the EGFR-stimulated cell growth of pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTwEh841g7NbVg90H21EOLACvtfcHk0lgOx9AO8gXF_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1ahtA%253D%253D&md5=e3174913573bb41c2cafd9fdaeafe828</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.631%26sid%3Dliteratum%253Aachs%26aulast%3DMerlin%26aufirst%3DJ.%26aulast%3DStechly%26aufirst%3DL.%26aulast%3Dde%2BBeauce%26aufirst%3DS.%26aulast%3DMonte%26aufirst%3DD.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26aulast%3DHuet%26aufirst%3DG.%26aulast%3DPigny%26aufirst%3DP.%26atitle%3DGalectin-3%2520Regulates%2520MUC1%2520and%2520EGFR%2520Cellular%2520Distribution%2520and%2520EGFR%2520Downstream%2520Pathways%2520in%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2514%26epage%3D2525%26doi%3D10.1038%2Fonc.2010.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piyush, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindrewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilkens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. G.</span></span> <span> </span><span class="NLM_article-title">Interaction of Galectin-3 with MUC1 on Cell Surface Promotes EGFR Dimerization and Activation in Human Epithelial Cancer Cells</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1947</span>, <span class="refDoi"> DOI: 10.1038/cdd.2017.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fcdd.2017.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28731466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Whsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1937-1947&author=T.+Piyushauthor=A.+R.+Chackoauthor=P.+Sindrewiczauthor=J.+Hilkensauthor=J.+M.+Rhodesauthor=L.+G.+Yu&title=Interaction+of+Galectin-3+with+MUC1+on+Cell+Surface+Promotes+EGFR+Dimerization+and+Activation+in+Human+Epithelial+Cancer+Cells&doi=10.1038%2Fcdd.2017.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells</span></div><div class="casAuthors">Piyush, Tushar; Chacko, Anisha R.; Sindrewicz, Paulina; Hilkens, John; Rhodes, Jonathan M.; Yu, Lu-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1937-1947</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) is an important regulator of epithelial cell growth and survival in normal and cancerous tissues and is a principal therapeutic target for cancer treatment.  EGFR is assocd. in epithelial cells with the heavily glycosylated transmembrane mucin protein MUC1, a natural ligand of galectin-3 that is overexpressed in cancer.  This study reveals that the expression of cell surface MUC1 is a crit. enhancer of EGF-induced EGFR activation in human breast and colon cancer cells.  Both the MUC1 extracellular and intracellular domains are involved in EGFR activation but the predominant influence comes from its extracellular domain.  Binding of galectin-3 to the MUC1 extracellular domain induces MUC1 cell surface polarization and increases MUC1-EGFR assocn.  This leads to a rapid increase of EGFR homo-/hetero-dimerization and subsequently increased, and also prolonged, EGFR activation and signalling.  This effect requires both the galectin-3 C-terminal carbohydrate recognition domain and its N-terminal ligand multi-merization domain.  Thus, interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in epithelial cancer cells.  As MUC1 and galectin-3 are both commonly overexpressed in most types of epithelial cancers, their interaction and impact on EGFR activation likely makes important contribution to EGFR-assocd. tumorigenesis and cancer progression and may also influence the effectiveness of EGFR-targeted cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWvlvyk6dQB7Vg90H21EOLACvtfcHk0lgOx9AO8gXF_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Whsr3J&md5=f84a77b21a402b5b66d8293c18a843b7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2017.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2017.119%26sid%3Dliteratum%253Aachs%26aulast%3DPiyush%26aufirst%3DT.%26aulast%3DChacko%26aufirst%3DA.%2BR.%26aulast%3DSindrewicz%26aufirst%3DP.%26aulast%3DHilkens%26aufirst%3DJ.%26aulast%3DRhodes%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DL.%2BG.%26atitle%3DInteraction%2520of%2520Galectin-3%2520with%2520MUC1%2520on%2520Cell%2520Surface%2520Promotes%2520EGFR%2520Dimerization%2520and%2520Activation%2520in%2520Human%2520Epithelial%2520Cancer%2520Cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2017%26volume%3D24%26spage%3D1937%26epage%3D1947%26doi%3D10.1038%2Fcdd.2017.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbashov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">The MUC1 and Galectin-3 Oncoproteins Function in a Microrna-Dependent Regulatory Loop</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.07.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.molcel.2007.07.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17889671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=992-1004&author=S.+Ramasamyauthor=S.+Duraisamyauthor=S.+Barbashovauthor=T.+Kawanoauthor=S.+Kharbandaauthor=D.+Kufe&title=The+MUC1+and+Galectin-3+Oncoproteins+Function+in+a+Microrna-Dependent+Regulatory+Loop&doi=10.1016%2Fj.molcel.2007.07.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop</span></div><div class="casAuthors">Ramasamy, Selvi; Duraisamy, Sekhar; Barbashov, Sergei; Kawano, Takeshi; Kharbanda, Surender; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The MUC1 heterodimeric transmembrane glycoprotein is aberrantly overexpressed by diverse human carcinomas.  Galectin-3 is a β-galactoside binding protein that has also been assocd. with the development of human cancers.  The present results demonstrate that MUC1 induces galectin-3 expression by a post-transcriptional mechanism.  We show that the MUC1 C-terminal subunit is glycosylated on Asn-36 and that this modification is necessary for upregulation of galectin-3.  N-glycosylated MUC1-C increases galectin-3 mRNA levels by suppressing expression of the microRNA miR-322 and thereby stabilizing galectin-3 transcripts.  The results show that, in turn, galectin-3 binds to MUC1-C at the glycosylated Asn-36 site.  The significance of the MUC1-C-galectin-3 interaction is supported by the demonstration that galectin-3 forms a bridge between MUC1 and the epidermal growth factor receptor (EGFR) and that galectin-3 is essential for EGF-mediated interactions between MUC1 and EGFR.  These findings indicate that MUC1 and galectin-3 function as part of a miR-322-dependent regulatory loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2JggLDX0XMbVg90H21EOLACvtfcHk0lgdhFnrvDQcvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrzM&md5=7a83310af1b9f1e8c06343a9029a9dd4</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.07.031%26sid%3Dliteratum%253Aachs%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DBarbashov%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DT.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DThe%2520MUC1%2520and%2520Galectin-3%2520Oncoproteins%2520Function%2520in%2520a%2520Microrna-Dependent%2520Regulatory%2520Loop%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.molcel.2007.07.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">Heregulin Targets Gamma-Catenin to the Nucleolus by a Mechanism Dependent on the DF3/MUC1 Oncoprotein</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12939402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Glu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=765-775&author=Y.+Liauthor=W.+H.+Yuauthor=J.+Renauthor=W.+Chenauthor=L.+Huangauthor=S.+Kharbandaauthor=M.+Lodaauthor=D.+Kufe&title=Heregulin+Targets+Gamma-Catenin+to+the+Nucleolus+by+a+Mechanism+Dependent+on+the+DF3%2FMUC1+Oncoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Heregulin Targets γ-Catenin to the Nucleolus by a Mechanism Dependent on the DF3/MUC1 Oncoprotein</span></div><div class="casAuthors">Li, Yongqing; Yu, Wei-hsuan; Ren, Jian; Chen, Wen; Huang, Lei; Kharbanda, Surender; Loda, Massimo; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">765-775</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The DF3/MUC1 transmembrane oncoprotein is aberrantly overexpressed in most human breast carcinomas and interacts with the Wnt effector γ-catenin.  Here, we demonstrate that MUC1 assocs. constitutively with ErbB2 in human breast cancer cells and that treatment with heregulin/neuregulin-1 (HRG) increases the formation of MUC1-ErbB2 complexes.  The importance of the MUC1-ErbB2 interaction is supported by the demonstration that HRG induces binding of MUC1 and γ-catenin and targeting of the MUC1-γ-catenin complex to the nucleolus.  Significantly, nucleolar localization of γ-catenin in response to HRG is dependent on MUC1 expression.  Moreover, mutation of a RRK motif in the MUC1 cytoplasmic domain abrogates HRG-induced nucleolar localization of MUC1 and γ-catenin.  In concert with these results, we show nucleolar localization of MUC1 and γ-catenin in human breast carcinomas but not in normal mammary ductal epithelium.  These findings demonstrate that MUC1 functions in cross talk between ErbB2 and Wnt pathways by acting as a shuttle for HRG-induced nucleolar targeting of γ-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSCi8cG9eoi7Vg90H21EOLACvtfcHk0lgdhFnrvDQcvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Glu7w%253D&md5=db2970b47ae70ebbc5f365e4fca0dfda</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DW.%2BH.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DHeregulin%2520Targets%2520Gamma-Catenin%2520to%2520the%2520Nucleolus%2520by%2520a%2520Mechanism%2520Dependent%2520on%2520the%2520DF3%252FMUC1%2520Oncoprotein%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2003%26volume%3D1%26spage%3D765%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jepson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haq, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Muc4/Sialomucin Complex, the Intramembrane Erbb2 Ligand, Induces Specific Phosphorylation of Erbb2 and Enhances Expression of P27(Kip), but Does Not Activate Mitogen-Activated Kinase or Protein Kinaseb/Akt Pathways</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7524</span>– <span class="NLM_lpage">7532</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1205970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fsj.onc.1205970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12386815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFWjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=7524-7532&author=S.+Jepsonauthor=M.+Komatsuauthor=B.+Haqauthor=M.+E.+Arangoauthor=D.+Huangauthor=C.+A.+Carrawayauthor=K.+L.+Carraway&title=Muc4%2FSialomucin+Complex%2C+the+Intramembrane+Erbb2+Ligand%2C+Induces+Specific+Phosphorylation+of+Erbb2+and+Enhances+Expression+of+P27%28Kip%29%2C+but+Does+Not+Activate+Mitogen-Activated+Kinase+or+Protein+Kinaseb%2FAkt+Pathways&doi=10.1038%2Fsj.onc.1205970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinase B/Akt pathways</span></div><div class="casAuthors">Jepson, Scott; Komatsu, Masanobu; Haq, Bushra; Arango, Maria E.; Huang, Daming; Carothers-Carraway, Coralie A.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">7524-7532</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Muc4/sialomucin complex (SMC) is a multifunctional glycoprotein complex which can repress apoptosis in transfected tumor cells.  Its transmembrane subunit acts as an intramembrane ligand for the receptor tyrosine kinase ErbB2 to induce the phosphorylation of ErbB2 and, by acting synergistically with the ErbB3 ligand neuregulin, can potentiate the phosphorylation of ErbB2 and ErbB3.  In the present study the authors show that Muc4/SMC alone robustly induces the phosphorylation of ErbB2 to enhance the tyrosine phosphate epitope (Tyr1248) recognized by anti-phospho-ErbB2.  Although this tyrosine phosphorylation has been implicated in cell transformation, it does not activate any of the three mitogen-activated protein kinases (MAPKs) or protein kinase B/Akt of the phosphatidyl inositol 3-kinase pathway.  Instead, Muc4/SMC expression induces up-regulation of the cell cycle inhibitor p27kip, consistent with the expression of Muc4/SMC in differentiated, rather than proliferative, epithelial cells.  Interestingly, a combination of Muc4/SMC and neuregulin down-regulate p27kip and activate protein kinase B/Akt.  These observations suggest that Muc4/SMC acts as a regulator of differentiation by inducing a limited phosphorylation of ErbB2 and a modulator of proliferation when acting synergistically with neuregulin to induce a more extensive phosphorylation on both ErbB2 and ErbB3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN3D_sdWZnpLVg90H21EOLACvtfcHk0lgdhFnrvDQcvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFWjsbg%253D&md5=5c6902252480750a79cf4bab36a6867c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205970%26sid%3Dliteratum%253Aachs%26aulast%3DJepson%26aufirst%3DS.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DHaq%26aufirst%3DB.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DCarraway%26aufirst%3DC.%2BA.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DMuc4%252FSialomucin%2520Complex%252C%2520the%2520Intramembrane%2520Erbb2%2520Ligand%252C%2520Induces%2520Specific%2520Phosphorylation%2520of%2520Erbb2%2520and%2520Enhances%2520Expression%2520of%2520P27%2528Kip%2529%252C%2520but%2520Does%2520Not%2520Activate%2520Mitogen-Activated%2520Kinase%2520or%2520Protein%2520Kinaseb%252FAkt%2520Pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D7524%26epage%3D7532%26doi%3D10.1038%2Fsj.onc.1205970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span> <span> </span><span class="NLM_article-title">The MUC4Mucin Mediates Gemcitabine Resistance of Human Pancreatic Cancer Cells via the Concentrative Nucleoside Transporter Family</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1723</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2012.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22580602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFCjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1714-1723&author=N.+Skrypekauthor=B.+Ducheneauthor=M.+Hebbarauthor=E.+Leteurtreauthor=I.+van+Seuningenauthor=N.+Jonckheere&title=The+MUC4Mucin+Mediates+Gemcitabine+Resistance+of+Human+Pancreatic+Cancer+Cells+via+the+Concentrative+Nucleoside+Transporter+Family&doi=10.1038%2Fonc.2012.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family</span></div><div class="casAuthors">Skrypek, N.; Duchene, B.; Hebbar, M.; Leteurtre, E.; van Seuningen, I.; Jonckheere, N.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1714-1723</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The fluorinated analog of deoxycytidine, Gemcitabine (Gemzar), is the main chemotherapeutic drug in pancreatic cancer, but survival remains weak mainly because of the high resistance of tumors to the drug.  Recent works have shown that the mucin MUC4 may confer an advantage to pancreatic tumor cells by modifying their susceptibility to drugs.  However, the cellular mechanism(s) responsible for this MUC4-mediated resistance is unknown.  The aim of this work was to identify the cellular mechanisms responsible for gemcitabine resistance linked to MUC4 expression.  CAPAN-2 and CAPAN-1 adenocarcinomatous pancreatic cancer (PC) cell lines were used to establish stable MUC4-deficient clones (MUC4-KD) by shRNA interference.  Measurement of the IC50 index using tetrazolium salt test indicated that MUC4-deficient cells were more sensitive to gemcitabine.  This was correlated with increased Bax/BclXL ratio and apoptotic cell no.  Expression of Equilibrative/Concentrative Nucleoside Transporter (hENT1, hCNT1/3), deoxycytidine kinase (dCK), ribonucleotide reductase (RRM1/2) and Multidrug-Resistance Protein (MRP3/4/5) was evaluated by quant. RT-PCR (qRT-PCR) and western blotting.  Alteration of MRP3, MRP4, hCNT1 and hCNT3 expression was obsd. in MUC4-KD cells, but only hCNT1 alteration was correlated to MUC4 expression and sensitivity to gemcitabine.  Decreased activation of MAPK, JNK and NF-κB pathways was obsd. in MUC4-deficient cells, in which the NF-κB pathway was found to have an important role in both sensitivity to gemcitabine and hCNT1 regulation.  Finally, and in accordance with our in vitro data, we found that MUC4 expression was conversely correlated to that of hCNT1 in tissues from patients with pancreatic adenocarcinoma.  This work describes a new mechanism of PC cell resistance to gemcitabine, in which the MUC4 mucin neg. regulates the hCNT1 transporter expression via the NF-κB pathway.  Altogether, these data point out to MUC4 and hCNT1 as potential targets to ameliorate the response of pancreatic tumors to gemcitabine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8VP_IcPyGbVg90H21EOLACvtfcHk0lgdhFnrvDQcvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFCjur4%253D&md5=d4d9a0c31fc51e609dc9acec17fab98c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.179%26sid%3Dliteratum%253Aachs%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DDuchene%26aufirst%3DB.%26aulast%3DHebbar%26aufirst%3DM.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26aulast%3DJonckheere%26aufirst%3DN.%26atitle%3DThe%2520MUC4Mucin%2520Mediates%2520Gemcitabine%2520Resistance%2520of%2520Human%2520Pancreatic%2520Cancer%2520Cells%2520via%2520the%2520Concentrative%2520Nucleoside%2520Transporter%2520Family%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1714%26epage%3D1723%26doi%3D10.1038%2Fonc.2012.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasseur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span> <span> </span><span class="NLM_article-title">The Oncogenic Receptor Erbb2 Modulates Gemcitabine and Irinotecan/SN-38 Chemoresistance of Human Pancreatic Cancer Cells via Hcnt1 Transporter and Multidrug-Resistance Associated Protein MRP-2</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10853</span>– <span class="NLM_lpage">10867</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.3414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=25890497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2MjlvFOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10853-10867&author=N.+Skrypekauthor=R.+Vasseurauthor=A.+Vincentauthor=B.+Ducheneauthor=I.+Van+Seuningenauthor=N.+Jonckheere&title=The+Oncogenic+Receptor+Erbb2+Modulates+Gemcitabine+and+Irinotecan%2FSN-38+Chemoresistance+of+Human+Pancreatic+Cancer+Cells+via+Hcnt1+Transporter+and+Multidrug-Resistance+Associated+Protein+MRP-2&doi=10.18632%2Foncotarget.3414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2</span></div><div class="casAuthors">Skrypek Nicolas; Vasseur Romain; Vincent Audrey; Duchene Belinda; Van Seuningen Isabelle; Jonckheere Nicolas; Skrypek Nicolas; Vasseur Romain; Vincent Audrey; Duchene Belinda; Van Seuningen Isabelle; Jonckheere Nicolas; Skrypek Nicolas; Vasseur Romain; Vincent Audrey; Duchene Belinda; Van Seuningen Isabelle; Jonckheere Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">10853-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma (PDAC) is one of the most deadly cancers because of a lack of early diagnostic markers and efficient therapeutics.  The fluorinated analog of deoxycytidine, gemcitabine and emerging FOLFIRINOX protocol (5-fluorouracil (5-FU), irinotecan/SN-38, oxaliplatin and leucovorin) are the main chemotherapies to treat PDAC.  The ErbB2/HER2 oncogenic receptor is commonly overexpressed in PDAC.  In this context, we aimed to decipher the ErbB2-mediated mechanisms of chemoresistance to the two main chemotherapy protocols used to treat PDAC.ErbB2 knocking down (KD) in CAPAN-1 and CAPAN-2 cells led to an increased sensitivity to gemcitabine and an increased resistance to irinotecan/SN-38 both in vitro and in vivo (subcutaneous xenografts) This was correlated to an increase of hCNT1 and hCNT3 transporters and ABCG2, MRP1 and MRP2 ATP-binding cassette transporters expression and resistance to cell death.  We also show that MRP2 is repressed following activation of JNK, Erk1/2 and NF-κB pathways by ErbB2.  Finally, in datasets of human PDAC samples, ErbB2 and MRP2 expression was conversely correlated.  Altogether, we propose that ErbB2 mediates several intracellular mechanisms linked to PDAC cell chemoresistance that may represent potential targets in order to ameliorate chemotherapy response and allow stratification of patients eligible for either gemcitabine or FOLFIRINOX treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRguiwWAI9SK3tlzo9xastyfW6udTcc2eYxAPJOp-C3ULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjlvFOktg%253D%253D&md5=a42400ac34247a4df37f953b153cea8a</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3414%26sid%3Dliteratum%253Aachs%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DVasseur%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DA.%26aulast%3DDuchene%26aufirst%3DB.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26aulast%3DJonckheere%26aufirst%3DN.%26atitle%3DThe%2520Oncogenic%2520Receptor%2520Erbb2%2520Modulates%2520Gemcitabine%2520and%2520Irinotecan%252FSN-38%2520Chemoresistance%2520of%2520Human%2520Pancreatic%2520Cancer%2520Cells%2520via%2520Hcnt1%2520Transporter%2520and%2520Multidrug-Resistance%2520Associated%2520Protein%2520MRP-2%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D10853%26epage%3D10867%26doi%3D10.18632%2Foncotarget.3414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vannatta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinayek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span> <span> </span><span class="NLM_article-title">Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F0008-5472.CAN-08-0587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19176398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=765-774&author=S.+C.+Chauhanauthor=K.+Vannattaauthor=M.+C.+Ebelingauthor=N.+Vinayekauthor=A.+Watanabeauthor=K.+K.+Pandeyauthor=M.+C.+Bellauthor=M.+D.+Kochauthor=H.+Aburataniauthor=Y.+Lioauthor=M.+Jaggi&title=Expression+and+Functions+of+Transmembrane+Mucin+MUC13+in+Ovarian+Cancer&doi=10.1158%2F0008-5472.CAN-08-0587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and functions of transmembrane mucin MUC13 in ovarian cancer</span></div><div class="casAuthors">Chauhan, Subhash C.; Vannatta, Kelley; Ebeling, Mara C.; Vinayek, Namita; Watanabe, Akira; Pandey, Krishan K.; Bell, Maria C.; Koch, Michael D.; Aburatani, Hiroyuki; Lio, Yuhlong; Jaggi, Meena</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">765-774</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MUC13, a transmembrane mucin, is normally expressed in gastrointestinal and airway epithelium.  Its aberrant expression has been correlated with gastric colon and cancer.  However, the expression and functions of MUC13 in ovarian cancer are unknown.  In the present study, the expression profile and functions of MUC13 were analyzed to elucidate its potential role in ovarian cancer diagnosis and pathogenesis.  A recently generated monoclonal antibody (clone PPZ0020) was used to det. the expression profile of MUC13 by immunohistochem. using ovarian cancer tissue microarrays and 56 addnl. epithelial ovarian cancer (EOC) samples.  The expression of MUC13 was significantly (P < 0.005) higher in cancer samples compared with the normal ovary/benign tissues.  Among all ovarian cancer types, MUC13 expression was specifically present in EOC.  For the functional analyses, a full-length MUC13 gene cloned in pcDNA3.1 was expressed in a MUC13 null ovarian cancer cell line, SKOV-3.  Here, we show that the exogenous MUC13 expression induced morphol. changes, including scattering of cells.  These changes were abrogated through c-Jun NH2 kinase (JNK) chem. inhibitor (SP600125) or JNK2 siRNA.  Addnl., a marked redn. in cell-cell adhesion and significant (P < 0.05) increases in cell motility, proliferation, and tumorigenesis in a xenograft mouse model system were obsd. upon exogenous MUC13 expression.  These cellular characteristics were correlated with up-regulation of HER2, p21-activated kinase 1, and p38 protein expression.  Our findings show the aberrant expression of MUC13 in ovarian cancer and that its expression alters the cellular characteristics of SKOV-3 cells.  This implies a significant role of MUC13 in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0_cDsdOkC7Vg90H21EOLACvtfcHk0ljLYrDT5ScKuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOksb8%253D&md5=4b2339466e0f9f83285214e3215b6d5a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0587%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DVannatta%26aufirst%3DK.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DVinayek%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DK.%2BK.%26aulast%3DBell%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DM.%2BD.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DLio%26aufirst%3DY.%26aulast%3DJaggi%26aufirst%3DM.%26atitle%3DExpression%2520and%2520Functions%2520of%2520Transmembrane%2520Mucin%2520MUC13%2520in%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D765%26epage%3D774%26doi%3D10.1158%2F0008-5472.CAN-08-0587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puumala, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">Functions and Regulation of MUC13 Mucin in Colon Cancer Cells</span>. <i>J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1378</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1007/s00535-013-0885-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs00535-013-0885-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24097071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SgurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=1378-1391&author=B.+K.+Guptaauthor=D.+M.+Maherauthor=M.+C.+Ebelingauthor=P.+D.+Stephensonauthor=S.+E.+Puumalaauthor=M.+R.+Kochauthor=H.+Aburataniauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=Functions+and+Regulation+of+MUC13+Mucin+in+Colon+Cancer+Cells&doi=10.1007%2Fs00535-013-0885-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Functions and regulation of MUC13 mucin in colon cancer cells</span></div><div class="casAuthors">Gupta, Brij K.; Maher, Diane M.; Ebeling, Mara C.; Stephenson, Phillip D.; Puumala, Susan E.; Koch, Michael R.; Aburatani, Hiroyuki; Jaggi, Meena; Chauhan, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1378-1391</span>CODEN:
                <span class="NLM_cas:coden">JOGAET</span>;
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">Background: MUC13 is overexpressed and aberrantly localized in colon cancer tissue; however, the specific functions and regulation of MUC13 expression are unknown.  Methods: Stable cell lines with either overexpressed or suppressed MUC13 levels were analyzed to det. cell growth, colony formation, cell migration, and cell invasion assays.  The mol. mechanisms involved in MUC13 regulation were elucidated via chromatin immunopptn. (ChIP) and anal. of interleukin 6 (IL6) treatments.  Colon cancer tissues were analyzed by immunohistochem. (IHC) for the protein levels of MUC13 and P-STAT5 in colon cancer cells.  Results: Overexpression of MUC13 increased cell growth, colony formation, cell migration, and invasion.  In concordance, MUC13 silencing decreased these tumorigenic features.  Overexpression of MUC13 also modulated various cancer-assocd. proteins, including telomerase reverse transcriptase, sonic hedgehog, B cell lymphoma murine like site 1, and GATA like transcription factor 1.  Addnl., MUC13-overexpressing cells showed increased HER2 and P-ERK expression.  ChIP anal. revealed binding of STAT5 to the predicted MUC13 promoter.  IL6 treatment of colon cancer cells increased the expression of MUC13 via activation of the JAK2/STAT5 signaling pathway.  Suppression of JAK2 and STAT5 signaling by chem. inhibitors abolished IL6-induced MUC13 expression.  IHC anal. showed increased expression of both P-STAT5 and MUC13 in colon cancer as compared to adjacent normal tissue.  Conclusions: The results of this study, for the first time, suggest functional roles of MUC13 in colon cancer progression and provide information regarding the regulation of MUC13 expression via JAK2/STAT5 which may reveal promising therapeutic approaches for colon cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBpXJHADk3ebVg90H21EOLACvtfcHk0ljLYrDT5ScKuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SgurbK&md5=d76df872e42d78da86aa0973b8699a31</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs00535-013-0885-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-013-0885-z%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DB.%2BK.%26aulast%3DMaher%26aufirst%3DD.%2BM.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DStephenson%26aufirst%3DP.%2BD.%26aulast%3DPuumala%26aufirst%3DS.%2BE.%26aulast%3DKoch%26aufirst%3DM.%2BR.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DFunctions%2520and%2520Regulation%2520of%2520MUC13%2520Mucin%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2014%26volume%3D49%26spage%3D1378%26epage%3D1391%26doi%3D10.1007%2Fs00535-013-0885-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshacharyulu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haridas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachagani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganti, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnusamy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">Novel HER3/MUC4 Oncogenic Signaling Aggravates the Tumorigenic Phenotypes of Pancreatic Cancer Cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21085</span>– <span class="NLM_lpage">21099</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.3912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26035354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2MfpsVGgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=21085-21099&author=I.+Lakshmananauthor=P.+Seshacharyuluauthor=D.+Haridasauthor=S.+Rachaganiauthor=S.+Guptaauthor=S.+Joshiauthor=C.+Gudaauthor=Y.+Yanauthor=M.+Jainauthor=A.+K.+Gantiauthor=M.+P.+Ponnusamyauthor=S.+K.+Batra&title=Novel+HER3%2FMUC4+Oncogenic+Signaling+Aggravates+the+Tumorigenic+Phenotypes+of+Pancreatic+Cancer+Cells&doi=10.18632%2Foncotarget.3912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells</span></div><div class="casAuthors">Lakshmanan Imayavaramban; Seshacharyulu Parthasarathy; Haridas Dhanya; Rachagani Satyanarayana; Gupta Suprit; Joshi Suhasini; Jain Maneesh; Ponnusamy Moorthy P; Batra Surinder K; Guda Chittibabu; Yan Ying; Jain Maneesh; Ponnusamy Moorthy P; Batra Surinder K; Ganti Apar K; Ganti Apar K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">21085-99</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Several studies have demonstrated that MUC4 is involved in progression and metastasis of pancreatic cancer (PC).  Here, we report that HER3/MUC4 interaction in HER2 low cells is critical in driving pancreatic tumorigenesis.  Upon HER2 knockdown, we observed elevated expression of HER3 and MUC4 and their interactions, which was confirmed by immunoprecipitation and bioinformatics analyses.  In paired human PC tissues, higher percentage of HER3 positivity (10/33, 30.3%; p = 0.001) was observed than HER2 (5/33, 15.1%; p = 0.031), which was further confirmed in spontaneous mice (KPC; KrasG12D; Trp53R172H/+; Pdx-Cre) tumors of different weeks.  Mechanistically, increased phosphorylation of ERK and expression of PI3K and c-Myc were observed in HER2 knockdown cells, suggesting a positive role for HER3/MUC4 in HER2 low cells.  Further, HER2 knockdown resulted in increased proliferation, motility and tumorigenicity of PC cells.  Consistently, transient knockdown of HER3 by siRNA in HER2 knockdown cells led to decreased proliferation.  These observations led us to conclude that HER3 interacts with MUC4 to promote proliferation in HER2 low PC cells.  Further, deficiency of both HER2 and HER3 leads to decreased proliferation of PC cells.  Hence targeting these newly identified HER3/MUC4 signals would improve the PC patients survival by intercepting MUC4 mediated oncogenic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOtduiqRtz8fcsfMJQC1ZdfW6udTcc2eZKspRgjtVnwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfpsVGgtQ%253D%253D&md5=2551f03a4268593686e3032b27057783</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3912%26sid%3Dliteratum%253Aachs%26aulast%3DLakshmanan%26aufirst%3DI.%26aulast%3DSeshacharyulu%26aufirst%3DP.%26aulast%3DHaridas%26aufirst%3DD.%26aulast%3DRachagani%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DGuda%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DGanti%26aufirst%3DA.%2BK.%26aulast%3DPonnusamy%26aufirst%3DM.%2BP.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DNovel%2520HER3%252FMUC4%2520Oncogenic%2520Signaling%2520Aggravates%2520the%2520Tumorigenic%2520Phenotypes%2520of%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D21085%26epage%3D21099%26doi%3D10.18632%2Foncotarget.3912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular Architecture of the Erbb2 Extracellular Domain Homodimer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1695</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.2713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=25633808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2MrgvVygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1695-1706&author=S.+Huauthor=Y.+Sunauthor=Y.+Mengauthor=X.+Wangauthor=W.+Yangauthor=W.+Fuauthor=H.+Guoauthor=W.+Qianauthor=S.+Houauthor=B.+Liauthor=Z.+Raoauthor=Z.+Louauthor=Y.+Guo&title=Molecular+Architecture+of+the+Erbb2+Extracellular+Domain+Homodimer&doi=10.18632%2Foncotarget.2713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular architecture of the ErbB2 extracellular domain homodimer</span></div><div class="casAuthors">Hu Shi; Guo Huaizu; Qian Weizhu; Hou Sheng; Li Bohua; Guo Yajun; Hu Shi; Sun Yuna; Rao Zihe; Hu Shi; Sun Yuna; Rao Zihe; Lou Zhiyong; Hu Shi; Yang Weili; Fu Wenyan; Hou Sheng; Li Bohua; Guo Yajun; Meng Yanchun; Wang Xiaoze; Yang Weili; Guo Yajun; Meng Yanchun; Guo Huaizu; Qian Weizhu; Hou Sheng; Guo Yajun; Meng Yanchun; Hou Sheng; Guo Yajun</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1695-706</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human epidermal growth factor receptors (HERs or ErbBs) play crucial roles in numerous cellular processes.  ErbB2 is a key member of ErbB family, and its overexpression is recognized as a frequent molecular abnormality.  In cancer, this overexpression correlates with aggressive disease and poor patient outcomes.  Dimer-dependent phosphorylation is a key event for the signal transduction of ErbBs.  However, the molecular mechanism of the dimerization of ErbB2 remains elusive.  In the present work, we report the homodimer architecture of the ErbB2 extracellular domain (ECD) which is unique compared with other dimer-models of ErbBs.  The structure of the ErbB2 ECD homodimer represents a "back to head" interaction, in which a protruding β-hairpin arm in domain II of one ErbB2 protomer is inserted into a C-shaped pocket created by domains I-III of the adjacent ErbB2 protomer.  This dimerized architecture and its impact on the phosphorylation of ErbB2 intracellular domain were further verified by a mutagenesis study.  We also elucidated the different impacts of two clinically administered therapeutic antibodies, trastuzumab and pertuzumab, on ErbB2 dimerization.  This information not only provides an understanding of the molecular mechanism of ErbBs dimerization but also elucidates ErbB2-targeted therapy at the molecular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl0pGDyilHAsve_zCu79I8fW6udTcc2eZKspRgjtVnwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrgvVygsw%253D%253D&md5=849cce64a78a7439c541995d965e63e1</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2713%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DHou%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRao%26aufirst%3DZ.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DY.%26atitle%3DMolecular%2520Architecture%2520of%2520the%2520Erbb2%2520Extracellular%2520Domain%2520Homodimer%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D1695%26epage%3D1706%26doi%3D10.18632%2Foncotarget.2713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmon, M. A.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.cell.2010.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20723758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=568-579&author=D.+Alvaradoauthor=D.+E.+Kleinauthor=M.+A.+Lemmon&title=Structural+Basis+for+Negative+Cooperativity+in+Growth+Factor+Binding+to+an+EGF+Receptor&doi=10.1016%2Fj.cell.2010.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor</span></div><div class="casAuthors">Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">568-579</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Transmembrane signaling by the epidermal growth factor receptor (EGFR) involves ligand-induced dimerization and allosteric regulation of the intracellular tyrosine kinase domain.  Crystallog. studies have shown how ligand binding induces dimerization of the EGFR extracellular region but cannot explain the "high-affinity" and "low-affinity" classes of cell-surface EGF-binding sites inferred from curved Scatchard plots.  From a series of crystal structures of the Drosophila EGFR extracellular region, we show here how Scatchard plot curvature arises from neg. cooperative ligand binding.  The first ligand-binding event induces formation of an asym. dimer with only one bound ligand.  The unoccupied site in this dimer is structurally restrained, leading to reduced affinity for binding of the second ligand, and thus neg. cooperativity.  Our results explain the cell-surface binding characteristics of EGF receptors and suggest how individual EGFR ligands might stabilize distinct dimeric species with different signaling properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5brpwwp9arVg90H21EOLACvtfcHk0lhcwCvGp3a63Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzO&md5=203a9818de72b925546622c98324775c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarado%26aufirst%3DD.%26aulast%3DKlein%26aufirst%3DD.%2BE.%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26atitle%3DStructural%2520Basis%2520for%2520Negative%2520Cooperativity%2520in%2520Growth%2520Factor%2520Binding%2520to%2520an%2520EGF%2520Receptor%26jtitle%3DCell%26date%3D2010%26volume%3D142%26spage%3D568%26epage%3D579%26doi%3D10.1016%2Fj.cell.2010.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekels, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandarian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaworski, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span> <span> </span><span class="NLM_article-title">Activity of Recombinant Cysteine-Rich Domain Proteins Derived from the Membrane-Bound MUC17/Muc3 Family Mucins</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1800</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2010.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.bbagen.2010.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1800&publication_year=2010&pages=629-638&author=S.+B.+Hoauthor=Y.+Luuauthor=L.+L.+Shekelsauthor=S.+K.+Batraauthor=B.+Kandarianauthor=D.+B.+Evansauthor=P.+G.+Zaworskiauthor=C.+L.+Wolfeauthor=R.+L.+Heinrikson&title=Activity+of+Recombinant+Cysteine-Rich+Domain+Proteins+Derived+from+the+Membrane-Bound+MUC17%2FMuc3+Family+Mucins&doi=10.1016%2Fj.bbagen.2010.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins</span></div><div class="casAuthors">Ho, Samuel B.; Luu, Ying; Shekels, Laurie L.; Batra, Surinder K.; Kandarian, Brandon; Evans, David B.; Zaworski, Phillip G.; Wolfe, Cindy L.; Heinrikson, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1800</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">629-638</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The membrane-bound mucins, MUC17 (human) and Muc3 (mouse), are highly expressed on the apical surface of intestinal epithelia and have cytoprotective properties.  Their extracellular regions contain two EGF-like Cys-rich domains (CRD1 and CRD2) connected by an intervening linker segment with SEA module (L), and may function to stimulate intestinal cell restitution.  The purpose of this study was to det. the effect of size, recombinant host source, and external tags on mucin CRD1-L-CRD2 protein activity.  Four recombinant Muc3-CRD proteins and three MUC17-CRD proteins were generated using Escherichia coli or baculovirus-insect cell systems and tested in colonic cell cultures for activity related to cell migration and apoptosis.  N-terminal glutathione-S-transferase (GST) or C-terminal His8 tags had no effect on either the cell migration or anti-apoptosis activity of Muc3-CRD1-L-CRD2.  His-tagged Muc3-CRD1-L-CRD2 proteins with truncated linker regions, or the linker region alone, did not demonstrate biol. activity.  The human recombinant MUC17-CRD1-L-CRD2-His8 was shown to have anti-apoptotic and pro-migratory activity, but did not stimulate cell proliferation.  This protein showed similar in vitro biol. activity, whether produced in E. coli or a baculovirus-insect cell system.  Recombinant mucin proteins contg. a bivalent display of Cys-rich domains accelerate colon cell migration and inhibit apoptosis, require a full-length intervening Linker-SEA segment for optimal biol. activity, and are functional when synthesized in either E. coli and insect cell systems.  These results indicate that an E. coli-derived full-length His8-tagged human MUC17 CRD1-L-CRD2 recombinant protein is a biol. active candidate for further development as a therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTkjY2azqFirVg90H21EOLACvtfcHk0li6uDQQvo_s5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWitrg%253D&md5=7db0956641c4c45165a484b7aacf0ee6</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2010.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2010.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BB.%26aulast%3DLuu%26aufirst%3DY.%26aulast%3DShekels%26aufirst%3DL.%2BL.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DKandarian%26aufirst%3DB.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DZaworski%26aufirst%3DP.%2BG.%26aulast%3DWolfe%26aufirst%3DC.%2BL.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26atitle%3DActivity%2520of%2520Recombinant%2520Cysteine-Rich%2520Domain%2520Proteins%2520Derived%2520from%2520the%2520Membrane-Bound%2520MUC17%252FMuc3%2520Family%2520Mucins%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2010%26volume%3D1800%26spage%3D629%26epage%3D638%26doi%3D10.1016%2Fj.bbagen.2010.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price-Schiavi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fregien, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carothers Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">5263</span>– <span class="NLM_lpage">5266</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.9.5263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.274.9.5263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10026131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXhsFamtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=5263-5266&author=K.+L.+Carrawayauthor=E.+A.+Rossiauthor=M.+Komatsuauthor=S.+A.+Price-Schiaviauthor=D.+Huangauthor=P.+M.+Guyauthor=M.+E.+Carvajalauthor=N.+Fregienauthor=C.+A.+Carothers+Carrawayauthor=K.+L.+Carraway&title=An+Intramembrane+Modulator+of+the+ErbB2+Receptor+Tyrosine+Kinase+That+Potentiates+Neuregulin+Signaling&doi=10.1074%2Fjbc.274.9.5263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling</span></div><div class="casAuthors">Carraway, Kermit L., III; Rossi, Edmund A.; Komatsu, Masanobu; Price-Schiavi, Shari A.; Huang, Daming; Guy, Pamela M.; Carvajal, Maria E.; Fregien, Nevis; Carothers-Carraway, Coralie A.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5263-5266</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The ErbB2 receptor tyrosine kinase plays a crit. role in a variety of developmental processes, and its aberrant activation may contribute to the progression of some breast and ovarian tumors.  ASGP2, a transmembrane glycoprotein found on the surface of the highly metastatic ascites 13762 rat mammary adenocarcinoma cell line, is constitutively assocd. with ErbB2 in these cells and in mammary tissue from pregnant rats.  Expression studies indicate that ASGP2 interacts directly and specifically with ErbB2 through one of its epidermal growth factor-like domains and that the co-expression of the two proteins in the same cell dramatically facilitates their direct stable interaction.  Ectopic expression of ASGP2 in human melanoma tumor cells potentiates the response of endogenous ErbB2 to the neuregulin-1 growth factor.  These observations point to a novel intramembrane mechanism for the modulation of receptor tyrosine kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKn0loK5wo7Vg90H21EOLACvtfcHk0li6uDQQvo_s5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsFamtbg%253D&md5=b8bd37d92cad51160b4c31f4664f2a2f</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.9.5263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.9.5263%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26aulast%3DRossi%26aufirst%3DE.%2BA.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DPrice-Schiavi%26aufirst%3DS.%2BA.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DGuy%26aufirst%3DP.%2BM.%26aulast%3DCarvajal%26aufirst%3DM.%2BE.%26aulast%3DFregien%26aufirst%3DN.%26aulast%3DCarothers%2BCarraway%26aufirst%3DC.%2BA.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DAn%2520Intramembrane%2520Modulator%2520of%2520the%2520ErbB2%2520Receptor%2520Tyrosine%2520Kinase%2520That%2520Potentiates%2520Neuregulin%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D5263%26epage%3D5266%26doi%3D10.1074%2Fjbc.274.9.5263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontecilla-Camps, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlaud, G. J.</span></span> <span> </span><span class="NLM_article-title">Evolutionary Conserved Rigid Module-domain Interactions can be Detected at the Sequence Level: The Examples of Complement and Blood Coagulation Proteases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1998.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1006%2Fjmbi.1998.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9735300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlClsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=459-470&author=C.+Gaboriaudauthor=V.+Rossiauthor=J.+C.+Fontecilla-Campsauthor=G.+J.+Arlaud&title=Evolutionary+Conserved+Rigid+Module-domain+Interactions+can+be+Detected+at+the+Sequence+Level%3A+The+Examples+of+Complement+and+Blood+Coagulation+Proteases&doi=10.1006%2Fjmbi.1998.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary conserved rigid module-domain interactions can be detected at the sequence level: the examples of complement and blood coagulation proteases</span></div><div class="casAuthors">Gaboriaud, Christine; Rossi, Veronique; Fontecilla-Camps, Juan Carlos; Arlaud, Gerard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">459-470</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Several extracellular modular proteins, including proteases of the complement and blood coagulation cascades, are shown here to exhibit conserved sequence patterns specific for a particular module-domain assocn.  This was detected by comparative anal. of sequence variability in different multiple sequence alignments, which provides a new tool to investigate the evolution of modular proteins.  A first example deals with the proteins featuring a common complement control protein (CCP) module-serine protease (SP) domain pattern at their C-terminal end, defined here as the CCP-SP sub-family.  These proteins include the complement proteases C1r, C1s and MASPs, the Limulus clotting factor C, and the proteins of the haptoglobin family.  A second example deals with blood coagulation factors VII, IX and X and protein C, all featuring a common epidermal growth factor (EGF)-SP C-terminal assembly.  Highly specific motifs are found at the connection between the CCP or EGF module and the activation peptide of the SP domain: [P/A]-x-C-x-[P/A]-[I/V]-C-G-x-[P/S/K] in the case of the CCP-SP proteins, and C-x-[P/S]-x-x-x-[Y/F]-P-C-G in the case of the EGF-SP proteins.  Each motif is strictly conserved in the whole sub-family and it is detected in no more than one other known protein sequence.  Strikingly, most of the conserved residues specific to each sub-family appear to be clustered at the interface between the SP domain and the CCP or EGF module.  We propose that a rigid module-domain interaction occurs in these proteins and has been conserved through evolution.  The functional implications of these assemblies, underlined by such evolutionary constraints, are discussed.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbykjyHOn0rVg90H21EOLACvtfcHk0li6uDQQvo_s5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlClsbY%253D&md5=91a3ddb534b55599f4d26eeffbd0a86e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2008%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriaud%26aufirst%3DC.%26aulast%3DRossi%26aufirst%3DV.%26aulast%3DFontecilla-Camps%26aufirst%3DJ.%2BC.%26aulast%3DArlaud%26aufirst%3DG.%2BJ.%26atitle%3DEvolutionary%2520Conserved%2520Rigid%2520Module-domain%2520Interactions%2520can%2520be%2520Detected%2520at%2520the%2520Sequence%2520Level%253A%2520The%2520Examples%2520of%2520Complement%2520and%2520Blood%2520Coagulation%2520Proteases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D282%26spage%3D459%26epage%3D470%26doi%3D10.1006%2Fjmbi.1998.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varshney, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilentz, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argani, P.</span></span> <span> </span><span class="NLM_article-title">MUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia</span>. <i>Am. J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1309/7Y7N-M1WM-R0YK-M2VA</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1309%2F7Y7N-M1WM-R0YK-M2VA" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12090430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD38zkslKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2002&pages=791-796&author=M.+J.+Swartzauthor=S.+K.+Batraauthor=G.+C.+Varshneyauthor=M.+A.+Hollingsworthauthor=C.+J.+Yeoauthor=J.+L.+Cameronauthor=R.+E.+Wilentzauthor=R.+H.+Hrubanauthor=P.+Argani&title=MUC4+Expression+Increases+Progressively+in+Pancreatic+Intraepithelial+Neoplasia&doi=10.1309%2F7Y7N-M1WM-R0YK-M2VA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4 expression increases progressively in pancreatic intraepithelial neoplasia</span></div><div class="casAuthors">Swartz Michael J; Batra Surinder K; Varshney Grish C; Hollingsworth Michael A; Yeo Charles J; Cameron John L; Wilentz Robb E; Hruban Ralph H; Argani Pedram</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-6</span>
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma is believed to develop from histologically identifiable intraductal lesions known as pancreatic intraepithelial neoplasias (PanINs) that undergo a series of architectural, cytologic, and genetic changes, a progression model similar to the adenoma-carcinoma sequence in the colon.  The apomucin MUC4 has been implicated in invasive pancreatic adenocarcinoma.  MUC4 expression is not detectable at the RNA level in normal pancreas but is detectable at high levels in invasive pancreatic adenocarcinoma.  We documented the pattern of expression of MUC4 in PanINs by studying a series of 71 PanIN lesions immunohistochemically using a new monoclonal antibody to MUC4.  Five (17%) of 30 PanIN-1 lesions, 10 (36%) of 28 PanIN-2 lesions, 11 (85%) of 13 PanIN-3 lesions, and 25 (89%) of 28 invasive adenocarcinomas labeled with the MUC4 antibody used in the study.  In addition, afew nonneoplastic lesions labeled with the MUC4 antibody, including reactive ducts in chronic pancreatitis, atrophic ducts filled with inspissated secretions, and ducts showing squamous metaplasia.  Our data help establish the patterns of MUC4 expression in neoplastic precursors in the pancreas and add further support to the progression model for pancreatic adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMRBXQMQ_EXlUIs6wFK5xJfW6udTcc2eYw89doXkMPtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zkslKhtA%253D%253D&md5=9c1f25b1200e253c97f5bbe5b01d6e9b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1309%2F7Y7N-M1WM-R0YK-M2VA&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252F7Y7N-M1WM-R0YK-M2VA%26sid%3Dliteratum%253Aachs%26aulast%3DSwartz%26aufirst%3DM.%2BJ.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DVarshney%26aufirst%3DG.%2BC.%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCameron%26aufirst%3DJ.%2BL.%26aulast%3DWilentz%26aufirst%3DR.%2BE.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DArgani%26aufirst%3DP.%26atitle%3DMUC4%2520Expression%2520Increases%2520Progressively%2520in%2520Pancreatic%2520Intraepithelial%2520Neoplasia%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2002%26volume%3D117%26spage%3D791%26epage%3D796%26doi%3D10.1309%2F7Y7N-M1WM-R0YK-M2VA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessein, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseyn, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frénois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">The Mucin MUC4 and its Membrane Partner Erbb2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e32232</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0032232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1371%2Fjournal.pone.0032232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22393391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=N.+Jonckheereauthor=N.+Skrypekauthor=J.+Merlinauthor=A.+F.+Desseinauthor=P.+Dumontauthor=E.+Leteurtreauthor=A.+Harrisauthor=J.+L.+Desseynauthor=C.+Susiniauthor=F.+Fr%C3%A9noisauthor=I.+Van+Seuningen&title=The+Mucin+MUC4+and+its+Membrane+Partner+Erbb2+Regulate+Biological+Properties+of+Human+CAPAN-2+Pancreatic+Cancer+Cells+via+Different+Signalling+Pathways&doi=10.1371%2Fjournal.pone.0032232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Dumont, Patrick; Leteurtre, Emmanuelle; Harris, Ann; Desseyn, Jean-Luc; Susini, Christiane; Frenois, Frederic; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e32232</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mucin MUC4 and its membrane partner the ErbB2 oncogenic receptor are potential interacting partners in human pancreatic tumor development.  However, the way they function is still largely unknown.  In this work, we aimed to identify the cellular mechanisms and the intracellular signalling pathways under the control of both ErbB2 and MUC4 in a human pancreatic adenocarcinomatous cell line.  Using co-immunopptn. and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 via the EGF domains of MUC4.  Stable cell clones were generated in which either MUC4 or ErbB2 were knocked down (KD) by a shRNA approach.  Biol. properties of these cells were then studied in vitro and in vivo.  Our results show that ErbB2-KD cells are more apoptotic and less proliferative (decreased cyclin D1 and increased p27kip1 expression) while migration and invasive properties were not altered.  MUC4-KD clones were less proliferative with decreased cyclin D1 expression, G1 cell cycle arrest and altered ErbB2/ErbB3 expression.  Their migration properties were reduced whereas invasive properties were increased.  Importantly, inhibition of ErbB2 and MUC4 expression did not impair the same signalling pathways (inhibition of MUC4 expression affected the JNK pathway whereas that of ErbB2 altered the MAPK pathway).  Finally, ErbB2-KD and MUC4-KD cells showed impaired tumor growth in vivo.  Our results show that ErbB2 and MUC4, which interact phys., activate different intracellular signalling pathways to regulate biol. properties of CAPAN-2 pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraoUloWRMMlrVg90H21EOLACvtfcHk0liKG5MGDTGHYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D&md5=656b500d070b2e9b6d64ee65a37aa624</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0032232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0032232%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DMerlin%26aufirst%3DJ.%26aulast%3DDessein%26aufirst%3DA.%2BF.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DDesseyn%26aufirst%3DJ.%2BL.%26aulast%3DSusini%26aufirst%3DC.%26aulast%3DFr%25C3%25A9nois%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DThe%2520Mucin%2520MUC4%2520and%2520its%2520Membrane%2520Partner%2520Erbb2%2520Regulate%2520Biological%2520Properties%2520of%2520Human%2520CAPAN-2%2520Pancreatic%2520Cancer%2520Cells%2520via%2520Different%2520Signalling%2520Pathways%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0032232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yacoubian, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrman, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">MicroRNA-145 Targets MUC13 and Suppresses Growth and Invasion of Pancreatic Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">7599</span>– <span class="NLM_lpage">7609</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.2281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=25277192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ntVamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=7599-7609&author=S.+Khanauthor=M.+C.+Ebelingauthor=M.+S.+Zamanauthor=M.+Sikanderauthor=M.+M.+Yallapuauthor=N.+Chauhanauthor=A.+M.+Yacoubianauthor=S.+W.+Behrmanauthor=N.+Zafarauthor=D.+Kumarauthor=P.+A.+Thompsonauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=MicroRNA-145+Targets+MUC13+and+Suppresses+Growth+and+Invasion+of+Pancreatic+Cancer&doi=10.18632%2Foncotarget.2281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer</span></div><div class="casAuthors">Khan Sheema; Zaman Mohd S; Sikander Mohammed; Yallapu Murali M; Chauhan Neeraj; Jaggi Meena; Chauhan Subhash C; Ebeling Mara C; Yacoubian Ashley M; Zafar Nadeem; Behrman Stephen W; Kumar Deepak; Thompson Paul A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7599-609</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic cancer has a poor prognosis due to late diagnosis and ineffective therapeutic multimodality.  MUC13, a transmembrane mucin is highly involved in pancreatic cancer progression.  Thus, understanding its regulatory molecular mechanisms may offer new avenue of therapy for prevention/treatment of pancreatic cancer.  Herein, we report a novel microRNA (miR-145)-mediated mechanism regulating aberrant MUC13 expression in pancreatic cancer.  We report that miR-145 expression inversely correlates with MUC13 expression in pancreatic cancer cells and human tumor tissues. miR-145 is predominantly present in normal pancreatic tissues and early Pancreatic Ductal Adenocarcinoma (PDAC) precursor lesions (PanIN I) and is progressively suppressed over the course of development from PanIN II/III to late stage poorly differentiated PDAC.  We demonstrate that miR-145 targets 3' untranslated region of MUC13 and thus downregulates MUC13 protein expression in cells.  Interestingly, transfection of miR-145 inhibits cell proliferation, invasion and enhances gemcitabine sensitivity.  It causes reduction of HER2, P-AKT, PAK1 and an increase in p53.  Similar results were found when MUC13 was specifically inhibited by shRNA directed at MUC13.  Additionally, intratumoral injections of miR-145 in xenograft mice inhibited tumor growth via suppression of MUC13 and its downstream target, HER2.  These results suggest miR-145 as a novel regulator of MUC13 in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbVVQKsYBUc5cXNb62YGmbfW6udTcc2eYw89doXkMPtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ntVamsg%253D%253D&md5=18f1327ba6886fc875b058b569ea0fa6</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2281%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DZaman%26aufirst%3DM.%2BS.%26aulast%3DSikander%26aufirst%3DM.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DChauhan%26aufirst%3DN.%26aulast%3DYacoubian%26aufirst%3DA.%2BM.%26aulast%3DBehrman%26aufirst%3DS.%2BW.%26aulast%3DZafar%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DMicroRNA-145%2520Targets%2520MUC13%2520and%2520Suppresses%2520Growth%2520and%2520Invasion%2520of%2520Pancreatic%2520Cancer%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D7599%26epage%3D7609%26doi%3D10.18632%2Foncotarget.2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lahdaoui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delpu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrisani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Mir-219–1-3p is a Negative Regulator of the Mucin MUC4 Expression and is a Tumor Suppressor in Pancreatic Cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1038/onc.2014.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2014.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24608432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvV2jsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=780-788&author=F.+Lahdaouiauthor=Y.+Delpuauthor=A.+Vincentauthor=F.+Renaudauthor=M.+Messagerauthor=B.+Ducheneauthor=E.+Leteurtreauthor=C.+Marietteauthor=J.+Torrisaniauthor=N.+Jonckheereauthor=I.+van+Seuningen&title=Mir-219%E2%80%931-3p+is+a+Negative+Regulator+of+the+Mucin+MUC4+Expression+and+is+a+Tumor+Suppressor+in+Pancreatic+Cancer&doi=10.1038%2Fonc.2014.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer</span></div><div class="casAuthors">Lahdaoui, F.; Delpu, Y.; Vincent, A.; Renaud, F.; Messager, M.; Duchene, B.; Leteurtre, E.; Mariette, C.; Torrisani, J.; Jonckheere, N.; Van Seuningen, I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">780-788</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers in the world with one of the worst outcome.  The oncogenic mucin MUC4 has been identified as an actor of pancreatic carcinogenesis as it is involved in many processes regulating pancreatic cancer cell biol.  MUC4 is not expressed in healthy pancreas whereas it is expressed very early in pancreatic carcinogenesis.  Targeting MUC4 in these early steps may thus appear as a promising strategy to slow-down pancreatic tumorigenesis.  MiRNA neg. regulation of MUC4 could be one mechanism to efficiently downregulate MUC4 gene expression in early pancreatic neoplastic lesions.  Using in silico studies, we found two putative binding sites for miR-219-1-3p in the 3'-UTR of MUC4 and showed that miR-219-1-3p expression is downregulated both in PDAC-derived cell lines and human PDAC tissues compared with their normal counterparts.  We then showed that miR-219-1-3p neg. regulates MUC4 mucin expression via its direct binding to MUC4 3'-UTR.  MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lines induced a decrease of cell proliferation assocd. with a decrease of cyclin D1 and a decrease of Akt and Erk pathway activation.  MiR-219-1-3p overexpression also decreased cell migration.  Furthermore, miR-219-1-3p expression was found to be conversely correlated with Muc4 expression in early pancreatic intraepithelial neoplasia lesions of Pdx1-Cre;LSL-KrasG12D mice.  Most interestingly, in vivo studies showed that miR-219-1-3p injection in xenografted pancreatic tumors in mice decreased both tumor growth and MUC4 mucin expression.  Altogether, these results identify miR-219-1-3p as a new neg. regulator of MUC4 oncomucin that possesses tumor-suppressor activity in PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2j-hTxJqNOrVg90H21EOLACvtfcHk0lhL-nNqdUJYjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvV2jsbs%253D&md5=2fd7228df915a21743420b9a79901db1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.11%26sid%3Dliteratum%253Aachs%26aulast%3DLahdaoui%26aufirst%3DF.%26aulast%3DDelpu%26aufirst%3DY.%26aulast%3DVincent%26aufirst%3DA.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DMessager%26aufirst%3DM.%26aulast%3DDuchene%26aufirst%3DB.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3DMariette%26aufirst%3DC.%26aulast%3DTorrisani%26aufirst%3DJ.%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26atitle%3DMir-219%25E2%2580%25931-3p%2520is%2520a%2520Negative%2520Regulator%2520of%2520the%2520Mucin%2520MUC4%2520Expression%2520and%2520is%2520a%2520Tumor%2520Suppressor%2520in%2520Pancreatic%2520Cancer%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D780%26epage%3D788%26doi%3D10.1038%2Fonc.2014.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dokmanovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. J.</span></span> <span> </span><span class="NLM_article-title">Cardiotoxicity Of Erbb2-Targeted Therapies and its Impact on Drug Development, a Spotlight on Trastuzumab</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1337746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1080%2F17425255.2017.1337746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28571477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1ensLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=755-766&author=M.+Dokmanovicauthor=K.+E.+Kingauthor=N.+Mohanauthor=Y.+Endoauthor=W.+J.+Wu&title=Cardiotoxicity+Of+Erbb2-Targeted+Therapies+and+its+Impact+on+Drug+Development%2C+a+Spotlight+on+Trastuzumab&doi=10.1080%2F17425255.2017.1337746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab</span></div><div class="casAuthors">Dokmanovic, Milos; King, Kathryn E.; Mohan, Nishant; Endo, Yukinori; Wu, Wen Jin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">755-766</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Trastuzumab, a therapeutic monoclonal antibody directed against ErbB2, is often noted as a successful example of targeted therapy.  Trastuzumab improved outcomes for many patients with ErbB2-pos. breast and gastric cancers, however, cardiac side effects [e.g., left ventricular dysfunction and congestive heart failure (CHF)] were reported in the early phase clin. studies.  This finding, subsequently corroborated by multiple clin. studies, raised concerns that the obsd. cardiotoxicity induced by trastuzumab might adversely impact the clin. development of other therapeutics targeting ErbB family members.: In this review we summarize both basic research and clin. findings regarding trastuzumab-induced cardiotoxicity and assess if there has been an impact of trastuzumab-induced cardiotoxicity on the development of other agents targeting ErbB family members.: There are a no. of scientific gaps that are critically important to address for the continued success of HER2-targeted agents.  These include: 1) elucidating the mol. mechanisms contributing to cardiotoxicity; 2) developing relevant preclin. testing systems for predicting cardiotoxicity; 3) developing clin. strategies to identify patients at risk of cardiotoxicity; and 4) enhancing management of clin. symptoms of cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorbY04GiyZBLVg90H21EOLACvtfcHk0lhL-nNqdUJYjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1ensLw%253D&md5=0247a9ff192e22b5d92753c8b501c49e</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1337746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1337746%26sid%3Dliteratum%253Aachs%26aulast%3DDokmanovic%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DK.%2BE.%26aulast%3DMohan%26aufirst%3DN.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%2BJ.%26atitle%3DCardiotoxicity%2520Of%2520Erbb2-Targeted%2520Therapies%2520and%2520its%2520Impact%2520on%2520Drug%2520Development%252C%2520a%2520Spotlight%2520on%2520Trastuzumab%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D755%26epage%3D766%26doi%3D10.1080%2F17425255.2017.1337746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedländer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapanen, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovin, T. M.</span></span> <span> </span><span class="NLM_article-title">Decreased Accessibility and Lack of Activation of Erbb2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15695389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=473-482&author=P.+Nagyauthor=E.+Friedl%C3%A4nderauthor=M.+Tannerauthor=A.+I.+Kapanenauthor=K.+L.+Carrawayauthor=J.+Isolaauthor=T.+M.+Jovin&title=Decreased+Accessibility+and+Lack+of+Activation+of+Erbb2+in+JIMT-1%2C+a+Herceptin-Resistant%2C+MUC4-Expressing+Breast+Cancer+Cell+Line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line</span></div><div class="casAuthors">Nagy, Peter; Friedlaender, Elza; Tanner, Minna; Kapanen, Anita I.; Carraway, Kermit L.; Isola, Jorma; Jovin, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">473-482</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overexpression of erbB2 in breast tumors is assocd. with poor prognosis and is a target of receptor-oriented cancer therapy.  Trastuzumab (Herceptin), a monoclonal antibody against a membrane-proximal epitope in the extracellular region of erbB2, shows a therapeutic effect against a fraction of erbB2-amplified breast tumors.  Unfortunately, resistance to Herceptin is common, and its cause is as yet unclear.  Here the authors investigated the properties of erbB2 in a Herceptin-resistant cell line, JIMT-1, established from a breast cancer patient showing erbB2 gene amplification and primary resistance to Herceptin.  The expression profile of erbB proteins, Herceptin-induced erbB2 internalization, and down-regulation in JIMT-1 were similar to those in Herceptin-sensitive lines.  However, the mean no. of Herceptin Mab binding sites in JIMT-1 was 1/5 that of the expressed erbB2 mols., although 5% to 10% of the cells showed a ∼ 10-fold higher Herceptin binding than the main population.  Herceptin Fab and Mab 2C4, an antibody binding to an epitope in the ectodomain further removed from the membrane, bound more efficiently to JIMT-1 cells than Herceptin Mab, implying that erbB2 was partly masked.  The expression of MUC4, a membrane-assocd. mucin that according to reports contributes to the masking of membrane proteins, was higher in JIMT-1 than in Herceptin-sensitive lines, and its level was inversely correlated with the Herceptin binding capacity of single cells.  Knockdown of MUC4 expression by RNA interference increased the binding of Herceptin.  Western blotting showed a low level of proteolytic processing, shedding, and tyrosine phosphorylation of erbB2 in JIMT-1.  The latter finding may explain its Herceptin-resistant phenotype characterizing both the low and high Herceptin binding subpopulations.  The authors conclude that masking of erbB2 in JIMT-1 leads to diminished Herceptin binding and isolation of erbB2 from its normal interaction and activation partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAgcvhORF8KLVg90H21EOLACvtfcHk0lhL-nNqdUJYjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqsA%253D%253D&md5=72b05c3a22b40002676e2caf9a00c330</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DP.%26aulast%3DFriedl%25C3%25A4nder%26aufirst%3DE.%26aulast%3DTanner%26aufirst%3DM.%26aulast%3DKapanen%26aufirst%3DA.%2BI.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26aulast%3DIsola%26aufirst%3DJ.%26aulast%3DJovin%26aufirst%3DT.%2BM.%26atitle%3DDecreased%2520Accessibility%2520and%2520Lack%2520of%2520Activation%2520of%2520Erbb2%2520in%2520JIMT-1%252C%2520a%2520Herceptin-Resistant%252C%2520MUC4-Expressing%2520Breast%2520Cancer%2520Cell%2520Line%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D473%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rexer, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arteaga, C. L.</span></span> <span> </span><span class="NLM_article-title">Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications</span>. <i>Crit. Rev. Oncog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1615/CritRevOncog.v17.i1.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1615%2FCritRevOncog.v17.i1.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22471661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC38rhvVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1-16&author=B.+N.+Rexerauthor=C.+L.+Arteaga&title=Intrinsic+and+Acquired+Resistance+to+HER2-Targeted+Therapies+in+HER2+Gene-Amplified+Breast+Cancer%3A+Mechanisms+and+Clinical+Implications&doi=10.1615%2FCritRevOncog.v17.i1.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications</span></div><div class="casAuthors">Rexer Brent N; Arteaga Carlos L</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncogenesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0893-9675</span>.
    </div><div class="casAbstract">Approximately 25% of human breast cancers overexpress the HER2 (ErbB2) proto-oncogene, which confers a more aggressive tumor phenotype and associates with a poor prognosis in patients with this disease.  Two approved therapies targeting HER2, the monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib, are clinically active against this type of breast cancer.  However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.  This suggests that tumors acquire or possess intrinsic mechanisms of resistance that allow escape from HER2 inhibition.  This review focuses on mechanisms of intrinsic and/or acquired resistance to HER2-targeted therapies that have been identified in preclinical and clinical studies.  These mechanisms involve alterations to HER2 itself, coexpression or acquisition of bypass signaling through other receptor or intracellular signaling pathways, defects in mechanisms of cell cycle regulation or apoptosis, and host factors that may modulate drug response.  Emerging clinical evidence already suggests that combinations of therapies targeting HER2 as well as these resistance pathways will be effective in overcoming or preventing resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-aUq9kTcyKsERNNga7KD-fW6udTcc2eZatvg5Mu6Trbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rhvVyitQ%253D%253D&md5=66e4d56a35c84d3ec3276e97e91b97cb</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1615%2FCritRevOncog.v17.i1.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevOncog.v17.i1.20%26sid%3Dliteratum%253Aachs%26aulast%3DRexer%26aufirst%3DB.%2BN.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26atitle%3DIntrinsic%2520and%2520Acquired%2520Resistance%2520to%2520HER2-Targeted%2520Therapies%2520in%2520HER2%2520Gene-Amplified%2520Breast%2520Cancer%253A%2520Mechanisms%2520and%2520Clinical%2520Implications%26jtitle%3DCrit.%2520Rev.%2520Oncog.%26date%3D2012%26volume%3D17%26spage%3D1%26epage%3D16%26doi%3D10.1615%2FCritRevOncog.v17.i1.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miladinovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, Y. EI.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croucher, D. R.</span></span> <span> </span><span class="NLM_article-title">Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">43</span>, <span class="refDoi"> DOI: 10.1186/s13058-019-1127-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2Fs13058-019-1127-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=30898150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BB3cbmsl2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=43&author=S.+P.+Kennedyauthor=J.+Z.+R.+Hanauthor=N.+Portmanauthor=M.+Nobisauthor=J.+F.+Hastingsauthor=K.+J.+Murphyauthor=S.+L.+Lathamauthor=A.+L.+Cadellauthor=D.+Miladinovicauthor=G.+R.+Marriottauthor=Y.+EI.+O%E2%80%99Donnellauthor=R.+F.+Shearerauthor=J.+T.+Williamsauthor=A.+G.+Munozauthor=T.+R.+Coxauthor=D.+N.+Watkinsauthor=D.+N.+Saundersauthor=P.+Timpsonauthor=E.+Limauthor=W.+Kolchauthor=D.+R.+Croucher&title=Targeting+Promiscuous+Heterodimerization+Overcomes+Innate+Resistance+to+ERBB2+Dimerization+Inhibitors+in+Breast+Cancer&doi=10.1186%2Fs13058-019-1127-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer</span></div><div class="casAuthors">Kennedy Sean P; Han Jeremy Z R; Portman Neil; Nobis Max; Hastings Jordan F; Murphy Kendelle J; Latham Sharissa L; Cadell Antonia L; Miladinovic Dushan; Marriott Gabriella R; O'Donnell Yolande E I; Shearer Robert F; Williams James T; Cox Thomas R; Watkins D Neil; Saunders Darren N; Timpson Paul; Lim Elgene; Croucher David R; Kennedy Sean P; Munoz Amaya Garcia; Kolch Walter; Portman Neil; Cox Thomas R; Watkins D Neil; Timpson Paul; Lim Elgene; Croucher David R; Williams James T; Saunders Darren N; Kolch Walter; Kolch Walter; Croucher David R</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research : BCR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The oncogenic receptor tyrosine kinase (RTK) ERBB2 is known to dimerize with other EGFR family members, particularly ERBB3, through which it potently activates PI3K signalling.  Antibody-mediated inhibition of this ERBB2/ERBB3/PI3K axis has been a cornerstone of treatment for ERBB2-amplified breast cancer patients for two decades.  However, the lack of response and the rapid onset of relapse in many patients now question the assumption that the ERBB2/ERBB3 heterodimer is the sole relevant effector target of these therapies.  METHODS:  Through a systematic protein-protein interaction screen, we have identified and validated alternative RTKs that interact with ERBB2.  Using quantitative readouts of signalling pathway activation and cell proliferation, we have examined their influence upon the mechanism of trastuzumab- and pertuzumab-mediated inhibition of cell growth in ERBB2-amplified breast cancer cell lines and a patient-derived xenograft model.  RESULTS:  We now demonstrate that inactivation of ERBB3/PI3K by these therapeutic antibodies is insufficient to inhibit the growth of ERBB2-amplified breast cancer cells.  Instead, we show extensive promiscuity between ERBB2 and an array of RTKs from outside of the EGFR family.  Paradoxically, pertuzumab also acts as an artificial ligand to promote ERBB2 activation and ERK signalling, through allosteric activation by a subset of these non-canonical RTKs.  However, this unexpected activation mechanism also increases the sensitivity of the receptor network to the ERBB2 kinase inhibitor lapatinib, which in combination with pertuzumab, displays a synergistic effect in single-agent resistant cell lines and PDX models.  CONCLUSIONS:  The interaction of ERBB2 with a number of non-canonical RTKs activates a compensatory signalling response following treatment with pertuzumab, although a counter-intuitive combination of ERBB2 antibody therapy and a kinase inhibitor can overcome this innate therapeutic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6yC1eUZaTXpVVjGoY74BafW6udTcc2eZatvg5Mu6Trbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbmsl2ksA%253D%253D&md5=c4ebdbf76c5d545ca3fe9234702931f7</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1186%2Fs13058-019-1127-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-019-1127-y%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DS.%2BP.%26aulast%3DHan%26aufirst%3DJ.%2BZ.%2BR.%26aulast%3DPortman%26aufirst%3DN.%26aulast%3DNobis%26aufirst%3DM.%26aulast%3DHastings%26aufirst%3DJ.%2BF.%26aulast%3DMurphy%26aufirst%3DK.%2BJ.%26aulast%3DLatham%26aufirst%3DS.%2BL.%26aulast%3DCadell%26aufirst%3DA.%2BL.%26aulast%3DMiladinovic%26aufirst%3DD.%26aulast%3DMarriott%26aufirst%3DG.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DY.%2BEI.%26aulast%3DShearer%26aufirst%3DR.%2BF.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DMunoz%26aufirst%3DA.%2BG.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DWatkins%26aufirst%3DD.%2BN.%26aulast%3DSaunders%26aufirst%3DD.%2BN.%26aulast%3DTimpson%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DE.%26aulast%3DKolch%26aufirst%3DW.%26aulast%3DCroucher%26aufirst%3DD.%2BR.%26atitle%3DTargeting%2520Promiscuous%2520Heterodimerization%2520Overcomes%2520Innate%2520Resistance%2520to%2520ERBB2%2520Dimerization%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2019%26volume%3D21%26spage%3D43%26doi%3D10.1186%2Fs13058-019-1127-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Schematic view of EGF-containing TM mucins. Schematic representation of the non-proline/serine/threonine rich domain (PTS) part of TM mucin family members. Asserted cleavage sites are marked with red lines. All of the mucins have at least two epidermal growth factor (EGF) domains. MUC4 exhibits three unique domains: NIDO, AMOP, and von Willebrand factor D (VWD). All of the other mucins except MUC4 have a SEA domain involved in their cleavage.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeling of the SEA-like domain of MUC4 by homology. Sequence alignment between MUC4 and a less canonical but crystallized SEA domain (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WIQ">4WIQ</a>). With 15.6% identical and 33.6% homologous sequences, a potential structure model of the putative MUC4 SEA domain was built.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Phylogenic tree based on EGF-like domain alignment with clustering. The tree was built with the Blosum62 matrix by Average Distance on Jalview. Several clusters could be observed, and EGF-like domains of mucins are not mixed with domains from NIDO or HSPG2. MUC13 appears to be the most primitive mucin, being furthermore the closest to 63sp. Mucins are grouped together, with the EGF1 and EGF2 domains clearly separated. The fourth possible EGF domain of MUC4 (CR) exhibits no tight relationship with the others and thus may arise from a distinct origin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Alignment and phylogenic tree of EGF-containing TM mucins with clustering based on the full EGF–SEA–EGF module. Using ClustalO and Blosum62 with correction focused on the cysteine residues for the EGF domains and on the hydrophobic residues for the SEA domain, an alignment and a tree were built showing MUC4 as a member of only one mucin subfamily that includes MUC13, MUC12, MUC17, and MUC3A/3B.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Focus on the EGF1 domain of MUC3A/3B. Comparison of sequences of the first four cysteines and the last four of MUC3-EGF1, leading to 33.6% identical and >50% homologous sequences. This argues for the presence of two repetitive EGF-like domains with only four cysteines instead of one containing eight cysteines. Moreover, alignment of all of the homologous cysteines with this hypothesis leads to a coherent tree.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Schematic representation of cysteine connections for the EGF2 domain of MUC13. Two connections are envisaged for the extra cysteines of MUC13, with (A) the two extra cysteines forming another loop and (B) the two extra cysteines stabilizing a large loop with two disulfide bridges. This last hypothesis results in a structure homologous to the formal structure of EGF but with a more rigid Ct part.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representation and molecular modeling of two possible structures of the MUC4 EGF1 domain. Two possible structures for EGF1, modeled (A) according to the alignment of hypothesis 1 and (B) according to the alignment of hypothesis 2. Virtually no difference is found in the residues that should be involved in the interaction with ErbB2. Nevertheless, hypothesis 2 leads to a more rigid structure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Schematic representation of the possible targetable interfaces on mucins to impair their complexes with ErbB receptors. Several targetable assumed protein interfaces in the ErbB2–mucin pathways can be identified, either to directly impair binding of this mucin to the ErbB receptor or to modulate this interaction by allosteric means. (1) Targeting an EGF domain on an EGF–ErbB interface. (2) Targeting the SEA domain on an EGF–ErbB interface. (3) Targeting an interface that includes a partial combination of the two previous ones or targeting both at the same time with a dual ligand. (4) Stabilizing the autocatalytic loop involved in the cleavage of the SEA domain. (5) Impairing the intra-SEA domain interaction. (6) Targeting allosteric interfaces, possibly disrupting the interface between the SEA and EGF domains.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/medium/jm9b02001_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Phylogenetic relationship of Ct regions of several proteins from humans and invertebrates with EGF–SEA–EGF or SEA–EGF modules. Alignment was performed with the ClustalO algorithm, adding to the previously studied mucins, several human proteins all having EGF domains listed as potential ligands and having in addition a SEA domain (uromudulin-like, UROL1 and UROL2; chondroitin sulfate proteoglycan 5, NGC; interphotoreceptor matrix proteoglycans 1 and 2, IMPG1 and IMPG2, respectively; heart development protein with EGF-like domains 1, HEG1), two proteins of <i>Drosophila megalonaster</i> (muc-like1 and muc-like2), two proteins of <i>C. elegans</i> (Mua3 and MUP4), and a sea urchin protein (63sp). A rootless maximum likelihood tree was constructed from this alignment using MegaX. As expected, human proteins are separated from invertebrate proteins and appear to be linked. HEG1 appears to be strongly related to MUC13 and more closely related to invertebrate proteins than to other mucins of its family, enforcing its ancestral characteristic. From this tree, an outer group is composed of MEP and NGC, in which no SEA domain can be found.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-10/acs.jmedchem.9b02001/20200520/images/large/jm9b02001_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02001&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 100 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker-Nasir, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoessli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakoori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasir ud, D.</span></span> <span> </span><span class="NLM_article-title">Mucin Glycoproteins</span>. <i>Proc. Pak. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXotFyntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2003&pages=205-232&author=E.+Walker-Nasirauthor=I.+Ahmadauthor=D.+Hoessliauthor=A.+Shakooriauthor=D.+Nasir+ud&title=Mucin+Glycoproteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin glycoproteins</span></div><div class="casAuthors">Walker-Nasir, Evelyne; Ahmad, Ishtiaq; Hoessli, Daniel C.; Shakoori, A. R.; Nasir-ud-Din</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the Pakistan Academy of Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-232</span>CODEN:
                <span class="NLM_cas:coden">PKSPAW</span>;
        ISSN:<span class="NLM_cas:issn">0377-2969</span>.
    
            (<span class="NLM_cas:orgname">Pakistan Academy of Sciences</span>)
        </div><div class="casAbstract">A review discusses mucin glycoproteins, their classification, phys. and biochem. properties, gene expression and regulation, biosynthesis, and their role in normal physiol. and in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVI5zO0W0I2rVg90H21EOLACvtfcHk0lhOi3yuHZV8ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXotFyntw%253D%253D&md5=9a9d79271e467ab275eefd0c1da000f5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker-Nasir%26aufirst%3DE.%26aulast%3DAhmad%26aufirst%3DI.%26aulast%3DHoessli%26aufirst%3DD.%26aulast%3DShakoori%26aufirst%3DA.%26aulast%3DNasir%2Bud%26aufirst%3DD.%26atitle%3DMucin%2520Glycoproteins%26jtitle%3DProc.%2520Pak.%2520Acad.%2520Sci.%26date%3D2003%26volume%3D40%26spage%3D205%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">Distinct Evolution of the Human Carcinoma-Associated Transmembrane Mucins, MUC1, MUC4 AND MUC16</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">28</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2005.12.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.gene.2005.12.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=16500040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD28Xktlaqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2006&pages=28-34&author=S.+Duraisamyauthor=S.+Ramasamyauthor=S.+Kharbandaauthor=D.+Kufe&title=Distinct+Evolution+of+the+Human+Carcinoma-Associated+Transmembrane+Mucins%2C+MUC1%2C+MUC4+AND+MUC16&doi=10.1016%2Fj.gene.2005.12.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 and MUC16</span></div><div class="casAuthors">Duraisamy, Sekhar; Ramasamy, Selvi; Kharbanda, Surender; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">28-34</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The MUC family of mucins consists of secreted and membrane-bound forms.  Overexpression of the membrane-bound family members, MUC1 (CA15-3), MUC4 and MUC16 (CA125), is found in diverse human carcinomas.  However, despite being classified in the same family, little is known about the genetic origins of the carcinoma-assocd. mucins.  The present results show that MUC1 homologs are restricted to mammalian species.  MUC1 has no sequence similarity with the other membrane-bound mucins, except for the presence of a sea urchin sperm protein-enterokinase-agrin (SEA) domain.  The results indicate that the MUC1 SEA domain originated from heparin sulfate proteoglycan of basement membrane (HSPG2; perlecan), an inducer of tumor cell growth.  MUC4 has no SEA domain, but does have (i) a NIDO domain that evolved from an ancestor common to nidogen, and (ii) AMOP and VWD domains that originated from an ancestor common to the Sushi-domain contg. protein.  MUC16 contains multiple SEA domains that are found in a chicken gene and were subsequently repeated through duplication events.  The SEA domains in MUC16 appear to have evolved from agrin before the divergence of birds and mammals.  These findings indicate that MUC1, MUC4 and MUC16 evolved from distinct ancestors and that the membrane-bound mucins consist of different subgroups based on their genetic backgrounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDizS-jtQ-fbVg90H21EOLACvtfcHk0lhOi3yuHZV8ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xktlaqu7w%253D&md5=61372ada19695f06903e5eb795e762a0</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2005.12.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2005.12.021%26sid%3Dliteratum%253Aachs%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DDistinct%2520Evolution%2520of%2520the%2520Human%2520Carcinoma-Associated%2520Transmembrane%2520Mucins%252C%2520MUC1%252C%2520MUC4%2520AND%2520MUC16%26jtitle%3DGene%26date%3D2006%26volume%3D373%26spage%3D28%26epage%3D34%26doi%3D10.1016%2Fj.gene.2005.12.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Corfield, A. P.</span></span> <span> </span><span class="NLM_article-title">Mucins: a Biologically Relevant Glycan Barrier in Mucosal Protection</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1850</i></span>,  <span class="NLM_fpage">236</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2014.05.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.bbagen.2014.05.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24821013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlOltbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1850&publication_year=2015&pages=236-252&author=A.+P.+Corfield&title=Mucins%3A+a+Biologically+Relevant+Glycan+Barrier+in+Mucosal+Protection&doi=10.1016%2Fj.bbagen.2014.05.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins: A biologically relevant glycan barrier in mucosal protection</span></div><div class="casAuthors">Corfield, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1850</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">236-252</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The mucins found as components of mucus gel layers at mucosal surfaces throughout the body play roles in protection as part of the defensive barrier on an organ and tissue specific basis.  The human MUC gene family codes up to 20 known proteins, which can be divided into secreted and membrane-assocd. forms each with a typical protein domain structure.  The secreted mucins are adapted to cross link in order to allow formation of the extended mucin networks found in the secreted mucus gels.  The membrane-assocd. mucins possess membrane specific domains which enable their various biol. functions as part of the glycocalyx.  All mucins are highly O-glycosylated and this is tissue specific and linked with specific biol. functions at these locations.  Mucin biol. is dynamic and the processes of degrdn. and turnover are well integrated with biosynthesis to maintain a continuous mucosal protection against all external aggressive forces.  Interaction of mucins with microflora plays an important role in normal function.  Mucins are modified in a variety of diseases and this may be due to abberant mucin peptide or glycosylation.  Mucins represent a family of glycoprotein having fundamental roles in mucosal protection and communication with external environment.  The review emphasizes the nature of mucins as glycoproteins and their role in presenting an array of glycan structures at the mucosal cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-E-3BmX8E3bVg90H21EOLACvtfcHk0lipo5nopVtzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlOltbzL&md5=c30f2b809562ef2945cb3e3a13a72b1c</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2014.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2014.05.003%26sid%3Dliteratum%253Aachs%26aulast%3DCorfield%26aufirst%3DA.%2BP.%26atitle%3DMucins%253A%2520a%2520Biologically%2520Relevant%2520Glycan%2520Barrier%2520in%2520Mucosal%2520Protection%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2015%26volume%3D1850%26spage%3D236%26epage%3D252%26doi%3D10.1016%2Fj.bbagen.2014.05.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, B. J.</span></span> <span> </span><span class="NLM_article-title">Mucins in Cancer: Protection and Control of the Cell Surface</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1038/nrc1251</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fnrc1251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=14681689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVGnu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=45-60&author=M.+A.+Hollingsworthauthor=B.+J.+Swanson&title=Mucins+in+Cancer%3A+Protection+and+Control+of+the+Cell+Surface&doi=10.1038%2Fnrc1251"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins in cancer: protection and control of the cell surface</span></div><div class="casAuthors">Hollingsworth, Michael A.; Swanson, Benjamin J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-60</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mucins - large extracellular proteins that are heavily glycosylated with complex oligosaccharides - establish a selective mol. barrier at the epithelial surface and engage in morphogenetic signal transduction.  Alterations in mucin expression or glycosylation accompany the development of cancer and influence cellular growth, differentiation, transformation, adhesion, invasion and immune surveillance.  Mucins are used as diagnostic markers in cancer, and are under investigation as therapeutic targets for cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCTyd5l3B-TLVg90H21EOLACvtfcHk0lipo5nopVtzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVGnu7w%253D&md5=26a6f24250cb21c6cd2a707c3b9f9790</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrc1251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1251%26sid%3Dliteratum%253Aachs%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DSwanson%26aufirst%3DB.%2BJ.%26atitle%3DMucins%2520in%2520Cancer%253A%2520Protection%2520and%2520Control%2520of%2520the%2520Cell%2520Surface%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26spage%3D45%26epage%3D60%26doi%3D10.1038%2Fnrc1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartman, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buisine, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niehans, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toribara, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crabtree, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. B.</span></span> <span> </span><span class="NLM_article-title">The MUC6 Secretory Mucin Gene is Expressed in a Wide Variety ofEpithelial Tissues</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">405</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1096-9896(199812)186:4<398::AID-PATH192>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10209489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXmtVyisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=1998&pages=398-405&author=A.+E.+Bartmanauthor=M.+P.+Buisineauthor=J.+P.+Aubertauthor=G.+A.+Niehansauthor=N.+W.+Toribaraauthor=Y.+S.+Kimauthor=E.+J.+Kellyauthor=J.+E.+Crabtreeauthor=S.+B.+Ho&title=The+MUC6+Secretory+Mucin+Gene+is+Expressed+in+a+Wide+Variety+ofEpithelial+Tissues&doi=10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues</span></div><div class="casAuthors">Bartman, Allen E.; Buisine, Marie-Pierre; Aubert, Jean-Pierre; Niehans, Gloria A.; Toribara, Neil W.; Kim, Young S.; Kelly, Eric J.; Crabtree, Jean E.; Ho, Samuel B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">398-405</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-3417</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Secretory mucins play an important role in the cytoprotection of epithelial surfaces and are used as tumor markers in a variety of cancers.  The MUC6 secretory mucin was originally isolated from a gastric cDNA library.  The aim was to det. the specific type and location of MUC6 mucin gene expression in a wide range of human adult and fetal epithelial tissues.  In situ hybridization, RNA anal., and immunohistochem. were used to quantify and localize mucin gene expression.  The data obtained show that MUC6 is highly expressed in gastric mucosa, duodenal Brunner's glands, gall bladder, seminal vesicle, pancreatic centroacinar cells and ducts, and periductal glands of the common bile duct; focal expression is seen in basal endometrial and endocervical glands.  MUC6 epitopes were also highly expressed in 7/10 pancreatic cancers and 7/10 cholangiocarcinomas and focally expressed in 4/10 endocervical adenocarcinomas.  Expression of MUC6 occurs early in fetal development and was obsd. in Brunner's glands and pancreatic ducts at 18-19 wk and in gastric glands at 20 wk' gestation.  The tissue distribution of the MUC6 secretory mucin indicates that it may function to protect epithelial tissues from a wide range of substances.  Expression of MUC6 is frequently preserved in pancreatic and bile duct adenocarcinomas, but it is only sparsely expressed in endocervical carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMb7P2h1Yt87Vg90H21EOLACvtfcHk0lipo5nopVtzfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmtVyisg%253D%253D&md5=a4a42b210261a58f91de2d5332ae43ae</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291096-9896%2528199812%2529186%253A4%253C398%253A%253AAID-PATH192%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DBartman%26aufirst%3DA.%2BE.%26aulast%3DBuisine%26aufirst%3DM.%2BP.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26aulast%3DNiehans%26aufirst%3DG.%2BA.%26aulast%3DToribara%26aufirst%3DN.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKelly%26aufirst%3DE.%2BJ.%26aulast%3DCrabtree%26aufirst%3DJ.%2BE.%26aulast%3DHo%26aufirst%3DS.%2BB.%26atitle%3DThe%2520MUC6%2520Secretory%2520Mucin%2520Gene%2520is%2520Expressed%2520in%2520a%2520Wide%2520Variety%2520ofEpithelial%2520Tissues%26jtitle%3DJ.%2520Pathol.%26date%3D1998%26volume%3D186%26spage%3D398%26epage%3D405%26doi%3D10.1002%2F%28SICI%291096-9896%28199812%29186%3A4%3C398%3A%3AAID-PATH192%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">Intestinal Mucins in Health and Disease</span>. <i>Digestion</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1159/000198115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1159%2F000198115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2004&pages=234-263&author=J.+F.+Forstner&title=Intestinal+Mucins+in+Health+and+Disease&doi=10.1159%2F000198115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1159%2F000198115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000198115%26sid%3Dliteratum%253Aachs%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DIntestinal%2520Mucins%2520in%2520Health%2520and%2520Disease%26jtitle%3DDigestion%26date%3D2004%26volume%3D17%26spage%3D234%26epage%3D263%26doi%3D10.1159%2F000198115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Putten, J. P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strijbis, K.</span></span> <span> </span><span class="NLM_article-title">Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer</span>. <i>J. Innate Immun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1159/000453594</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1159%2F000453594" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28052300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFeisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=281-299&author=J.+P.+M.+van%0APuttenauthor=K.+Strijbis&title=Transmembrane+Mucins%3A+Signaling+Receptors+at+the+Intersection+of+Inflammation+and+Cancer&doi=10.1159%2F000453594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer</span></div><div class="casAuthors">van Putten, Jos P. M.; Strijbis, Karin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Innate Immunity</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">281-299</span>CODEN:
                <span class="NLM_cas:coden">JIIOB2</span>;
        ISSN:<span class="NLM_cas:issn">1662-811X</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Mucosal surfaces line our body cavities and provide the interaction surface between commensal and pathogenic microbiota and the host.  The barrier function of the mucosal layer is largely maintained by gel-forming mucin proteins that are secreted by goblet cells.  In addn., mucosal epithelial cells express cell-bound mucins that have both barrier and signaling functions.  The family of transmembrane mucins consists of diverse members that share a few characteristics.  The highly glycosylated extracellular mucin domains inhibit invasion by pathogenic bacteria and can form a tight mesh structure that protects cells in harmful conditions.  The intracellular tails of transmembrane mucins can be phosphorylated and connect to signaling pathways that regulate inflammation, cell-cell interactions, differentiation, and apoptosis.  Transmembrane mucins play important roles in preventing infection at mucosal surfaces, but are also renowned for their contributions to the development, progression, and metastasis of adenocarcinomas.  In general, transmembrane mucins seem to have evolved to monitor and repair damaged epithelia, but these functions can be highjacked by cancer cells to yield a survival advantage.  This review presents an overview of the current knowledge of the functions of transmembrane mucins in inflammatory processes and carcinogenesis in order to better understand the diverse functions of these multifunctional proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppBljisk5Z6LVg90H21EOLACvtfcHk0lhmSru8Vv0NUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFeisbo%253D&md5=d38d559090bd6d2e3ef174d7f1254edf</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1159%2F000453594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000453594%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BPutten%26aufirst%3DJ.%2BP.%2BM.%26aulast%3DStrijbis%26aufirst%3DK.%26atitle%3DTransmembrane%2520Mucins%253A%2520Signaling%2520Receptors%2520at%2520the%2520Intersection%2520of%2520Inflammation%2520and%2520Cancer%26jtitle%3DJ.%2520Innate%2520Immun.%26date%3D2017%26volume%3D9%26spage%3D281%26epage%3D299%26doi%3D10.1159%2F000453594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Membrane-Bound Mucin Modular Domains: from Structure to Function</span>. <i>Biochimie</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1086</span>, <span class="refDoi"> DOI: 10.1016/j.biochi.2012.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.biochi.2012.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=23178705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhslynu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2013&pages=1077-1086&author=N.+Jonckheereauthor=N.+Skrypekauthor=F.+Frenoisauthor=I.+Van+Seuningen&title=Membrane-Bound+Mucin+Modular+Domains%3A+from+Structure+to+Function&doi=10.1016%2Fj.biochi.2012.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Membrane-bound mucin modular domains: From structure to function</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Frenois, Frederic; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Biochimie</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1077-1086</span>CODEN:
                <span class="NLM_cas:coden">BICMBE</span>;
        ISSN:<span class="NLM_cas:issn">0300-9084</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  Mucins belong to a heterogeneous family of large O-glycoproteins composed of a long peptidic chain called apomucin on which are linked hundreds of oligosaccharidic chains.  Among mucins, membrane-bound mucins are modular proteins and have a structural organization usually contg. Pro/Thr/Ser-rich O-glycosylated domains (PTS), EGF-like and SEA domains.  Via these modular domains, the membrane-bound mucins participate in cell signaling and cell interaction with their environment in normal and pathol. conditions.  Moreover, the recent knowledge of these domains and their biol. activities led to the development of new therapeutic approaches involving mucins.  In this review, we show 3D structures of EGF and SEA domains.  We also describe the functional features of the evolutionary conserved domains of membrane-bound mucins and discuss consequences of splice events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrX6h5d5eX1wrVg90H21EOLACvtfcHk0lhmSru8Vv0NUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhslynu7nM&md5=8d88b659cf4fba257cd8d70bbbc40690</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.biochi.2012.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biochi.2012.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DFrenois%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DMembrane-Bound%2520Mucin%2520Modular%2520Domains%253A%2520from%2520Structure%2520to%2520Function%26jtitle%3DBiochimie%26date%3D2013%26volume%3D95%26spage%3D1077%26epage%3D1086%26doi%3D10.1016%2Fj.biochi.2012.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, K.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Y.</span></span> <span> </span><span class="NLM_article-title">NIDO, AMOP and Vwd Domains of MUC4 Play Synergic Role in MUC4 Mediated Signaling</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">10385</span>– <span class="NLM_lpage">10399</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.14420</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.14420" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28060749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC1c7jtVOmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=10385-10399&author=Y.+Zhuauthor=J.-J.+Zhangauthor=Y.-P.+Pengauthor=X.+Liuauthor=K.-L.+Xieauthor=J.+Tangauthor=K.-R.+Jiangauthor=W.-T.+Gaoauthor=L.+Tianauthor=K.+Zhangauthor=Z.-K.+Xuauthor=Y.+Miao&title=NIDO%2C+AMOP+and+Vwd+Domains+of+MUC4+Play+Synergic+Role+in+MUC4+Mediated+Signaling&doi=10.18632%2Foncotarget.14420"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NIDO, AMOP and vWD domains of MUC4 play synergic role in MUC4 mediated signaling</span></div><div class="casAuthors">Zhu Yi; Zhang Jing-Jing; Peng Yun-Peng; Liu Xian; Jiang Kui-Rong; Gao Wen-Tao; Tian Lei; Zhang Kai; Miao Yi; Zhu Yi; Zhang Jing-Jing; Peng Yun-Peng; Liu Xian; Jiang Kui-Rong; Gao Wen-Tao; Tian Lei; Zhang Kai; Miao Yi; Zhu Yi; Zhang Jing-Jing; Peng Yun-Peng; Liu Xian; Xie Kun-Ling; Tang Jie; Jiang Kui-Rong; Gao Wen-Tao; Tian Lei; Zhang Kai; Xu Ze-Kuan; Miao Yi; Xie Kun-Ling; Tang Jie</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">10385-10399</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">MUC4 mucin is well known as an important potential target to overcome pancreatic cancer.  Three unique domains (NIDO, AMOP, and vWD) with unclear roles only present in MUC4 but are not found in other membrane-bound mucins.  Our previous studies first reported that its splice variant, MUC4/Y can be a model of MUC4 (MUC4 gene fragment is more than 30KB, too huge to clone and eukaryotic express) in pancreatic cancer.  More importantly, based on MUC4/Y with the appropriate length of gene sequence, it is easy to construct the unique domain-lacking models of MUC4/Y (MUC4) for research.  The present study focuses on investigation of the respective role of the unique NIDO, AMOP, and vWD domain or their synergistic effect on MUC4(MUC4/Y)-mediated functions and mechanisms by series of in vitro assays, sequence-based transcriptome analysis, validation of qRT-PCR & Western blot, and systematic comparative analysis.  Our results demonstrate: 1) NIDO, AMOP, and vWD domain or their synergy play significant roles on MUC4/Y-mediated malignant function of pancreatic cancer, downstream of molecule mechanisms, particularly MUC4/Y-triggered malignancy-related positive feedback loops, respectively. 2) The synergistic roles of three unique domains on MUC4/Y-mediated functions and mechanisms are more prominent than the respective domain because the synergy of three domain plays the more remarkable effects on MUC4/Y-mediated signaling hub.  Thus, to improve reversed effects of domain-lacking and break the synergism of domains will contribute to block MUC4/Y(MUC4) triggering various oncogenic signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRr6PjoGs2VCu2mnZh2OgS0fW6udTcc2ea_gIk83e5wfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7jtVOmug%253D%253D&md5=30def6751b6cd7fd6d22524f69f7721e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.14420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.14420%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.-J.%26aulast%3DPeng%26aufirst%3DY.-P.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DXie%26aufirst%3DK.-L.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DK.-R.%26aulast%3DGao%26aufirst%3DW.-T.%26aulast%3DTian%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DXu%26aufirst%3DZ.-K.%26aulast%3DMiao%26aufirst%3DY.%26atitle%3DNIDO%252C%2520AMOP%2520and%2520Vwd%2520Domains%2520of%2520MUC4%2520Play%2520Synergic%2520Role%2520in%2520MUC4%2520Mediated%2520Signaling%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D10385%26epage%3D10399%26doi%3D10.18632%2Foncotarget.14420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">Evolution of the Human MUC1 Oncoprotein</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">677</span>, <span class="refDoi"> DOI: 10.3892/ijo.31.3.671</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.3892%2Fijo.31.3.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17671696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2007&pages=671-677&author=S.+Duraisamyauthor=T.+Kufeauthor=S.+Ramasamyauthor=D.+Kufe&title=Evolution+of+the+Human+MUC1+Oncoprotein&doi=10.3892%2Fijo.31.3.671"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of the human MUC1 oncoprotein</span></div><div class="casAuthors">Duraisamy, Sekhar; Kufe, Turner; Ramasamy, Selvi; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">671-677</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">The mucin (MUC) family consists of secreted and membrane-bound forms.  The transmembrane mucin 1 (MUC1) is a heterodimer that is aberrantly overexpressed by diverse human carcinomas and certain hematol. malignancies.  The MUC1 N-terminal (MUC1-N) and C-terminal (MUC1-C) subunits are generated by autocleavage within a SEA domain.  The MUC1 cytoplasmic domain (MUC 1-CD) located downstream of the SEA domain is sufficient for the induction of anchorage-independent growth and tumorigenicity; however, no information is available regarding the origin of these transforming sequences.  Previous work demonstrated that, except for the SEA domain, MUC1 has no sequence homol. with other membrane-bound mucins.  The present results demonstrate that MUC 1-CD evolved from repeat regions in the MUC5B secreted mucin.  We also show that MUC1 sequences upstream to the SEA domain emerged from MUC5B.  These findings indicate that both the MUC1-N and MUC1-C subunits evolved from secreted gel-forming mucins and that the MUC 1-CD oncogenic function emerged by diversification after evolution from MUC5B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWinU9uWTx-LVg90H21EOLACvtfcHk0lhmSru8Vv0NUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVagurnF&md5=4b59c367d8685388d60c5d576675aa55</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3892%2Fijo.31.3.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.31.3.671%26sid%3Dliteratum%253Aachs%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DT.%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DEvolution%2520of%2520the%2520Human%2520MUC1%2520Oncoprotein%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2007%26volume%3D31%26spage%3D671%26epage%3D677%26doi%3D10.3892%2Fijo.31.3.671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Mucins and Pancreatic Cancer</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1794</span>– <span class="NLM_lpage">1812</span>, <span class="refDoi"> DOI: 10.3390/cancers2041794</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.3390%2Fcancers2041794" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24281201" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVWksrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=1794-1812&author=N.+Jonckheereauthor=N.+Skrypekauthor=I.+Van+Seuningen&title=Mucins+and+Pancreatic+Cancer&doi=10.3390%2Fcancers2041794"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins and Pancreatic cancer</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1794-1812</span>CODEN:
                <span class="NLM_cas:coden">CANCCT</span>;
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    
            (<span class="NLM_cas:orgname">Molecular Diversity Preservation International</span>)
        </div><div class="casAbstract">A review.  Pancreatic cancer is characterized by an often dramatic outcome (five year survival <5%) related to a late diagnosis and a lack of efficient therapy.  Therefore, clinicians desperately need new biomarkers and new therapeutic tools to develop new efficient therapies.  Mucins belong to an ever increasing family of O-glycoproteins.  Secreted mucins are the main component of mucus protecting the epithelia whereas membrane-bound mucins are thought to play important biol. roles in cell-cell and cell-matrix interactions, in cell signaling and in modulating biol. properties of cancer cells.  In this review, we will focus on the altered expression pattern of mucins in pancreatic cancer, from the early neoplastic lesion Pancreatic Intraepithelial Neoplasia (PanIN) to invasive pancreatic carcinomas, and the mol. mechanisms (including genetic and epigenetic regulation) and signaling pathways known to control their expression.  Moreover, we will discuss the recent advances about the biol. of both secreted and membrane-bound mucins and their key roles in pancreatic carcinogenesis and resistance to therapy.  Finally, we will discuss exciting opportunities that mucins offer as potential therapeutic targets in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGQ7BWDwTvZrVg90H21EOLACvtfcHk0lg4XKTbR5vjCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVWksrnL&md5=f3e8517a154d4f38d63112fbb0584155</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3390%2Fcancers2041794&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers2041794%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DMucins%2520and%2520Pancreatic%2520Cancer%26jtitle%3DCancers%26date%3D2010%26volume%3D2%26spage%3D1794%26epage%3D1812%26doi%3D10.3390%2Fcancers2041794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Mucins and Tumor Resistance to Chemotherapeutic Drugs</span>. <i>Biochim. Biophys. Acta, Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>1846</i></span>,  <span class="NLM_fpage">142</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1016/j.bbcan.2014.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.bbcan.2014.04.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24785432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Oqsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1846&publication_year=2014&pages=142-151&author=N.+Jonckheereauthor=N.+Skrypekauthor=I.+Van+Seuningen&title=Mucins+and+Tumor+Resistance+to+Chemotherapeutic+Drugs&doi=10.1016%2Fj.bbcan.2014.04.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Mucins and tumor resistance to chemotherapeutic drugs</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Reviews on Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">1846</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">142-151</span>CODEN:
                <span class="NLM_cas:coden">BBACEU</span>;
        ISSN:<span class="NLM_cas:issn">0304-419X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Epithelial cancer patients not considered eligible for surgical resection frequently benefit from chemotherapy.  Chemotherapy is the treatment of cancer with one or combination of cytotoxic or cytostatic drugs.  Recent advances in chemotherapy allowed a great no. of cancer patients to receive treatment with significant results.  Unfortunately, resistance to chemotherapeutic drug treatment is a major challenge for clinicians in the majority of epithelial cancers because it is responsible for the inefficiency of therapies.  Mucins belong to a heterogeneous group of large O-glycoproteins that can be either secreted or membrane-bound.  Implications of mucins have been described in relation to cancer cell behavior and cell signaling pathways assocd. with epithelial tumorigenesis.  Because of the frequent alteration of the pattern of mucin expression in cancers as well as their structural and functional characteristics, mucins are thought to also be involved in response to therapies.  In this report, we review the roles of mucins in chemoresistance and the assocd. underlying mol. mechanisms (phys. barrier, resistance to apoptosis, drug metab., cell stemness, epithelial-mesenchymal transition) and discuss the therapeutic tools/strategies and/or prognosis biomarkers for personalized chemotherapy that could be proposed from these studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGow0lu7CzPacrVg90H21EOLACvtfcHk0lg4XKTbR5vjCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Oqsr3I&md5=982babca9b26013312bb7755fa077530</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.bbcan.2014.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbcan.2014.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DMucins%2520and%2520Tumor%2520Resistance%2520to%2520Chemotherapeutic%2520Drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Rev.%2520Cancer%26date%3D2014%26volume%3D1846%26spage%3D142%26epage%3D151%26doi%3D10.1016%2Fj.bbcan.2014.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pourgholami, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chua, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, D. L.</span></span> <span> </span><span class="NLM_article-title">MUC1 as a Potential Target in Anticancer Therapies</span>. <i>Am. J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">118</span>, <span class="refDoi"> DOI: 10.1097/COC.0b013e31828f5a07</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1097%2FCOC.0b013e31828f5a07" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=23608828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs12ktbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2015&pages=108-118&author=K.+Pillaiauthor=M.+H.+Pourgholamiauthor=T.+C.+Chuaauthor=D.+L.+Morris&title=MUC1+as+a+Potential+Target+in+Anticancer+Therapies&doi=10.1097%2FCOC.0b013e31828f5a07"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 as a Potential Target in Anticancer Therapies</span></div><div class="casAuthors">Pillai, Krishna; Pourgholami, Mohammad H.; Chua, Terence C.; Morris, David L.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">108-118</span>CODEN:
                <span class="NLM_cas:coden">AJCODI</span>;
        ISSN:<span class="NLM_cas:issn">0277-3732</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">MUC1 is a glycoprotein that is overexpressed in tumor cells.  In normal cells it forms a protective layer against microbes and toxic chems., besides providing lubrication on ductal surfaces.  Oversecretion of MUC1 provide cancer cells with invasiveness, metastasis, and resistance to death induced by reactive oxygen species.  MUC1 is made up of 2 heterodimers, MUC1-N and MUC1-C.  MUC1-N is heavily glycosylated at 5 regions of the variable N-tandem repeats.  MUC1-C is divisible into extracellular, intracellular, and cytoplasmic domain (MUC1-C/CD).  The extracellular domain serves as a docking site for epidermal growth factor receptors and other receptor kinases; the transmembrane domain serves to relay messages from extracellular to MUC1-C/CD.  The MUC1-C/CD has 5 phosphorylating sites that on interacting with the SH2 domain of specific proteins can stimulate tumor growth.  Therapies targeting MUC1 consists of monoclonal antibodies (MAb), vaccines, or small mols. (aptamers).  MAb therapies are mainly aimed at MUC1-N with little success, however, new generation of MAb are being developed for MUC1-C.  Vaccines (peptide, carbohydrate, glycopeptide, DNA, and dendritic cell) have been developed that recognizes the aberrant glycosylated region of the variable N-tandem repeats in MUC1-N, whereas new generation vaccines are aimed at the cytoplasmic region of MUC1-C.  Aptamers (peptides that resemble DNA, RNA) have been used for blocking the dimerization of CQC region and the 5 phosphorylating region of MUC1-C.  In addn., aptamers have been used as cytotoxic drug carriers.  However, none of the therapies for MUC1 are currently in clin. application, as they need further refinement and evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqetDDOl6c_RLVg90H21EOLACvtfcHk0lg4XKTbR5vjCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs12ktbk%253D&md5=a446f5365795baab0f3d4b6e53c99d86</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1097%2FCOC.0b013e31828f5a07&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FCOC.0b013e31828f5a07%26sid%3Dliteratum%253Aachs%26aulast%3DPillai%26aufirst%3DK.%26aulast%3DPourgholami%26aufirst%3DM.%2BH.%26aulast%3DChua%26aufirst%3DT.%2BC.%26aulast%3DMorris%26aufirst%3DD.%2BL.%26atitle%3DMUC1%2520as%2520a%2520Potential%2520Target%2520in%2520Anticancer%2520Therapies%26jtitle%3DAm.%2520J.%2520Clin.%2520Oncol.%26date%3D2015%26volume%3D38%26spage%3D108%26epage%3D118%26doi%3D10.1097%2FCOC.0b013e31828f5a07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahdaoui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Targeting MUC4 in Pancreatic Cancer: miRNAs</span>. <i>Oncoscience</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">799</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.18632/oncoscience.249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncoscience.249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26682251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC28rivVWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=799-800&author=N.+Jonckheereauthor=F.+Lahdaouiauthor=I.+Van+Seuningen&title=Targeting+MUC4+in+Pancreatic+Cancer%3A+miRNAs&doi=10.18632%2Foncoscience.249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting MUC4 in pancreatic cancer: miRNAs</span></div><div class="casAuthors">Jonckheere Nicolas; Lahdaoui Fatima; Van Seuningen Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">Oncoscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">799-800</span>
        ISSN:<span class="NLM_cas:issn">2331-4737</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQF3fV9CLD7bEEksK8CslK8fW6udTcc2eYG8u3jG3wckLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rivVWqtg%253D%253D&md5=d575441f9ffa3d90c4687016b59ccf46</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.18632%2Foncoscience.249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncoscience.249%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DLahdaoui%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DTargeting%2520MUC4%2520in%2520Pancreatic%2520Cancer%253A%2520miRNAs%26jtitle%3DOncoscience%26date%3D2015%26volume%3D2%26spage%3D799%26epage%3D800%26doi%3D10.18632%2Foncoscience.249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Setua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doxtater, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">miR-145: Revival of a Dragon in Pancreatic Cancer</span>. <i>J. Nat. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28616589" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&author=S.+Setuaauthor=S.+hanauthor=K.+Doxtaterauthor=M.+M.+Yallapuauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=miR-145%3A+Revival+of+a+Dragon+in+Pancreatic+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetua%26aufirst%3DS.%26aulast%3Dhan%26aufirst%3DS.%26aulast%3DDoxtater%26aufirst%3DK.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DmiR-145%253A%2520Revival%2520of%2520a%2520Dragon%2520in%2520Pancreatic%2520Cancer%26jtitle%3DJ.%2520Nat.%2520Sci.%26date%3D2017%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olayioye, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neve, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, N. E.</span></span> <span> </span><span class="NLM_article-title">The ErbB Signaling Network: Receptor Heterodimerization in Development and Cancer</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">3159</span>– <span class="NLM_lpage">3167</span>, <span class="refDoi"> DOI: 10.1093/emboj/19.13.3159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1093%2Femboj%2F19.13.3159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10880430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlt1ajtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=3159-3167&author=M.+A.+Olayioyeauthor=R.+M.+Neveauthor=H.+A.+Laneauthor=N.+E.+Hynes&title=The+ErbB+Signaling+Network%3A+Receptor+Heterodimerization+in+Development+and+Cancer&doi=10.1093%2Femboj%2F19.13.3159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The ErbB signaling network: receptor heterodimerization in development and cancer</span></div><div class="casAuthors">Olayioye, Monilola A.; Neve, Richard M.; Lane, Heidi A.; Hynes, Nancy E.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3159-3167</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review, with ∼126 refs., on individual ErbB receptors and their signaling pot. and examples of specific ErbB heterodimers in signaling and development.  The authors particular emphasis is on their role in mammary gland biol. , an organ in which the ErbB family and its ligands are critically involved in development, differentiation and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr03qEN815kibVg90H21EOLACvtfcHk0lhmdy-8AOAcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlt1ajtLY%253D&md5=3e70478dda68f1cfd5ab5bdb910e96a2</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F19.13.3159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F19.13.3159%26sid%3Dliteratum%253Aachs%26aulast%3DOlayioye%26aufirst%3DM.%2BA.%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DLane%26aufirst%3DH.%2BA.%26aulast%3DHynes%26aufirst%3DN.%2BE.%26atitle%3DThe%2520ErbB%2520Signaling%2520Network%253A%2520Receptor%2520Heterodimerization%2520in%2520Development%2520and%2520Cancer%26jtitle%3DEMBO%2520J.%26date%3D2000%26volume%3D19%26spage%3D3159%26epage%3D3167%26doi%3D10.1093%2Femboj%2F19.13.3159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymkowski, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">MUC17, a Novel Membrane-Tethered Mucin</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">466</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2002.6475</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1006%2Fbbrc.2002.6475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11855812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtlGmtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2002&pages=466-475&author=J.+R.+Gumauthor=S.+C.+Crawleyauthor=J.+W.+Hicksauthor=D.+E.+Szymkowskiauthor=Y.+S.+Kim&title=MUC17%2C+a+Novel+Membrane-Tethered+Mucin&doi=10.1006%2Fbbrc.2002.6475"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">MUC17, a Novel Membrane-Tethered Mucin</span></div><div class="casAuthors">Gum, James R., Jr.; Crawley, Suzanne C.; Hicks, James W.; Szymkowski, David E.; Kim, Young S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">466-475</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Membrane mucins have several functions in epithelial cells including cytoprotection, extravasation during metastases, maintenance of luminal structure, and signal transduction.  In this paper we describe a large membrane mucin expressed in the normal intestine.  This novel mucin, designated MUC17, contains an extended, repetitive extracellular glycosylation domain and a carboxyl terminus with two EGF-like domains, a SEA module domain, a transmembrane domain, and a cytoplasmic domain with potential serine and tyrosine phosphorylation sites.  RNA blot anal. and in situ hybridization indicates that MUC17 is expressed in select pancreatic and colon cancer cell lines and in intestinal absorptive cells.  Radiation hybrid mapping localized MUC17 to chromosome 7q22 where it resides in close proximity with three other membrane mucin genes, MUC3A, MUC3B, and MUC12.  Thus, these membrane mucins reside together in a gene cluster, but are expressed in different tissues and are likely to have different functions as well.  (c) 2002 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBHXjqsqOkKLVg90H21EOLACvtfcHk0lhmdy-8AOAcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtlGmtLw%253D&md5=27d9ff1bee3f4e22da2bec5420c05576</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2002.6475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2002.6475%26sid%3Dliteratum%253Aachs%26aulast%3DGum%26aufirst%3DJ.%2BR.%26aulast%3DCrawley%26aufirst%3DS.%2BC.%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DSzymkowski%26aufirst%3DD.%2BE.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DMUC17%252C%2520a%2520Novel%2520Membrane-Tethered%2520Mucin%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D291%26spage%3D466%26epage%3D475%26doi%3D10.1006%2Fbbrc.2002.6475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escande, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">Structural Organization and Classification of the Human Mucin Genes</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">D1192</span>– <span class="NLM_lpage">D1206</span>, <span class="refDoi"> DOI: 10.2741/Moniaux</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.2741%2FMoniaux" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11578969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFCgt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=D1192-D1206&author=N.+Moniauxauthor=F.+Escandeauthor=N.+Porchetauthor=J.+P.+Aubertauthor=S.+K.+Batra&title=Structural+Organization+and+Classification+of+the+Human+Mucin+Genes&doi=10.2741%2FMoniaux"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural organization and classification of the human mucin genes</span></div><div class="casAuthors">Moniaux, Nicolas; Escande, Fabienne; Porcher, Nicole; Aubert, Jean-Pierre; Batra, Surinder K.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience [online computer file]</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">D1192-D1206</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review with refs.  The cells of living organisms in contact with the external environment are const. attacked by different kinds of substances such as micro-organisms, toxins, and pollutants.  With evolution, defense mechanisms, such as the secretion of mucus has been developed.  Mucins are the main components of mucus.  They are synthesized and secreted by specialized cells of the epithelium and in some case, by non mucin-secreting cells.  Little was known about the structure of mucins until a decade ago.  This is principally due to heavy glycosylation of mucins, which complicated their anal.  With the application of mol. biol. methods, structures of the mucin core peptides (apomucins) are beginning to be elucidated.  A total of eleven human mucin (MUC) genes have been identified and numbered in chronol. order of their description: MUC1-4, MUC5Ac, MUC5B, MUC6-8, and MUC11-12.  Of these, the complete cDNA sequence are published only for six mucins MUC1, MUC2, MUC4, MUC5B, MUC5AC, and MUC7.  Human mucin genes, in general, show three common features: (I) a nucleotide tandem repeat domain; (II) a predicted peptide domain contg. a high percentage of serines and threonines; (III) complex RNA expression.  The tandem repeats in mucins make up the majority of the backbone.  Related to their structure, mucins can be classified in three distinct subfamilies: gel-forming, sol., and membrane-bound.  Each member from one family possesses common characteristics and probably specific functions.  For a long time, they were thought to have the unique function of protecting and lubricating the epithelial surfaces.  The study of the mucins structure as well as the relationship between structure and function show that mucins also possess other important functions, such as growth, direct implication in the fetal development, the epithelial renewal and differentiation, the epithelial integrity, carcinogenesis, and metastasis.  This review presents the actual knowledge of the mucins structure and the best-characterized function related to their structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV7aAAizjakLVg90H21EOLACvtfcHk0lhmdy-8AOAcMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFCgt7o%253D&md5=9e384d8b1d380e1a32c5f390bd9eda73</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2741%2FMoniaux&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252FMoniaux%26sid%3Dliteratum%253Aachs%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DEscande%26aufirst%3DF.%26aulast%3DPorchet%26aufirst%3DN.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DStructural%2520Organization%2520and%2520Classification%2520of%2520the%2520Human%2520Mucin%2520Genes%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2001%26volume%3D6%26spage%3DD1192%26epage%3DD1206%26doi%3D10.2741%2FMoniaux" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Packer, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callaghan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuckin, M. A.</span></span> <span> </span><span class="NLM_article-title">Expression of the Cell Surface Mucin Gene Family in Adenocarcinomas</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1119</span>– <span class="NLM_lpage">1126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15375564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFWkt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1119-1126&author=L.+M.+Packerauthor=S.+J.+Williamsauthor=S.+Callaghanauthor=D.+C.+Gotleyauthor=M.+A.+McGuckin&title=Expression+of+the+Cell+Surface+Mucin+Gene+Family+in+Adenocarcinomas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of the cell surface mucin gene family in adenocarcinomas</span></div><div class="casAuthors">Packer, Leisl M.; Williams, Stephanie J.; Callaghan, Shirley; Gotley, David C.; McGuckin, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1119-1126</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">Cell surface mucins are complex glycoproteins expressed on the apical membrane surface of mucosal epithelial cells.  In malignant epithelial cells they are thought to influence cell adhesion, and are clin. targets for tumor immunotherapy and serum tumor marker assays.  The authors have compared expression of MUC1, MUC3, MUC4, MUC11, MUC12 and MUC13 mRNA in epithelial cancers and/or cell lines with non-malignant tissues.  In non-malignant tissues, MUC3, 4, 11, 12 and 13 were expressed at highest levels in gastrointestinal tissues, whereas MUC1 was more widely distributed.  Significant down-regulation of the MUC4, MUC12 and MUC13 genes was obsd. in colonic cancers compared with normal tissue, whereas MUC1 was upregulated.  In rectal cancers, levels of all 6 mucin genes were not significantly different to those in normal rectal tissues.  Both MUC1 and MUC4 were down-regulated in gastric cancers, whereas cancer and normal tissue levels were similar for MUC3, 11, 12 and 13.  In esophageal cancers there was a general trend toward higher levels than in normal tissue for MUC1, 3, 12 and 13.  In ovarian cancers MUC1 levels were very high, whereas only low levels of all other mucins were obsd.  The authors also report expression in renal cell carcinomas, bladder carcinomas and breast cancer cell lines.  The reported expression profiles of the cell surface mucin gene family will help direct biol. and clin. studies of these mols. in mucosal biol., and in malignant and inflammatory diseases of epithelial tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVTdk2bWbNbVg90H21EOLACvtfcHk0lgD8yUkFtBD3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFWkt74%253D&md5=c7a30eafb15cf99a660901824b0237d9</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPacker%26aufirst%3DL.%2BM.%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DCallaghan%26aufirst%3DS.%26aulast%3DGotley%26aufirst%3DD.%2BC.%26aulast%3DMcGuckin%26aufirst%3DM.%2BA.%26atitle%3DExpression%2520of%2520the%2520Cell%2520Surface%2520Mucin%2520Gene%2520Family%2520in%2520Adenocarcinomas%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2004%26volume%3D25%26spage%3D1119%26epage%3D1126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuckin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyre, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antalis, T. M.</span></span> <span> </span><span class="NLM_article-title">Two Novel Mucin Genes Down-Regulated in Colorectal Cancer Identified by Differential Display</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4083</span>– <span class="NLM_lpage">4089</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10463611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXlsVOlurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1999&pages=4083-4089&author=S.+J.+Williamsauthor=M.+A.+McGuckinauthor=D.+C.+Gotleyauthor=H.+J.+Eyreauthor=G.+R.+Sutherlandauthor=T.+M.+Antalis&title=Two+Novel+Mucin+Genes+Down-Regulated+in+Colorectal+Cancer+Identified+by+Differential+Display"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Two novel mucin genes down-regulated in colorectal cancer identified by differential display</span></div><div class="casAuthors">Williams, Stephanie J.; McGuckin, Michael A.; Gotley, David C.; Eyre, Helen J.; Sutherland, Grant R.; Antalis, Toni M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4083-4089</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">AACR Subscription Office</span>)
        </div><div class="casAbstract">Epithelial mucins are large, secreted and cell surface glycoproteins involved in epithelial cell protection, adhesion modulation, and signaling.  Using differential display, the authors have identified two novel mucin cDNAs (dd34 and dd29), hereafter designated MUC11 and MUC12, resp., that are down-regulated in colorectal cancers.  Northern blots demonstrated polydisperse signals characteristic of mucin transcripts in RNA from normal colon that were absent in colorectal cancer.  Both cDNAs were mapped by fluorescence in situ hybridization to chromosome band 7q22, the location of the MUC3 mucin gene, thus suggesting that there may be a cluster of mucin genes at this locus.  The sequences of both differential display clones were extended by a combination of screening libraries and PCR.  The 2.8-kb MUC11 cDNA composite encoded 35 serine/threonine-rich, mucin-like degenerate 28 amino acid tandem repeats.  The MUC12 cDNA composite encoded a putative transmembrane mucin contg. two extracellular cysteine-rich, EGF-like domains, a coiled-coil region, and a mucin-like domain consisting of 28 amino acid degenerate tandem repeats.  Distinct patterns of expression of MUC11, MUC12, and MUC3 mRNAs were obsd. in a range of normal human tissues.  MUC12 mRNA was not expressed in any of six colorectal cancer cell lines examd. and was down-regulated or absent in 6 of 15 (40%) tumors compared with matched normal colonic tissue.  In contrast, MUC11 showed a different pattern of mRNA expression, with four of these lines showing low levels and the other two lines showing relatively high levels of MUC11 transcripts.  Expression of MUC11 was down-regulated in the tumors of 12 of 15 (80%) paired samples.  Structural homol. of MUC12 with rat, mouse, and human MUC3 and human and rat MUC4/ASGP2 indicate that there is a distinct subfamily of transmembrane mucins with conserved epidermal growth factor domains.  The homol. of MUC12 with epidermal growth factor-like growth factors and its down-regulation in colorectal cancers, together with known interactions between rat MUC4 and c-erbB-2 growth factor receptors, suggests that MUC12 may be involved in epithelial cell growth regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-kQoBC9zYYrVg90H21EOLACvtfcHk0lgD8yUkFtBD3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlsVOlurw%253D&md5=9ed3c916d0e3741b066bbe43a438ce96</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DMcGuckin%26aufirst%3DM.%2BA.%26aulast%3DGotley%26aufirst%3DD.%2BC.%26aulast%3DEyre%26aufirst%3DH.%2BJ.%26aulast%3DSutherland%26aufirst%3DG.%2BR.%26aulast%3DAntalis%26aufirst%3DT.%2BM.%26atitle%3DTwo%2520Novel%2520Mucin%2520Genes%2520Down-Regulated%2520in%2520Colorectal%2520Cancer%2520Identified%2520by%2520Differential%2520Display%26jtitle%3DCancer%2520Res.%26date%3D1999%26volume%3D59%26spage%3D4083%26epage%3D4089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wreschner, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eyre, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuckin, M. A.</span></span> <span> </span><span class="NLM_article-title">Muc13, a Novel Human Cell Surface Mucin Expressed by Epithelial and Hemopoietic Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">18327</span>– <span class="NLM_lpage">18336</span>, <span class="refDoi"> DOI: 10.1074/jbc.M008850200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M008850200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11278439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktFWmtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=18327-18336&author=S.+J.+Williamsauthor=D.+H.+Wreschnerauthor=M.+Tranauthor=H.+J.+Eyreauthor=G.+R.+Sutherlandauthor=M.+A.+McGuckin&title=Muc13%2C+a+Novel+Human+Cell+Surface+Mucin+Expressed+by+Epithelial+and+Hemopoietic+Cells&doi=10.1074%2Fjbc.M008850200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">MUC13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells</span></div><div class="casAuthors">Williams, Stephanie J.; Wreschner, Daniel H.; Tran, Mai; Eyre, Helen J.; Sutherland, Grant R.; McGuckin, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">18327-18336</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Transmembrane mucins are glycoproteins involved in barrier function in epithelial tissues.  To identify novel transmembrane mucin genes, we performed a tblastn search of the GenBank EST data bases with a serine/threonine-rich search string, and a rodent gene expressed in bone marrow was identified.  We detd. the cDNA sequence of the human orthologue of this gene, MUC13, which localizes to chromosome band 3q13.3 and generates 3.2-kilobase pair transcripts encoding a 512-amino acid protein comprised of an N-terminal mucin repeat domain, three epidermal growth factor-like sequences, a SEA module, a transmembrane domain, and a cytoplasmic tail (GenBank accession no. AF286113).  MUC13 mRNA is expressed most highly in the large intestine and trachea, and at moderate levels in the kidney, small intestine, appendix, and stomach.  In situ hybridization in murine tissues revealed expression in intestinal epithelial and lymphoid cells.  Immunohistochem. demonstrated the human MUC13 protein on the apical membrane of both columnar and goblet cells in the gastrointestinal tract, as well as within goblet cell thecae, indicative of secretion in addn. to presence on the cell surface.  MUC13 is cleaved, and the β-subunit contg. the cytoplasmic tail undergoes homodimerization.  Including MUC13, there are at least five cell surface mucins expressed in the gastrointestinal tract.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9mVDySvfUQbVg90H21EOLACvtfcHk0lgD8yUkFtBD3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktFWmtrc%253D&md5=a0aeccbe883586e922260da9456dbbe4</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M008850200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M008850200%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DWreschner%26aufirst%3DD.%2BH.%26aulast%3DTran%26aufirst%3DM.%26aulast%3DEyre%26aufirst%3DH.%2BJ.%26aulast%3DSutherland%26aufirst%3DG.%2BR.%26aulast%3DMcGuckin%26aufirst%3DM.%2BA.%26atitle%3DMuc13%252C%2520a%2520Novel%2520Human%2520Cell%2520Surface%2520Mucin%2520Expressed%2520by%2520Epithelial%2520and%2520Hemopoietic%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D18327%26epage%3D18336%26doi%3D10.1074%2Fjbc.M008850200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behera, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Praharaj, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehury, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negi, S.</span></span> <span> </span><span class="NLM_article-title">Exploring the Role and Diversity of Mucins in Health and Disease with Special Insight into Non-Communicable Diseases</span>. <i>Glycoconjugate J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">575</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1007/s10719-015-9606-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs10719-015-9606-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26239922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yrsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2015&pages=575-613&author=S.+K.+Beheraauthor=A.+B.+Praharajauthor=B.+Dehuryauthor=S.+Negi&title=Exploring+the+Role+and+Diversity+of+Mucins+in+Health+and+Disease+with+Special+Insight+into+Non-Communicable+Diseases&doi=10.1007%2Fs10719-015-9606-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases</span></div><div class="casAuthors">Behera, Santosh Kumar; Praharaj, Ardhendu Bhusan; Dehury, Budheswar; Negi, Sapna</div><div class="citationInfo"><span class="NLM_cas:title">Glycoconjugate Journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">575-613</span>CODEN:
                <span class="NLM_cas:coden">GLJOEW</span>;
        ISSN:<span class="NLM_cas:issn">0282-0080</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mucins are major glycoprotein components of the mucus that coats the surfaces of cells lining the respiratory, digestive, gastrointestinal and urogenital tracts.  They function to protect epithelial cells from infection, dehydration and phys. or chem. injury, as well as to aid the passage of materials through a tract i.e., lubrication.  They are also implicated in the pathogenesis of benign and malignant diseases of secretory epithelial cells.  In Human there are two types of mucins, membrane-bound and secreted that are originated from mucous producing goblet cells localized in the epithelial cell layer or in mucous producing glands and encoded by MUC gene.  Mucins belong to a heterogeneous family of high mol. wt. proteins composed of a long peptidic chain with a large no. of tandem repeats that form the so-called mucin domain.  The mol. wt. is generally high, ranging between 0.2 and 10 million Dalton and all mucins contain one or more domains which are highly glycosylated.  The size and no. of repeats vary between mucins and the genetic polymorphism represents no. of repeats (VNTR polymorphisms), which means the size of individual mucins can differ substantially between individuals which can be used as markers.  In human it is only MUC1 and MUC7 that have mucin domains with less than 40 % serine and threonine which in turn could reduce no. of PTS domains.  Mucins can be considered as powerful two-edged sword, as its normal function protects from unwanted substances and organisms at an arm's length while, malfunction of mucus may be an important factor in human diseases.  In this review we have unearthed the current status of different mucin proteins in understanding its role and function in various non-communicable diseases in human with special ref. to its organ specific locations.  The findings described in this review may be of direct relevance to the major research area in biomedicine with ref. to mucin and mucin assocd. diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHWImBD_UyPrVg90H21EOLACvtfcHk0lhnJH3eyIOptA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yrsbfI&md5=4bee3b7b9620462c8347ec87264fbe91</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs10719-015-9606-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10719-015-9606-6%26sid%3Dliteratum%253Aachs%26aulast%3DBehera%26aufirst%3DS.%2BK.%26aulast%3DPraharaj%26aufirst%3DA.%2BB.%26aulast%3DDehury%26aufirst%3DB.%26aulast%3DNegi%26aufirst%3DS.%26atitle%3DExploring%2520the%2520Role%2520and%2520Diversity%2520of%2520Mucins%2520in%2520Health%2520and%2520Disease%2520with%2520Special%2520Insight%2520into%2520Non-Communicable%2520Diseases%26jtitle%3DGlycoconjugate%2520J.%26date%3D2015%26volume%3D32%26spage%3D575%26epage%3D613%26doi%3D10.1007%2Fs10719-015-9606-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span> <span> </span><span class="NLM_article-title">MUC genes: mucin or not mucin? That is the question</span>. <i>Med. Sci. (Paris)</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">569</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1051/medsci/2004205569</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1051%2Fmedsci%2F2004205569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15190477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ovFGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2004&pages=569-574&author=N.+Porchetauthor=J.+P.+Aubert&title=MUC+genes%3A+mucin+or+not+mucin%3F+That+is+the+question&doi=10.1051%2Fmedsci%2F2004205569"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">MUC genes: mucin or not mucin? That is the question</span></div><div class="casAuthors">Porchet Nicole; Aubert Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Medecine sciences : M/S</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">569-74</span>
        ISSN:<span class="NLM_cas:issn">0767-0974</span>.
    </div><div class="casAbstract">Mucins are macromolecules lying the cells in contact with external environment and protect the epithelium against constant attacks such as digestive fluids, microorganisms, pollutants, and toxins.  Mucins are the main components of mucus and are synthesized and secreted by specialized cells of the epithelium (goblet cells, cells of mucous glands) or non mucin-secreting cells.  Human mucin genes show common features: large size of their mRNAs, large nucleotide tandem repeat domains, complex expression both at tissular and cellular level.  Since 1987, 21 MUC symbols have been used to designate genes encoding O-glycoproteins containing tandem repeat domains rich in serine, threonine and proline.  Some of these genes encode true mucins while others encode non mucin adhesion O-glycoproteins.  In this paper, we propose a classification based on sequence similarities and expression areas.  Two main families can be distinguished: secreted mucins or gel-forming mucins (MUC2, MUC5AC, MUC5B, MUC6), and membrane-bound mucins (MUC1, MUC3, MUC4, MUC12, MUC17).  Muc-deficient mice will provide important models in the study of functional relationships between these two mucin families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRWSA7JRbXU0NoizSOkG_FfW6udTcc2eYM5TyvYDu0ZLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ovFGnug%253D%253D&md5=f7803fe7b8483a0cb8fbbda80aa44b61</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1051%2Fmedsci%2F2004205569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1051%252Fmedsci%252F2004205569%26sid%3Dliteratum%253Aachs%26aulast%3DPorchet%26aufirst%3DN.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26atitle%3DMUC%2520genes%253A%2520mucin%2520or%2520not%2520mucin%253F%2520That%2520is%2520the%2520question%26jtitle%3DMed.%2520Sci.%2520%2528Paris%2529%26date%3D2004%26volume%3D20%26spage%3D569%26epage%3D574%26doi%3D10.1051%2Fmedsci%2F2004205569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dolan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Abad, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arike, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelaseyed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, G. C.</span></span> <span> </span><span class="NLM_article-title">The Human Transmembrane Mucin MUC17 Responds to Tnfα by Increased Presentation at the Plasma Membrane</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>476</i></span>,  <span class="NLM_fpage">2281</span>– <span class="NLM_lpage">2295</span>, <span class="refDoi"> DOI: 10.1042/BCJ20190180</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2FBCJ20190180" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=31387973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVCnurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=476&publication_year=2019&pages=2281-2295&author=H.+Schneiderauthor=E.+Bergerauthor=B.+Dolanauthor=B.+Martinez-Abadauthor=L.+Arikeauthor=T.+Pelaseyedauthor=G.+C.+Hansson&title=The+Human+Transmembrane+Mucin+MUC17+Responds+to+Tnf%CE%B1+by+Increased+Presentation+at+the+Plasma+Membrane&doi=10.1042%2FBCJ20190180"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The human transmembrane mucin MUC17 responds to TNFα by increased presentation at the plasma membrane</span></div><div class="casAuthors">Schneider, Hannah; Berger, Evelin; Dolan, Brendan; Martinez-Abad, Beatriz; Arike, Liisa; Pelaseyed, Thaher; Hansson, Gunnar C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">476</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2281-2295</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Here, we identified two unknown phosphorylated serine residues, S4428 and S4492, in the cytoplasmic tail of human MUC17.  We have previously demonstrated that MUC17 is anchored to the apical membrane domain via an interaction with the scaffolding protein PDZK1.  S4492, localized in the C-terminal PDZ binding motif of MUC17, was mutated to generate phosphomimetic and phosphodeficient variants of MUC17.  Using Caco-2 cells as a model system, we found that induction of an inflammatory state by long-term stimulation with the proinflammatory cytokine TNFα resulted in an increase of MUC17 protein levels and enhanced insertion of MUC17 and its two phospho-variants into apical membranes.  Up-regulation and apical insertion of MUC17 was followed by shedding of MUC17-contg. vesicles.  Transmembrane mucins have previously been shown to play a role in the prevention of bacterial colonization by acting as sheddable decoys for encroaching bacteria.  Overexpression and increased presentation at the plasma membrane of wild-type MUC17 and its phosphodeficient variant MUC17 S-4492A protected Caco-2 cells against adhesion of enteropathogenic Escherichia coli, indicating that C-terminal phosphorylation of MUC17 may play a functional role in epithelial cell protection.  We propose a new function for MUC17 in inflammation, where MUC17 acts as a second line of defense by preventing attachment of bacteria to the epithelial cell glycocalyx in the small intestine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRzvER6zG8W7Vg90H21EOLACvtfcHk0lhnJH3eyIOptA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVCnurrP&md5=e9aecaf30ceb530b6619e979ab366baf</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1042%2FBCJ20190180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBCJ20190180%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DE.%26aulast%3DDolan%26aufirst%3DB.%26aulast%3DMartinez-Abad%26aufirst%3DB.%26aulast%3DArike%26aufirst%3DL.%26aulast%3DPelaseyed%26aufirst%3DT.%26aulast%3DHansson%26aufirst%3DG.%2BC.%26atitle%3DThe%2520Human%2520Transmembrane%2520Mucin%2520MUC17%2520Responds%2520to%2520Tnf%25CE%25B1%2520by%2520Increased%2520Presentation%2520at%2520the%2520Plasma%2520Membrane%26jtitle%3DBiochem.%2520J.%26date%3D2019%26volume%3D476%26spage%3D2281%26epage%3D2295%26doi%3D10.1042%2FBCJ20190180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bafna, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">MUC4Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">2065</span>– <span class="NLM_lpage">2070</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-6041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F0008-5472.CAN-07-6041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=18381409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=2065-2070&author=P.+Chaturvediauthor=A.+P.+Singhauthor=S.+Chakrabortyauthor=S.+C.+Chauhanauthor=S.+Bafnaauthor=J.+L.+Mezaauthor=P.+K.+Singhauthor=M.+A.+Hollingsworthauthor=P.+P.+Mehtaauthor=S.+K.+Batra&title=MUC4Mucin+Interacts+with+and+Stabilizes+the+HER2+Oncoprotein+in+Human+Pancreatic+Cancer+Cells&doi=10.1158%2F0008-5472.CAN-07-6041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4 Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells</span></div><div class="casAuthors">Chaturvedi, Pallavi; Singh, Ajay P.; Chakraborty, Subhankar; Chauhan, Subhash C.; Bafna, Sangeeta; Meza, Jane L.; Singh, Pankaj K.; Hollingsworth, Michael A.; Mehta, Parmender P.; Batra, Surinder K.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2065-2070</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MUC4, a high-mol. wt. transmembrane glycoprotein, is overexpressed in pancreatic cancer and is implicated in its pathogenesis.  It is a heterodimeric protein contg. a large extracellular, heavily glycosylated subunit, MUC4α, and a transmembrane growth factor-like subunit, MUC4β.  In the present study, we have shown the interaction of human MUC4 with the receptor tyrosine kinase HER2 in pancreatic adenocarcinoma cells by reciprocal coimmunopptn. and cocapping studies.  MUC4 colocalized with HER2 at the cell surface and in the cytoplasm.  Silencing of MUC4 by transient or stable expression of MUC4-targeted short-interfering RNA led to the down-regulation of HER2 with a concomitant decrease in its phosphorylated form (pY1248-HER2).  Further analyses revealed that the MUC4-knockdown-mediated decrease in HER2 expression occurred due to the drop in the stability of the receptor.  In MUC4-knockdown pancreatic cancer cells, we also obsd. a reduced phosphorylation of the focal adhesion kinase and p42/44 mitogen-activated protein kinase, which are downstream effector proteins in HER2 signaling.  Our findings add a new dimension to MUC4 function as a modulator of cell signaling and provide mechanistic evidence for its role in pancreatic cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbz1l8961rMLVg90H21EOLACvtfcHk0lhnJH3eyIOptA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktVyqtb8%253D&md5=97c108255745915d2a50825ccc25a733</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-6041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-6041%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DA.%2BP.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DBafna%26aufirst%3DS.%26aulast%3DMeza%26aufirst%3DJ.%2BL.%26aulast%3DSingh%26aufirst%3DP.%2BK.%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DMehta%26aufirst%3DP.%2BP.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DMUC4Mucin%2520Interacts%2520with%2520and%2520Stabilizes%2520the%2520HER2%2520Oncoprotein%2520in%2520Human%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D2065%26epage%3D2070%26doi%3D10.1158%2F0008-5472.CAN-07-6041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lodish, H.</span>; <span class="NLM_string-name">Berk, A.</span>; <span class="NLM_string-name">Zipursky, S. L.</span>; <span class="NLM_string-name">Mastsudaira, P.</span>; <span class="NLM_string-name">Baltimore, D.</span>; <span class="NLM_string-name">Darnell, J.</span></span> <i>Molecular and Cellular Biology</i>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">W. H. Freeman</span>: <span class="NLM_publisher-loc">New York</span>, <span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=H.+Lodish&author=A.+Berk&author=S.+L.+Zipursky&author=P.+Mastsudaira&author=D.+Baltimore&author=J.+Darnell&title=Molecular+and+Cellular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DLodish%26aufirst%3DH.%26btitle%3DMolecular%2520and%2520Cellular%2520Biology%26pub%3DW.%2520H.%2520Freeman%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span>; <span class="NLM_string-name">Farooq, A.</span>; <span class="NLM_string-name">Carothers Carraway, C. A.</span></span> <span> </span><span class="NLM_article-title">The Membrane Mucin Muc4 as a Modulator for the Receptor Tyrosine Kinase Erbb2</span>. In  <i>Recent Progress in Cancer Research</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, C. K.</span></span>, Ed.; <span class="NLM_publisher-name">Transworld Research Network</span>: <span class="NLM_publisher-loc">Kerala, India</span>, <span class="NLM_year">2007</span>; pp  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">75</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=59-75&author=K.+L.+Carraway&author=A.+Farooq&author=C.+A.+Carothers+Carrawayauthor=C.+K.+Tang&title=Recent+Progress+in+Cancer+Research"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DThe%2520Membrane%2520Mucin%2520Muc4%2520as%2520a%2520Modulator%2520for%2520the%2520Receptor%2520Tyrosine%2520Kinase%2520Erbb2%26btitle%3DRecent%2520Progress%2520in%2520Cancer%2520Research%26aulast%3DTang%26aufirst%3DC.%2BK.%26pub%3DTransworld%2520Research%2520Network%26date%3D2007%26spage%3D59%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessein, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">The Mucin MUC4 and its Membrane Partner Erbb2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e32232</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0032232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1371%2Fjournal.pone.0032232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22393391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=N.+Jonckheereauthor=N.+Skrypekauthor=J.+Merlinauthor=A.+F.+Desseinauthor=P.+Dumontauthor=E.+Leteurtreauthor=A.+Harrisauthor=J.+Desseynauthor=C.+Susiniauthor=F.+Frenoisauthor=I.+Van+Seuningen&title=The+Mucin+MUC4+and+its+Membrane+Partner+Erbb2+Regulate+Biological+Properties+of+Human+CAPAN-2+Pancreatic+Cancer+Cells+via+Different+Signalling+Pathways&doi=10.1371%2Fjournal.pone.0032232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Dumont, Patrick; Leteurtre, Emmanuelle; Harris, Ann; Desseyn, Jean-Luc; Susini, Christiane; Frenois, Frederic; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e32232</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mucin MUC4 and its membrane partner the ErbB2 oncogenic receptor are potential interacting partners in human pancreatic tumor development.  However, the way they function is still largely unknown.  In this work, we aimed to identify the cellular mechanisms and the intracellular signalling pathways under the control of both ErbB2 and MUC4 in a human pancreatic adenocarcinomatous cell line.  Using co-immunopptn. and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 via the EGF domains of MUC4.  Stable cell clones were generated in which either MUC4 or ErbB2 were knocked down (KD) by a shRNA approach.  Biol. properties of these cells were then studied in vitro and in vivo.  Our results show that ErbB2-KD cells are more apoptotic and less proliferative (decreased cyclin D1 and increased p27kip1 expression) while migration and invasive properties were not altered.  MUC4-KD clones were less proliferative with decreased cyclin D1 expression, G1 cell cycle arrest and altered ErbB2/ErbB3 expression.  Their migration properties were reduced whereas invasive properties were increased.  Importantly, inhibition of ErbB2 and MUC4 expression did not impair the same signalling pathways (inhibition of MUC4 expression affected the JNK pathway whereas that of ErbB2 altered the MAPK pathway).  Finally, ErbB2-KD and MUC4-KD cells showed impaired tumor growth in vivo.  Our results show that ErbB2 and MUC4, which interact phys., activate different intracellular signalling pathways to regulate biol. properties of CAPAN-2 pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraoUloWRMMlrVg90H21EOLACvtfcHk0liHI0M3JYo_MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D&md5=656b500d070b2e9b6d64ee65a37aa624</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0032232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0032232%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DMerlin%26aufirst%3DJ.%26aulast%3DDessein%26aufirst%3DA.%2BF.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DDesseyn%26aufirst%3DJ.%26aulast%3DSusini%26aufirst%3DC.%26aulast%3DFrenois%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DThe%2520Mucin%2520MUC4%2520and%2520its%2520Membrane%2520Partner%2520Erbb2%2520Regulate%2520Biological%2520Properties%2520of%2520Human%2520CAPAN-2%2520Pancreatic%2520Cancer%2520Cells%2520via%2520Different%2520Signalling%2520Pathways%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0032232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganju, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafeez, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ise, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrman, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghimire, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradhan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span> <span> </span><span class="NLM_article-title">MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">491</span>, <span class="refDoi"> DOI: 10.1038/onc.2016.218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2016.218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=27321183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVSrsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2017&pages=491&author=S.+Khanauthor=M.+Sikanderauthor=M.+C.+Ebelingauthor=A.+Ganjuauthor=S.+Kumariauthor=M.+M.+Yallapuauthor=B.+B.+Hafeezauthor=T.+Iseauthor=S.+Nagataauthor=N.+Zafarauthor=S.+W.+Behrmanauthor=J.+Y.+Wanauthor=H.+M.+Ghimireauthor=P.+Sahayauthor=P.+Pradhanauthor=S.+C.+Chauhanauthor=M.+Jaggi&title=MUC13+Interaction+with+Receptor+Tyrosine+Kinase+HER2+Drives+Pancreatic+Ductal+Adenocarcinoma+Progression&doi=10.1038%2Fonc.2016.218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MUC13 interaction with receptor tyrosine kinase HER2 drives pancreatic ductal adenocarcinoma progression</span></div><div class="casAuthors">Khan, S.; Sikander, M.; Ebeling, M. C.; Ganju, A.; Kumari, S.; Yallapu, M. M.; Hafeez, B. B.; Ise, T.; Nagata, S.; Zafar, N.; Behrman, S. W.; Wan, J. Y.; Ghimire, H. M.; Sahay, P.; Pradhan, P.; Chauhan, S. C.; Jaggi, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491-500</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although MUC13, a transmembrane mucin, is aberrantly expressed in pancreatic ductal adenocarcinoma (PDAC) and generally correlates with increased expression of HER2, the underlying mechanism remains poorly understood.  Herein, we found that MUC13 co-localizes and interacts with HER2 in PDAC cells (reciprocal co-immunopptn., immunofluorescence, proximity ligation, co-capping assays) and tissues (immunohistofluorescence).  The results from this study demonstrate that MUC13 functionally interacts and activates HER2 at p1248 in PDAC cells, leading to stimulation of HER2 signaling cascade, including ERK1/2, FAK, AKT and PAK1 as well as regulation of the growth, cytoskeleton remodeling and motility, invasion of PDAC cells-all collectively contributing to PDAC progression.  Interestingly, all of these phenotypic effects of MUC13-HER2 co-localization could be effectively compromised by depleting MUC13 and mediated by the first and second EGF-like domains of MUC13.  Further, MUC13-HER2 co-localization also holds true in PDAC tissues with a strong functional correlation with events contributing to increased degree of disorder and cancer aggressiveness.  In brief, findings presented here provide compelling evidence of a functional ramification of MUC13-HER2: this interaction could be potentially exploited for targeted therapeutics in a subset of patients harboring an aggressive form of PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoapvPnMZTrQrVg90H21EOLACvtfcHk0liHI0M3JYo_MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVSrsLbL&md5=8bea92c022d6054cbced6eafb44c8720</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fonc.2016.218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2016.218%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DSikander%26aufirst%3DM.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DGanju%26aufirst%3DA.%26aulast%3DKumari%26aufirst%3DS.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DHafeez%26aufirst%3DB.%2BB.%26aulast%3DIse%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DZafar%26aufirst%3DN.%26aulast%3DBehrman%26aufirst%3DS.%2BW.%26aulast%3DWan%26aufirst%3DJ.%2BY.%26aulast%3DGhimire%26aufirst%3DH.%2BM.%26aulast%3DSahay%26aufirst%3DP.%26aulast%3DPradhan%26aufirst%3DP.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DJaggi%26aufirst%3DM.%26atitle%3DMUC13%2520Interaction%2520with%2520Receptor%2520Tyrosine%2520Kinase%2520HER2%2520Drives%2520Pancreatic%2520Ductal%2520Adenocarcinoma%2520Progression%26jtitle%3DOncogene%26date%3D2017%26volume%3D36%26spage%3D491%26doi%3D10.1038%2Fonc.2016.218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">C-Terminal Domain of Rodent Intestinal Mucin Muc3 is Proteolytically Cleaved in the Endoplasmic Reticulum to Generate Extracellular and Membrane Components</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>366</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">631</span>, <span class="refDoi"> DOI: 10.1042/bj20020289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20020289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12027806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFGltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2002&pages=623-631&author=R.+Wangauthor=I.+A.+Khatriauthor=J.+F.+Forstner&title=C-Terminal+Domain+of+Rodent+Intestinal+Mucin+Muc3+is+Proteolytically+Cleaved+in+the+Endoplasmic+Reticulum+to+Generate+Extracellular+and+Membrane+Components&doi=10.1042%2Fbj20020289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">C-terminal domain of rodent intestinal mucin Muc3 is proteolytically cleaved in the endoplasmic reticulum to generate extracellular and membrane components</span></div><div class="casAuthors">Wang, Rongquan; Khatri, Ismat A.; Forstner, Janet F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">623-631</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Although human MUC3 and rodent Muc3 are both membrane-assocd. intestinal mucins, the present study has explored the possibility that rodent Muc3 might exist in sol. as well as membrane forms.  No evidence was obtained for the existence of sol. splice variants; however, expts. with heterologous cells transfected with cDNA encoding the 381-residue C-terminal domain of rodent Muc3 showed that a definitive proteolytic cleavage occurs during processing in the endoplasmic reticulum.  The products consisted of a V5-tagged 30 kDa extracellular glycopeptide and a Myc-tagged 49 kDa membrane-assocd. glycopeptide.  Throughout their cellular transport to the plasma membrane, the two fragments remained assocd. by noncovalent SDS-sensitive interactions.  Site-specific mutagenesis pinpointed the need for glycine and serine residues in the cleavage sequence Leu-Ser-Lys-Gly-Ser-Ile-Val-Val, which is localized between the two epidermal-growth-factor-like motifs of the mucin.  A similar cleavage sequence (Phe-Arg-Pro-Gly ↓ Ser-Val-Val-Val, where ↓ signifies the cleavage site) has been reported in human MUC1 and analogous sites are present in human MUC3, MUC12 and MUC17.  Thus early proteolytic cleavage may be a conserved characteristic of many membrane-assocd. mucins, possibly as a prelude to later release of their large extracellular domains at cell surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1Q77ZPGCwTbVg90H21EOLACvtfcHk0liMrxQ_TLbp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFGltbk%253D&md5=6d96ba89e3c08417a52eeee46241c13f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1042%2Fbj20020289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20020289%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%26aulast%3DKhatri%26aufirst%3DI.%2BA.%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DC-Terminal%2520Domain%2520of%2520Rodent%2520Intestinal%2520Mucin%2520Muc3%2520is%2520Proteolytically%2520Cleaved%2520in%2520the%2520Endoplasmic%2520Reticulum%2520to%2520Generate%2520Extracellular%2520and%2520Membrane%2520Components%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D366%26spage%3D623%26epage%3D631%26doi%3D10.1042%2Fbj20020289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Contribution of the Conservative Cleavage Motif to Posttranslational Processing of the Carboxyl Terminal Domain of Rodent Muc3</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1007/s11010-008-9753-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs11010-008-9753-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=18401557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtlSru7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2008&pages=155-166&author=Y.+Liauthor=Z.+Pengauthor=Y.+Heauthor=W.+Chenauthor=X.+Bianauthor=D.+Fangauthor=R.+Wang&title=Contribution+of+the+Conservative+Cleavage+Motif+to+Posttranslational+Processing+of+the+Carboxyl+Terminal+Domain+of+Rodent+Muc3&doi=10.1007%2Fs11010-008-9753-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of the conservative cleavage motif to posttranslational processing of the carboxyl terminal domain of rodent Muc3</span></div><div class="casAuthors">Li, Yicheng; Peng, Zhihong; He, Yonghong; Chen, Wensheng; Bian, Xiuwu; Fang, Dianchun; Wang, Rongquan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">155-166</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In previous work, we showed by transient expression studies in COS-1 cells that the C-terminal domain of rat intestinal membrane mucin (rMuc3) that was cloned in the pSecTag2 plasmid (named as p20) is posttranslationally cleaved twice.  One location is between the glycine and the serine within a LS1KGS2IV1V2 motif, and the other is in the 49-kDa membrane-tethered fragment at an undefined site.  The SEA (sea urchin sperm protein, enterokinase and agrin) module of rMuc3 is responsible for the cleavage and assocn. of the cleaved fragments.  The present study demonstrates how the conservative cleavage motif LS1KGS2IV1V2 contributes to posttranslational processing through mutagenesis of each residue in the LS1KGS2IV1V2 motif.  Mutation of S2 to alanine (p20s2/a) completely prevented cleavage.  While p20k/a (in this construct the K is replaced by A) and p20s1/a (in this construct the S1 is replaced by A) (6 and 3%) showed almost the same result as the wild-type p20 transfectant (4%), 79, 39, 22, 17, and 14% of the products from p20g/a (in this construct the G is replaced by A), p20i/a (in this construct the I is replaced by A), p20l/a (in this construct the L is replaced by A), p20v2/a (in this construct the V2 is replaced by A), and p20v1/a (in this construct the V1 is replaced by A) remained uncleaved.  The cleaved N-terminal fragment of the p20s1/a transfectant was 26-kDa, but the N-terminal fragments from p20, p20g/a, p20l/a, p20k/a, p20i/a, p20v1/a, and p20v2/a were 30-kDa.  The S1 residue was possibly O-glycosylated, which was supported by deglycosylation with O-cocktail (a mixt. of glycosidases).  The N-terminal fragment of p20s1/a-transfected cells was present at high levels in the spent media.  Thus, the S2, G, I, L, V2, and V1 residues within the conserved cleavage motif, LS1KGS2IV1V2, are important for cleavage and contribute to the structural formation and conformational stress of the small loop between the β2 and the β3 strands.  The S1 residue is possibly O-glycosylated, and mutation of S1 residue to alanine does not affect the cleavage of the LS1KGS2IV1V2 motif, but it is important for the dissocn. and further release of the cleaved N-terminal fragment from the cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJSuhCZ08LbVg90H21EOLACvtfcHk0liMrxQ_TLbp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtlSru7w%253D&md5=5fe652b625a6d762df34fff662040eca</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs11010-008-9753-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11010-008-9753-1%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DBian%26aufirst%3DX.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DContribution%2520of%2520the%2520Conservative%2520Cleavage%2520Motif%2520to%2520Posttranslational%2520Processing%2520of%2520the%2520Carboxyl%2520Terminal%2520Domain%2520of%2520Rodent%2520Muc3%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2008%26volume%3D313%26spage%3D155%26epage%3D166%26doi%3D10.1007%2Fs11010-008-9753-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Role of N-glycosylation of the SEA Module of Rodent Muc3 in Posttranslational Processing of its Carboxy-Terminal Domain</span>. <i>Glycobiology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1094</span>– <span class="NLM_lpage">1102</span>, <span class="refDoi"> DOI: 10.1093/glycob/cwp095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1093%2Fglycob%2Fcwp095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19561031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtV2ks77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1094-1102&author=Y.+Heauthor=Y.+Liauthor=Z.+Pengauthor=H.+Yuauthor=X.+Zhangauthor=L.+Chenauthor=Q.+Jiauthor=W.+Chenauthor=R.+Wang&title=Role+of+N-glycosylation+of+the+SEA+Module+of+Rodent+Muc3+in+Posttranslational+Processing+of+its+Carboxy-Terminal+Domain&doi=10.1093%2Fglycob%2Fcwp095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Role of N-glycosylation of the SEA module of rodent Muc3 in posttranslational processing of its carboxy-terminal domain</span></div><div class="casAuthors">He, Yonghong; Li, Yicheng; Peng, Zhihong; Yu, Hao; Zhang, Xin; Chen, Lei; Ji, Qing; Chen, Wensheng; Wang, Rongquan</div><div class="citationInfo"><span class="NLM_cas:title">Glycobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1094-1102</span>CODEN:
                <span class="NLM_cas:coden">GLYCE3</span>;
        ISSN:<span class="NLM_cas:issn">0959-6658</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A prominent feature of the rodent Muc3 SEA module is the precursor cleavage event that segregates the O-glycosylated N-terminal fragment and transmembrane domain into the noncovalently attached heterodimer.  There are seven potential N-glycosylation sites that occur in a cluster in the SEA module of Muc3.  However, it is unknown if these sites are modified or what the function of these N-glycans may be in the SEA module.  Our data show that the proteolytic cleavage of the rodent Muc3 SEA module was partially prevented by treatment with tunicamycin, an inhibitor of N-glycosylation.  Each single mutant of the seven N-glycosylation sites (N1A, N2A, N3A, N4A, N5A, N6A, and N7A) and multiple mutants, including double (N34A) and triple (N345A) mutants, and mutants with four (N3457A), five (N34567A), six (N134567A and N234567A), seven (N1234567A) mutations, confirmed that all seven of these potential sites are N-glycosylated simultaneously.  The proteolytic cleavage of the SEA module was not affected when it lacked only one, two, or three N-glycans, but was partially inhibited when lacking four, five, and six N-glycans.  In all, 2%, 48%, 85%, and 73% of the products from N3457A, N34567A, N134567A, and N234567A transfectants, resp., remained uncleaved.  The proteolytic cleavage was completely prevented in the N1234567A transfectant, which eliminated all seven N-glycans in the SEA module.  The interaction of the heterodimer was independent of the N-glycans within the rodent Muc3 SEA module.  Thus, the N-glycosylation pattern constituted a control point for the modulation of the proteolytic cleavage of the SEA module.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreEWFBaBwgnLVg90H21EOLACvtfcHk0liMrxQ_TLbp5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtV2ks77M&md5=06d79e5f9899acbd45c809d3f1f811b6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fglycob%2Fcwp095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fglycob%252Fcwp095%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DRole%2520of%2520N-glycosylation%2520of%2520the%2520SEA%2520Module%2520of%2520Rodent%2520Muc3%2520in%2520Posttranslational%2520Processing%2520of%2520its%2520Carboxy-Terminal%2520Domain%26jtitle%3DGlycobiology%26date%3D2009%26volume%3D19%26spage%3D1094%26epage%3D1102%26doi%3D10.1093%2Fglycob%2Fcwp095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span> <span> </span><span class="NLM_article-title">Autoproteolysis of the SEA Module of Rmuc3 C-Terminal Domain Modulate its Functional Composition</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>503</i></span>,  <span class="NLM_fpage">238</span>– <span class="NLM_lpage">247</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.abb.2010.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20727344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=503&publication_year=2010&pages=238-247&author=Z.+Pengauthor=Y.+Heauthor=Y.+Yangauthor=R.+Zhuauthor=J.+Baiauthor=Y.+Liauthor=H.+Yuauthor=X.+Zhangauthor=L.+Chenauthor=W.+Chenauthor=D.+Fangauthor=R.+Wang&title=Autoproteolysis+of+the+SEA+Module+of+Rmuc3+C-Terminal+Domain+Modulate+its+Functional+Composition&doi=10.1016%2Fj.abb.2010.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Autoproteolysis of the SEA module of rMuc3 C-terminal domain modulates its functional composition</span></div><div class="casAuthors">Peng, Zhihong; He, Yonghong; Yang, Yongtao; Zhu, Rong; Bai, Jianying; Li, Yicheng; Yu, Hao; Zhang, Xin; Chen, Lei; Chen, Wensheng; Fang, Dianchun; Wang, Rongquan</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">503</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">238-247</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RMuc3 is a typical transmembrane mucin and contains a 174 amino acid domain called an SEA module in its C-terminal domain which is cleaved in eukaryotic cells.  However, the mechanism by which the rMuc3 SEA module is proteolyzed and its biol. significance has to be elucidated.  In this study, we showed that the rMuc3 C-terminal domain was cleaved at LSKGSIVV motif within SEA module in prokaryotic cells, the time-dependence of the cleavage was found in the purified rMuc3 C-terminal domain carrying a mutated LSKASIVV motif expressed in bacteria.  Thus, the cleavage of rMuc3 SEA module depended on autoproteolysis.  The autoproteolysis of the SEA module of rMuc3 C-terminal domain played a crit. role in the migration and invasion of the LoVo human colon cancer cells with rMuc3 C-terminal domain in vitro.  The rMuc3 C-terminal domain induced a significant activation of HER/ErbB2 phosphorylated form (py1248) in LoVo cells.  Inhibition of the phosphorylation by gefitinib (ZD1839) did attenuate migration and invasion of LoVo cells with rMuc3 C-terminal domain.  Thus, rMuc3 C-terminal domain undergoes autoproteolysis at its SEA module, which maintains its availability for the potentiation of the signaling process that is modulated by HER/ErbB2 phosphorylation to promote the migration and invasion of LoVo cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOtC1zJrckLbVg90H21EOLACvtfcHk0ljPun4hIG498w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WhsLbE&md5=49df82391362f28f33ea2d808134fd0a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DR.%26aulast%3DBai%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26atitle%3DAutoproteolysis%2520of%2520the%2520SEA%2520Module%2520of%2520Rmuc3%2520C-Terminal%2520Domain%2520Modulate%2520its%2520Functional%2520Composition%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D503%26spage%3D238%26epage%3D247%26doi%3D10.1016%2Fj.abb.2010.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span> <span> </span><span class="NLM_article-title">MUC13 Mucin Augments Pancreatic Tumorigenesis</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-11-0598</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F1535-7163.MCT-11-0598" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22027689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVWnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=24-33&author=S.+C.+Chauhanauthor=M.+C.+Ebelingauthor=D.+M.+Maherauthor=M.+D.+Kochauthor=A.+Watanabeauthor=H.+Aburataniauthor=Y.+Lioauthor=M.+Jaggi&title=MUC13+Mucin+Augments+Pancreatic+Tumorigenesis&doi=10.1158%2F1535-7163.MCT-11-0598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">MUC13 Mucin Augments Pancreatic Tumorigenesis</span></div><div class="casAuthors">Chauhan, Subhash C.; Ebeling, Mara C.; Maher, Diane M.; Koch, Michael D.; Watanabe, Akira; Aburatani, Hiroyuki; Lio, Yuhlong; Jaggi, Meena</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-33</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The high death rate of pancreatic cancer is attributed to the lack of reliable methods for early detection and underlying mol. mechanisms of its aggressive pathogenesis.  Although MUC13, a newly identified transmembrane mucin, is known to be aberrantly expressed in ovarian and gastro-intestinal cancers, its role in pancreatic cancer is unknown.  Herein, we investigated the expression profile and functions of MUC13 in pancreatic cancer progression.  The expression profile of MUC13 in pancreatic cancer was investigated using a recently generated monoclonal antibody (clone PPZ0020) and pancreatic tissue microarrays.  The expression of MUC13 was significantly (P < 0.005) higher in cancer samples compared with normal/nonneoplastic pancreatic tissues.  For functional analyses, full-length MUC13 was expressed in MUC13 null pancreatic cancer cell lines, MiaPaca and Panc1.  MUC13 overexpression caused a significant (P < 0.05) increase in cell motility, invasion, proliferation, and anchorage-dependent or -independent clonogenicity while decreasing cell-cell and cell-substratum adhesion.  Exogenous MUC13 expression significantly (P < 0.05) enhanced pancreatic tumor growth and reduced animal survival in a xenograft mouse model.  These tumorigenic characteristics correlated with the upregulation/phosphorylation of HER2, p21-activated kinase 1 (PAK1), extracellular signal-regulated kinase (ERK), Akt, and metastasin (S100A4), and the suppression of p53.  Conversely, suppression of MUC13 in HPAFII pancreatic cancer cells by short hairpin RNA resulted in suppression of tumorigenic characteristics, repression of HER2, PAK1, ERK, and S100A4, and upregulation of p53.  MUC13 suppression also significantly (P < 0.05) reduced tumor growth and increased animal survival.  These results imply a role of MUC13 in pancreatic cancer and suggest its potential use as a diagnostic and therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJzNhtWxDCObVg90H21EOLACvtfcHk0ljPun4hIG498w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVWnug%253D%253D&md5=e875631de1d3498829c49510a3a5c0eb</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0598%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DMaher%26aufirst%3DD.%2BM.%26aulast%3DKoch%26aufirst%3DM.%2BD.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DLio%26aufirst%3DY.%26aulast%3DJaggi%26aufirst%3DM.%26atitle%3DMUC13%2520Mucin%2520Augments%2520Pancreatic%2520Tumorigenesis%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26spage%3D24%26epage%3D33%26doi%3D10.1158%2F1535-7163.MCT-11-0598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corredor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polk, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekels, L. L.</span></span> <span> </span><span class="NLM_article-title">Cysteine-Rich Domains of Muc3 Intestinal Mucin Promote Cell Migration, Inhibit Apoptosis, and Accelerate Wound Healing</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>131</i></span>,  <span class="NLM_fpage">1501</span>– <span class="NLM_lpage">1517</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2006.09.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1053%2Fj.gastro.2006.09.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17101324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlantrfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2006&pages=1501-1517&author=S.+B.+Hoauthor=L.+A.+Dvorakauthor=R.+E.+Moorauthor=A.+C.+Jacobsonauthor=M.+R.+Freyauthor=J.+Corredorauthor=D.+B.+Polkauthor=L.+L.+Shekels&title=Cysteine-Rich+Domains+of+Muc3+Intestinal+Mucin+Promote+Cell+Migration%2C+Inhibit+Apoptosis%2C+and+Accelerate+Wound+Healing&doi=10.1053%2Fj.gastro.2006.09.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Cysteine-rich domains of MUC3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing</span></div><div class="casAuthors">Ho, Samuel B.; Dvorak, Leah A.; Moor, Rachel E.; Jacobson, Amanda C.; Frey, Mark R.; Corredor, Julissa; Polk, D. Brent; Shekels, Laurie L.</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1501-1517</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Muc3 intestinal mucin contains an extracellular cysteine-rich domain with 2 epidermal growth factor (EGF)-like motifs.  The aim of this study was to det. the functional properties of Muc3 proteins.  Glutathione S-transferase-fusion proteins contg. both Muc3 EGF-like domains (m3EGF1,2) or truncated versions (m3EGF1 and m3EGF2) were purified from Escherichia coli.  Mouse colon (young adult mouse colon) and human A431 and LoVo cells were examd. for migration and tyrosine phosphorylation in response to recombinant proteins.  LoVo cells were transfected with a human MUC3A transmembrane-EGF1,2 construct and a stable clone was isolated (LhM3c14).  Endogenous MUC3A in LoVo was inhibited by specific small interfering RNA transfection.  Apoptosis was quantitated by nuclear morphol. or terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate biotin nick-end labeling assay.  Colitis was induced in mice by oral 5% dextran sodium sulfate or rectal 5% acetic acid, followed by enema treatments.  m3EGF1,2 stimulated cell migration in all cell lines, but did not induce proliferation.  Migration was inhibited by a tyrosine phosphorylation inhibitor, genistein, but not by the EGF receptor inhibitor, tyrphostin (AG1478).  Inhibition of endogenous MUC3A in LoVo reduced baseline migration.  Tyrosine phosphorylation of ErbB receptors was not obsd. after treatment of cells with m3EGF1,2.  LoVo cells pretreated with m3EGF1,2 and transfected LhM3c14 cells showed reduced apoptosis in response to tumor necrosis factor α or Fas-receptor stimulation.  Administration of m3EGF1,2 per rectum significantly reduced mucosal ulceration and apoptosis in exptl. acute colitis.  Truncated proteins m3EGF1 and m3EGF2 had no effect.  The Muc3 mucin cysteine-rich domain plays an active role in epithelial restitution, and represents a potential novel therapeutic agent for intestinal wound healing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk3i6efVJG87Vg90H21EOLACvtfcHk0ljPun4hIG498w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlantrfK&md5=29bcfd935b97c40706b3af00eb8521a6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2006.09.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2006.09.006%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BB.%26aulast%3DDvorak%26aufirst%3DL.%2BA.%26aulast%3DMoor%26aufirst%3DR.%2BE.%26aulast%3DJacobson%26aufirst%3DA.%2BC.%26aulast%3DFrey%26aufirst%3DM.%2BR.%26aulast%3DCorredor%26aufirst%3DJ.%26aulast%3DPolk%26aufirst%3DD.%2BB.%26aulast%3DShekels%26aufirst%3DL.%2BL.%26atitle%3DCysteine-Rich%2520Domains%2520of%2520Muc3%2520Intestinal%2520Mucin%2520Promote%2520Cell%2520Migration%252C%2520Inhibit%2520Apoptosis%252C%2520and%2520Accelerate%2520Wound%2520Healing%26jtitle%3DGastroenterology%26date%3D2006%26volume%3D131%26spage%3D1501%26epage%3D1517%26doi%3D10.1053%2Fj.gastro.2006.09.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buisine, M P</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devisme, L</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savidge, T C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gespach, C</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosselin, B</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J P</span></span> <span> </span><span class="NLM_article-title">Mucin Gene Expression in Human Embryonic and Fetal Intestine</span>. <i>Gut</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1136/gut.43.4.519</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1136%2Fgut.43.4.519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9824580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADyaK1M%252FntFahtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=519-524&author=M+P+Buisineauthor=L+Devismeauthor=T+C+Savidgeauthor=C+Gespachauthor=B+Gosselinauthor=N+Porchetauthor=J+P+Aubert&title=Mucin+Gene+Expression+in+Human+Embryonic+and+Fetal+Intestine&doi=10.1136%2Fgut.43.4.519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin gene expression in human embryonic and fetal intestine</span></div><div class="casAuthors">Buisine M P; Devisme L; Savidge T C; Gespach C; Gosselin B; Porchet N; Aubert J P</div><div class="citationInfo"><span class="NLM_cas:title">Gut</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">519-24</span>
        ISSN:<span class="NLM_cas:issn">0017-5749</span>.
    </div><div class="casAbstract">BACKGROUND:  The intestinal epithelium is covered by a continuous layer of mucus which is secreted by well differentiated epithelial cells.  Disregulation of the expression of mucins has been reported to have possible implications in the neoplastic process which affects intestinal mucosae.  It is well known that preneoplastic and neoplastic tissues can express fetal phenotypic characteristics.  AIMS:  To assess whether the expression of mucin genes in the intestinal tract is linked to the stage of cellular differentiation and tissue development, by studying the expression of six mucin genes in human fetal small intestine and colon, and also adult tissues.  METHODS:  In situ hybridisation was used to study mRNA expression of MUC2, MUC3, MUC4, MUC5B, MUC5AC, and MUC6 in 32 human embryos and fetuses (6.5-27 weeks gestation).  Normal adult mucosae were used as controls.  RESULTS:  Three mucin genes, MUC2, MUC4, and MUC5AC, were differently expressed in fetal intestine compared with expression in normal adults.  CONCLUSION:  These differences in mucin gene expression suggest a possible regulatory role for these products in intestinal epithelial cell differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmzg6Bx2Gf7SXXDYhVZBdlfW6udTcc2eZ68i4SrOO4dbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FntFahtw%253D%253D&md5=e44b470c30251c1aa000a3c626b82804</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1136%2Fgut.43.4.519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fgut.43.4.519%26sid%3Dliteratum%253Aachs%26aulast%3DBuisine%26aufirst%3DM%2BP%26aulast%3DDevisme%26aufirst%3DL%26aulast%3DSavidge%26aufirst%3DT%2BC%26aulast%3DGespach%26aufirst%3DC%26aulast%3DGosselin%26aufirst%3DB%26aulast%3DPorchet%26aufirst%3DN%26aulast%3DAubert%26aufirst%3DJ%2BP%26atitle%3DMucin%2520Gene%2520Expression%2520in%2520Human%2520Embryonic%2520and%2520Fetal%2520Intestine%26jtitle%3DGut%26date%3D1998%26volume%3D43%26spage%3D519%26epage%3D524%26doi%3D10.1136%2Fgut.43.4.519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Constantinou, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgado, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, D. D.</span></span> <span> </span><span class="NLM_article-title">Transmembrane Mucin Expression and Function in Embryo Implantation and Placentation</span>. <i>Adv. Anat., Embryol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1007/978-3-319-15856-3_4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2F978-3-319-15856-3_4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26450494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC28zgsVSjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2015&pages=51-68&author=P.+E.+Constantinouauthor=M.+Morgadoauthor=D.+D.+Carson&title=Transmembrane+Mucin+Expression+and+Function+in+Embryo+Implantation+and+Placentation&doi=10.1007%2F978-3-319-15856-3_4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Transmembrane Mucin Expression and Function in Embryo Implantation and Placentation</span></div><div class="casAuthors">Constantinou Pamela E; Morgado Micaela; Carson Daniel D; Carson Daniel D</div><div class="citationInfo"><span class="NLM_cas:title">Advances in anatomy, embryology, and cell biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-68</span>
        ISSN:<span class="NLM_cas:issn">0301-5556</span>.
    </div><div class="casAbstract">Transmembrane mucins (TMs) are extremely large, complex glycoproteins that line the apical surfaces of simple epithelia including those of the female reproductive tract.  TMs provide a physical barrier consistent with their role as part of the innate immune system.  This barrier function must be overcome in the context of embryo implantation to permit blastocyst attachment.  Three major TMs have been identified in uterine epithelia of multiple species: MUC1, MUC4, and MUC16.  MUC1 has been found in all species studied to date, whereas expression of MUC4 and MUC16 have been less well studied and may be species specific.  The strategies for removing mucins to permit embryo attachment also vary in a species-specific way and include both hormonal suppression of TM gene expression and membrane clearance via cell surface proteases.  Studies emerging from the cancer literature indicate that TMs can modulate a surprisingly wide variety of signal transduction processes.  Furthermore, various cell surface proteins have been identified that bind either the oligosaccharide or protein motifs of TMs suggesting that these molecules may support cell attachment in some contexts, including trophoblast interactions with cells of the immune system.  The intimate association of TMs at sites of embryo-maternal interaction and the varied functions these complex molecules can play make them key players in embryo implantation and placentation processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRy2yIyExYNymlSCSgBhwJFfW6udTcc2eZmXblRk5A2krntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zgsVSjtg%253D%253D&md5=a96ed918cd17831aa07b18d230715e87</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1007%2F978-3-319-15856-3_4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-319-15856-3_4%26sid%3Dliteratum%253Aachs%26aulast%3DConstantinou%26aufirst%3DP.%2BE.%26aulast%3DMorgado%26aufirst%3DM.%26aulast%3DCarson%26aufirst%3DD.%2BD.%26atitle%3DTransmembrane%2520Mucin%2520Expression%2520and%2520Function%2520in%2520Embryo%2520Implantation%2520and%2520Placentation%26jtitle%3DAdv.%2520Anat.%252C%2520Embryol.%2520Cell%2520Biol.%26date%3D2015%26volume%3D216%26spage%3D51%26epage%3D68%26doi%3D10.1007%2F978-3-319-15856-3_4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, I. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fichtner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kay, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prehn, J. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. P.</span></span> <span> </span><span class="NLM_article-title">Mucin Glycoproteins Block Apoptosis; Promote Invasion, Proliferation, and Migration; and Cause Chemoresistance through Diverse Pathways in Epithelial Cancers</span>. <i>Cancer Metastasis Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1007/s10555-019-09781-w</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs10555-019-09781-w" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=30680581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVCjtLvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2019&pages=237-257&author=I.+S.+Reynoldsauthor=M.+Fichtnerauthor=D.+A.+McNamaraauthor=E.+W.+Kayauthor=J.+H.+M.+Prehnauthor=J.+P.+Burke&title=Mucin+Glycoproteins+Block+Apoptosis%3B+Promote+Invasion%2C+Proliferation%2C+and+Migration%3B+and+Cause+Chemoresistance+through+Diverse+Pathways+in+Epithelial+Cancers&doi=10.1007%2Fs10555-019-09781-w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin glycoproteins block apoptosis; promote invasion, proliferation, and migration; and cause chemoresistance through diverse pathways in epithelial cancers</span></div><div class="casAuthors">Reynolds, Ian S.; Fichtner, Michael; McNamara, Deborah A.; Kay, Elaine W.; Prehn, Jochen H. M.; Burke, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">237-257</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Overexpression of mucin glycoproteins has been demonstrated in many epithelial-derived cancers.  The significance of this overexpression remains uncertain.  The aim of this paper was to define the assocn. of mucin glycoproteins with apoptosis, cell growth, invasion, migration, adhesion, and clonogenicity in vitro as well as tumor growth, tumorigenicity, and metastasis in vivo in epithelial-derived cancers by performing a systematic review of all published data.  A systematic review of PubMed, Embase, and the Cochrane Central Register of Controlled Trials was performed to identify all papers that evaluated the assocn. between mucin glycoproteins with apoptosis, cell growth, invasion, migration, adhesion, and clonogenicity in vitro as well as tumor growth, tumorigenicity, and metastasis in vivo in epithelial-derived cancers.  PRISMA guidelines were adhered to.  Results of individual studies were extd. and pooled together based on the organ in which the cancer was derived from.  The initial search revealed 2031 papers, of which 90 were deemed eligible for inclusion in the study.  The studies included details on MUC1, MUC2, MUC4, MUC5AC, MUC5B, MUC13, and MUC16.  The majority of studies evaluated MUC1.  MUC1 overexpression was consistently assocd. with resistance to apoptosis and resistance to chemotherapy.  There was also evidence that overexpression of MUC2, MUC4, MUC5AC, MUC5B, MUC13, and MUC16 conferred resistance to apoptosis in epithelial-derived cancers.  The overexpression of mucin glycoproteins is assocd. with resistance to apoptosis in numerous epithelial cancers.  They cause resistance through diverse signaling pathways.  Targeting the expression of mucin glycoproteins represents a potential therapeutic target in the treatment of epithelial-derived cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoK0HgIuw40SrVg90H21EOLACvtfcHk0lhMItYWfBgCJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVCjtLvE&md5=c537ecc850fa0d592311d8f57f3408e8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs10555-019-09781-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-019-09781-w%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DI.%2BS.%26aulast%3DFichtner%26aufirst%3DM.%26aulast%3DMcNamara%26aufirst%3DD.%2BA.%26aulast%3DKay%26aufirst%3DE.%2BW.%26aulast%3DPrehn%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26atitle%3DMucin%2520Glycoproteins%2520Block%2520Apoptosis%253B%2520Promote%2520Invasion%252C%2520Proliferation%252C%2520and%2520Migration%253B%2520and%2520Cause%2520Chemoresistance%2520through%2520Diverse%2520Pathways%2520in%2520Epithelial%2520Cancers%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2019%26volume%3D38%26spage%3D237%26epage%3D257%26doi%3D10.1007%2Fs10555-019-09781-w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinall, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">MUC3 Human Intestinal Mucin. Analysis of Gene Structure, the Carboxyl Terminus, and a Novel Upstream Repetitive Region</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">26678</span>– <span class="NLM_lpage">26686</span>, <span class="refDoi"> DOI: 10.1074/jbc.272.42.26678</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.272.42.26678" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9334251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2sXmvV2it7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=26678-26686&author=J.+R.+Gumauthor=J.+J.+Hoauthor=W.+S.+Prattauthor=J.+W.+Hicksauthor=A.+S.+Hillauthor=L.+E.+Vinallauthor=A.+M.+Robertonauthor=D.+M.+Swallowauthor=Y.+S.+Kim&title=MUC3+Human+Intestinal+Mucin.+Analysis+of+Gene+Structure%2C+the+Carboxyl+Terminus%2C+and+a+Novel+Upstream+Repetitive+Region&doi=10.1074%2Fjbc.272.42.26678"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region</span></div><div class="casAuthors">Gum, James R., Jr.; Ho, Jenny J. L.; Pratt, Wendy S.; Hicks, James W.; Hill, Alex S.; Vinall, Lynne E.; Roberton, Anthony M.; Swallow, Dallas M.; Kim, Young S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">26678-26686</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MUC3 is a large mucin glycoprotein expressed by the human intestine and gall bladder.  In this manuscript, we present details of the deduced protein structure of MUC3.  The MUC3 carboxyl-terminal domain is 617 residues in length, including 511 residues of a non-repetitive mucin-like domain (27% Thr, 22% Ser, and 11% Pro) and a 106-residue Cys-rich domain with homol. to the epidermal growth factor (EGF)-like structural motifs found in many proteins.  The region of MUC3 located upstream of the previously described 51-base pair (bp) tandem repeats, which encode a major Ser and Thr-rich domain, consists of a second type of repetitive structure with an imperfect periodicity of approx. 1125 bp.  This domain is also mucin-like and appears to be considerably larger than 2000 residues (6000 bp).  The MUC3 gene itself is large and complex.  Using pulse field gel electrophoresis and blot anal., the smallest fragment found that contained all human genomic DNA hybridizing to the 51-bp tandem repeat probe was 200 kilobases with restriction enzyme SwaI.  Both PvuII and PstI produced two sets of hybridizing fragments that were hypervariable within the human population with a pattern suggestive of both a variation in the no. of tandem repeats (VNTR) and sequence polymorphism.  These fragments varied independently of each other, but no genetic recombination was detected in a study of 40 human families.  Thus, the MUC3 gene encodes a very large glycoprotein with a structure very different from that of any mucin currently described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKsYYDWJqIybVg90H21EOLACvtfcHk0lhMItYWfBgCJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvV2it7g%253D&md5=24908161ac35ce86ddcbadeeb07fe43d</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.42.26678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.42.26678%26sid%3Dliteratum%253Aachs%26aulast%3DGum%26aufirst%3DJ.%2BR.%26aulast%3DHo%26aufirst%3DJ.%2BJ.%26aulast%3DPratt%26aufirst%3DW.%2BS.%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DHill%26aufirst%3DA.%2BS.%26aulast%3DVinall%26aufirst%3DL.%2BE.%26aulast%3DRoberton%26aufirst%3DA.%2BM.%26aulast%3DSwallow%26aufirst%3DD.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DMUC3%2520Human%2520Intestinal%2520Mucin.%2520Analysis%2520of%2520Gene%2520Structure%252C%2520the%2520Carboxyl%2520Terminus%252C%2520and%2520a%2520Novel%2520Upstream%2520Repetitive%2520Region%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D26678%26epage%3D26686%26doi%3D10.1074%2Fjbc.272.42.26678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, D. M.</span></span> <span> </span><span class="NLM_article-title">Multiple Transcripts of MUC3: Evidence for Two Genes, MUC3A and MUC3B</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">916</span>– <span class="NLM_lpage">923</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2000.3406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1006%2Fbbrc.2000.3406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10973822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtFGltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=916-923&author=W.+S.+Prattauthor=S.+Crawleyauthor=J.+Hicksauthor=J.+Hoauthor=M.+Nashauthor=Y.+S.+Kimauthor=J.+R.+J.+Gumauthor=D.+M.+Swallow&title=Multiple+Transcripts+of+MUC3%3A+Evidence+for+Two+Genes%2C+MUC3A+and+MUC3B&doi=10.1006%2Fbbrc.2000.3406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B</span></div><div class="casAuthors">Pratt, Wendy S.; Crawley, Suzanne; Hicks, Jim; Ho, Jenny; Nash, Matthew; Kim, Young S.; Gum, James R.; Swallow, Dallas M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">916-923</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">The MUC3 gene encodes a transmembrane mucin-type glycoprotein.  A no. of consistent single nucleotide changes were obsd. in different MUC3 cDNAs from a single individual, suggesting the presence of at least three different transcripts per individual.  This transcript heterogeneity is due both to the existence of a second copy of the MUC3 gene and to allelic changes.  Sequencing of the second MUC3 shows that it has the same C-terminal domain and intron/exon structure as the previously described MUC3.  The tandem repeat domain has the same amino acid consensus sequence but shows more substitutions.  The unique exonic sequences range from 94 to 100% identity at the nucleotide level and correspondingly few amino acid changes have been identified.  The introns show around 95% identity.  We propose to name this second gene MUC3B, MUC3A being reserved for the first MUC3 gene.  MUC3B, like MUC3A, is expressed in intestine and Caco-2 cells.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk8ca8l86QmbVg90H21EOLACvtfcHk0lgxZN5wXUqOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtFGltrs%253D&md5=c1fe1a9626cbd0688f6c8a8a59725126</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2000.3406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2000.3406%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DW.%2BS.%26aulast%3DCrawley%26aufirst%3DS.%26aulast%3DHicks%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DJ.%26aulast%3DNash%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DGum%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DSwallow%26aufirst%3DD.%2BM.%26atitle%3DMultiple%2520Transcripts%2520of%2520MUC3%253A%2520Evidence%2520for%2520Two%2520Genes%252C%2520MUC3A%2520and%2520MUC3B%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2000%26volume%3D275%26spage%3D916%26epage%3D923%26doi%3D10.1006%2Fbbrc.2000.3406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nollet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porchet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degand, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laine, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, J. P.</span></span> <span> </span><span class="NLM_article-title">Complete Sequence of The Human Mucin MUC4: a Putative Cell Membrane-Associated Mucin</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>338</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">333</span>, <span class="refDoi"> DOI: 10.1042/0264-6021:3380325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj3380325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10024507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXitVGks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1999&pages=325-333&author=N.+Moniauxauthor=S.+Nolletauthor=N.+Porchetauthor=P.+Degandauthor=A.+Laineauthor=J.+P.+Aubert&title=Complete+Sequence+of+The+Human+Mucin+MUC4%3A+a+Putative+Cell+Membrane-Associated+Mucin&doi=10.1042%2F0264-6021%3A3380325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin</span></div><div class="casAuthors">Moniaux, Nicolas; Nollet, Severine; Porchet, Nicole; Degand, Pierre; Laine, Anne; Aubert, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">325-333</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The MUC4 gene, which encodes a human epithelial mucin, is expressed in various epithelial tissues, just as well in adult as in poorly differentiated cells in the embryo and fetus.  Its N-terminus and central sequences have previously been reported as comprising a 27-residue peptide signal, followed by a large domain varying in length from 3285 to 7285 amino acid residues.  The present study establishes the whole coding sequence of MUC4 in which the C-terminus is 1156 amino acid residues long and shares a high degree of similarity with the rat sialomucin complex (SMC).  SMC is a heterodimeric glycoprotein complex composed of mucin (ascites sialoglycoprotein 1, ASGP-1) and transmembrane (ASGP-2) subunits.  The same organization is found in MUC4, where the presence of a GlyAspProHis proteolytic site may cleave the large precursor into two subunits, MUC4α and MUC4β.  Like ASGP-2, which binds the receptor tyrosine kinase p185neu, MUC4β possesses two epidermal growth factor-like domains, a transmembrane sequence and a potential phosphorylated site.  MUC4, the human homolog of rat SMC, may be a heterodimeric bifunctional cell-surface glycoprotein of 2.12 μm.  These results confer a new biol. role for MUC4 as a ligand for ErbB2 in cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBgPHz2KOx17Vg90H21EOLACvtfcHk0lgxZN5wXUqOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXitVGks7k%253D&md5=b3fded696fa0312672e1f5e7c8244d83</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1042%2Fbj3380325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3380325%26sid%3Dliteratum%253Aachs%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DNollet%26aufirst%3DS.%26aulast%3DPorchet%26aufirst%3DN.%26aulast%3DDegand%26aufirst%3DP.%26aulast%3DLaine%26aufirst%3DA.%26aulast%3DAubert%26aufirst%3DJ.%2BP.%26atitle%3DComplete%2520Sequence%2520of%2520The%2520Human%2520Mucin%2520MUC4%253A%2520a%2520Putative%2520Cell%2520Membrane-Associated%2520Mucin%26jtitle%3DBiochem.%2520J.%26date%3D1999%26volume%3D338%26spage%3D325%26epage%3D333%26doi%3D10.1042%2F0264-6021%3A3380325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigoutsos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparrow, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunwoodie, S. L.</span></span> <span> </span><span class="NLM_article-title">Evolution of Distinct EGF Domains with Specific Functions</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">1091</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1110/ps.041207005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1110%2Fps.041207005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15772310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=1091-1103&author=M.+A.+Woutersauthor=I.+Rigoutsosauthor=C.+K.+Chuauthor=L.+L.+Fengauthor=D.+B.+Sparrowauthor=S.+L.+Dunwoodie&title=Evolution+of+Distinct+EGF+Domains+with+Specific+Functions&doi=10.1110%2Fps.041207005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evolution of distinct EGF domains with specific functions</span></div><div class="casAuthors">Wouters, Merridee A.; Rigoutsos, Isidore; Chu, Carmen K.; Feng, Lina L.; Sparrow, Duncan B.; Dunwoodie, Sally L.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1091-1103</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">EGF domains are extracellular protein modules cross-linked by three intra-domain disulfides.  Past studies suggest the existence of two types of EGF domain with three-disulfides, human EGF-like (hEGF) domains and complement C1r-like (cEGF) domains, but to date no functional information has been related to the two different types, and they are not differentiated in sequence or structure databases.  We have developed new sequence patterns based on the different C-termini to search specifically for the two types of EGF domains in sequence databases.  The exhibited sensitivity and specificity of the new pattern-based method represents a significant advancement over the currently available sequence detection techniques.  We re-annotated EGF sequences in the latest release of Swiss-Prot looking for functional relationships that might correlate with EGF type.  We show that important post-translational modifications of three-disulfide EGFs, including unusual forms of glycosylation and post-translational proteolytic processing, are dependent on EGF subtype.  For example, EGF domains that are shed from the cell surface and mediate intercellular signaling are all hEGFs, as are all human EGF receptor family ligands.  Addnl. exptl. data suggest that functional specialization has accompanied subtype divergence.  Based on our structural anal. of EGF domains with three-disulfide bonds and comparison to laminin and integrin-like EGF domains with an addnl. inter-domain disulfide, we propose that these hEGF and cEGF domains may have arisen from a four-disulfide ancestor by selective loss of different cysteine residues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE3REf-ife8LVg90H21EOLACvtfcHk0lgxZN5wXUqOSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislOmsrY%253D&md5=7cff3e1aba722fcdcaf6f998dd4d7b9d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1110%2Fps.041207005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.041207005%26sid%3Dliteratum%253Aachs%26aulast%3DWouters%26aufirst%3DM.%2BA.%26aulast%3DRigoutsos%26aufirst%3DI.%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DFeng%26aufirst%3DL.%2BL.%26aulast%3DSparrow%26aufirst%3DD.%2BB.%26aulast%3DDunwoodie%26aufirst%3DS.%2BL.%26atitle%3DEvolution%2520of%2520Distinct%2520EGF%2520Domains%2520with%2520Specific%2520Functions%26jtitle%3DProtein%2520Sci.%26date%3D2005%26volume%3D14%26spage%3D1091%26epage%3D1103%26doi%3D10.1110%2Fps.041207005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gum, J. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hicks, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberton, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span> <span> </span><span class="NLM_article-title">Initiation of Transcription of the MUC3A Human Intestinal Mucin from a TATA-Less Promoter and Comparison with the MUC3B Amino Terminus</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">49600</span>– <span class="NLM_lpage">49609</span>, <span class="refDoi"> DOI: 10.1074/jbc.M305769200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M305769200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12958310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49600-49609&author=J.+R.+J.+Gumauthor=J.+W.+Hicksauthor=S.+C.+Crawleyauthor=C.+M.+Dahlauthor=S.+C.+Yangauthor=A.+M.+Robertonauthor=Y.+S.+Kim&title=Initiation+of+Transcription+of+the+MUC3A+Human+Intestinal+Mucin+from+a+TATA-Less+Promoter+and+Comparison+with+the+MUC3B+Amino+Terminus&doi=10.1074%2Fjbc.M305769200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Initiation of Transcription of the MUC3A Human Intestinal Mucin from a TATA-less Promoter and Comparison with the MUC3B Amino Terminus</span></div><div class="casAuthors">Gum, James R., Jr.; Hicks, James W.; Crawley, Suzanne C.; Dahl, Christine M.; Yang, Stacey C.; Roberton, Anthony M.; Kim, Young S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49600-49609</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Human intestinal mucin genes MUC3A and MUC3B are members of a membrane mucin gene family residing at chromosome 7q22.  In this paper, we utilized genomic and cDNA cloning to elucidate the sequence of the 5'-region of the MUC3A gene including the gene promoter and the amino terminus coding sequence.  Following its 21-residue signal peptide, the amino terminus of the mucin consists of a 233-residue Thr-, Ser-, and Pro-rich nonrepetitive sequence that is contiguous with its hypervariable domain of 375-residue repeats.  RNase protection anal. and 5'-GeneRacer PCR indicated that MUC3A gene transcripts initiate from multiple start sites along a region spanning ∼180 bases.  The 5'-flanking region of the gene had promoter activity when fused to a luciferase reporter gene in all of the tested cell lines.  This region contained binding sites for several transcription factors, including those implicated in the regulation of intestinal genes, but lacked a cognate TATA box.  These features of the gene promoter may enable the gene to be expressed at variable levels in several cell types with different repertoires of transcription factors.  We also utilized 5'-GeneRacer PCR to det. the sequence of the 5'-terminus of the MUC3B message.  The amino termini of the MUC3A and MUC3B mucins are 91% conserved at the amino acid level.  Thus, MUC3A and MUC3B have highly conserved amino and carboxyl termini, suggesting a recent duplication of the entire ancestral gene.  It remains to be detd. whether other members of the 7q22 membrane mucin gene family have amino-terminal domains similar to MUC3A and MUC3B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX9JuJz1tmsbVg90H21EOLACvtfcHk0liw83RD9vnwoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrtb8%253D&md5=297fda904bd75ab6f7323307c42ba78e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305769200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305769200%26sid%3Dliteratum%253Aachs%26aulast%3DGum%26aufirst%3DJ.%2BR.%2BJ.%26aulast%3DHicks%26aufirst%3DJ.%2BW.%26aulast%3DCrawley%26aufirst%3DS.%2BC.%26aulast%3DDahl%26aufirst%3DC.%2BM.%26aulast%3DYang%26aufirst%3DS.%2BC.%26aulast%3DRoberton%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BS.%26atitle%3DInitiation%2520of%2520Transcription%2520of%2520the%2520MUC3A%2520Human%2520Intestinal%2520Mucin%2520from%2520a%2520TATA-Less%2520Promoter%2520and%2520Comparison%2520with%2520the%2520MUC3B%2520Amino%2520Terminus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49600%26epage%3D49609%26doi%3D10.1074%2Fjbc.M305769200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palmai-Pallag, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khodabukus, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinarsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leir, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A.</span></span> <span> </span><span class="NLM_article-title">The Role of the SEA (Sea Urchin Sperm Protein, Enterokinase and Agrin) Module in Cleavage of Membrane-Tethered Mucins</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">2901</span>– <span class="NLM_lpage">2911</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2005.04711.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1111%2Fj.1742-4658.2005.04711.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15943821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1Cmsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=2005&pages=2901-2911&author=T.+Palmai-Pallagauthor=N.+Khodabukusauthor=L.+Kinarskyauthor=S.+H.+Leirauthor=S.+Shermanauthor=M.+A.+Hollingsworthauthor=A.+Harris&title=The+Role+of+the+SEA+%28Sea+Urchin+Sperm+Protein%2C+Enterokinase+and+Agrin%29+Module+in+Cleavage+of+Membrane-Tethered+Mucins&doi=10.1111%2Fj.1742-4658.2005.04711.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane-tethered mucins</span></div><div class="casAuthors">Palmai-Pallag, Timea; Khodabukus, Naila; Kinarsky, Leo; Leir, Shih-Hsing; Sherman, Simon; Hollingsworth, Michael A.; Harris, Ann</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2901-2911</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The membrane-tethered mucins are cell surface-assocd. dimeric or multimeric mols. with extracellular, transmembrane and cytoplasmic portions, that arise from cleavage of the primary polypeptide chain.  Following the first cleavage, which may be cotranslational, the subunits remain closely assocd. through undefined noncovalent interactions.  These mucins all share a common structural motif, the SEA module that is found in many other membrane-assocd. proteins that are released from the cell surface and has been implicated in both the cleavage events and assocn. of the subunits.  Here we examine the SEA modules of three membrane-tethered mucins, MUC1, MUC3 and MUC12, which have significant sequence homol. within the SEA domain.  We previously identified the primary cleavage site within the MUC1 SEA domain as FRPG/SVVV, a sequence that is highly conserved in MUC3 and MUC12.  We now show by site-directed mutagenesis that the F, G and S residues are important for the efficiency of the cleavage reaction but not indispensable and that amino acids outside this motif are probably important.  These data are consistent with a new model of the MUC1 SEA domain that is based on the soln. structure of the MUC16 SEA module, derived by NMR spectroscopy.  Further, we demonstrate that cleavage of human MUC3 and MUC12 occurs within the SEA domain.  However, the SEA domains of MUC1, MUC3 and MUC12 are not interchangeable, suggesting that either these modules alone are insufficient to mediate efficient cleavage or that the 3D structure of the hybrid mols. does not adequately recreate an accessible cleavage site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGAQm6_LkJ97Vg90H21EOLACvtfcHk0liw83RD9vnwoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1Cmsrs%253D&md5=5d9a53d3f6e5a1a290aac1c4bd137e4a</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2005.04711.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2005.04711.x%26sid%3Dliteratum%253Aachs%26aulast%3DPalmai-Pallag%26aufirst%3DT.%26aulast%3DKhodabukus%26aufirst%3DN.%26aulast%3DKinarsky%26aufirst%3DL.%26aulast%3DLeir%26aufirst%3DS.%2BH.%26aulast%3DSherman%26aufirst%3DS.%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DHarris%26aufirst%3DA.%26atitle%3DThe%2520Role%2520of%2520the%2520SEA%2520%2528Sea%2520Urchin%2520Sperm%2520Protein%252C%2520Enterokinase%2520and%2520Agrin%2529%2520Module%2520in%2520Cleavage%2520of%2520Membrane-Tethered%2520Mucins%26jtitle%3DFEBS%2520J.%26date%3D2005%26volume%3D272%26spage%3D2901%26epage%3D2911%26doi%3D10.1111%2Fj.1742-4658.2005.04711.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">Mucin 13: Structure, Function, and Potential Roles in Cancer Pathogenesis</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">537</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-10-0443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F1541-7786.MCR-10-0443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=21450906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtVGlsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=531-537&author=D.+M.+Maherauthor=B.+K.+Guptaauthor=S.+Nagataauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=Mucin+13%3A+Structure%2C+Function%2C+and+Potential+Roles+in+Cancer+Pathogenesis&doi=10.1158%2F1541-7786.MCR-10-0443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Mucin 13: Structure, Function, and Potential Roles in Cancer Pathogenesis</span></div><div class="casAuthors">Maher, Diane M.; Gupta, Brij K.; Nagata, Satoshi; Jaggi, Meena; Chauhan, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">531-537</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Mucin 13 (MUC13) is a high-mol.-wt. transmembrane glycoprotein that is frequently and aberrantly expressed in a variety of epithelial carcinomas, including gastric, colorectal, and ovarian cancers.  On the basis of the high expression of MUC13 in cancer cells as well as recent lab. findings suggesting a malignant phenotype of MUC13-transfected cell lines, the oncogenic potential of MUC13 has emerged.  The various functional domains of MUC13 may confer oncogenic potential to MUC13.  For example, the bulky extracellular domain with extensive modification with glycan chains may prevent cell-cell and cell-extracellular matrix binding whereas the cytoplasmic tail contg. serine and tyrosine residues for potential phosphorylation may participate in cell signaling.  MUC13 exhibits the characteristics suitable as an early marker for cancer screening and presents a promising target for antibody-guided targeted therapy.  Mol Cancer Res; 9(5); 531-7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo38FEcWYk_77Vg90H21EOLACvtfcHk0liw83RD9vnwoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtVGlsb4%253D&md5=72dec84545e4d80f1927fade058f2da7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-10-0443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-10-0443%26sid%3Dliteratum%253Aachs%26aulast%3DMaher%26aufirst%3DD.%2BM.%26aulast%3DGupta%26aufirst%3DB.%2BK.%26aulast%3DNagata%26aufirst%3DS.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DMucin%252013%253A%2520Structure%252C%2520Function%252C%2520and%2520Potential%2520Roles%2520in%2520Cancer%2520Pathogenesis%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2011%26volume%3D9%26spage%3D531%26epage%3D537%26doi%3D10.1158%2F1541-7786.MCR-10-0443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogiso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishitani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nureki, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamanaka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakamoto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirouzu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, S.</span></span> <span> </span><span class="NLM_article-title">Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">775</span>– <span class="NLM_lpage">787</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(02)00963-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2FS0092-8674%2802%2900963-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12297050" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2002&pages=775-787&author=H.+Ogisoauthor=R.+Ishitaniauthor=O.+Nurekiauthor=S.+Fukaiauthor=M.+Yamanakaauthor=J.+H.+Kimauthor=K.+Saitoauthor=A.+Sakamotoauthor=M.+Inoueauthor=M.+Shirouzuauthor=S.+Yokoyama&title=Crystal+Structure+of+the+Complex+of+Human+Epidermal+Growth+Factor+and+Receptor+Extracellular+Domains&doi=10.1016%2FS0092-8674%2802%2900963-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains</span></div><div class="casAuthors">Ogiso, Hideo; Ishitani, Ryuichiro; Nureki, Osamu; Fukai, Shuya; Yamanaka, Mari; Kim, Jae-Hoon; Saito, Kazuki; Sakamoto, Ayako; Inoue, Mio; Shirouzu, Mikako; Yokoyama, Shigeyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">775-787</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Epidermal growth factor (EGF) regulates cell proliferation and differentiation by binding to the EGF receptor (EGFR) extracellular region, comprising domains I-IV, with the resultant dimerization of the receptor tyrosine kinase.  In this study, the crystal structure of a 2:2 complex of human EGF and the EGFR extracellular region has been detd. at 3.3 Å resoln.  EGFR domains I-III are arranged in a C shape, and EGF is docked between domains I and III.  The 1:1 EGF•EGFR complex dimerizes through a direct receptor•receptor interaction, in which a protruding β-hairpin arm of each domain II holds the body of the other.  The unique "receptor-mediated dimerization" was verified by EGFR mutagenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqILejwMfkBaLVg90H21EOLACvtfcHk0lilhfH2VxsIhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKisL8%253D&md5=f909ae76aad06fb0a8704ee101e76310</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900963-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900963-7%26sid%3Dliteratum%253Aachs%26aulast%3DOgiso%26aufirst%3DH.%26aulast%3DIshitani%26aufirst%3DR.%26aulast%3DNureki%26aufirst%3DO.%26aulast%3DFukai%26aufirst%3DS.%26aulast%3DYamanaka%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DSakamoto%26aufirst%3DA.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DShirouzu%26aufirst%3DM.%26aulast%3DYokoyama%26aufirst%3DS.%26atitle%3DCrystal%2520Structure%2520of%2520the%2520Complex%2520of%2520Human%2520Epidermal%2520Growth%2520Factor%2520and%2520Receptor%2520Extracellular%2520Domains%26jtitle%3DCell%26date%3D2002%26volume%3D110%26spage%3D775%26epage%3D787%26doi%3D10.1016%2FS0092-8674%2802%2900963-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Woning, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venselaar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rotterdam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs-Oomen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leeuwen, J. E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zoelen, E. J. J.</span></span> <span> </span><span class="NLM_article-title">Role of the C-Terminal Linear Region of EGF-Like Growth Factors in ErbB Specificity</span>. <i>Growth Factors</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">172</span>, <span class="refDoi"> DOI: 10.1080/08977190902891010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1080%2F08977190902891010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19384683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotlagtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=163-172&author=S.+P.+van%0Ader+Woningauthor=H.+Venselaarauthor=W.+van+Rotterdamauthor=S.+Jacobs-Oomenauthor=J.+E.+M.+van+Leeuwenauthor=E.+J.+J.+van+Zoelen&title=Role+of+the+C-Terminal+Linear+Region+of+EGF-Like+Growth+Factors+in+ErbB+Specificity&doi=10.1080%2F08977190902891010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the C-terminal linear region of EGF-like growth factors in ErbB specificity</span></div><div class="casAuthors">van der Woning, Sebastian P.; Venselaar, Hanka; van Rotterdam, Walter; Jacobs-Oomen, Saskia; van Leeuwen, Jeroen E. M.; van Zoelen, Everardus J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Growth Factors</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">163-172</span>CODEN:
                <span class="NLM_cas:coden">GRFAEC</span>;
        ISSN:<span class="NLM_cas:issn">0897-7194</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">The epidermal growth factor (EGF)-like growth factors bind their ErbB receptors in a highly selective manner.  Recently, the authors have shown that the sequence YYDLL in the C-terminal linear region is compatible with binding to all ligand-binding ErbB receptors.  In the present study, the authors show that introduction of the YYDLL sequence into the ErbB1 specific ligands EGF and transforming growth factor-α (TGFα) broadened their receptor specificity towards ErbB4.  Upon introduction of the YYDLL sequence into epiregulin, which by itself binds ErbB1 and ErbB4 but not ErbB3, its binding specificity was broadened to ErbB3, concomitant with enhanced affinity for ErbB4.  Introduction of the YYDLL sequence into NRG1β resulted in a 10-fold increase in affinity for ErbB3, without affecting its receptor specificity.  Remarkably, the strongly enhanced affinity for ErbB3 neg. influenced their mitogenic activity towards cells coexpressing ErbB2 and ErbB3.  These observations are discussed in terms of the optimized ErbB affinity, selectivity and mitogenic potential that have taken place during evolution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz-9GnGuDqlrVg90H21EOLACvtfcHk0lilhfH2VxsIhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotlagtrg%253D&md5=a4b961455018e63a4408a09217fc7972</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1080%2F08977190902891010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F08977190902891010%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWoning%26aufirst%3DS.%2BP.%26aulast%3DVenselaar%26aufirst%3DH.%26aulast%3Dvan%2BRotterdam%26aufirst%3DW.%26aulast%3DJacobs-Oomen%26aufirst%3DS.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DJ.%2BE.%2BM.%26aulast%3Dvan%2BZoelen%26aufirst%3DE.%2BJ.%2BJ.%26atitle%3DRole%2520of%2520the%2520C-Terminal%2520Linear%2520Region%2520of%2520EGF-Like%2520Growth%2520Factors%2520in%2520ErbB%2520Specificity%26jtitle%3DGrowth%2520Factors%26date%3D2009%26volume%3D27%26spage%3D163%26epage%3D172%26doi%3D10.1080%2F08977190902891010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bork, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patthy, L.</span></span> <span> </span><span class="NLM_article-title">The SEA Module: a New Extracellular Domain Associated with O-Glycosylation</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1421</span>– <span class="NLM_lpage">1425</span>, <span class="refDoi"> DOI: 10.1002/pro.5560040716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fpro.5560040716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=7670383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=1421-1425&author=P.+Borkauthor=L.+Patthy&title=The+SEA+Module%3A+a+New+Extracellular+Domain+Associated+with+O-Glycosylation&doi=10.1002%2Fpro.5560040716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The SEA module: a new extracellular domain associated with O-glycosylation</span></div><div class="casAuthors">Bork, Peer; Patthy, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1421-5</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Using a variety of homol. search methods and multiple alignments, a new extracellular module was identified in (1) agrin, (2) enterokinase, (3) a 63-kDa sea urchin sperm protein, (4) perlecan, (5) the breast cancer marker MUC1 (episialin), (6) the cell surface antigen 114/A10, and (7/8) two functionally uncharacterized, probably extracellular, Caenorhabditis elegans proteins.  Despite the functional diversity of these adhesive proteins, a common denominator seems to be their existence in heavily glycosylated environments.  In addn., the better characterized proteins mentioned above contain all O-glycosidic-linked carbohydrates such as heparan sulfate that contribute considerably to their mol. masses.  The common module might regulate or assist binding to neighboring carbohydrate moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnywONmeXVM7Vg90H21EOLACvtfcHk0lilhfH2VxsIhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D&md5=e9f3b8fcf8a3bcbaaf27588d9aeffede</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560040716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560040716%26sid%3Dliteratum%253Aachs%26aulast%3DBork%26aufirst%3DP.%26aulast%3DPatthy%26aufirst%3DL.%26atitle%3DThe%2520SEA%2520Module%253A%2520a%2520New%2520Extracellular%2520Domain%2520Associated%2520with%2520O-Glycosylation%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D1421%26epage%3D1425%26doi%3D10.1002%2Fpro.5560040716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sandford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sgotto, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aparicio, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaudin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chissoe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pepin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chothia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P.</span></span> <span> </span><span class="NLM_article-title">Comparative Analysis of the Polycystic Kidney Disease 1 (PKD1) Gene Reveals an Integral Membrane Glycoprotein with Multiple Evolutionary Conserved Domains</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1483</span>– <span class="NLM_lpage">1489</span>, <span class="refDoi"> DOI: 10.1093/hmg/6.9.1483</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1093%2Fhmg%2F6.9.1483" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9285785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVGitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1997&pages=1483-1489&author=R.+Sandfordauthor=B.+Sgottoauthor=S.+Aparicioauthor=S.+Brennerauthor=M.+Vaudinauthor=R.+K.+Wilsonauthor=S.+Chissoeauthor=K.+Pepinauthor=A.+Batemanauthor=C.+Chothiaauthor=J.+Hughesauthor=P.+Harris&title=Comparative+Analysis+of+the+Polycystic+Kidney+Disease+1+%28PKD1%29+Gene+Reveals+an+Integral+Membrane+Glycoprotein+with+Multiple+Evolutionary+Conserved+Domains&doi=10.1093%2Fhmg%2F6.9.1483"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains</span></div><div class="casAuthors">Sandford, Richard; Sgotto, Barbara; Aparicio, Sam; Brenner, Sydney; Vaudin, Mark; Wilson, Richard K.; Chissoe, Stephanie; Pepin, Kym; Bateman, Alex; Chothia, Cyrus; Hughes, Jim; Harris, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1483-1489</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">PKD1 is the major locus of the common genetic disorder autosomal dominant polycystic kidney disease (ADPKD).  Anal. of the predicted protein sequence of the human PKD1 gene, polycystin, shows a large mol. with a unique arrangement of extracellular domains and multiple putative transmembrane regions.  The precise function of polycystin remains unclear with a paucity of mutations to define key structural and functional domains.  To refine the structure of this protein the authors have cloned the genomic region encoding the Fugu PKD1 gene.  Fugu PKD1 spans 36 kb of genomic DNA and has greater complexity with 54 exons compared with 46 in man.  Comparative anal. of the predicted protein sequences shows a lower level of homol. than in similar studies with identity of 40 and 59% similarity.  However key structural motifs including leucine rich repeats (LRR), a C-type lectin and LDL-A like domains and 16 PKD repeats are maintained.  A region of homol. with the sea urchin REJ protein was also confirmed in Fugu but found to extend over 1000 amino acids.  Several highly conserved intra- and extra-cellular regions, with no known sequence homologies, that are likely to be of functional importance were detected.  The likely structure of the membrane assocd. region has been refined with similarity to the PKD2 protein and voltage gated Ca2+ and Na+ channels highlighted over part of this area.  The overall protein structure has therefore been clarified and this comparative anal. derived structure will form the basis for the functional study of polycystin and its individual domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps1tuih9LFkrVg90H21EOLACvtfcHk0li9E_o5WWkv8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVGitrs%253D&md5=7078b5da3e9d29e88ba8e1de8fa5937c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F6.9.1483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F6.9.1483%26sid%3Dliteratum%253Aachs%26aulast%3DSandford%26aufirst%3DR.%26aulast%3DSgotto%26aufirst%3DB.%26aulast%3DAparicio%26aufirst%3DS.%26aulast%3DBrenner%26aufirst%3DS.%26aulast%3DVaudin%26aufirst%3DM.%26aulast%3DWilson%26aufirst%3DR.%2BK.%26aulast%3DChissoe%26aufirst%3DS.%26aulast%3DPepin%26aufirst%3DK.%26aulast%3DBateman%26aufirst%3DA.%26aulast%3DChothia%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DP.%26atitle%3DComparative%2520Analysis%2520of%2520the%2520Polycystic%2520Kidney%2520Disease%25201%2520%2528PKD1%2529%2520Gene%2520Reveals%2520an%2520Integral%2520Membrane%2520Glycoprotein%2520with%2520Multiple%2520Evolutionary%2520Conserved%2520Domains%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D1997%26volume%3D6%26spage%3D1483%26epage%3D1489%26doi%3D10.1093%2Fhmg%2F6.9.1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishin, N. V.</span></span> <span> </span><span class="NLM_article-title">Expansion of Divergent SEA Domains in Cell Surface Proteins and Nucleoporin 54</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">630</span>, <span class="refDoi"> DOI: 10.1002/pro.3096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fpro.3096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=27977898" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisV2ru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=617-630&author=J.+Peiauthor=N.+V.+Grishin&title=Expansion+of+Divergent+SEA+Domains+in+Cell+Surface+Proteins+and+Nucleoporin+54&doi=10.1002%2Fpro.3096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Expansion of divergent SEA domains in cell surface proteins and nucleoporin 54</span></div><div class="casAuthors">Pei, Jimin; Grishin, Nick V.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">617-630</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">1469-896X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">SEA (sea urchin sperm protein, enterokinase, agrin) domains, many of which possess autoproteolysis activity, have been found in a no. of cell surface and secreted proteins.  Despite high sequence divergence, SEA domains were also proposed to be present in dystroglycan based on a conserved autoproteolysis motif and receptor-type protein phosphatase IA-2 based on structural similarity.  The presence of a SEA domain adjacent to the transmembrane segment appears to be a recurring theme in quite a no. of type I transmembrane proteins on the cell surface, such as MUC1, dystroglycan, IA-2, and Notch receptors.  By comparative sequence and structural analyses, we identified dystroglycan-like proteins with SEA domains in Capsaspora owczarzaki of the Filasterea group, one of the closest single-cell relatives of metazoans.  We also detected novel and divergent SEA domains in a variety of cell surface proteins such as EpCAM, α/ε-sarcoglycan, PTPRR, collectrin/Tmem27, amnionless, CD34, KIAA0319, fibrocystin-like protein, and a no. of cadherins.  While these proteins are mostly from metazoans or their single cell relatives such as choanoflagellates and Filasterea, fibrocystin-like proteins with SEA domains were found in several other eukaryotic lineages including green algae, Alveolata, Euglenozoa, and Haptophyta, suggesting an ancient evolutionary origin.  In addn., the intracellular protein Nucleoporin 54 (Nup54) acquired a divergent SEA domain in choanoflagellates and metazoans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1fXi3UtZFQ7Vg90H21EOLACvtfcHk0li9E_o5WWkv8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisV2ru74%253D&md5=46694eb3e8caa25827dc7a924ffa2a85</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1002%2Fpro.3096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.3096%26sid%3Dliteratum%253Aachs%26aulast%3DPei%26aufirst%3DJ.%26aulast%3DGrishin%26aufirst%3DN.%2BV.%26atitle%3DExpansion%2520of%2520Divergent%2520SEA%2520Domains%2520in%2520Cell%2520Surface%2520Proteins%2520and%2520Nucleoporin%252054%26jtitle%3DProtein%2520Sci.%26date%3D2017%26volume%3D26%26spage%3D617%26epage%3D630%26doi%3D10.1002%2Fpro.3096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Secretion of Muc4/Sialomucin Complex: Implication of Intracellular Proteolysis</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1042/bj20020862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20020862" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12186632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XosVOgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2002&pages=41-48&author=M.+Komatsuauthor=M.+E.+Arangoauthor=K.+L.+Carraway&title=Synthesis+and+Secretion+of+Muc4%2FSialomucin+Complex%3A+Implication+of+Intracellular+Proteolysis&doi=10.1042%2Fbj20020862"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis</span></div><div class="casAuthors">Komatsu, Masanobu; Arango, Maria E.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Muc4/sialomucin complex (SMC) is a heterodimeric glycoprotein complex implicated in epithelial protection and overexpressed in some tumors.  It is encoded by a single gene, and the two subunits are produced by proteolytic cleavage at a time before substantial O-glycosylation, near the time of transit from the endoplasmic reticulum to the Golgi.  Although Muc4/SMC is translated as a membrane protein, it is produced as a sol. form in many epithelia.  Transfection expts. using Cos-7, HBL-100 human epithelial, MCF-7 human breast tumor and HC11 mouse mammary cell lines showed that sol. rat Muc4/SMC is produced by a proteolytic cleavage mechanism and released by secretion from multiple cell lines, including both human and mouse normal epithelial cells and tumor cells.  Similar transfection expts. demonstrated the same mechanism for the human analog MUC4.  Gel electrophoresis analyses of deglycosylated membrane and sol. transmembrane subunits and of the membrane-assocd. cleavage fragment indicated a released cleavage product of 25 kDa, resulting from cleavage between two epidermal growth factor-like domains.  Further evidence for this site was obtained from deletion mutants removing this region of the protein, which blocked secretion.  Finally, pulse-chase analyses of Muc4/SMC biosynthesis indicated no kinetic difference between the timing of the cleavage to release the sol. form and that to produce the two subunits, indicating that the sol. form is created early in transit to the cell surface.  These studies provide the first clear evidence that membrane mucins can be released from cells by an intracellular proteolytic mechanism that leads to secretion of the sol. form of the mucin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTdwdfME2jeLVg90H21EOLACvtfcHk0li9E_o5WWkv8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XosVOgtbs%253D&md5=092ea987bafd76faa9b7477b82cb8800</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2Fbj20020862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20020862%26sid%3Dliteratum%253Aachs%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DSynthesis%2520and%2520Secretion%2520of%2520Muc4%252FSialomucin%2520Complex%253A%2520Implication%2520of%2520Intracellular%2520Proteolysis%26jtitle%3DBiochem.%2520J.%26date%3D2002%26volume%3D368%26spage%3D41%26epage%3D48%26doi%3D10.1042%2Fbj20020862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staros, J. V.</span></span> <span> </span><span class="NLM_article-title">Insights Into the Evolution of the Erbb Receptor Family and Their Ligands from Sequence Analysis</span>. <i>BMC Evol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">79</span>, <span class="refDoi"> DOI: 10.1186/1471-2148-6-79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2F1471-2148-6-79" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17026767" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD28nhvVyhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=79&author=R.+A.+Steinauthor=J.+V.+Staros&title=Insights+Into+the+Evolution+of+the+Erbb+Receptor+Family+and+Their+Ligands+from+Sequence+Analysis&doi=10.1186%2F1471-2148-6-79"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis</span></div><div class="casAuthors">Stein Richard A; Staros James V</div><div class="citationInfo"><span class="NLM_cas:title">BMC evolutionary biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">79</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  In the time since we presented the first molecular evolutionary study of the ErbB family of receptors and the EGF family of ligands, there has been a dramatic increase in genomic sequences available.  We have utilized this greatly expanded data set in this study of the ErbB family of receptors and their ligands.  RESULTS:  In our previous analysis we postulated that EGF family ligands could be characterized by the presence of a splice site in the coding region between the fourth and fifth cysteines of the EGF module and the placement of that module near the transmembrane domain.  The recent identification of several new ligands for the ErbB receptors supports this characterization of an ErbB ligand; further, applying this characterization to available sequences suggests additional potential ligands for these receptors, the EGF modules from previously identified proteins: interphotoreceptor matrix proteoglycan-2, the alpha and beta subunit of meprin A, and mucins 3, 4, 12, and 17.  The newly available sequences have caused some reorganizations of relationships among the ErbB ligand family, but they add support to the previous conclusion that three gene duplication events gave rise to the present family of four ErbB receptors among the tetrapods.  CONCLUSION:  This study provides strong support for the hypothesis that the presence of an easily identifiable sequence motif can distinguish EGF family ligands from other EGF-like modules and reveals several potential new EGF family ligands.  It also raises interesting questions about the evolution of ErbB2 and ErbB3: Does ErbB2 in teleosts function differently from ErbB2 in tetrapods in terms of ligand binding and intramolecular tethering? When did ErbB3 lose kinase activity, and what is the functional significance of the divergence of its kinase domain among teleosts?</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRi1nU8Avu4MGLFM_lbR1VmfW6udTcc2ebXMQVnAirTSLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28nhvVyhtQ%253D%253D&md5=84e75c48950823330d28c0679b66a8d2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1186%2F1471-2148-6-79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2148-6-79%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BA.%26aulast%3DStaros%26aufirst%3DJ.%2BV.%26atitle%3DInsights%2520Into%2520the%2520Evolution%2520of%2520the%2520Erbb%2520Receptor%2520Family%2520and%2520Their%2520Ligands%2520from%2520Sequence%2520Analysis%26jtitle%3DBMC%2520Evol.%2520Biol.%26date%3D2006%26volume%3D6%26spage%3D79%26doi%3D10.1186%2F1471-2148-6-79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansson, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuelsson, T.</span></span> <span> </span><span class="NLM_article-title">An Inventory of Mucin Genes in the Chicken Genome Shows that the Mucin Domain of Muc13 is Encoded by Multiple Exons and that Ovomucin is Part of a Locus of Related Gel-Forming Mucins</span>. <i>BMC Genomics</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">197</span>, <span class="refDoi"> DOI: 10.1186/1471-2164-7-197</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2F1471-2164-7-197" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=16887038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD28rgtFegsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=197&author=T.+Langauthor=G.+C.+Hanssonauthor=T.+Samuelsson&title=An+Inventory+of+Mucin+Genes+in+the+Chicken+Genome+Shows+that+the+Mucin+Domain+of+Muc13+is+Encoded+by+Multiple+Exons+and+that+Ovomucin+is+Part+of+a+Locus+of+Related+Gel-Forming+Mucins&doi=10.1186%2F1471-2164-7-197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">An inventory of mucin genes in the chicken genome shows that the mucin domain of Muc13 is encoded by multiple exons and that ovomucin is part of a locus of related gel-forming mucins</span></div><div class="casAuthors">Lang Tiange; Hansson Gunnar C; Samuelsson Tore</div><div class="citationInfo"><span class="NLM_cas:title">BMC genomics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">197</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Mucins are large glycoproteins that cover epithelial surfaces of the body.  All mucins contain at least one PTS domain, a region rich in proline, threonine and serine.  Mucins are also characterized by von Willebrand D (VWD) domains or SEA domains.  We have developed computational methods to identify mucin genes and proteins based on these properties of the proteins.  Using such methods we are able to characterize different organisms where genome sequence is available with respect to their mucin repertoire.  RESULTS:  We have here made a comprehensive analysis of potential mucins encoded by the chicken (Gallus gallus) genome.  Three transmembrane mucins (Muc4, Muc13, and Muc16) and four gel-forming mucins (Muc6, Muc2, Muc5ac, and Muc5b) were identified.  The gel-forming mucins are encoded within a locus similar to the corresponding human mucins.  However, the chicken has an additional gene inserted between Muc2 and Muc5ac that encodes the the alpha-subunit of ovomucin, a protein similar to Muc2, but it is lacking a PTS domain.  We also show that the beta-subunit of ovomucin is the orthologue of human MUC6.  The transmembrane Muc13 gene is in chicken as well as in mammals adjacent to the HEG (heart of glass) gene.  HEG has PTS, EGF and transmembrane domains like Muc13, suggesting that these two proteins are evolutionary related.  Unlike previously known mucins, the PTS domain of Muc13 is encoded by multiple exons, where each exon encodes a repeat unit of the PTS domain.  CONCLUSION:  We report new mucin homologues in chicken and this information will aid in understanding the evolution of mucins in vertebrates.  The fact that ovomucin, a protein not found in mammals, was located in the same locus as other gel-forming mucins provides strong support that these proteins are evolutionary related.  Furthermore, a relationship of HEG and the transmembrane Muc13 is suggested on the basis of their biochemical properties and their presence in the same locus.  Finally, our finding that the chicken Muc13 is distributed between multiple exons raises the interesting possibility that the length of the PTS domain could be controlled by alternative splicing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSDcsBNFcQGDDAyhZbj3lKdfW6udTcc2eaSiAYyuGpvprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28rgtFegsA%253D%253D&md5=77a5ca6b6c37c51c5ebefe78b970f091</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1186%2F1471-2164-7-197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2164-7-197%26sid%3Dliteratum%253Aachs%26aulast%3DLang%26aufirst%3DT.%26aulast%3DHansson%26aufirst%3DG.%2BC.%26aulast%3DSamuelsson%26aufirst%3DT.%26atitle%3DAn%2520Inventory%2520of%2520Mucin%2520Genes%2520in%2520the%2520Chicken%2520Genome%2520Shows%2520that%2520the%2520Mucin%2520Domain%2520of%2520Muc13%2520is%2520Encoded%2520by%2520Multiple%2520Exons%2520and%2520that%2520Ovomucin%2520is%2520Part%2520of%2520a%2520Locus%2520of%2520Related%2520Gel-Forming%2520Mucins%26jtitle%3DBMC%2520Genomics%26date%3D2006%26volume%3D7%26spage%3D197%26doi%3D10.1186%2F1471-2164-7-197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mather, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oganessyan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foundling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esmon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bode, W.</span></span> <span> </span><span class="NLM_article-title">The 2.8 A Crystal Structure of Gla-Domainless Activated Protein C</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">6822</span>– <span class="NLM_lpage">6831</span>, <span class="refDoi"> DOI: 10.1002/j.1460-2075.1996.tb01073.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fj.1460-2075.1996.tb01073.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9003757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2sXosFejtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1996&pages=6822-6831&author=T.+Matherauthor=V.+Oganessyanauthor=P.+Hofauthor=R.+Huberauthor=S.+Foundlingauthor=C.+Esmonauthor=W.+Bode&title=The+2.8+A+Crystal+Structure+of+Gla-Domainless+Activated+Protein+C&doi=10.1002%2Fj.1460-2075.1996.tb01073.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.8 Å crystal structure of Gla-domainless activated protein C</span></div><div class="casAuthors">Mather, Timothy; Oganessyan, Vaheh; Hof, Peter; Huber, Robert; Foundling, Steven; Esmon, Charles; Bode, Wolfram</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6822-6831</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The structure of the Gla-domainless form of the human anticoagulant enzyme activated protein C has been solved at 2.8 Å resoln.  The light chain is composed of two domains: an epidermal growth factor (EGF)-like domain modified by a large insert contg. an addnl. disulfide, followed by a typical EGF-like domain.  The arrangement of the long axis of these domains describes an angle of ∼80°.  Disulfide linked to the light chain is the catalytic domain, which is generally trypsin-like but contains a large insertion loop at the edge of the active site, a third helical segment, a prominent cationic patch analogous to the anion binding exosite I of thrombin and a trypsin-like Ca[II] binding site.  The arrangement of loops around the active site partially restricts access to the cleft.  The S2 and S4 subsites are much more polar than in factor Xa and thrombin, and the S2 site is unrestricted.  While quite open and exposed, the active site contains a prominent groove, the surface of which is very polar with evidence for binding sites on the primed side, in addn. to those typical of the trypsin class found on the non-primed side.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkej7gdt0PFLVg90H21EOLACvtfcHk0lg2KeTHWC067w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXosFejtw%253D%253D&md5=8ccddc7ab7574d36a707326b5657f09d</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1002%2Fj.1460-2075.1996.tb01073.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fj.1460-2075.1996.tb01073.x%26sid%3Dliteratum%253Aachs%26aulast%3DMather%26aufirst%3DT.%26aulast%3DOganessyan%26aufirst%3DV.%26aulast%3DHof%26aufirst%3DP.%26aulast%3DHuber%26aufirst%3DR.%26aulast%3DFoundling%26aufirst%3DS.%26aulast%3DEsmon%26aufirst%3DC.%26aulast%3DBode%26aufirst%3DW.%26atitle%3DThe%25202.8%2520A%2520Crystal%2520Structure%2520of%2520Gla-Domainless%2520Activated%2520Protein%2520C%26jtitle%3DEMBO%2520J.%26date%3D1996%26volume%3D15%26spage%3D6822%26epage%3D6831%26doi%3D10.1002%2Fj.1460-2075.1996.tb01073.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kado, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizohata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagatoishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iijima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinoda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyafusa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshizumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujitani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibasaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsumoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span> <span> </span><span class="NLM_article-title">Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5: Structural, Functional, and Molecular Dynamics Simulation Analyses</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span>,  <span class="NLM_fpage">2319</span>– <span class="NLM_lpage">2330</span>, <span class="refDoi"> DOI: 10.1074/jbc.M115.656009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M115.656009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26627827" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=2319-2330&author=Y.+Kadoauthor=E.+Mizohataauthor=S.+Nagatoishiauthor=M.+Iijimaauthor=K.+Shinodaauthor=T.+Miyafusaauthor=T.+Nakayamaauthor=T.+Yoshizumiauthor=A.+Sugiyamaauthor=T.+Kawamuraauthor=Y.-H.+Leeauthor=H.+Matsumuraauthor=H.+Doiauthor=H.+Fujitaniauthor=T.+Kodamaauthor=Y.+Shibasakiauthor=K.+Tsumotoauthor=T.+Inoue&title=Epiregulin+Recognition+Mechanisms+by+Anti-epiregulin+Antibody+9E5%3A+Structural%2C+Functional%2C+and+Molecular+Dynamics+Simulation+Analyses&doi=10.1074%2Fjbc.M115.656009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Epiregulin Recognition Mechanisms by Anti-epiregulin Antibody 9E5</span></div><div class="casAuthors">Kado, Yuji; Mizohata, Eiichi; Nagatoishi, Satoru; Iijima, Mariko; Shinoda, Keiko; Miyafusa, Takamitsu; Nakayama, Taisuke; Yoshizumi, Takuma; Sugiyama, Akira; Kawamura, Takeshi; Lee, Young-Hun; Matsumura, Hiroyoshi; Doi, Hirofumi; Fujitani, Hideaki; Kodama, Tatsuhiko; Shibasaki, Yoshikazu; Tsumoto, Kouhei; Inoue, Tsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2319-2330</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Epiregulin (EPR) is a ligand of the epidermal growth factor (EGF) family that upon binding to its epidermal growth factor receptor (EGFR) stimulates proliferative signaling, esp. in colon cancer cells.  Here, we describe the three-dimensional structure of the EPR antibody (the 9E5(Fab) fragment) in the presence and absence of EPR.  Among the six complementarity-detg. regions (CDRs), CDR1-3 in the light chain and CDR2 in the heavy chain predominantly recognize EPR.  In particular, CDR3 in the heavy chain dramatically moves with cis-trans isomerization of Pro103.  A mol. dynamics simulation and mutational analyses revealed that Arg40 in EPR is a key residue for the specific binding of 9E5 IgG.  From isothermal titrn. calorimetry anal., the dissocn. const. was detd. to be 6.5 nm.  Surface plasmon resonance anal. revealed that the dissocn. rate of 9E5 IgG is extremely slow.  The superimposed structure of 9E5(Fab)·EPR on the known complex structure of EGF·EGFR showed that the 9E5(Fab) para-tope overlaps with Domains I and III on the EGFR, which reveals that the 9E5(Fab)·EPR complex could not bind to the EGFR.  The 9E5 antibody will also be useful in medicine as a neutralizing antibody specific for colon cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGob94WIFMCWBLVg90H21EOLACvtfcHk0lg2KeTHWC067w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1Cqsbg%253D&md5=56461f527bfd11fd88802296a0132b1d</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M115.656009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M115.656009%26sid%3Dliteratum%253Aachs%26aulast%3DKado%26aufirst%3DY.%26aulast%3DMizohata%26aufirst%3DE.%26aulast%3DNagatoishi%26aufirst%3DS.%26aulast%3DIijima%26aufirst%3DM.%26aulast%3DShinoda%26aufirst%3DK.%26aulast%3DMiyafusa%26aufirst%3DT.%26aulast%3DNakayama%26aufirst%3DT.%26aulast%3DYoshizumi%26aufirst%3DT.%26aulast%3DSugiyama%26aufirst%3DA.%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DY.-H.%26aulast%3DMatsumura%26aufirst%3DH.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DFujitani%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DShibasaki%26aufirst%3DY.%26aulast%3DTsumoto%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DT.%26atitle%3DEpiregulin%2520Recognition%2520Mechanisms%2520by%2520Anti-epiregulin%2520Antibody%25209E5%253A%2520Structural%252C%2520Functional%252C%2520and%2520Molecular%2520Dynamics%2520Simulation%2520Analyses%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26spage%3D2319%26epage%3D2330%26doi%3D10.1074%2Fjbc.M115.656009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">The Role of the AMOP Domain of MUC4/Y Promoted Tumor Angiogenesis and Metastasis in Pancreatic Cancer</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">34</span>, <span class="refDoi"> DOI: 10.1186/s13046-016-0369-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2Fs13046-016-0369-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26884069" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2016&pages=34&author=J.+Tangauthor=Y.+Zhuauthor=K.+Xieauthor=X.+Zhangauthor=X.+Zhiauthor=W.+Wangauthor=Z.+Liauthor=Q.+Zhangauthor=L.+Wangauthor=J.+Wangauthor=Z.+Xu&title=The+Role+of+the+AMOP+Domain+of+MUC4%2FY+Promoted+Tumor+Angiogenesis+and+Metastasis+in+Pancreatic+Cancer&doi=10.1186%2Fs13046-016-0369-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1186%2Fs13046-016-0369-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13046-016-0369-0%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DThe%2520Role%2520of%2520the%2520AMOP%2520Domain%2520of%2520MUC4%252FY%2520Promoted%2520Tumor%2520Angiogenesis%2520and%2520Metastasis%2520in%2520Pancreatic%2520Cancer%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2016%26volume%3D35%26spage%3D34%26doi%3D10.1186%2Fs13046-016-0369-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnanapragassam, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">Role of MUC4-NIDO Domain in the MUC4-Mediated Metastasis of Pancreatic Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">3346</span>– <span class="NLM_lpage">3356</span>, <span class="refDoi"> DOI: 10.1038/onc.2011.505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2011.505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22105367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=3346-3356&author=S.+Senapatiauthor=V.+S.+Gnanapragassamauthor=N.+Moniauxauthor=N.+Momiauthor=S.+K.+Batra&title=Role+of+MUC4-NIDO+Domain+in+the+MUC4-Mediated+Metastasis+of+Pancreatic+Cancer+Cells&doi=10.1038%2Fonc.2011.505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells</span></div><div class="casAuthors">Senapati, S.; Gnanapragassam, V. S.; Moniaux, N.; Momi, N.; Batra, S. K.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3346-3356</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MUC4 is a large transmembrane type I glycoprotein that is overexpressed in pancreatic cancer (PC) and has been shown to be assocd. with its progression and metastasis.  However, the exact cellular and mol. mechanism(s) through which MUC4 promotes metastasis of PC cells has been sparsely studied.  Here we showed that the nidogen-like (NIDO) domain of MUC4, which is similar to the G1-domain present in the nidogen or entactin (an extracellular matrix protein), contributes to the protein-protein interaction property of MUC4.  By this interaction, MUC4 promotes breaching of basement membrane (BM) integrity, and spreading of cancer cells.  These observations are corroborated with the data from our study using an engineered MUC4 protein without the NIDO domain, which was ectopically expressed in the MiaPaCa PC cells, lacking endogenous MUC4 and nidogen protein.  The in vitro studies demonstrated an enhanced invasiveness of MiaPaCa cells expressing MUC4 (MiaPaCa-MUC4) compared with vector-transfected cells (MiaPaCa-Vec; P=0.003) or cells expressing MUC4 without the NIDO domain (MiaPaCa-MUC4-NIDOΔ; P=0.03).  However, the absence of NIDO-domain has no significant role on cell growth and motility (P=0.93).  In the in vivo studies, all the mice orthotopically implanted with MiPaCa-MUC4 cells developed metastasis to the liver as compared with MiaPaCa-Vec or the MiaPaCa-MUC4-NIDOΔ group, hence, supporting our in vitro observations.  Addnl., a reduced binding (P=0.0004) of MiaPaCa-MUC4-NIDOΔ cells to the fibulin-2 coated plates compared with MiaPaCa-MUC4 cells indicated a possible interaction between the MUC4-NIDO domain and fibulin-2, a nidogen-interacting protein.  Furthermore, in PC tissue samples, MUC4 colocalized with the fibulin-2 present in the BM.  Altogether, our findings demonstrate that the MUC4-NIDO domain significantly contributes to the MUC4-mediated metastasis of PC cells.  This may be partly due to the interaction between the MUC4-NIDO domain and fibulin-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeiyORyYPmRbVg90H21EOLACvtfcHk0ljzOjwNsXSsUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2gtrrP&md5=649969f81badd3f3a4c2ca3acfa3f50c</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fonc.2011.505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2011.505%26sid%3Dliteratum%253Aachs%26aulast%3DSenapati%26aufirst%3DS.%26aulast%3DGnanapragassam%26aufirst%3DV.%2BS.%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DMomi%26aufirst%3DN.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DRole%2520of%2520MUC4-NIDO%2520Domain%2520in%2520the%2520MUC4-Mediated%2520Metastasis%2520of%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D2012%26volume%3D31%26spage%3D3346%26epage%3D3356%26doi%3D10.1038%2Fonc.2011.505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bork, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patthy, L.</span></span> <span> </span><span class="NLM_article-title">The SEA Module: A New Extracellular Domain Associated with O-Glycosylation</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1421</span>– <span class="NLM_lpage">1425</span>, <span class="refDoi"> DOI: 10.1002/pro.5560040716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fpro.5560040716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=7670383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1995&pages=1421-1425&author=P.+Borkauthor=L.+Patthy&title=The+SEA+Module%3A+A+New+Extracellular+Domain+Associated+with+O-Glycosylation&doi=10.1002%2Fpro.5560040716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The SEA module: a new extracellular domain associated with O-glycosylation</span></div><div class="casAuthors">Bork, Peer; Patthy, Laszlo</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1421-5</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Using a variety of homol. search methods and multiple alignments, a new extracellular module was identified in (1) agrin, (2) enterokinase, (3) a 63-kDa sea urchin sperm protein, (4) perlecan, (5) the breast cancer marker MUC1 (episialin), (6) the cell surface antigen 114/A10, and (7/8) two functionally uncharacterized, probably extracellular, Caenorhabditis elegans proteins.  Despite the functional diversity of these adhesive proteins, a common denominator seems to be their existence in heavily glycosylated environments.  In addn., the better characterized proteins mentioned above contain all O-glycosidic-linked carbohydrates such as heparan sulfate that contribute considerably to their mol. masses.  The common module might regulate or assist binding to neighboring carbohydrate moieties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnywONmeXVM7Vg90H21EOLACvtfcHk0ljzOjwNsXSsUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXms1Knsrk%253D&md5=e9f3b8fcf8a3bcbaaf27588d9aeffede</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fpro.5560040716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpro.5560040716%26sid%3Dliteratum%253Aachs%26aulast%3DBork%26aufirst%3DP.%26aulast%3DPatthy%26aufirst%3DL.%26atitle%3DThe%2520SEA%2520Module%253A%2520A%2520New%2520Extracellular%2520Domain%2520Associated%2520with%2520O-Glycosylation%26jtitle%3DProtein%2520Sci.%26date%3D1995%26volume%3D4%26spage%3D1421%26epage%3D1425%26doi%3D10.1002%2Fpro.5560040716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">Evidence for a Second Peptide Cleavage in the C-Terminal Domain of Rodent Intestinal Mucin Muc3</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>378</i></span>,  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1042/bj20030944</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20030944" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=14572308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlSns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=2004&pages=207-212&author=I.+A.+Khatriauthor=R.+Wangauthor=J.+F.+Forstner&title=Evidence+for+a+Second+Peptide+Cleavage+in+the+C-Terminal+Domain+of+Rodent+Intestinal+Mucin+Muc3&doi=10.1042%2Fbj20030944"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a second peptide cleavage in the C-terminal domain of rodent intestinal mucin Muc3</span></div><div class="casAuthors">Khatri, Ismat A.; Wang, Rongquan; Forstner, Janet F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">378</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">207-212</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Rat intestinal mucin Muc3 (rMuc3), like its human homolog (MUC3) and several other membrane mucins, contains a C-terminally located SEA (sea urchin sperm protein, enterokinase and agrin) module, with an intrinsic proteolytic site sequence G↓SIVV (where G↓S is the glycine serine cleavage site).  As shown previously, expression of the C-terminal domain of rMuc3 in COS-1 cells yields a V5 epitope-tagged N-terminal glycopeptide of 30 kDa and a Myc- and His epitope-tagged C-terminal glycopeptide of 49 kDa.  The present study shows that the 49 kDa membrane-anchored fragment undergoes a further cleavage reaction which decreases its size to 30 kDa.  Western blotting, pulse-chase metabolic incubations, immunopptn. and deglycosylation with N-glycosidase F were used to detect and identify the proteolytic products.  Both the first and second cleavages are presumed to facilitate solubilization of Muc3 at the apical surface of enterocytes and/or enhance the potential for Muc3 to participate in ligand-receptor and signal transduction events for enterocyte function in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRsUFKr-B9xbVg90H21EOLACvtfcHk0ljzOjwNsXSsUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlSns7w%253D&md5=05fc60f3f92f301162529c66e4523f52</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1042%2Fbj20030944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20030944%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DI.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DEvidence%2520for%2520a%2520Second%2520Peptide%2520Cleavage%2520in%2520the%2520C-Terminal%2520Domain%2520of%2520Rodent%2520Intestinal%2520Mucin%2520Muc3%26jtitle%3DBiochem.%2520J.%26date%3D2004%26volume%3D378%26spage%3D207%26epage%3D212%26doi%3D10.1042%2Fbj20030944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, P. J.</span></span> <span> </span><span class="NLM_article-title">Post-Translational Regulation of Signaling Mucins</span>. <i>Curr. Opin. Struct. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1016/j.sbi.2011.08.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.sbi.2011.08.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=21889329" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12rtbjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=590-596&author=P.+J.+Cullen&title=Post-Translational+Regulation+of+Signaling+Mucins&doi=10.1016%2Fj.sbi.2011.08.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational regulation of signaling mucins</span></div><div class="casAuthors">Cullen, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">590-596</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Signaling mucins are large transmembrane glycoproteins that regulate signal transduction pathways.  Recent advances have shown that two major types of post-translational modifications, protein glycosylation and proteolytic processing, play important and unexpected roles in regulating signaling mucin function.  New O-glycosyltransferases and proteases have been identified, and the structure of the domain that undergoes auto-proteolysis has been solved.  A picture is beginning to emerge where specific glycosyl modifications and regulated processing control the signaling and adherence properties of signaling glycoproteins and contribute to the routing of signals to specific pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfv1AQ5My24LVg90H21EOLACvtfcHk0lgW8Ghrv_-jDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12rtbjO&md5=e713a54fb806de937597039ed26d2dd8</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.sbi.2011.08.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.sbi.2011.08.007%26sid%3Dliteratum%253Aachs%26aulast%3DCullen%26aufirst%3DP.%2BJ.%26atitle%3DPost-Translational%2520Regulation%2520of%2520Signaling%2520Mucins%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2011%26volume%3D21%26spage%3D590%26epage%3D596%26doi%3D10.1016%2Fj.sbi.2011.08.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wreschner, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mcguckin, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baruch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoeli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziv, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaretsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smorodinsky, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keydar, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neophytou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, S.</span></span> <span> </span><span class="NLM_article-title">Generation of Ligand–Receptor Alliances by “SEA” Module-Mediated Cleavage of Membrane-Associated Mucin Proteins</span>. <i>Protein Sci.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">698</span>– <span class="NLM_lpage">706</span>, <span class="refDoi"> DOI: 10.1110/ps.16502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1110%2Fps.16502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11847293" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFKnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=698-706&author=D.+H.+Wreschnerauthor=M.+A.+Mcguckinauthor=S.+J.+Williamsauthor=A.+Baruchauthor=M.+Yoeliauthor=R.+Zivauthor=L.+Okunauthor=J.+Zaretskyauthor=N.+Smorodinskyauthor=I.+Keydarauthor=P.+Neophytouauthor=M.+Staceyauthor=H.+Linauthor=S.+Gordon&title=Generation+of+Ligand%E2%80%93Receptor+Alliances+by+%E2%80%9CSEA%E2%80%9D+Module-Mediated+Cleavage+of+Membrane-Associated+Mucin+Proteins&doi=10.1110%2Fps.16502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins</span></div><div class="casAuthors">Wreschner, Daniel H.; McGuckin, Michael A.; Williams, Stefanie J.; Baruch, Amos; Yoeli, Merav; Ziv, Ravit; Okun, Liron; Zaretsky, Joseph; Smorodinsky, Nechama; Keydar, Iafa; Neophytou, Pavlos; Stacey, Martin; Lin, His-Hsien; Gordon, Siamon</div><div class="citationInfo"><span class="NLM_cas:title">Protein Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">698-706</span>CODEN:
                <span class="NLM_cas:coden">PRCIEI</span>;
        ISSN:<span class="NLM_cas:issn">0961-8368</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A mechanism is described whereby one and the same gene can encode both a receptor protein as well as its specific ligand.  Generation of this receptor-ligand partnership is effected by proteolytic cleavage within a specific module located in a membrane resident protein.  It is postulated here that the "SEA" module, found in a no. of heavily O-linked glycosylated membrane-assocd. proteins, serves as a site for proteolytic cleavage.  The subunits generated by proteolytic cleavage of the SEA module reassoc., and can subsequently elicit a signaling cascade.  We hypothesize that all membrane resident proteins contg. such a "SEA" module will undergo cleavage, thereby generating a receptor-ligand alliance.  This requires that the protein subunits resulting from the proteolytic cleavage reassoc. with each other in a highly specific fashion.  The same SEA module that serves as the site for proteolytic cleavage, probably also contains the binding sites for reassocn. of the resultant two subunits.  More than one type of module can function as a site for proteolytic cleavage; this can occur not only in one-pass membrane proteins but also in 7-transmembrane proteins and other membrane-assocd. proteins.  The proposal presented here is likely to have significant practical consequences.  It could well lead to the rational design and identification of mols. that, by binding to one of the cleaved partners, will act either as agonists or antagonists, alter signal transduction and, hence, cellular behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzSq8IG_iRLVg90H21EOLACvtfcHk0lgW8Ghrv_-jDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFKnu7k%253D&md5=d374ddd38865a307e6bc9f9b96af2934</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1110%2Fps.16502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1110%252Fps.16502%26sid%3Dliteratum%253Aachs%26aulast%3DWreschner%26aufirst%3DD.%2BH.%26aulast%3DMcguckin%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DS.%2BJ.%26aulast%3DBaruch%26aufirst%3DA.%26aulast%3DYoeli%26aufirst%3DM.%26aulast%3DZiv%26aufirst%3DR.%26aulast%3DOkun%26aufirst%3DL.%26aulast%3DZaretsky%26aufirst%3DJ.%26aulast%3DSmorodinsky%26aufirst%3DN.%26aulast%3DKeydar%26aufirst%3DI.%26aulast%3DNeophytou%26aufirst%3DP.%26aulast%3DStacey%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DH.%26aulast%3DGordon%26aufirst%3DS.%26atitle%3DGeneration%2520of%2520Ligand%25E2%2580%2593Receptor%2520Alliances%2520by%2520%25E2%2580%259CSEA%25E2%2580%259D%2520Module-Mediated%2520Cleavage%2520of%2520Membrane-Associated%2520Mucin%2520Proteins%26jtitle%3DProtein%2520Sci.%26date%3D2002%26volume%3D11%26spage%3D698%26epage%3D706%26doi%3D10.1110%2Fps.16502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forstner, J. F.</span></span> <span> </span><span class="NLM_article-title">SEA (Sea-Urchin Sperm Protein, Enterokinase and Agrin)-Module Cleavage, Association of Fragments and Membrane Targeting of Rat Intestinal Mucin Muc3</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>372</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">270</span>, <span class="refDoi"> DOI: 10.1042/bj20021333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1042%2Fbj20021333" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12605599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFehsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2003&pages=263-270&author=I.+A.+Khatriauthor=R.+Wangauthor=J.+F.+Forstner&title=SEA+%28Sea-Urchin+Sperm+Protein%2C+Enterokinase+and+Agrin%29-Module+Cleavage%2C+Association+of+Fragments+and+Membrane+Targeting+of+Rat+Intestinal+Mucin+Muc3&doi=10.1042%2Fbj20021333"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">SEA (sea-urchin sperm protein, enterokinase and agrin)-module cleavage, association of fragments and membrane targeting of rat intestinal mucin Muc3</span></div><div class="casAuthors">Khatri, Ismat A.; Wang, Rongquan; Forstner, Janet F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">263-270</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">In a previous study we showed, by transient expression studies in COS-1 cells, that the C-terminal domain of rat intestinal membrane mucin Muc3 was cleaved between glycine and serine within a GSIVV (one-letter) amino acid sequence during its residence in the endoplasmic reticulum.  The extracellular domain fragment remained linked to the membrane-assocd. fragment by non-covalent interactions.  The present study demonstrates that cleavage depends not only on the presence of the G/SIVV site (where G/S is the glycine↓serine cleavage site), but also on more distant C-terminal sequences in the SEA (sea-urchin sperm protein, enterokinase and agrin) module.  Inhibition of N-glycosylation by tunicamycin treatment of transfected cells did not prevent re-assocn. of fragments, although cleavage was partially impaired, as some of the non-glycosylated, non-cleaved products were seen to accumulate in cells.  Membrane targeting of the Muc3 domain and its cleavage products occurred in transfected cells and was not impaired in mutants in which the cleavage site was mutated.  Targeting was also not impaired for products devoid of N-linked oligosaccharides.  Our studies thus indicate that (a) cleavage within the SEA module of rat Muc3 requires participation of peptide sequences located C-terminal of and distant from the cleavage site, (b) re-assocn. of the fragments requires the SEA module, but is independent of N-linked oligosaccharides, and (c) membrane targeting of the mucin is independent of the SEA-module-cleavage reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPRwgCV4Vlw7Vg90H21EOLACvtfcHk0lgW8Ghrv_-jDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFehsr0%253D&md5=eac5cf271ff24de54e223760f5105ded</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1042%2Fbj20021333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021333%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DI.%2BA.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DForstner%26aufirst%3DJ.%2BF.%26atitle%3DSEA%2520%2528Sea-Urchin%2520Sperm%2520Protein%252C%2520Enterokinase%2520and%2520Agrin%2529-Module%2520Cleavage%252C%2520Association%2520of%2520Fragments%2520and%2520Membrane%2520Targeting%2520of%2520Rat%2520Intestinal%2520Mucin%2520Muc3%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D372%26spage%3D263%26epage%3D270%26doi%3D10.1042%2Fbj20021333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kini, R. M.</span></span> <span> </span><span class="NLM_article-title">Structural Determinants in Protein Folding: A Single Conserved Hydrophobic Residue Determines Folding of EGF Domains</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1021/cb300445a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb300445a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGmtb%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=161-169&author=A.+S.+Ngauthor=R.+M.+Kini&title=Structural+Determinants+in+Protein+Folding%3A+A+Single+Conserved+Hydrophobic+Residue+Determines+Folding+of+EGF+Domains&doi=10.1021%2Fcb300445a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Determinants in Protein Folding: A Single Conserved Hydrophobic Residue Determines Folding of EGF Domains</span></div><div class="casAuthors">Ng, A. S. Angie; Kini, R. Manjunatha</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-169</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The epidermal growth factor (EGF) domain is evolutionarily conserved despite hypervariability in amino acid sequences.  They fold into a three-looped conformation with a disulfide pairing of C1-C3, C2-C4,and C5-C6.  To elucidate the structural determinants that dictate the EGF fold, we selected the fourth and fifth EGF domains of thrombomodulin (TM) as models; the former domain folds into the canonical conformation, while the latter domain folds with alternate disulfide pairing of C1-C2, C3-C4, and C5-C6.  Since their third disulfide (C5-C6) is conserved, we examd. the folding tendencies of synthetic peptides corresponding to truncated domain four (t-TMEGF4) and five (t-TMEGF5), encompassing the segment C1 to C4.  These peptides fold into their resp. disulfide isoforms indicating that they contain all the required structural determinants.  On the basis of the folding tendencies of these peptides in the absence and presence of 6 M Gn·HCl or 0.5 M NaCl, we detd. that hydrophobic interactions are needed for the canonical EGF fold but not for the noncanonical fold.  Sequence alignment of extant EGF domains and examn. of their three-dimensional structures allowed us to identify a highly conserved hydrophobic residue in intercysteine loop 3 as the key contributor, which nucleates the hydrophobic core and acts as the lynch pin.  When this hydrophobic residue (Tyr25) was substituted with a more hydrophilic Thr, the hydrophobic interactions were disrupted, and t-TMEGF4-Y25T folds similar to t-TMEGF5.  Taken together, our results for the first time demonstrate that a single conserved hydrophobic residue acts as the key determinant in the folding of EGF domains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs2VNg2SRlWrVg90H21EOLACvtfcHk0ljjnLU2JK06FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGmtb%252FF&md5=6b847fda239412e7408f638be2dc8960</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fcb300445a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb300445a%26sid%3Dliteratum%253Aachs%26aulast%3DNg%26aufirst%3DA.%2BS.%26aulast%3DKini%26aufirst%3DR.%2BM.%26atitle%3DStructural%2520Determinants%2520in%2520Protein%2520Folding%253A%2520A%2520Single%2520Conserved%2520Hydrophobic%2520Residue%2520Determines%2520Folding%2520of%2520EGF%2520Domains%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D161%26epage%3D169%26doi%3D10.1021%2Fcb300445a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
Zoelen, E. J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenferink, A. E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van de Poll, M. L. M.</span></span> <span> </span><span class="NLM_article-title">The EGF Domain: Requirements for Binding to Receptors of the ErbB Family</span>. <i>Vitam. Horm. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">131</span>, <span class="refDoi"> DOI: 10.1016/S0083-6729(00)59005-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2FS0083-6729%2800%2959005-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10714238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXivVCgsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2000&pages=99-131&author=E.+J.+J.+van%0AZoelenauthor=C.+Stortelersauthor=A.+E.+G.+Lenferinkauthor=M.+L.+M.+van+de+Poll&title=The+EGF+Domain%3A+Requirements+for+Binding+to+Receptors+of+the+ErbB+Family&doi=10.1016%2FS0083-6729%2800%2959005-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">The EGF domain: requirements for binding to receptors of the ErbB family</span></div><div class="casAuthors">Van Zoelen, Everardus J. J.; Stortelers, Catelijne; Lenferink, Anne E. G.; Van De Poll, Monique L. M.</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">99-131</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review with ∼100 refs.  Epidermal growth factor (EGF) has been the prototype growth-stimulating peptide for many years.  It has a characteristic structure with three disulfide bridges, which is essential for its activity.  However, many other proteins, including both growth factors and proteins with unrelated functions, have similar EGF-like domains.  This indicates that besides a characteristic conformation provided by the EGF-like domain, specific amino acids are required to provide specificity in protein functioning.  Currently, more than 10 different growth factors with an EGF-like domain have been characterized which all exert their action by binding to the four members of the erbB family of receptors.  In this review, studies are described on the structure-function relationship of these EGF-like growth factor mols. in an attempt to analyze the individual amino acids that det. their binding specificity to the individual members of the erbB family.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2VeDIe-OkirVg90H21EOLACvtfcHk0ljjnLU2JK06FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXivVCgsbY%253D&md5=4748e7e2e5da7c9312b172d39c686534</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2800%2959005-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252800%252959005-0%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BZoelen%26aufirst%3DE.%2BJ.%2BJ.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3DLenferink%26aufirst%3DA.%2BE.%2BG.%26aulast%3Dvan%2Bde%2BPoll%26aufirst%3DM.%2BL.%2BM.%26atitle%3DThe%2520EGF%2520Domain%253A%2520Requirements%2520for%2520Binding%2520to%2520Receptors%2520of%2520the%2520ErbB%2520Family%26jtitle%3DVitam.%2520Horm.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2000%26volume%3D59%26spage%3D99%26epage%3D131%26doi%3D10.1016%2FS0083-6729%2800%2959005-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Campion, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadaki, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niyogi, S. K.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the Role of Electrostatic Residues in Human Epidermal Growth Factor by Site-Directed Mutagenesis and Chemical Modification</span>. <i>J. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">42</span>, <span class="refDoi"> DOI: 10.1002/jcb.240500108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fjcb.240500108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1358899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK38XmsVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1992&pages=35-42&author=S.+R.+Campionauthor=D.+K.+Tadakiauthor=S.+K.+Niyogi&title=Evaluation+of+the+Role+of+Electrostatic+Residues+in+Human+Epidermal+Growth+Factor+by+Site-Directed+Mutagenesis+and+Chemical+Modification&doi=10.1002%2Fjcb.240500108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the role of electrostatic residues in human epidermal growth factor by site-directed mutagenesis and chemical modification</span></div><div class="casAuthors">Campion, Stephen R.; Tadaki, Douglas K.; Niyogi, Salil K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-42</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    </div><div class="casAbstract">Four residues in the carboxy-terminal domain of human (h) EGF, glutamate 40, glutamine 43, arginine 45, and aspartate 46 were targeted for site-directed mutagenesis to evaluate their potential role in EGF receptor-ligand interaction.  One or more mutations were generated at each of these sites and the altered recombinant hEGF gene products were purified and evaluated by radioreceptor competition binding assay.  Charge-conservative replacement of glutamate 40 with aspartate resulted in a decrease in receptor binding affinity to 30% relative to wild-type hEGF.  On the other hand, removal of the electrostatic charge by substitution of glutamate 40 with glutamine or alanine resulted in only a slightly greater decrease in receptor binding to 25% relative receptor affinity.  The introduction of a pos. charge upon substitution of glutamine 43 with lysine had no effect on receptor binding.  The substitution of arginine 45 with lysine also showed no effect on receptor binding, unlike the abs. requirement obsd. for the arginine side-chain at position 41 [Engler DA, et al. 1992].  Subsequent elimination of the pos. charge of lysine 45 by reaction with K cyanate showed that the electrostatic property of the residue at this site, as well as that at lysine 28 and lysine 48, was not required for receptor-ligand assocn.  The most highly conserved of the 4 residues studied in this report, aspartate 46, was replaced with alanine, tyrosine, and arginine, resulting in a decrease in relative receptor affinity to 23, 14, and 4%, resp., and suggests the importance of an acidic group at this site of EGF.  The ability to generate sufficient yields of mutant recombinant EGF protein was sensitive to the type of side-chain substitutions generated at the sites described in this report and may indicate a role for these residues in the formation of the EGF structure apparently required for productive yields of EGF proteins in the expression system used in this study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvgaPMUrav1bVg90H21EOLACvtfcHk0ljjnLU2JK06FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XmsVGksr4%253D&md5=6d801f77d5e225e021c71727964a0ed5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1002%2Fjcb.240500108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.240500108%26sid%3Dliteratum%253Aachs%26aulast%3DCampion%26aufirst%3DS.%2BR.%26aulast%3DTadaki%26aufirst%3DD.%2BK.%26aulast%3DNiyogi%26aufirst%3DS.%2BK.%26atitle%3DEvaluation%2520of%2520the%2520Role%2520of%2520Electrostatic%2520Residues%2520in%2520Human%2520Epidermal%2520Growth%2520Factor%2520by%2520Site-Directed%2520Mutagenesis%2520and%2520Chemical%2520Modification%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D1992%26volume%3D50%26spage%3D35%26epage%3D42%26doi%3D10.1002%2Fjcb.240500108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stein, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staros, J. V.</span></span> <span> </span><span class="NLM_article-title">Evolutionary Analysis of the Erbb Receptor and Ligand Families</span>. <i>J. Mol. Evol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">397</span>– <span class="NLM_lpage">412</span>, <span class="refDoi"> DOI: 10.1007/s002390010043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs002390010043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10824084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksVGltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2000&pages=397-412&author=R.+A.+Steinauthor=J.+V.+Staros&title=Evolutionary+Analysis+of+the+Erbb+Receptor+and+Ligand+Families&doi=10.1007%2Fs002390010043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary analysis of the ErbB receptor and ligand families</span></div><div class="casAuthors">Stein, Richard A.; Staros, James V.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Evolution</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">397-412</span>CODEN:
                <span class="NLM_cas:coden">JMEVAU</span>;
        ISSN:<span class="NLM_cas:issn">0022-2844</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag New York Inc.</span>)
        </div><div class="casAbstract">We have compared all available deduced protein sequences of the ErbB family of receptors and their ligands.  Anal. of the aligned sequences of the receptors indicates that there are some differences in the receptors that are specific to invertebrates.  In addn., comparison of the vertebrate ErbB receptors suggest that a gene duplication event generated two ancestral receptors, the ErbB3/ErbB4 precursor and the ErbB1/ErbB2 precursor.  Subsequent gene duplications of these precursors generated the four receptors present in mammals.  Anal. of the sequences for the known ligands of the ErbB receptors suggests that the vertebrate ligands segregate into the ErbB1 ligands and the ErbB3/ErbB4 ligands, paralleling the evolution of the receptors; however, it is difficult to ascertain any correlation between the invertebrate and the vertebrate ligands.  Even though ErbB3 is kinase-impaired, there is significant conservation of the kinase domain within the vertebrate lineage (human, rat, and Fugu rubripes), suggesting some function for this domain other than kinase activity, such as mediating protein-protein interactions that are involved in receptor dimerization and/or activation of the kinase domain of the heterodimerization partner.  To date, no ligand for ErbB2 has been identified, and comparison of the extracellular domains of ErbB2 reveals two regions that are not conserved across the mammalian species.  These two regions of divergence align with sequences in ErbB1 that have been shown to be proximal to the amino-terminus and to the carboxyl-terminal region, resp., of bound EGF.  Further, one of these regions contains an insertion, relative to the other members of the mammalian ErbB family, which might affect the ligand binding site and provide a structural basis for this receptor's apparent inability to bind ligand independently.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGproQ_DD_pbOrVg90H21EOLACvtfcHk0ljjnLU2JK06FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksVGltb0%253D&md5=fedca1f34402d5ee3c920559c4b93524</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1007%2Fs002390010043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002390010043%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DR.%2BA.%26aulast%3DStaros%26aufirst%3DJ.%2BV.%26atitle%3DEvolutionary%2520Analysis%2520of%2520the%2520Erbb%2520Receptor%2520and%2520Ligand%2520Families%26jtitle%3DJ.%2520Mol.%2520Evol.%26date%3D2000%26volume%3D50%26spage%3D397%26epage%3D412%26doi%3D10.1007%2Fs002390010043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Woning, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Rotterdam, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabuurs, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venselaar, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs-Oomen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vriend, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stortelers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Zoelen, E. J. J.</span></span> <span> </span><span class="NLM_article-title">Negative Constraints Underlie the ErbB Specificity of Epidermal Growth Factor-like Ligands</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">40033</span>– <span class="NLM_lpage">40040</span>, <span class="refDoi"> DOI: 10.1074/jbc.M603168200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M603168200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17032651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCrt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=40033-40040&author=S.+P.+van%0Ader+Woningauthor=W.+van+Rotterdamauthor=S.+B.+Nabuursauthor=H.+Venselaarauthor=S.+Jacobs-Oomenauthor=M.+Wingensauthor=G.+Vriendauthor=C.+Stortelersauthor=E.+J.+J.+van+Zoelen&title=Negative+Constraints+Underlie+the+ErbB+Specificity+of+Epidermal+Growth+Factor-like+Ligands&doi=10.1074%2Fjbc.M603168200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Negative Constraints Underlie the ErbB Specificity of Epidermal Growth Factor-like Ligands</span></div><div class="casAuthors">van der Woning, Sebastian P.; van Rotterdam, Walter; Nabuurs, Sander B.; Venselaar, Hanka; Jacobs-Oomen, Saskia; Wingens, Miriam; Vriend, Gert; Stortelers, Catelijne; van Zoelen, Everardus J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">40033-40040</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Epidermal growth factor (EGF)-like growth factors bind their ErbB receptors in a highly selective manner, but the mol. basis for this specificity is poorly understood.  We have previously shown that certain residues in human EGF (Ser2-Asp3) and TGFα (Glu26) are not essential for their binding to ErbB1 but prevent binding to ErbB3 and ErbB4.  In the present study, we have used a phage display approach to affinity-optimize the C-terminal linear region of EGF-like growth factors for binding to each ErbB receptor and thereby shown that Arg45 in EGF impairs binding to both ErbB3 and ErbB4.  By omitting all these so-called neg. constraints from EGF, we designed a ligand designated panerbin that binds ErbB1, ErbB3, and ErbB4 with similarly high affinity as their wild-type ligands.  Homol. models, based on the known crystal structure of TGFα-bound ErbB1, showed that panerbin is able to bind ErbB1, ErbB3, and ErbB4 in a highly similar manner with respect to position and no. of interaction sites.  Upon in silico introduction of the exptl. known neg. constraints into panerbin, we found that Arg45 induced local charge repulsion and Glu26 induced steric hindrance in a receptor-specific manner, whereas Ser2-Asp3 impaired binding due to a disordered conformation.  Furthermore, radiolabeled panerbin was used to quantify the level of all three receptors on human breast cancer cells in a single radioreceptor assay.  It is concluded that the ErbB specificity of EGF-like growth factors primarily results from the presence of a limited no. of residues that impair the unintended interaction with other ErbB receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3k8RP-SAobrVg90H21EOLACvtfcHk0ljJpry8Gq_WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCrt77K&md5=61885859819aadccf4a5ad433f9966de</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M603168200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M603168200%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWoning%26aufirst%3DS.%2BP.%26aulast%3Dvan%2BRotterdam%26aufirst%3DW.%26aulast%3DNabuurs%26aufirst%3DS.%2BB.%26aulast%3DVenselaar%26aufirst%3DH.%26aulast%3DJacobs-Oomen%26aufirst%3DS.%26aulast%3DWingens%26aufirst%3DM.%26aulast%3DVriend%26aufirst%3DG.%26aulast%3DStortelers%26aufirst%3DC.%26aulast%3Dvan%2BZoelen%26aufirst%3DE.%2BJ.%2BJ.%26atitle%3DNegative%2520Constraints%2520Underlie%2520the%2520ErbB%2520Specificity%2520of%2520Epidermal%2520Growth%2520Factor-like%2520Ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D40033%26epage%3D40040%26doi%3D10.1074%2Fjbc.M603168200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmon, M. A.</span></span> <span> </span><span class="NLM_article-title">ErbB2 Resembles an Autoinhibited Invertebrate Epidermal Growth Factor Receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>461</i></span>,  <span class="NLM_fpage">287</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1038/nature08297</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fnature08297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19718021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=287-291&author=D.+Alvaradoauthor=D.+E.+Kleinauthor=M.+A.+Lemmon&title=ErbB2+Resembles+an+Autoinhibited+Invertebrate+Epidermal+Growth+Factor+Receptor&doi=10.1038%2Fnature08297"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor</span></div><div class="casAuthors">Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7261</span>),
    <span class="NLM_cas:pages">287-291</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The orphan receptor tyrosine kinase ErbB2 (also known as HER2 or Neu) transforms cells when overexpressed, and it is an important therapeutic target in human cancer.  Structural studies have suggested that the oncogenic (and ligand-independent) signaling properties of ErbB2 result from the absence of a key intramol. 'tether' in the extracellular region that autoinhibits other human ErbB receptors, including the epidermal growth factor (EGF) receptor.  Although ErbB2 is unique among the four human ErbB receptors, here we show that it is the closest structural relative of the single EGF receptor family member in Drosophila melanogaster (dEGFR).  Genetic and biochem. data show that dEGFR is tightly regulated by growth factor ligands, yet a crystal structure shows that it too lacks the intramol. tether seen in human EGFR, ErbB3 and ErbB4.  Instead, a distinct set of autoinhibitory interdomain interactions hold unliganded dEGFR in an inactive state.  All of these interactions are maintained (and even extended) in ErbB2, arguing against the suggestion that ErbB2 lacks autoinhibition.  We therefore suggest that normal and pathogenic ErbB2 signaling may be regulated by ligands in the same way as dEGFR.  Our findings have important implications for ErbB2 regulation in human cancer, and for developing therapeutic approaches that target novel aspects of this orphan receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8HfE12q2H6bVg90H21EOLACvtfcHk0ljJpry8Gq_WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKhs7rE&md5=defcc42cc5f04104c2aa27a8de600266</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1038%2Fnature08297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08297%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarado%26aufirst%3DD.%26aulast%3DKlein%26aufirst%3DD.%2BE.%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26atitle%3DErbB2%2520Resembles%2520an%2520Autoinhibited%2520Invertebrate%2520Epidermal%2520Growth%2520Factor%2520Receptor%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D287%26epage%3D291%26doi%3D10.1038%2Fnature08297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kozloski, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carothers Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Mechanistic and Signaling Analysis of Muc4–ErbB2 Signaling Module: New Insights into the Mechanism of Ligand- Independent ErbB2 Activity</span>. <i>J. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>224</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">657</span>, <span class="refDoi"> DOI: 10.1002/jcp.22163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1002%2Fjcp.22163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20432461" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVWnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=224&publication_year=2010&pages=649-657&author=G.+A.+Kozloskiauthor=C.+A.+Carothers+Carrawayauthor=K.+L.+Carraway&title=Mechanistic+and+Signaling+Analysis+of+Muc4%E2%80%93ErbB2+Signaling+Module%3A+New+Insights+into+the+Mechanism+of+Ligand-+Independent+ErbB2+Activity&doi=10.1002%2Fjcp.22163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanistic and signaling analysis of Muc4-ErbB2 signaling module: New insights into the mechanism of ligand-independent ErbB2 activity</span></div><div class="casAuthors">Kozloski, Goldi A.; Carothers-Carraway, Coralie A.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">224</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-657</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The membrane mucin Muc4 is aberrantly expressed in numerous epithelial carcinomas and is currently used as a cancer diagnostic and prognostic tool.  Muc4 can also potentiate signal transduction by modulating differential ErbB2 phosphorylation in the absence and in the presence of the ErbB3 sol. ligand heregulin (HRG-β1).  These features of Muc4 suggest that Muc4 is not merely a cancer marker, but an oncogenic factor with a unique-binding/activation relationship with the receptor ErbB2.  In the present study, we examd. the signaling mechanisms that are assocd. with the Muc4-ErbB2 module by analyzing ErbB2 differential signaling in response to Muc4 expression.  Our study was carried out in the A375 human melanoma and BT-474 breast cancer cell lines as our model systems.  Quant. and comparative signaling modulations were evaluated by immunoblot using phospho-specific antibodies, and densitometry anal.  Signaling complex components were identified by chem. crosslinking, fractionation by gel filtration, immunopptn., and immunoblotting.  Activated downstream signaling pathways were analyzed by an antibody microarray screen and immunoblot analyses.  Our results indicate that Muc4 modulates ErbB2 signaling potential significantly by stabilizing and directly interacting with the ErbB2-ErbB3 heterodimer.  Further analyses indicate that Muc4 promotes ErbB2 autocatalysis, but it has no effect on ErbB3 phosphorylation, although the chem. crosslinking data indicated that the signaling module is composed of Muc4, ErbB2, and ErbB3.  Our microarray anal. indicates that Muc4 expression promotes cell migration by increasing the phosphorylation of the focal adhesion kinase and also through an increase in the levels of β-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSHZaHK27N9rVg90H21EOLACvtfcHk0ljJpry8Gq_WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVWnt7g%253D&md5=4edd43e804c4c8fd3c472ec7767d431c</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fjcp.22163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.22163%26sid%3Dliteratum%253Aachs%26aulast%3DKozloski%26aufirst%3DG.%2BA.%26aulast%3DCarothers%2BCarraway%26aufirst%3DC.%2BA.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DMechanistic%2520and%2520Signaling%2520Analysis%2520of%2520Muc4%25E2%2580%2593ErbB2%2520Signaling%2520Module%253A%2520New%2520Insights%2520into%2520the%2520Mechanism%2520of%2520Ligand-%2520Independent%2520ErbB2%2520Activity%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2010%26volume%3D224%26spage%3D649%26epage%3D657%26doi%3D10.1002%2Fjcp.22163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Attar, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholefield, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durrant, L. G.</span></span> <span> </span><span class="NLM_article-title">The Role of MUC1 and MUC3 in the Biology and Prognosis of Colorectal Cancer</span>. <i>World J. Surg. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">31</span>, <span class="refDoi"> DOI: 10.1186/1477-7819-5-31</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2F1477-7819-5-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17349047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD2s7nt1Wmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=31&author=T.+J.+Duncanauthor=N.+F.+Watsonauthor=A.+H.+Al-Attarauthor=J.+H.+Scholefieldauthor=L.+G.+Durrant&title=The+Role+of+MUC1+and+MUC3+in+the+Biology+and+Prognosis+of+Colorectal+Cancer&doi=10.1186%2F1477-7819-5-31"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer</span></div><div class="casAuthors">Duncan Timothy J; Watson Nicholas F S; Al-Attar Ahmad H; Scholefield John H; Durrant Lindy G</div><div class="citationInfo"><span class="NLM_cas:title">World journal of surgical oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  MUC1 and MUC3 are from a large family of glycoproteins with an aberrant expression profile in various malignancies.  Much interest has been focused on the role of these proteins in the development and progression of colorectal cancer; however, no previous studies have included the highly confounding variable of vascular invasion in their survival analysis.  Using high throughput tissue microarray technology we assessed the prognostic value of MUC1 and MUC3 expression in the largest cohort of colorectal cancer patients to date.  We propose that tumours lacking expression of MUC1 and MUC3 will be more likely to metastasise, due to previously observed loss of cell-cell adhesion, and this will therefore lead to more aggressive cancers with poorer prognosis.  METHODS:  A tissue micro-array was prepared from tumour samples of 462 consecutive patients undergoing resection of a primary colorectal cancer.  A comprehensive prospectively recorded data base with mean follow up of 75 months was collected and included common clinicopathological variables and disease specific survival.  Immunohistochemical analysis of MUC1 and MUC3 expression was performed using antibodies NCL-MUC1 and 1143/B7 respectively, results were correlated with the variables within the database.  RESULTS:  Positive expression of MUC1 and MUC3 was seen in 32% and 74% of tumours respectively.  On univariate analysis no correlation was seen with either MUC1 or MUC3 and any of the clinicopathological variables including tumour grade and stage, vascular invasion and tumour type.  Kaplan-Meier analysis demonstrated a significant reduction in disease specific survival with MUC1 positive tumours (p = 0.038), this was not seen with MUC3 (p = 0.552).  On multivariate analysis, using Cox proportional hazards model, MUC1 expression was shown to be an independent marker of prognosis (HR 1.339, 95%CI 1.002-1.790, p = 0.048).  CONCLUSION:  MUC1 expression in colorectal cancer is an independent marker of poor prognosis, even when vascular invasion is included in the analysis.  These results support previous studies suggesting a role for MUC1 in colorectal cancer development possibly through its effects on cell adhesion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtPIDEmh5WI8SzjBFCN0BJfW6udTcc2eYgQbYQe9DPhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7nt1Wmsw%253D%253D&md5=bfeade5cbe689683533a68f96336d091</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1186%2F1477-7819-5-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1477-7819-5-31%26sid%3Dliteratum%253Aachs%26aulast%3DDuncan%26aufirst%3DT.%2BJ.%26aulast%3DWatson%26aufirst%3DN.%2BF.%26aulast%3DAl-Attar%26aufirst%3DA.%2BH.%26aulast%3DScholefield%26aufirst%3DJ.%2BH.%26aulast%3DDurrant%26aufirst%3DL.%2BG.%26atitle%3DThe%2520Role%2520of%2520MUC1%2520and%2520MUC3%2520in%2520the%2520Biology%2520and%2520Prognosis%2520of%2520Colorectal%2520Cancer%26jtitle%3DWorld%2520J.%2520Surg.%2520Oncol.%26date%3D2007%26volume%3D5%26spage%3D31%26doi%3D10.1186%2F1477-7819-5-31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moniaux, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senapati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meza, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">MUC4Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes xith its Interaction to Extracellular Matrix Proteins</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-06-0353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F1541-7786.MCR-06-0353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17406026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvFOksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=309-320&author=P.+Chaturvediauthor=A.+P.+Singhauthor=N.+Moniauxauthor=S.+Senapatiauthor=S.+Chakrabortyauthor=J.+L.+Mezaauthor=S.+K.+Batra&title=MUC4Mucin+Potentiates+Pancreatic+Tumor+Cell+Proliferation%2C+Survival%2C+and+Invasive+Properties+and+Interferes+xith+its+Interaction+to+Extracellular+Matrix+Proteins&doi=10.1158%2F1541-7786.MCR-06-0353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins</span></div><div class="casAuthors">Chaturvedi, Pallavi; Singh, Ajay P.; Moniaux, Nicolas; Senapati, Shantibhushan; Chakraborty, Subhankar; Meza, Jane L.; Batra, Surinder K.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">309-320</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MUC4, a transmembrane mucin, is aberrantly expressed in pancreatic adenocarcinomas while remaining undetectable in the normal pancreas.  Recent studies have shown that the expression of MUC4 is assocd. with the progression of pancreatic cancer and is inversely correlated with the prognosis of pancreatic cancer patients.  In the present study, we have examd. the phenotypic and mol. consequences of MUC4 silencing with an aim of establishing the mechanistic basis for its obsd. role in the pathogenesis of pancreatic cancer.  The silencing of MUC4 expression was achieved by stable expression of a MUC4-specific short hairpin RNA in CD18/HPAF, a highly metastatic pancreatic adenocarcinoma cell line.  A significant decrease in MUC4 expression was detected in MUC4-knockdown (CD18/HPAF-siMUC4) cells compared with the parental and scrambled short interfering RNA-transfected (CD18/HPAF-Scr) control cells by immunoblot anal. and immunofluorescence confocal microscopy.  Consistent with our previous observation, inhibition of MUC4 expression restrained the pancreatic tumor cell growth and metastasis as shown in an orthotopic mouse model.  Our in vitro studies revealed that MUC4-assocd. increase in tumor cell growth resulted from both the enhanced proliferation and reduced cell death.  Furthermore, MUC4 expression was also assocd. with significantly increased invasiveness (P ≤ 0.05) and changes in actin organization.  The presence of MUC4 on the cell surface was shown to interfere with the tumor cell-extracellular matrix interactions, in part, by inhibiting the integrin-mediated cell adhesion.  An altered expression of growth- and metastasis-assocd. genes (LI-cadherin, CEACAM6, RAC1, AnnexinA1, thrombomodulin, epiregulin, S100A4, TP53, TP53BP, caspase-2, caspase-3, caspase-7, plakoglobin, and neuregulin-2) was also obsd. as a consequence of the silencing of MUC4.  In conclusion, our study provides exptl. evidence that supports the functional significance of MUC4 in pancreatic cancer progression and indicates a novel role for MUC4 in cancer cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpahEb7qd8HWLVg90H21EOLACvtfcHk0lhStohsmb3i1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvFOksLk%253D&md5=82889b3ef6cb08cf1fedeada96c87b39</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-06-0353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-06-0353%26sid%3Dliteratum%253Aachs%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DA.%2BP.%26aulast%3DMoniaux%26aufirst%3DN.%26aulast%3DSenapati%26aufirst%3DS.%26aulast%3DChakraborty%26aufirst%3DS.%26aulast%3DMeza%26aufirst%3DJ.%2BL.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DMUC4Mucin%2520Potentiates%2520Pancreatic%2520Tumor%2520Cell%2520Proliferation%252C%2520Survival%252C%2520and%2520Invasive%2520Properties%2520and%2520Interferes%2520xith%2520its%2520Interaction%2520to%2520Extracellular%2520Matrix%2520Proteins%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2007%26volume%3D5%26spage%3D309%26epage%3D320%26doi%3D10.1158%2F1541-7786.MCR-06-0353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joe, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maseda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizuka, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyazaki, H.</span></span> <span> </span><span class="NLM_article-title">Mucin 3 is Involved in Intestinal Epithelial Cell Apoptosis via N-(3-Oxododecanoyl)-L-Homoserine Lactone-Induced Suppression of Akt Phosphorylation</span>. <i>Am. J. Physiol. Cell. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>307</i></span>,  <span class="NLM_fpage">C162</span>– <span class="NLM_lpage">168</span>, <span class="refDoi"> DOI: 10.1152/ajpcell.00271.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1152%2Fajpcell.00271.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24848113" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2014&pages=C162-168&author=R.+Taguchiauthor=S.+Tanakaauthor=G.+H.+Joeauthor=H.+Masedaauthor=N.+Nomuraauthor=J.+Ohnishiauthor=S.+Ishizukaauthor=H.+Shimizuauthor=H.+Miyazaki&title=Mucin+3+is+Involved+in+Intestinal+Epithelial+Cell+Apoptosis+via+N-%283-Oxododecanoyl%29-L-Homoserine+Lactone-Induced+Suppression+of+Akt+Phosphorylation&doi=10.1152%2Fajpcell.00271.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1152%2Fajpcell.00271.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpcell.00271.2013%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DJoe%26aufirst%3DG.%2BH.%26aulast%3DMaseda%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DN.%26aulast%3DOhnishi%26aufirst%3DJ.%26aulast%3DIshizuka%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DH.%26atitle%3DMucin%25203%2520is%2520Involved%2520in%2520Intestinal%2520Epithelial%2520Cell%2520Apoptosis%2520via%2520N-%25283-Oxododecanoyl%2529-L-Homoserine%2520Lactone-Induced%2520Suppression%2520of%2520Akt%2520Phosphorylation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell.%2520Physiol.%26date%3D2014%26volume%3D307%26spage%3DC162%26epage%3D168%26doi%3D10.1152%2Fajpcell.00271.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liberelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuru, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencheikh, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ravez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quenon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drucbert, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foulon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melnyk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebegue, N.</span></span> <span> </span><span class="NLM_article-title">MUC4-ErbB2 Oncogenic Complex: Binding Studies Using Microscale Thermophoresis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">16678</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-53099-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fs41598-019-53099-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=31723153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BB3MjoslyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=16678&author=M.+Liberelleauthor=R.+Magnezauthor=X.+Thuruauthor=Y.+Bencheikhauthor=S.+Ravezauthor=C.+Quenonauthor=A.+S.+Drucbertauthor=C.+Foulonauthor=P.+Melnykauthor=I.+van+Seuningenauthor=N.+Lebegue&title=MUC4-ErbB2+Oncogenic+Complex%3A+Binding+Studies+Using+Microscale+Thermophoresis&doi=10.1038%2Fs41598-019-53099-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis</span></div><div class="casAuthors">Liberelle Maxime; Magnez Romain; Thuru Xavier; Bencheikh Yamina; Ravez Severine; Quenon Camille; Melnyk Patricia; Van Seuningen Isabelle; Lebegue Nicolas; Drucbert Anne-Sophie; Foulon Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16678</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The MUC4 membrane-bound mucin is a large O-glycoprotein involved in epithelial homeostasis.  At the cancer cell surface MUC4 interacts with ErbB2 receptor via EGF domains to promote cell proliferation and migration.  MUC4 is highly regarded as a therapeutic target in pancreatic cancer as it is not expressed in healthy pancreas, while it is neoexpressed in early preneoplastic stages (PanINs).  However, the association/dissociation constant of MUC4-ErbB2 complex is unknown.  Protein-protein interactions (PPIs) have become a major area of research in the past years and the characterization of their interactions, especially by biophysical methods, is intensively used in drug discovery.  To characterize the MUC4-ErbB2 interaction, we used MicroScale Thermophoresis (MST), a powerful method for quantitative protein interaction analysis under challenging conditions.  We worked with CHO cell lysates containing either the transmembrane β subunit of MUC4 (MUC4β) or a truncated mutant encompassing only the EGF domains (MUC4EGF3+1+2).  MST studies have led to the characterization of equilibrium dissociation constants (Kd) for MUC4β-ErbB2 (7-25 nM) and MUC4EGF3+1+2/ErbB2 (65-79 nM) complexes.  This work provides new information regarding the MUC4-ErbB2 interaction at the biophysical level and also confirms that the presence of the three EGF domains of MUC4 is sufficient to provide efficient interaction.  This technological approach will be very useful in the future to validate small molecule binding affinities targeting MUC4-ErbB2 complex for drug discovery development in cancer.  It will also be of high interest for the other known membrane mucins forming oncogenic complexes with ErbBs at the cancer cell surface.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRR32oE25Qk82mbXvSEQle5fW6udTcc2eYmbyXDrO6a37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjoslyitQ%253D%253D&md5=6d446720d0d786b817e653aa12dfd37c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-53099-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-53099-0%26sid%3Dliteratum%253Aachs%26aulast%3DLiberelle%26aufirst%3DM.%26aulast%3DMagnez%26aufirst%3DR.%26aulast%3DThuru%26aufirst%3DX.%26aulast%3DBencheikh%26aufirst%3DY.%26aulast%3DRavez%26aufirst%3DS.%26aulast%3DQuenon%26aufirst%3DC.%26aulast%3DDrucbert%26aufirst%3DA.%2BS.%26aulast%3DFoulon%26aufirst%3DC.%26aulast%3DMelnyk%26aufirst%3DP.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26aulast%3DLebegue%26aufirst%3DN.%26atitle%3DMUC4-ErbB2%2520Oncogenic%2520Complex%253A%2520Binding%2520Studies%2520Using%2520Microscale%2520Thermophoresis%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26spage%3D16678%26doi%3D10.1038%2Fs41598-019-53099-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsauer, V. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salas, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Muc4/Sialomucin Complex, the Intramembrane Erbb2 Ligand, Translocates Erbb2 to the Apical Surface in Polarized Epithelial Cells</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span>,  <span class="NLM_fpage">30142</span>– <span class="NLM_lpage">30147</span>, <span class="refDoi"> DOI: 10.1074/jbc.M303220200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M303220200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12748185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFOntLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=30142-30147&author=V.+P.+Ramsauerauthor=C.+A.+Carrawayauthor=P.+J.+Salasauthor=K.+L.+Carraway&title=Muc4%2FSialomucin+Complex%2C+the+Intramembrane+Erbb2+Ligand%2C+Translocates+Erbb2+to+the+Apical+Surface+in+Polarized+Epithelial+Cells&doi=10.1074%2Fjbc.M303220200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Muc4/Sialomucin Complex, the Intramembrane ErbB2 Ligand, Translocates ErbB2 to the Apical Surface in Polarized Epithelial Cells</span></div><div class="casAuthors">Ramsauer, Victoria P.; Carothers-Carraway, Coralie A.; Salas, Pedro J. I.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">30142-30147</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Muc4/Sialomucin complex (SMC) acts as an intramembrane ligand for the receptor tyrosine kinase ErbB2, inducing a limited phosphorylation of the receptor.  Because Muc4/SMC is found at the apical surfaces of polarized epithelial cells and ErbB2 is often basolateral, the question arises as to whether these components become assocd. in polarized cells.  To address this question, we examd. the localization of these proteins in polarized human colon carcinoma CACO-2 cells.  Dual color immunofluorescence anal. by confocal microscopy demonstrated the basolateral localization of the ErbB2 in these cells; it is primarily co-localized with E-cadherin at adherens junctions.  Expression of apical Muc4/SMC in these cells by transient transfection results in the localization of the ErbB2 at the apical surface.  Twocolor confocal microscopy indicated that ErbB2 is colocalized with Muc4/SMC in the transfected cells but not in untransfected cells in the same culture.  The change of localization of ErbB2 was confirmed by cell surface biotinylation of apical and basolateral proteins, followed by streptavidin pptn. and the subsequent detection of ErbB2 by immunoblotting.  In contrast, Na+/K+-ATPase maintains its basolateral localization in Muc4/SMC-transfected cells, indicating that the translocation of ErbB2 is not the result of depolarization of the cells.  A potential physiol. role for the apical localization of ErbB2 is indicated by the fact that ErbB2 phosphorylated at tyrosine 1248 is found predominantly in Muc4/SMC-transfected cells, but not in untransfected cells, and is co-localized with the apical Muc4/SMC.  The ability of Muc4/SMC to alter the localization of ErbB2, particularly a phosphorylated form of it, in epithelial cells, suggests that it has an important role in regulating ErbB2 signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7C5bnjbBBL7Vg90H21EOLACvtfcHk0lj2bySNxpz8mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFOntLg%253D&md5=2e0745557ae25127c0619fbd006ba9d3</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M303220200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M303220200%26sid%3Dliteratum%253Aachs%26aulast%3DRamsauer%26aufirst%3DV.%2BP.%26aulast%3DCarraway%26aufirst%3DC.%2BA.%26aulast%3DSalas%26aufirst%3DP.%2BJ.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DMuc4%252FSialomucin%2520Complex%252C%2520the%2520Intramembrane%2520Erbb2%2520Ligand%252C%2520Translocates%2520Erbb2%2520to%2520the%2520Apical%2520Surface%2520in%2520Polarized%2520Epithelial%2520Cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D30142%26epage%3D30147%26doi%3D10.1074%2Fjbc.M303220200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pochampalli, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">el Bejjani, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J. A.</span></span> <span> </span><span class="NLM_article-title">MUC1 is a Novel Regulator of Erbb1 Receptor Trafficking</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1693</span>– <span class="NLM_lpage">1701</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1209976</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fsj.onc.1209976" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=16983337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVSmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=1693-1701&author=M.+R.+Pochampalliauthor=R.+M.+el+Bejjaniauthor=J.+A.+Schroeder&title=MUC1+is+a+Novel+Regulator+of+Erbb1+Receptor+Trafficking&doi=10.1038%2Fsj.onc.1209976"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 is a novel regulator of ErbB1 receptor trafficking</span></div><div class="casAuthors">Pochampalli, M. R.; el Bejjani, R. M.; Schroeder, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1693-1701</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">ErbB receptors are key regulators of cell survival and growth in normal and transformed tissues.  The oncogenic glycoprotein MUC1 is a binding partner and substrate for erbB1 and MUC1 expression can potentiate erbB-dependent signal transduction.  After receptor activation, erbB1 is typically downregulated via an endocytic pathway that results in receptor degrdn. or recycling.  We report here that MUC1 expression inhibits the degrdn. of ligand-activated erbB1.  Through the use of both RNAi-mediated knock down and overexpression constructs of MUC1, we show that MUC1 expression inhibits erbB1 degrdn. after ligand treatment in breast epithelial cells.  This MUC1-mediated protection against erbB1 degrdn. can increase total cellular pools of erbB1 over time.  Biotinylation of surface proteins demonstrates that cell-surface assocd. erbB1 receptor is protected by MUC1 against ligand-induced degrdn., although this is accompanied by an increase in erbB1 internalization.  The MUC1-mediated protection against degrdn. occurs with a decrease in EGF-stimulated ubiquitination of erbB1, and an increase in erbB1 recycling.  These data indicate that MUC1 expression is a potent regulator of erbB1 receptor stability upon activation and may promote transformation through the inhibition of erbB1 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotVbvzuw3MP7Vg90H21EOLACvtfcHk0lj2bySNxpz8mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVSmtbw%253D&md5=81865b1d612e97b23befe28962504db3</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1209976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1209976%26sid%3Dliteratum%253Aachs%26aulast%3DPochampalli%26aufirst%3DM.%2BR.%26aulast%3Del%2BBejjani%26aufirst%3DR.%2BM.%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26atitle%3DMUC1%2520is%2520a%2520Novel%2520Regulator%2520of%2520Erbb1%2520Receptor%2520Trafficking%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D1693%26epage%3D1701%26doi%3D10.1038%2Fsj.onc.1209976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gendler, S. J.</span></span> <span> </span><span class="NLM_article-title">Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-Activated Protein Kinase Activation in the Mouse Mammary Gland</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">13057</span>– <span class="NLM_lpage">13064</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011248200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.M011248200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=11278868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFyms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=13057-13064&author=J.+A.+Schroederauthor=M.+C.+Thompsonauthor=M.+M.+Gardnerauthor=S.+J.+Gendler&title=Transgenic+MUC1+Interacts+with+Epidermal+Growth+Factor+Receptor+and+Correlates+with+Mitogen-Activated+Protein+Kinase+Activation+in+the+Mouse+Mammary+Gland&doi=10.1074%2Fjbc.M011248200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland</span></div><div class="casAuthors">Schroeder, Joyce A.; Thompson, Melissa C.; Gardner, Melissa Mockensturm; Gendler, Sandra J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">13057-13064</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">MUC1 is a large (>400 kDa), heavily glycosylated transmembrane protein that is aberrantly expressed on greater than 90% of human breast carcinomas and subsequent metastases.  The precise function of MUC1 over-expression in tumorigenesis is unknown, although various domains of MUC1 have been implicated in cell adhesion, cell signaling, and immunoregulation.  Stimulation of the MDA-MB-468 breast cancer line as well as mouse mammary glands with epidermal growth factor results in the co-immunopptn. of MUC1 with a tyrosine-phosphorylated protein of ∼180 kDa.  We have generated transgenic lines overexpressing full-length (MMF), cytoplasmic tail deleted (ΔCT), or tandem repeat deleted (ΔTR)-human MUC1 under the control of the mouse mammary tumor virus promoter to further examine the role of MUC1 in signaling and tumorigenesis.  Immunopptn. expts. revealed that full-length transgenic MUC1 phys. assocs. with all four erbB receptors, and co-localizes with erbB1 in the lactating gland.  Furthermore, we detected a sharp increase in ERK1/2 activation in MUC1 transgenic mammary glands compared with Muc1 null and wild-type animals.  These results point to a novel function of increased MUC1 expression, potentiation of erbB signaling through the activation of mitogenic MAP kinase pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjdmbb-yt3V7Vg90H21EOLACvtfcHk0lj2bySNxpz8mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFyms7Y%253D&md5=c1c1a53f838efc404e6cfe1ac9ae37b2</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011248200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011248200%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26aulast%3DThompson%26aufirst%3DM.%2BC.%26aulast%3DGardner%26aufirst%3DM.%2BM.%26aulast%3DGendler%26aufirst%3DS.%2BJ.%26atitle%3DTransgenic%2520MUC1%2520Interacts%2520with%2520Epidermal%2520Growth%2520Factor%2520Receptor%2520and%2520Correlates%2520with%2520Mitogen-Activated%2520Protein%2520Kinase%2520Activation%2520in%2520the%2520Mouse%2520Mammary%2520Gland%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D13057%26epage%3D13064%26doi%3D10.1074%2Fjbc.M011248200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bitler, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goverdhan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, J. A.</span></span> <span> </span><span class="NLM_article-title">MUC1 Regulates Nuclear Localization and Function of the Epidermal Growth Factor Receptor</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">1716</span>– <span class="NLM_lpage">1723</span>, <span class="refDoi"> DOI: 10.1242/jcs.062661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1242%2Fjcs.062661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20406885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXotFGrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2010&pages=1716-1723&author=B.+G.+Bitlerauthor=A.+Goverdhanauthor=J.+A.+Schroeder&title=MUC1+Regulates+Nuclear+Localization+and+Function+of+the+Epidermal+Growth+Factor+Receptor&doi=10.1242%2Fjcs.062661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">MUC1 regulates nuclear localization and function of the epidermal growth factor receptor</span></div><div class="casAuthors">Bitler, Benjamin G.; Goverdhan, Aarthi; Schroeder, Joyce A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1716-1723</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Alteration of protein trafficking and localization is assocd. with several diseases, including cystic fibrosis, breast cancer, colorectal cancer, leukemia and diabetes.  Specifically, aberrant nuclear localization of the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase, is a poor prognostic indicator in several epithelial carcinomas.  It is now appreciated that in addn. to signaling from the plasma membrane, EGFR also trafficks to the nucleus, and can directly bind the promoter regions of genes encoding cyclin D1 (CCND1) and B-Myb (MYBL2).  We have previously established that loss of MUC1 in an EGFR-dependent transgenic mouse model of breast cancer correlates with the loss of cyclin D1 expression.  Here, we provide evidence for a novel regulatory function of MUC1 in the trafficking and nuclear activity of EGFR.  We found that MUC1 and EGFR interact in the nucleus of breast cancer cells, which promotes the accumulation of chromatin-bound EGFR.  Addnl., the presence of MUC1 results in significant colocalization of EGFR and phosphorylated RNA polymerase II, indicating that MUC1 influences the assocn. of EGFR with transcriptionally active promoter regions.  Importantly, we found that the loss of MUC1 expression resulted in a decrease in the interaction between EGFR and the CCND1 promoter, which translated to a significant decrease in cyclin D1 protein expression.  This data offers insights into a novel regulatory mechanism of EGFR nuclear function and could have important implications for evaluating nuclear localization in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLRAoOWpAsWLVg90H21EOLACvtfcHk0ljCpRmpqYYSgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXotFGrsb8%253D&md5=7a8f76141b241b4f1a71dbe16b1d080c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1242%2Fjcs.062661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.062661%26sid%3Dliteratum%253Aachs%26aulast%3DBitler%26aufirst%3DB.%2BG.%26aulast%3DGoverdhan%26aufirst%3DA.%26aulast%3DSchroeder%26aufirst%3DJ.%2BA.%26atitle%3DMUC1%2520Regulates%2520Nuclear%2520Localization%2520and%2520Function%2520of%2520the%2520Epidermal%2520Growth%2520Factor%2520Receptor%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2010%26volume%3D123%26spage%3D1716%26epage%3D1723%26doi%3D10.1242%2Fjcs.062661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stechly, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Beauce, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monte, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pigny, P.</span></span> <span> </span><span class="NLM_article-title">Galectin-3 Regulates MUC1 and EGFR Cellular Distribution and EGFR Downstream Pathways in Pancreatic Cancer Cells</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2514</span>– <span class="NLM_lpage">2525</span>, <span class="refDoi"> DOI: 10.1038/onc.2010.631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2010.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=21258405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1ahtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=2514-2525&author=J.+Merlinauthor=L.+Stechlyauthor=S.+de+Beauceauthor=D.+Monteauthor=E.+Leteurtreauthor=I.+van+Seuningenauthor=G.+Huetauthor=P.+Pigny&title=Galectin-3+Regulates+MUC1+and+EGFR+Cellular+Distribution+and+EGFR+Downstream+Pathways+in+Pancreatic+Cancer+Cells&doi=10.1038%2Fonc.2010.631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells</span></div><div class="casAuthors">Merlin, J.; Stechly, L.; de Beauce, S.; Monte, D.; Leteurtre, E.; van Seuningen, I.; Huet, G.; Pigny, P.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2514-2525</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">MUC1 is a transmembrane glycoprotein which is typically expressed at the apical membrane of normal epithelial cells.  In cancer cells, the over-expression of MUC1 and its aberrant localization around the cell membrane and in the cytoplasm favors its interaction with different protein partners such as epidermal growth factor receptor (EGFR) and can promote tumor proliferation through the activation of oncogenic signaling pathways.  Our aims were to study the mechanisms inducing MUC1 cytoplasmic localization in pancreatic cancer cells, and to decipher their impact on EGFR cellular localization and activation.  Our results showed that galectin-3, an endogenous lectin, is co-expressed with MUC1 in human pancreatic ductal adenocarcinoma, and that it favors the endocytosis of MUC1 and EGFR.  Depletion of galectin-3 by RNA interference increased the interaction between MUC1 and EGFR, EGFR and ERK-1,2 phosphorylation, and translocation of EGFR to the nucleus.  On the contrary, silencing of galectin-3 led to a decrease of cyclin-D1 levels and of cell proliferation.  The galectin-3-dependent regulation of MUC1/EGFR functions may represent an interesting mechanism modulating the EGFR-stimulated cell growth of pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTwEh841g7NbVg90H21EOLACvtfcHk0ljCpRmpqYYSgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1ahtA%253D%253D&md5=e3174913573bb41c2cafd9fdaeafe828</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1038%2Fonc.2010.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2010.631%26sid%3Dliteratum%253Aachs%26aulast%3DMerlin%26aufirst%3DJ.%26aulast%3DStechly%26aufirst%3DL.%26aulast%3Dde%2BBeauce%26aufirst%3DS.%26aulast%3DMonte%26aufirst%3DD.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26aulast%3DHuet%26aufirst%3DG.%26aulast%3DPigny%26aufirst%3DP.%26atitle%3DGalectin-3%2520Regulates%2520MUC1%2520and%2520EGFR%2520Cellular%2520Distribution%2520and%2520EGFR%2520Downstream%2520Pathways%2520in%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncogene%26date%3D2011%26volume%3D30%26spage%3D2514%26epage%3D2525%26doi%3D10.1038%2Fonc.2010.631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piyush, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindrewicz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilkens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L. G.</span></span> <span> </span><span class="NLM_article-title">Interaction of Galectin-3 with MUC1 on Cell Surface Promotes EGFR Dimerization and Activation in Human Epithelial Cancer Cells</span>. <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1947</span>, <span class="refDoi"> DOI: 10.1038/cdd.2017.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fcdd.2017.119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28731466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Whsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1937-1947&author=T.+Piyushauthor=A.+R.+Chackoauthor=P.+Sindrewiczauthor=J.+Hilkensauthor=J.+M.+Rhodesauthor=L.+G.+Yu&title=Interaction+of+Galectin-3+with+MUC1+on+Cell+Surface+Promotes+EGFR+Dimerization+and+Activation+in+Human+Epithelial+Cancer+Cells&doi=10.1038%2Fcdd.2017.119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells</span></div><div class="casAuthors">Piyush, Tushar; Chacko, Anisha R.; Sindrewicz, Paulina; Hilkens, John; Rhodes, Jonathan M.; Yu, Lu-Gang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1937-1947</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) is an important regulator of epithelial cell growth and survival in normal and cancerous tissues and is a principal therapeutic target for cancer treatment.  EGFR is assocd. in epithelial cells with the heavily glycosylated transmembrane mucin protein MUC1, a natural ligand of galectin-3 that is overexpressed in cancer.  This study reveals that the expression of cell surface MUC1 is a crit. enhancer of EGF-induced EGFR activation in human breast and colon cancer cells.  Both the MUC1 extracellular and intracellular domains are involved in EGFR activation but the predominant influence comes from its extracellular domain.  Binding of galectin-3 to the MUC1 extracellular domain induces MUC1 cell surface polarization and increases MUC1-EGFR assocn.  This leads to a rapid increase of EGFR homo-/hetero-dimerization and subsequently increased, and also prolonged, EGFR activation and signalling.  This effect requires both the galectin-3 C-terminal carbohydrate recognition domain and its N-terminal ligand multi-merization domain.  Thus, interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in epithelial cancer cells.  As MUC1 and galectin-3 are both commonly overexpressed in most types of epithelial cancers, their interaction and impact on EGFR activation likely makes important contribution to EGFR-assocd. tumorigenesis and cancer progression and may also influence the effectiveness of EGFR-targeted cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWvlvyk6dQB7Vg90H21EOLACvtfcHk0ljCpRmpqYYSgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Whsr3J&md5=f84a77b21a402b5b66d8293c18a843b7</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2017.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2017.119%26sid%3Dliteratum%253Aachs%26aulast%3DPiyush%26aufirst%3DT.%26aulast%3DChacko%26aufirst%3DA.%2BR.%26aulast%3DSindrewicz%26aufirst%3DP.%26aulast%3DHilkens%26aufirst%3DJ.%26aulast%3DRhodes%26aufirst%3DJ.%2BM.%26aulast%3DYu%26aufirst%3DL.%2BG.%26atitle%3DInteraction%2520of%2520Galectin-3%2520with%2520MUC1%2520on%2520Cell%2520Surface%2520Promotes%2520EGFR%2520Dimerization%2520and%2520Activation%2520in%2520Human%2520Epithelial%2520Cancer%2520Cells%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2017%26volume%3D24%26spage%3D1937%26epage%3D1947%26doi%3D10.1038%2Fcdd.2017.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramasamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duraisamy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbashov, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">The MUC1 and Galectin-3 Oncoproteins Function in a Microrna-Dependent Regulatory Loop</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">1004</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2007.07.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.molcel.2007.07.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=17889671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=992-1004&author=S.+Ramasamyauthor=S.+Duraisamyauthor=S.+Barbashovauthor=T.+Kawanoauthor=S.+Kharbandaauthor=D.+Kufe&title=The+MUC1+and+Galectin-3+Oncoproteins+Function+in+a+Microrna-Dependent+Regulatory+Loop&doi=10.1016%2Fj.molcel.2007.07.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop</span></div><div class="casAuthors">Ramasamy, Selvi; Duraisamy, Sekhar; Barbashov, Sergei; Kawano, Takeshi; Kharbanda, Surender; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">992-1004</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The MUC1 heterodimeric transmembrane glycoprotein is aberrantly overexpressed by diverse human carcinomas.  Galectin-3 is a β-galactoside binding protein that has also been assocd. with the development of human cancers.  The present results demonstrate that MUC1 induces galectin-3 expression by a post-transcriptional mechanism.  We show that the MUC1 C-terminal subunit is glycosylated on Asn-36 and that this modification is necessary for upregulation of galectin-3.  N-glycosylated MUC1-C increases galectin-3 mRNA levels by suppressing expression of the microRNA miR-322 and thereby stabilizing galectin-3 transcripts.  The results show that, in turn, galectin-3 binds to MUC1-C at the glycosylated Asn-36 site.  The significance of the MUC1-C-galectin-3 interaction is supported by the demonstration that galectin-3 forms a bridge between MUC1 and the epidermal growth factor receptor (EGFR) and that galectin-3 is essential for EGF-mediated interactions between MUC1 and EGFR.  These findings indicate that MUC1 and galectin-3 function as part of a miR-322-dependent regulatory loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2JggLDX0XMbVg90H21EOLACvtfcHk0lj5HGH3b-kCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFahtrzM&md5=7a83310af1b9f1e8c06343a9029a9dd4</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2007.07.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2007.07.031%26sid%3Dliteratum%253Aachs%26aulast%3DRamasamy%26aufirst%3DS.%26aulast%3DDuraisamy%26aufirst%3DS.%26aulast%3DBarbashov%26aufirst%3DS.%26aulast%3DKawano%26aufirst%3DT.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DThe%2520MUC1%2520and%2520Galectin-3%2520Oncoproteins%2520Function%2520in%2520a%2520Microrna-Dependent%2520Regulatory%2520Loop%26jtitle%3DMol.%2520Cell%26date%3D2007%26volume%3D27%26spage%3D992%26epage%3D1004%26doi%3D10.1016%2Fj.molcel.2007.07.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kharbanda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kufe, D.</span></span> <span> </span><span class="NLM_article-title">Heregulin Targets Gamma-Catenin to the Nucleolus by a Mechanism Dependent on the DF3/MUC1 Oncoprotein</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">775</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12939402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Glu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2003&pages=765-775&author=Y.+Liauthor=W.+H.+Yuauthor=J.+Renauthor=W.+Chenauthor=L.+Huangauthor=S.+Kharbandaauthor=M.+Lodaauthor=D.+Kufe&title=Heregulin+Targets+Gamma-Catenin+to+the+Nucleolus+by+a+Mechanism+Dependent+on+the+DF3%2FMUC1+Oncoprotein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Heregulin Targets γ-Catenin to the Nucleolus by a Mechanism Dependent on the DF3/MUC1 Oncoprotein</span></div><div class="casAuthors">Li, Yongqing; Yu, Wei-hsuan; Ren, Jian; Chen, Wen; Huang, Lei; Kharbanda, Surender; Loda, Massimo; Kufe, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">765-775</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The DF3/MUC1 transmembrane oncoprotein is aberrantly overexpressed in most human breast carcinomas and interacts with the Wnt effector γ-catenin.  Here, we demonstrate that MUC1 assocs. constitutively with ErbB2 in human breast cancer cells and that treatment with heregulin/neuregulin-1 (HRG) increases the formation of MUC1-ErbB2 complexes.  The importance of the MUC1-ErbB2 interaction is supported by the demonstration that HRG induces binding of MUC1 and γ-catenin and targeting of the MUC1-γ-catenin complex to the nucleolus.  Significantly, nucleolar localization of γ-catenin in response to HRG is dependent on MUC1 expression.  Moreover, mutation of a RRK motif in the MUC1 cytoplasmic domain abrogates HRG-induced nucleolar localization of MUC1 and γ-catenin.  In concert with these results, we show nucleolar localization of MUC1 and γ-catenin in human breast carcinomas but not in normal mammary ductal epithelium.  These findings demonstrate that MUC1 functions in cross talk between ErbB2 and Wnt pathways by acting as a shuttle for HRG-induced nucleolar targeting of γ-catenin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSCi8cG9eoi7Vg90H21EOLACvtfcHk0lj5HGH3b-kCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Glu7w%253D&md5=db2970b47ae70ebbc5f365e4fca0dfda</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DW.%2BH.%26aulast%3DRen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DKharbanda%26aufirst%3DS.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DKufe%26aufirst%3DD.%26atitle%3DHeregulin%2520Targets%2520Gamma-Catenin%2520to%2520the%2520Nucleolus%2520by%2520a%2520Mechanism%2520Dependent%2520on%2520the%2520DF3%252FMUC1%2520Oncoprotein%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2003%26volume%3D1%26spage%3D765%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jepson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haq, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arango, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">Muc4/Sialomucin Complex, the Intramembrane Erbb2 Ligand, Induces Specific Phosphorylation of Erbb2 and Enhances Expression of P27(Kip), but Does Not Activate Mitogen-Activated Kinase or Protein Kinaseb/Akt Pathways</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7524</span>– <span class="NLM_lpage">7532</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1205970</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fsj.onc.1205970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12386815" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFWjsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2002&pages=7524-7532&author=S.+Jepsonauthor=M.+Komatsuauthor=B.+Haqauthor=M.+E.+Arangoauthor=D.+Huangauthor=C.+A.+Carrawayauthor=K.+L.+Carraway&title=Muc4%2FSialomucin+Complex%2C+the+Intramembrane+Erbb2+Ligand%2C+Induces+Specific+Phosphorylation+of+Erbb2+and+Enhances+Expression+of+P27%28Kip%29%2C+but+Does+Not+Activate+Mitogen-Activated+Kinase+or+Protein+Kinaseb%2FAkt+Pathways&doi=10.1038%2Fsj.onc.1205970"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinase B/Akt pathways</span></div><div class="casAuthors">Jepson, Scott; Komatsu, Masanobu; Haq, Bushra; Arango, Maria E.; Huang, Daming; Carothers-Carraway, Coralie A.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">7524-7532</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Muc4/sialomucin complex (SMC) is a multifunctional glycoprotein complex which can repress apoptosis in transfected tumor cells.  Its transmembrane subunit acts as an intramembrane ligand for the receptor tyrosine kinase ErbB2 to induce the phosphorylation of ErbB2 and, by acting synergistically with the ErbB3 ligand neuregulin, can potentiate the phosphorylation of ErbB2 and ErbB3.  In the present study the authors show that Muc4/SMC alone robustly induces the phosphorylation of ErbB2 to enhance the tyrosine phosphate epitope (Tyr1248) recognized by anti-phospho-ErbB2.  Although this tyrosine phosphorylation has been implicated in cell transformation, it does not activate any of the three mitogen-activated protein kinases (MAPKs) or protein kinase B/Akt of the phosphatidyl inositol 3-kinase pathway.  Instead, Muc4/SMC expression induces up-regulation of the cell cycle inhibitor p27kip, consistent with the expression of Muc4/SMC in differentiated, rather than proliferative, epithelial cells.  Interestingly, a combination of Muc4/SMC and neuregulin down-regulate p27kip and activate protein kinase B/Akt.  These observations suggest that Muc4/SMC acts as a regulator of differentiation by inducing a limited phosphorylation of ErbB2 and a modulator of proliferation when acting synergistically with neuregulin to induce a more extensive phosphorylation on both ErbB2 and ErbB3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN3D_sdWZnpLVg90H21EOLACvtfcHk0lj5HGH3b-kCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFWjsbg%253D&md5=5c6902252480750a79cf4bab36a6867c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1205970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1205970%26sid%3Dliteratum%253Aachs%26aulast%3DJepson%26aufirst%3DS.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DHaq%26aufirst%3DB.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DCarraway%26aufirst%3DC.%2BA.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DMuc4%252FSialomucin%2520Complex%252C%2520the%2520Intramembrane%2520Erbb2%2520Ligand%252C%2520Induces%2520Specific%2520Phosphorylation%2520of%2520Erbb2%2520and%2520Enhances%2520Expression%2520of%2520P27%2528Kip%2529%252C%2520but%2520Does%2520Not%2520Activate%2520Mitogen-Activated%2520Kinase%2520or%2520Protein%2520Kinaseb%252FAkt%2520Pathways%26jtitle%3DOncogene%26date%3D2002%26volume%3D21%26spage%3D7524%26epage%3D7532%26doi%3D10.1038%2Fsj.onc.1205970" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span> <span> </span><span class="NLM_article-title">The MUC4Mucin Mediates Gemcitabine Resistance of Human Pancreatic Cancer Cells via the Concentrative Nucleoside Transporter Family</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1723</span>, <span class="refDoi"> DOI: 10.1038/onc.2012.179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2012.179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22580602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38XmvFCjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=1714-1723&author=N.+Skrypekauthor=B.+Ducheneauthor=M.+Hebbarauthor=E.+Leteurtreauthor=I.+van+Seuningenauthor=N.+Jonckheere&title=The+MUC4Mucin+Mediates+Gemcitabine+Resistance+of+Human+Pancreatic+Cancer+Cells+via+the+Concentrative+Nucleoside+Transporter+Family&doi=10.1038%2Fonc.2012.179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family</span></div><div class="casAuthors">Skrypek, N.; Duchene, B.; Hebbar, M.; Leteurtre, E.; van Seuningen, I.; Jonckheere, N.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1714-1723</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The fluorinated analog of deoxycytidine, Gemcitabine (Gemzar), is the main chemotherapeutic drug in pancreatic cancer, but survival remains weak mainly because of the high resistance of tumors to the drug.  Recent works have shown that the mucin MUC4 may confer an advantage to pancreatic tumor cells by modifying their susceptibility to drugs.  However, the cellular mechanism(s) responsible for this MUC4-mediated resistance is unknown.  The aim of this work was to identify the cellular mechanisms responsible for gemcitabine resistance linked to MUC4 expression.  CAPAN-2 and CAPAN-1 adenocarcinomatous pancreatic cancer (PC) cell lines were used to establish stable MUC4-deficient clones (MUC4-KD) by shRNA interference.  Measurement of the IC50 index using tetrazolium salt test indicated that MUC4-deficient cells were more sensitive to gemcitabine.  This was correlated with increased Bax/BclXL ratio and apoptotic cell no.  Expression of Equilibrative/Concentrative Nucleoside Transporter (hENT1, hCNT1/3), deoxycytidine kinase (dCK), ribonucleotide reductase (RRM1/2) and Multidrug-Resistance Protein (MRP3/4/5) was evaluated by quant. RT-PCR (qRT-PCR) and western blotting.  Alteration of MRP3, MRP4, hCNT1 and hCNT3 expression was obsd. in MUC4-KD cells, but only hCNT1 alteration was correlated to MUC4 expression and sensitivity to gemcitabine.  Decreased activation of MAPK, JNK and NF-κB pathways was obsd. in MUC4-deficient cells, in which the NF-κB pathway was found to have an important role in both sensitivity to gemcitabine and hCNT1 regulation.  Finally, and in accordance with our in vitro data, we found that MUC4 expression was conversely correlated to that of hCNT1 in tissues from patients with pancreatic adenocarcinoma.  This work describes a new mechanism of PC cell resistance to gemcitabine, in which the MUC4 mucin neg. regulates the hCNT1 transporter expression via the NF-κB pathway.  Altogether, these data point out to MUC4 and hCNT1 as potential targets to ameliorate the response of pancreatic tumors to gemcitabine treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-8VP_IcPyGbVg90H21EOLACvtfcHk0li10vS5T_9wWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmvFCjur4%253D&md5=d4d9a0c31fc51e609dc9acec17fab98c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fonc.2012.179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2012.179%26sid%3Dliteratum%253Aachs%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DDuchene%26aufirst%3DB.%26aulast%3DHebbar%26aufirst%3DM.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26aulast%3DJonckheere%26aufirst%3DN.%26atitle%3DThe%2520MUC4Mucin%2520Mediates%2520Gemcitabine%2520Resistance%2520of%2520Human%2520Pancreatic%2520Cancer%2520Cells%2520via%2520the%2520Concentrative%2520Nucleoside%2520Transporter%2520Family%26jtitle%3DOncogene%26date%3D2013%26volume%3D32%26spage%3D1714%26epage%3D1723%26doi%3D10.1038%2Fonc.2012.179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasseur, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span> <span> </span><span class="NLM_article-title">The Oncogenic Receptor Erbb2 Modulates Gemcitabine and Irinotecan/SN-38 Chemoresistance of Human Pancreatic Cancer Cells via Hcnt1 Transporter and Multidrug-Resistance Associated Protein MRP-2</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">10853</span>– <span class="NLM_lpage">10867</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.3414" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=25890497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2MjlvFOktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=10853-10867&author=N.+Skrypekauthor=R.+Vasseurauthor=A.+Vincentauthor=B.+Ducheneauthor=I.+Van+Seuningenauthor=N.+Jonckheere&title=The+Oncogenic+Receptor+Erbb2+Modulates+Gemcitabine+and+Irinotecan%2FSN-38+Chemoresistance+of+Human+Pancreatic+Cancer+Cells+via+Hcnt1+Transporter+and+Multidrug-Resistance+Associated+Protein+MRP-2&doi=10.18632%2Foncotarget.3414"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2</span></div><div class="casAuthors">Skrypek Nicolas; Vasseur Romain; Vincent Audrey; Duchene Belinda; Van Seuningen Isabelle; Jonckheere Nicolas; Skrypek Nicolas; Vasseur Romain; Vincent Audrey; Duchene Belinda; Van Seuningen Isabelle; Jonckheere Nicolas; Skrypek Nicolas; Vasseur Romain; Vincent Audrey; Duchene Belinda; Van Seuningen Isabelle; Jonckheere Nicolas</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">10853-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma (PDAC) is one of the most deadly cancers because of a lack of early diagnostic markers and efficient therapeutics.  The fluorinated analog of deoxycytidine, gemcitabine and emerging FOLFIRINOX protocol (5-fluorouracil (5-FU), irinotecan/SN-38, oxaliplatin and leucovorin) are the main chemotherapies to treat PDAC.  The ErbB2/HER2 oncogenic receptor is commonly overexpressed in PDAC.  In this context, we aimed to decipher the ErbB2-mediated mechanisms of chemoresistance to the two main chemotherapy protocols used to treat PDAC.ErbB2 knocking down (KD) in CAPAN-1 and CAPAN-2 cells led to an increased sensitivity to gemcitabine and an increased resistance to irinotecan/SN-38 both in vitro and in vivo (subcutaneous xenografts) This was correlated to an increase of hCNT1 and hCNT3 transporters and ABCG2, MRP1 and MRP2 ATP-binding cassette transporters expression and resistance to cell death.  We also show that MRP2 is repressed following activation of JNK, Erk1/2 and NF-κB pathways by ErbB2.  Finally, in datasets of human PDAC samples, ErbB2 and MRP2 expression was conversely correlated.  Altogether, we propose that ErbB2 mediates several intracellular mechanisms linked to PDAC cell chemoresistance that may represent potential targets in order to ameliorate chemotherapy response and allow stratification of patients eligible for either gemcitabine or FOLFIRINOX treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRguiwWAI9SK3tlzo9xastyfW6udTcc2ebKMjoQ6fpC4rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjlvFOktg%253D%253D&md5=a42400ac34247a4df37f953b153cea8a</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3414%26sid%3Dliteratum%253Aachs%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DVasseur%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DA.%26aulast%3DDuchene%26aufirst%3DB.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26aulast%3DJonckheere%26aufirst%3DN.%26atitle%3DThe%2520Oncogenic%2520Receptor%2520Erbb2%2520Modulates%2520Gemcitabine%2520and%2520Irinotecan%252FSN-38%2520Chemoresistance%2520of%2520Human%2520Pancreatic%2520Cancer%2520Cells%2520via%2520Hcnt1%2520Transporter%2520and%2520Multidrug-Resistance%2520Associated%2520Protein%2520MRP-2%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D10853%26epage%3D10867%26doi%3D10.18632%2Foncotarget.3414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vannatta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinayek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watanabe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandey, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bell, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lio, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span> <span> </span><span class="NLM_article-title">Expression and Functions of Transmembrane Mucin MUC13 in Ovarian Cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">774</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-08-0587</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1158%2F0008-5472.CAN-08-0587" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=19176398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=765-774&author=S.+C.+Chauhanauthor=K.+Vannattaauthor=M.+C.+Ebelingauthor=N.+Vinayekauthor=A.+Watanabeauthor=K.+K.+Pandeyauthor=M.+C.+Bellauthor=M.+D.+Kochauthor=H.+Aburataniauthor=Y.+Lioauthor=M.+Jaggi&title=Expression+and+Functions+of+Transmembrane+Mucin+MUC13+in+Ovarian+Cancer&doi=10.1158%2F0008-5472.CAN-08-0587"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and functions of transmembrane mucin MUC13 in ovarian cancer</span></div><div class="casAuthors">Chauhan, Subhash C.; Vannatta, Kelley; Ebeling, Mara C.; Vinayek, Namita; Watanabe, Akira; Pandey, Krishan K.; Bell, Maria C.; Koch, Michael D.; Aburatani, Hiroyuki; Lio, Yuhlong; Jaggi, Meena</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">765-774</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MUC13, a transmembrane mucin, is normally expressed in gastrointestinal and airway epithelium.  Its aberrant expression has been correlated with gastric colon and cancer.  However, the expression and functions of MUC13 in ovarian cancer are unknown.  In the present study, the expression profile and functions of MUC13 were analyzed to elucidate its potential role in ovarian cancer diagnosis and pathogenesis.  A recently generated monoclonal antibody (clone PPZ0020) was used to det. the expression profile of MUC13 by immunohistochem. using ovarian cancer tissue microarrays and 56 addnl. epithelial ovarian cancer (EOC) samples.  The expression of MUC13 was significantly (P < 0.005) higher in cancer samples compared with the normal ovary/benign tissues.  Among all ovarian cancer types, MUC13 expression was specifically present in EOC.  For the functional analyses, a full-length MUC13 gene cloned in pcDNA3.1 was expressed in a MUC13 null ovarian cancer cell line, SKOV-3.  Here, we show that the exogenous MUC13 expression induced morphol. changes, including scattering of cells.  These changes were abrogated through c-Jun NH2 kinase (JNK) chem. inhibitor (SP600125) or JNK2 siRNA.  Addnl., a marked redn. in cell-cell adhesion and significant (P < 0.05) increases in cell motility, proliferation, and tumorigenesis in a xenograft mouse model system were obsd. upon exogenous MUC13 expression.  These cellular characteristics were correlated with up-regulation of HER2, p21-activated kinase 1, and p38 protein expression.  Our findings show the aberrant expression of MUC13 in ovarian cancer and that its expression alters the cellular characteristics of SKOV-3 cells.  This implies a significant role of MUC13 in ovarian cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod0_cDsdOkC7Vg90H21EOLACvtfcHk0li10vS5T_9wWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOksb8%253D&md5=4b2339466e0f9f83285214e3215b6d5a</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-08-0587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-08-0587%26sid%3Dliteratum%253Aachs%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26aulast%3DVannatta%26aufirst%3DK.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DVinayek%26aufirst%3DN.%26aulast%3DWatanabe%26aufirst%3DA.%26aulast%3DPandey%26aufirst%3DK.%2BK.%26aulast%3DBell%26aufirst%3DM.%2BC.%26aulast%3DKoch%26aufirst%3DM.%2BD.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DLio%26aufirst%3DY.%26aulast%3DJaggi%26aufirst%3DM.%26atitle%3DExpression%2520and%2520Functions%2520of%2520Transmembrane%2520Mucin%2520MUC13%2520in%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D765%26epage%3D774%26doi%3D10.1158%2F0008-5472.CAN-08-0587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puumala, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aburatani, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">Functions and Regulation of MUC13 Mucin in Colon Cancer Cells</span>. <i>J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1378</span>– <span class="NLM_lpage">1391</span>, <span class="refDoi"> DOI: 10.1007/s00535-013-0885-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1007%2Fs00535-013-0885-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24097071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SgurbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=1378-1391&author=B.+K.+Guptaauthor=D.+M.+Maherauthor=M.+C.+Ebelingauthor=P.+D.+Stephensonauthor=S.+E.+Puumalaauthor=M.+R.+Kochauthor=H.+Aburataniauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=Functions+and+Regulation+of+MUC13+Mucin+in+Colon+Cancer+Cells&doi=10.1007%2Fs00535-013-0885-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Functions and regulation of MUC13 mucin in colon cancer cells</span></div><div class="casAuthors">Gupta, Brij K.; Maher, Diane M.; Ebeling, Mara C.; Stephenson, Phillip D.; Puumala, Susan E.; Koch, Michael R.; Aburatani, Hiroyuki; Jaggi, Meena; Chauhan, Subhash C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1378-1391</span>CODEN:
                <span class="NLM_cas:coden">JOGAET</span>;
        ISSN:<span class="NLM_cas:issn">0944-1174</span>.
    
            (<span class="NLM_cas:orgname">Springer Japan</span>)
        </div><div class="casAbstract">Background: MUC13 is overexpressed and aberrantly localized in colon cancer tissue; however, the specific functions and regulation of MUC13 expression are unknown.  Methods: Stable cell lines with either overexpressed or suppressed MUC13 levels were analyzed to det. cell growth, colony formation, cell migration, and cell invasion assays.  The mol. mechanisms involved in MUC13 regulation were elucidated via chromatin immunopptn. (ChIP) and anal. of interleukin 6 (IL6) treatments.  Colon cancer tissues were analyzed by immunohistochem. (IHC) for the protein levels of MUC13 and P-STAT5 in colon cancer cells.  Results: Overexpression of MUC13 increased cell growth, colony formation, cell migration, and invasion.  In concordance, MUC13 silencing decreased these tumorigenic features.  Overexpression of MUC13 also modulated various cancer-assocd. proteins, including telomerase reverse transcriptase, sonic hedgehog, B cell lymphoma murine like site 1, and GATA like transcription factor 1.  Addnl., MUC13-overexpressing cells showed increased HER2 and P-ERK expression.  ChIP anal. revealed binding of STAT5 to the predicted MUC13 promoter.  IL6 treatment of colon cancer cells increased the expression of MUC13 via activation of the JAK2/STAT5 signaling pathway.  Suppression of JAK2 and STAT5 signaling by chem. inhibitors abolished IL6-induced MUC13 expression.  IHC anal. showed increased expression of both P-STAT5 and MUC13 in colon cancer as compared to adjacent normal tissue.  Conclusions: The results of this study, for the first time, suggest functional roles of MUC13 in colon cancer progression and provide information regarding the regulation of MUC13 expression via JAK2/STAT5 which may reveal promising therapeutic approaches for colon cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBpXJHADk3ebVg90H21EOLACvtfcHk0li10vS5T_9wWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SgurbK&md5=d76df872e42d78da86aa0973b8699a31</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs00535-013-0885-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00535-013-0885-z%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DB.%2BK.%26aulast%3DMaher%26aufirst%3DD.%2BM.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DStephenson%26aufirst%3DP.%2BD.%26aulast%3DPuumala%26aufirst%3DS.%2BE.%26aulast%3DKoch%26aufirst%3DM.%2BR.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DFunctions%2520and%2520Regulation%2520of%2520MUC13%2520Mucin%2520in%2520Colon%2520Cancer%2520Cells%26jtitle%3DJ.%2520Gastroenterol.%26date%3D2014%26volume%3D49%26spage%3D1378%26epage%3D1391%26doi%3D10.1007%2Fs00535-013-0885-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmanan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seshacharyulu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haridas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rachagani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganti, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponnusamy, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span> <span> </span><span class="NLM_article-title">Novel HER3/MUC4 Oncogenic Signaling Aggravates the Tumorigenic Phenotypes of Pancreatic Cancer Cells</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">21085</span>– <span class="NLM_lpage">21099</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.3912</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.3912" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=26035354" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2MfpsVGgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=21085-21099&author=I.+Lakshmananauthor=P.+Seshacharyuluauthor=D.+Haridasauthor=S.+Rachaganiauthor=S.+Guptaauthor=S.+Joshiauthor=C.+Gudaauthor=Y.+Yanauthor=M.+Jainauthor=A.+K.+Gantiauthor=M.+P.+Ponnusamyauthor=S.+K.+Batra&title=Novel+HER3%2FMUC4+Oncogenic+Signaling+Aggravates+the+Tumorigenic+Phenotypes+of+Pancreatic+Cancer+Cells&doi=10.18632%2Foncotarget.3912"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells</span></div><div class="casAuthors">Lakshmanan Imayavaramban; Seshacharyulu Parthasarathy; Haridas Dhanya; Rachagani Satyanarayana; Gupta Suprit; Joshi Suhasini; Jain Maneesh; Ponnusamy Moorthy P; Batra Surinder K; Guda Chittibabu; Yan Ying; Jain Maneesh; Ponnusamy Moorthy P; Batra Surinder K; Ganti Apar K; Ganti Apar K</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">21085-99</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Several studies have demonstrated that MUC4 is involved in progression and metastasis of pancreatic cancer (PC).  Here, we report that HER3/MUC4 interaction in HER2 low cells is critical in driving pancreatic tumorigenesis.  Upon HER2 knockdown, we observed elevated expression of HER3 and MUC4 and their interactions, which was confirmed by immunoprecipitation and bioinformatics analyses.  In paired human PC tissues, higher percentage of HER3 positivity (10/33, 30.3%; p = 0.001) was observed than HER2 (5/33, 15.1%; p = 0.031), which was further confirmed in spontaneous mice (KPC; KrasG12D; Trp53R172H/+; Pdx-Cre) tumors of different weeks.  Mechanistically, increased phosphorylation of ERK and expression of PI3K and c-Myc were observed in HER2 knockdown cells, suggesting a positive role for HER3/MUC4 in HER2 low cells.  Further, HER2 knockdown resulted in increased proliferation, motility and tumorigenicity of PC cells.  Consistently, transient knockdown of HER3 by siRNA in HER2 knockdown cells led to decreased proliferation.  These observations led us to conclude that HER3 interacts with MUC4 to promote proliferation in HER2 low PC cells.  Further, deficiency of both HER2 and HER3 leads to decreased proliferation of PC cells.  Hence targeting these newly identified HER3/MUC4 signals would improve the PC patients survival by intercepting MUC4 mediated oncogenic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOtduiqRtz8fcsfMJQC1ZdfW6udTcc2eYSl_gsA7tDK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfpsVGgtQ%253D%253D&md5=2551f03a4268593686e3032b27057783</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.3912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.3912%26sid%3Dliteratum%253Aachs%26aulast%3DLakshmanan%26aufirst%3DI.%26aulast%3DSeshacharyulu%26aufirst%3DP.%26aulast%3DHaridas%26aufirst%3DD.%26aulast%3DRachagani%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DGuda%26aufirst%3DC.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DGanti%26aufirst%3DA.%2BK.%26aulast%3DPonnusamy%26aufirst%3DM.%2BP.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26atitle%3DNovel%2520HER3%252FMUC4%2520Oncogenic%2520Signaling%2520Aggravates%2520the%2520Tumorigenic%2520Phenotypes%2520of%2520Pancreatic%2520Cancer%2520Cells%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D21085%26epage%3D21099%26doi%3D10.18632%2Foncotarget.3912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span> <span> </span><span class="NLM_article-title">Molecular Architecture of the Erbb2 Extracellular Domain Homodimer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1695</span>– <span class="NLM_lpage">1706</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2713</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.2713" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=25633808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2MrgvVygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1695-1706&author=S.+Huauthor=Y.+Sunauthor=Y.+Mengauthor=X.+Wangauthor=W.+Yangauthor=W.+Fuauthor=H.+Guoauthor=W.+Qianauthor=S.+Houauthor=B.+Liauthor=Z.+Raoauthor=Z.+Louauthor=Y.+Guo&title=Molecular+Architecture+of+the+Erbb2+Extracellular+Domain+Homodimer&doi=10.18632%2Foncotarget.2713"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular architecture of the ErbB2 extracellular domain homodimer</span></div><div class="casAuthors">Hu Shi; Guo Huaizu; Qian Weizhu; Hou Sheng; Li Bohua; Guo Yajun; Hu Shi; Sun Yuna; Rao Zihe; Hu Shi; Sun Yuna; Rao Zihe; Lou Zhiyong; Hu Shi; Yang Weili; Fu Wenyan; Hou Sheng; Li Bohua; Guo Yajun; Meng Yanchun; Wang Xiaoze; Yang Weili; Guo Yajun; Meng Yanchun; Guo Huaizu; Qian Weizhu; Hou Sheng; Guo Yajun; Meng Yanchun; Hou Sheng; Guo Yajun</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1695-706</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human epidermal growth factor receptors (HERs or ErbBs) play crucial roles in numerous cellular processes.  ErbB2 is a key member of ErbB family, and its overexpression is recognized as a frequent molecular abnormality.  In cancer, this overexpression correlates with aggressive disease and poor patient outcomes.  Dimer-dependent phosphorylation is a key event for the signal transduction of ErbBs.  However, the molecular mechanism of the dimerization of ErbB2 remains elusive.  In the present work, we report the homodimer architecture of the ErbB2 extracellular domain (ECD) which is unique compared with other dimer-models of ErbBs.  The structure of the ErbB2 ECD homodimer represents a "back to head" interaction, in which a protruding β-hairpin arm in domain II of one ErbB2 protomer is inserted into a C-shaped pocket created by domains I-III of the adjacent ErbB2 protomer.  This dimerized architecture and its impact on the phosphorylation of ErbB2 intracellular domain were further verified by a mutagenesis study.  We also elucidated the different impacts of two clinically administered therapeutic antibodies, trastuzumab and pertuzumab, on ErbB2 dimerization.  This information not only provides an understanding of the molecular mechanism of ErbBs dimerization but also elucidates ErbB2-targeted therapy at the molecular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSl0pGDyilHAsve_zCu79I8fW6udTcc2eYSl_gsA7tDK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MrgvVygsw%253D%253D&md5=849cce64a78a7439c541995d965e63e1</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2713&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2713%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DFu%26aufirst%3DW.%26aulast%3DGuo%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DHou%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRao%26aufirst%3DZ.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DGuo%26aufirst%3DY.%26atitle%3DMolecular%2520Architecture%2520of%2520the%2520Erbb2%2520Extracellular%2520Domain%2520Homodimer%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D1695%26epage%3D1706%26doi%3D10.18632%2Foncotarget.2713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alvarado, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klein, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemmon, M. A.</span></span> <span> </span><span class="NLM_article-title">Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>142</i></span>,  <span class="NLM_fpage">568</span>– <span class="NLM_lpage">579</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2010.07.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.cell.2010.07.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=20723758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2010&pages=568-579&author=D.+Alvaradoauthor=D.+E.+Kleinauthor=M.+A.+Lemmon&title=Structural+Basis+for+Negative+Cooperativity+in+Growth+Factor+Binding+to+an+EGF+Receptor&doi=10.1016%2Fj.cell.2010.07.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor</span></div><div class="casAuthors">Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">142</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">568-579</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Transmembrane signaling by the epidermal growth factor receptor (EGFR) involves ligand-induced dimerization and allosteric regulation of the intracellular tyrosine kinase domain.  Crystallog. studies have shown how ligand binding induces dimerization of the EGFR extracellular region but cannot explain the "high-affinity" and "low-affinity" classes of cell-surface EGF-binding sites inferred from curved Scatchard plots.  From a series of crystal structures of the Drosophila EGFR extracellular region, we show here how Scatchard plot curvature arises from neg. cooperative ligand binding.  The first ligand-binding event induces formation of an asym. dimer with only one bound ligand.  The unoccupied site in this dimer is structurally restrained, leading to reduced affinity for binding of the second ligand, and thus neg. cooperativity.  Our results explain the cell-surface binding characteristics of EGF receptors and suggest how individual EGFR ligands might stabilize distinct dimeric species with different signaling properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW5brpwwp9arVg90H21EOLACvtfcHk0lhtC5WgdRuQ9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKhurzO&md5=203a9818de72b925546622c98324775c</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2010.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2010.07.015%26sid%3Dliteratum%253Aachs%26aulast%3DAlvarado%26aufirst%3DD.%26aulast%3DKlein%26aufirst%3DD.%2BE.%26aulast%3DLemmon%26aufirst%3DM.%2BA.%26atitle%3DStructural%2520Basis%2520for%2520Negative%2520Cooperativity%2520in%2520Growth%2520Factor%2520Binding%2520to%2520an%2520EGF%2520Receptor%26jtitle%3DCell%26date%3D2010%26volume%3D142%26spage%3D568%26epage%3D579%26doi%3D10.1016%2Fj.cell.2010.07.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekels, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandarian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaworski, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinrikson, R. L.</span></span> <span> </span><span class="NLM_article-title">Activity of Recombinant Cysteine-Rich Domain Proteins Derived from the Membrane-Bound MUC17/Muc3 Family Mucins</span>. <i>Biochim. Biophys. Acta, Gen. Subj.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1800</i></span>,  <span class="NLM_fpage">629</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1016/j.bbagen.2010.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1016%2Fj.bbagen.2010.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmvVWitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1800&publication_year=2010&pages=629-638&author=S.+B.+Hoauthor=Y.+Luuauthor=L.+L.+Shekelsauthor=S.+K.+Batraauthor=B.+Kandarianauthor=D.+B.+Evansauthor=P.+G.+Zaworskiauthor=C.+L.+Wolfeauthor=R.+L.+Heinrikson&title=Activity+of+Recombinant+Cysteine-Rich+Domain+Proteins+Derived+from+the+Membrane-Bound+MUC17%2FMuc3+Family+Mucins&doi=10.1016%2Fj.bbagen.2010.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins</span></div><div class="casAuthors">Ho, Samuel B.; Luu, Ying; Shekels, Laurie L.; Batra, Surinder K.; Kandarian, Brandon; Evans, David B.; Zaworski, Phillip G.; Wolfe, Cindy L.; Heinrikson, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, General Subjects</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1800</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">629-638</span>CODEN:
                <span class="NLM_cas:coden">BBGSB3</span>;
        ISSN:<span class="NLM_cas:issn">0304-4165</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The membrane-bound mucins, MUC17 (human) and Muc3 (mouse), are highly expressed on the apical surface of intestinal epithelia and have cytoprotective properties.  Their extracellular regions contain two EGF-like Cys-rich domains (CRD1 and CRD2) connected by an intervening linker segment with SEA module (L), and may function to stimulate intestinal cell restitution.  The purpose of this study was to det. the effect of size, recombinant host source, and external tags on mucin CRD1-L-CRD2 protein activity.  Four recombinant Muc3-CRD proteins and three MUC17-CRD proteins were generated using Escherichia coli or baculovirus-insect cell systems and tested in colonic cell cultures for activity related to cell migration and apoptosis.  N-terminal glutathione-S-transferase (GST) or C-terminal His8 tags had no effect on either the cell migration or anti-apoptosis activity of Muc3-CRD1-L-CRD2.  His-tagged Muc3-CRD1-L-CRD2 proteins with truncated linker regions, or the linker region alone, did not demonstrate biol. activity.  The human recombinant MUC17-CRD1-L-CRD2-His8 was shown to have anti-apoptotic and pro-migratory activity, but did not stimulate cell proliferation.  This protein showed similar in vitro biol. activity, whether produced in E. coli or a baculovirus-insect cell system.  Recombinant mucin proteins contg. a bivalent display of Cys-rich domains accelerate colon cell migration and inhibit apoptosis, require a full-length intervening Linker-SEA segment for optimal biol. activity, and are functional when synthesized in either E. coli and insect cell systems.  These results indicate that an E. coli-derived full-length His8-tagged human MUC17 CRD1-L-CRD2 recombinant protein is a biol. active candidate for further development as a therapeutic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTkjY2azqFirVg90H21EOLACvtfcHk0lh_PnyXWBAJfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmvVWitrg%253D&md5=7db0956641c4c45165a484b7aacf0ee6</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.bbagen.2010.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbagen.2010.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DHo%26aufirst%3DS.%2BB.%26aulast%3DLuu%26aufirst%3DY.%26aulast%3DShekels%26aufirst%3DL.%2BL.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DKandarian%26aufirst%3DB.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DZaworski%26aufirst%3DP.%2BG.%26aulast%3DWolfe%26aufirst%3DC.%2BL.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26atitle%3DActivity%2520of%2520Recombinant%2520Cysteine-Rich%2520Domain%2520Proteins%2520Derived%2520from%2520the%2520Membrane-Bound%2520MUC17%252FMuc3%2520Family%2520Mucins%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Gen.%2520Subj.%26date%3D2010%26volume%3D1800%26spage%3D629%26epage%3D638%26doi%3D10.1016%2Fj.bbagen.2010.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price-Schiavi, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guy, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvajal, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fregien, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carothers Carraway, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span> <span> </span><span class="NLM_article-title">An Intramembrane Modulator of the ErbB2 Receptor Tyrosine Kinase That Potentiates Neuregulin Signaling</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">5263</span>– <span class="NLM_lpage">5266</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.9.5263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1074%2Fjbc.274.9.5263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10026131" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1MXhsFamtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=5263-5266&author=K.+L.+Carrawayauthor=E.+A.+Rossiauthor=M.+Komatsuauthor=S.+A.+Price-Schiaviauthor=D.+Huangauthor=P.+M.+Guyauthor=M.+E.+Carvajalauthor=N.+Fregienauthor=C.+A.+Carothers+Carrawayauthor=K.+L.+Carraway&title=An+Intramembrane+Modulator+of+the+ErbB2+Receptor+Tyrosine+Kinase+That+Potentiates+Neuregulin+Signaling&doi=10.1074%2Fjbc.274.9.5263"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">An intramembrane modulator of the ErbB2 receptor tyrosine kinase that potentiates neuregulin signaling</span></div><div class="casAuthors">Carraway, Kermit L., III; Rossi, Edmund A.; Komatsu, Masanobu; Price-Schiavi, Shari A.; Huang, Daming; Guy, Pamela M.; Carvajal, Maria E.; Fregien, Nevis; Carothers-Carraway, Coralie A.; Carraway, Kermit L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5263-5266</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The ErbB2 receptor tyrosine kinase plays a crit. role in a variety of developmental processes, and its aberrant activation may contribute to the progression of some breast and ovarian tumors.  ASGP2, a transmembrane glycoprotein found on the surface of the highly metastatic ascites 13762 rat mammary adenocarcinoma cell line, is constitutively assocd. with ErbB2 in these cells and in mammary tissue from pregnant rats.  Expression studies indicate that ASGP2 interacts directly and specifically with ErbB2 through one of its epidermal growth factor-like domains and that the co-expression of the two proteins in the same cell dramatically facilitates their direct stable interaction.  Ectopic expression of ASGP2 in human melanoma tumor cells potentiates the response of endogenous ErbB2 to the neuregulin-1 growth factor.  These observations point to a novel intramembrane mechanism for the modulation of receptor tyrosine kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnKn0loK5wo7Vg90H21EOLACvtfcHk0lh_PnyXWBAJfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsFamtbg%253D&md5=b8bd37d92cad51160b4c31f4664f2a2f</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.9.5263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.9.5263%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26aulast%3DRossi%26aufirst%3DE.%2BA.%26aulast%3DKomatsu%26aufirst%3DM.%26aulast%3DPrice-Schiavi%26aufirst%3DS.%2BA.%26aulast%3DHuang%26aufirst%3DD.%26aulast%3DGuy%26aufirst%3DP.%2BM.%26aulast%3DCarvajal%26aufirst%3DM.%2BE.%26aulast%3DFregien%26aufirst%3DN.%26aulast%3DCarothers%2BCarraway%26aufirst%3DC.%2BA.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26atitle%3DAn%2520Intramembrane%2520Modulator%2520of%2520the%2520ErbB2%2520Receptor%2520Tyrosine%2520Kinase%2520That%2520Potentiates%2520Neuregulin%2520Signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D5263%26epage%3D5266%26doi%3D10.1074%2Fjbc.274.9.5263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaboriaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontecilla-Camps, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arlaud, G. J.</span></span> <span> </span><span class="NLM_article-title">Evolutionary Conserved Rigid Module-domain Interactions can be Detected at the Sequence Level: The Examples of Complement and Blood Coagulation Proteases</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">459</span>– <span class="NLM_lpage">470</span>, <span class="refDoi"> DOI: 10.1006/jmbi.1998.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1006%2Fjmbi.1998.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=9735300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlClsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=1998&pages=459-470&author=C.+Gaboriaudauthor=V.+Rossiauthor=J.+C.+Fontecilla-Campsauthor=G.+J.+Arlaud&title=Evolutionary+Conserved+Rigid+Module-domain+Interactions+can+be+Detected+at+the+Sequence+Level%3A+The+Examples+of+Complement+and+Blood+Coagulation+Proteases&doi=10.1006%2Fjmbi.1998.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Evolutionary conserved rigid module-domain interactions can be detected at the sequence level: the examples of complement and blood coagulation proteases</span></div><div class="casAuthors">Gaboriaud, Christine; Rossi, Veronique; Fontecilla-Camps, Juan Carlos; Arlaud, Gerard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">459-470</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Several extracellular modular proteins, including proteases of the complement and blood coagulation cascades, are shown here to exhibit conserved sequence patterns specific for a particular module-domain assocn.  This was detected by comparative anal. of sequence variability in different multiple sequence alignments, which provides a new tool to investigate the evolution of modular proteins.  A first example deals with the proteins featuring a common complement control protein (CCP) module-serine protease (SP) domain pattern at their C-terminal end, defined here as the CCP-SP sub-family.  These proteins include the complement proteases C1r, C1s and MASPs, the Limulus clotting factor C, and the proteins of the haptoglobin family.  A second example deals with blood coagulation factors VII, IX and X and protein C, all featuring a common epidermal growth factor (EGF)-SP C-terminal assembly.  Highly specific motifs are found at the connection between the CCP or EGF module and the activation peptide of the SP domain: [P/A]-x-C-x-[P/A]-[I/V]-C-G-x-[P/S/K] in the case of the CCP-SP proteins, and C-x-[P/S]-x-x-x-[Y/F]-P-C-G in the case of the EGF-SP proteins.  Each motif is strictly conserved in the whole sub-family and it is detected in no more than one other known protein sequence.  Strikingly, most of the conserved residues specific to each sub-family appear to be clustered at the interface between the SP domain and the CCP or EGF module.  We propose that a rigid module-domain interaction occurs in these proteins and has been conserved through evolution.  The functional implications of these assemblies, underlined by such evolutionary constraints, are discussed.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdbykjyHOn0rVg90H21EOLACvtfcHk0lh_PnyXWBAJfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlClsbY%253D&md5=91a3ddb534b55599f4d26eeffbd0a86e</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1998.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1998.2008%26sid%3Dliteratum%253Aachs%26aulast%3DGaboriaud%26aufirst%3DC.%26aulast%3DRossi%26aufirst%3DV.%26aulast%3DFontecilla-Camps%26aufirst%3DJ.%2BC.%26aulast%3DArlaud%26aufirst%3DG.%2BJ.%26atitle%3DEvolutionary%2520Conserved%2520Rigid%2520Module-domain%2520Interactions%2520can%2520be%2520Detected%2520at%2520the%2520Sequence%2520Level%253A%2520The%2520Examples%2520of%2520Complement%2520and%2520Blood%2520Coagulation%2520Proteases%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D282%26spage%3D459%26epage%3D470%26doi%3D10.1006%2Fjmbi.1998.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batra, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varshney, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingsworth, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilentz, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argani, P.</span></span> <span> </span><span class="NLM_article-title">MUC4 Expression Increases Progressively in Pancreatic Intraepithelial Neoplasia</span>. <i>Am. J. Clin. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1309/7Y7N-M1WM-R0YK-M2VA</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1309%2F7Y7N-M1WM-R0YK-M2VA" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=12090430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BD38zkslKhtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2002&pages=791-796&author=M.+J.+Swartzauthor=S.+K.+Batraauthor=G.+C.+Varshneyauthor=M.+A.+Hollingsworthauthor=C.+J.+Yeoauthor=J.+L.+Cameronauthor=R.+E.+Wilentzauthor=R.+H.+Hrubanauthor=P.+Argani&title=MUC4+Expression+Increases+Progressively+in+Pancreatic+Intraepithelial+Neoplasia&doi=10.1309%2F7Y7N-M1WM-R0YK-M2VA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">MUC4 expression increases progressively in pancreatic intraepithelial neoplasia</span></div><div class="casAuthors">Swartz Michael J; Batra Surinder K; Varshney Grish C; Hollingsworth Michael A; Yeo Charles J; Cameron John L; Wilentz Robb E; Hruban Ralph H; Argani Pedram</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical pathology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-6</span>
        ISSN:<span class="NLM_cas:issn">0002-9173</span>.
    </div><div class="casAbstract">Pancreatic adenocarcinoma is believed to develop from histologically identifiable intraductal lesions known as pancreatic intraepithelial neoplasias (PanINs) that undergo a series of architectural, cytologic, and genetic changes, a progression model similar to the adenoma-carcinoma sequence in the colon.  The apomucin MUC4 has been implicated in invasive pancreatic adenocarcinoma.  MUC4 expression is not detectable at the RNA level in normal pancreas but is detectable at high levels in invasive pancreatic adenocarcinoma.  We documented the pattern of expression of MUC4 in PanINs by studying a series of 71 PanIN lesions immunohistochemically using a new monoclonal antibody to MUC4.  Five (17%) of 30 PanIN-1 lesions, 10 (36%) of 28 PanIN-2 lesions, 11 (85%) of 13 PanIN-3 lesions, and 25 (89%) of 28 invasive adenocarcinomas labeled with the MUC4 antibody used in the study.  In addition, afew nonneoplastic lesions labeled with the MUC4 antibody, including reactive ducts in chronic pancreatitis, atrophic ducts filled with inspissated secretions, and ducts showing squamous metaplasia.  Our data help establish the patterns of MUC4 expression in neoplastic precursors in the pancreas and add further support to the progression model for pancreatic adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRMRBXQMQ_EXlUIs6wFK5xJfW6udTcc2eZoo8U2t3R5Arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38zkslKhtA%253D%253D&md5=9c1f25b1200e253c97f5bbe5b01d6e9b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1309%2F7Y7N-M1WM-R0YK-M2VA&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1309%252F7Y7N-M1WM-R0YK-M2VA%26sid%3Dliteratum%253Aachs%26aulast%3DSwartz%26aufirst%3DM.%2BJ.%26aulast%3DBatra%26aufirst%3DS.%2BK.%26aulast%3DVarshney%26aufirst%3DG.%2BC.%26aulast%3DHollingsworth%26aufirst%3DM.%2BA.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCameron%26aufirst%3DJ.%2BL.%26aulast%3DWilentz%26aufirst%3DR.%2BE.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DArgani%26aufirst%3DP.%26atitle%3DMUC4%2520Expression%2520Increases%2520Progressively%2520in%2520Pancreatic%2520Intraepithelial%2520Neoplasia%26jtitle%3DAm.%2520J.%2520Clin.%2520Pathol.%26date%3D2002%26volume%3D117%26spage%3D791%26epage%3D796%26doi%3D10.1309%2F7Y7N-M1WM-R0YK-M2VA" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skrypek, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merlin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dessein, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desseyn, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Susini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frénois, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">The Mucin MUC4 and its Membrane Partner Erbb2 Regulate Biological Properties of Human CAPAN-2 Pancreatic Cancer Cells via Different Signalling Pathways</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e32232</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0032232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1371%2Fjournal.pone.0032232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22393391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&author=N.+Jonckheereauthor=N.+Skrypekauthor=J.+Merlinauthor=A.+F.+Desseinauthor=P.+Dumontauthor=E.+Leteurtreauthor=A.+Harrisauthor=J.+L.+Desseynauthor=C.+Susiniauthor=F.+Fr%C3%A9noisauthor=I.+Van+Seuningen&title=The+Mucin+MUC4+and+its+Membrane+Partner+Erbb2+Regulate+Biological+Properties+of+Human+CAPAN-2+Pancreatic+Cancer+Cells+via+Different+Signalling+Pathways&doi=10.1371%2Fjournal.pone.0032232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways</span></div><div class="casAuthors">Jonckheere, Nicolas; Skrypek, Nicolas; Merlin, Johann; Dessein, Anne Frederique; Dumont, Patrick; Leteurtre, Emmanuelle; Harris, Ann; Desseyn, Jean-Luc; Susini, Christiane; Frenois, Frederic; Van Seuningen, Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e32232</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The mucin MUC4 and its membrane partner the ErbB2 oncogenic receptor are potential interacting partners in human pancreatic tumor development.  However, the way they function is still largely unknown.  In this work, we aimed to identify the cellular mechanisms and the intracellular signalling pathways under the control of both ErbB2 and MUC4 in a human pancreatic adenocarcinomatous cell line.  Using co-immunopptn. and GST pull-down, we show that MUC4 and ErbB2 interact in the human pancreatic adenocarcinomatous cell line CAPAN-2 via the EGF domains of MUC4.  Stable cell clones were generated in which either MUC4 or ErbB2 were knocked down (KD) by a shRNA approach.  Biol. properties of these cells were then studied in vitro and in vivo.  Our results show that ErbB2-KD cells are more apoptotic and less proliferative (decreased cyclin D1 and increased p27kip1 expression) while migration and invasive properties were not altered.  MUC4-KD clones were less proliferative with decreased cyclin D1 expression, G1 cell cycle arrest and altered ErbB2/ErbB3 expression.  Their migration properties were reduced whereas invasive properties were increased.  Importantly, inhibition of ErbB2 and MUC4 expression did not impair the same signalling pathways (inhibition of MUC4 expression affected the JNK pathway whereas that of ErbB2 altered the MAPK pathway).  Finally, ErbB2-KD and MUC4-KD cells showed impaired tumor growth in vivo.  Our results show that ErbB2 and MUC4, which interact phys., activate different intracellular signalling pathways to regulate biol. properties of CAPAN-2 pancreatic cancer cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraoUloWRMMlrVg90H21EOLACvtfcHk0lhl5m1XIvlTLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs12ltrs%253D&md5=656b500d070b2e9b6d64ee65a37aa624</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0032232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0032232%26sid%3Dliteratum%253Aachs%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3DSkrypek%26aufirst%3DN.%26aulast%3DMerlin%26aufirst%3DJ.%26aulast%3DDessein%26aufirst%3DA.%2BF.%26aulast%3DDumont%26aufirst%3DP.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3DHarris%26aufirst%3DA.%26aulast%3DDesseyn%26aufirst%3DJ.%2BL.%26aulast%3DSusini%26aufirst%3DC.%26aulast%3DFr%25C3%25A9nois%26aufirst%3DF.%26aulast%3DVan%2BSeuningen%26aufirst%3DI.%26atitle%3DThe%2520Mucin%2520MUC4%2520and%2520its%2520Membrane%2520Partner%2520Erbb2%2520Regulate%2520Biological%2520Properties%2520of%2520Human%2520CAPAN-2%2520Pancreatic%2520Cancer%2520Cells%2520via%2520Different%2520Signalling%2520Pathways%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26doi%3D10.1371%2Fjournal.pone.0032232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaman, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sikander, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yallapu, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yacoubian, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrman, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaggi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, S. C.</span></span> <span> </span><span class="NLM_article-title">MicroRNA-145 Targets MUC13 and Suppresses Growth and Invasion of Pancreatic Cancer</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">7599</span>– <span class="NLM_lpage">7609</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.2281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.18632%2Foncotarget.2281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=25277192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC2M7ntVamsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=7599-7609&author=S.+Khanauthor=M.+C.+Ebelingauthor=M.+S.+Zamanauthor=M.+Sikanderauthor=M.+M.+Yallapuauthor=N.+Chauhanauthor=A.+M.+Yacoubianauthor=S.+W.+Behrmanauthor=N.+Zafarauthor=D.+Kumarauthor=P.+A.+Thompsonauthor=M.+Jaggiauthor=S.+C.+Chauhan&title=MicroRNA-145+Targets+MUC13+and+Suppresses+Growth+and+Invasion+of+Pancreatic+Cancer&doi=10.18632%2Foncotarget.2281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer</span></div><div class="casAuthors">Khan Sheema; Zaman Mohd S; Sikander Mohammed; Yallapu Murali M; Chauhan Neeraj; Jaggi Meena; Chauhan Subhash C; Ebeling Mara C; Yacoubian Ashley M; Zafar Nadeem; Behrman Stephen W; Kumar Deepak; Thompson Paul A</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7599-609</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Pancreatic cancer has a poor prognosis due to late diagnosis and ineffective therapeutic multimodality.  MUC13, a transmembrane mucin is highly involved in pancreatic cancer progression.  Thus, understanding its regulatory molecular mechanisms may offer new avenue of therapy for prevention/treatment of pancreatic cancer.  Herein, we report a novel microRNA (miR-145)-mediated mechanism regulating aberrant MUC13 expression in pancreatic cancer.  We report that miR-145 expression inversely correlates with MUC13 expression in pancreatic cancer cells and human tumor tissues. miR-145 is predominantly present in normal pancreatic tissues and early Pancreatic Ductal Adenocarcinoma (PDAC) precursor lesions (PanIN I) and is progressively suppressed over the course of development from PanIN II/III to late stage poorly differentiated PDAC.  We demonstrate that miR-145 targets 3' untranslated region of MUC13 and thus downregulates MUC13 protein expression in cells.  Interestingly, transfection of miR-145 inhibits cell proliferation, invasion and enhances gemcitabine sensitivity.  It causes reduction of HER2, P-AKT, PAK1 and an increase in p53.  Similar results were found when MUC13 was specifically inhibited by shRNA directed at MUC13.  Additionally, intratumoral injections of miR-145 in xenograft mice inhibited tumor growth via suppression of MUC13 and its downstream target, HER2.  These results suggest miR-145 as a novel regulator of MUC13 in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSbVVQKsYBUc5cXNb62YGmbfW6udTcc2eZoo8U2t3R5Arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7ntVamsg%253D%253D&md5=18f1327ba6886fc875b058b569ea0fa6</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.2281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.2281%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DEbeling%26aufirst%3DM.%2BC.%26aulast%3DZaman%26aufirst%3DM.%2BS.%26aulast%3DSikander%26aufirst%3DM.%26aulast%3DYallapu%26aufirst%3DM.%2BM.%26aulast%3DChauhan%26aufirst%3DN.%26aulast%3DYacoubian%26aufirst%3DA.%2BM.%26aulast%3DBehrman%26aufirst%3DS.%2BW.%26aulast%3DZafar%26aufirst%3DN.%26aulast%3DKumar%26aufirst%3DD.%26aulast%3DThompson%26aufirst%3DP.%2BA.%26aulast%3DJaggi%26aufirst%3DM.%26aulast%3DChauhan%26aufirst%3DS.%2BC.%26atitle%3DMicroRNA-145%2520Targets%2520MUC13%2520and%2520Suppresses%2520Growth%2520and%2520Invasion%2520of%2520Pancreatic%2520Cancer%26jtitle%3DOncotarget%26date%3D2014%26volume%3D5%26spage%3D7599%26epage%3D7609%26doi%3D10.18632%2Foncotarget.2281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lahdaoui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delpu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messager, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duchene, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leteurtre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mariette, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrisani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonckheere, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Seuningen, I.</span></span> <span> </span><span class="NLM_article-title">Mir-219–1-3p is a Negative Regulator of the Mucin MUC4 Expression and is a Tumor Suppressor in Pancreatic Cancer</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">780</span>– <span class="NLM_lpage">788</span>, <span class="refDoi"> DOI: 10.1038/onc.2014.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1038%2Fonc.2014.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=24608432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvV2jsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2015&pages=780-788&author=F.+Lahdaouiauthor=Y.+Delpuauthor=A.+Vincentauthor=F.+Renaudauthor=M.+Messagerauthor=B.+Ducheneauthor=E.+Leteurtreauthor=C.+Marietteauthor=J.+Torrisaniauthor=N.+Jonckheereauthor=I.+van+Seuningen&title=Mir-219%E2%80%931-3p+is+a+Negative+Regulator+of+the+Mucin+MUC4+Expression+and+is+a+Tumor+Suppressor+in+Pancreatic+Cancer&doi=10.1038%2Fonc.2014.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer</span></div><div class="casAuthors">Lahdaoui, F.; Delpu, Y.; Vincent, A.; Renaud, F.; Messager, M.; Duchene, B.; Leteurtre, E.; Mariette, C.; Torrisani, J.; Jonckheere, N.; Van Seuningen, I.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">780-788</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers in the world with one of the worst outcome.  The oncogenic mucin MUC4 has been identified as an actor of pancreatic carcinogenesis as it is involved in many processes regulating pancreatic cancer cell biol.  MUC4 is not expressed in healthy pancreas whereas it is expressed very early in pancreatic carcinogenesis.  Targeting MUC4 in these early steps may thus appear as a promising strategy to slow-down pancreatic tumorigenesis.  MiRNA neg. regulation of MUC4 could be one mechanism to efficiently downregulate MUC4 gene expression in early pancreatic neoplastic lesions.  Using in silico studies, we found two putative binding sites for miR-219-1-3p in the 3'-UTR of MUC4 and showed that miR-219-1-3p expression is downregulated both in PDAC-derived cell lines and human PDAC tissues compared with their normal counterparts.  We then showed that miR-219-1-3p neg. regulates MUC4 mucin expression via its direct binding to MUC4 3'-UTR.  MiR-219-1-3p overexpression (transient and stable) in pancreatic cancer cell lines induced a decrease of cell proliferation assocd. with a decrease of cyclin D1 and a decrease of Akt and Erk pathway activation.  MiR-219-1-3p overexpression also decreased cell migration.  Furthermore, miR-219-1-3p expression was found to be conversely correlated with Muc4 expression in early pancreatic intraepithelial neoplasia lesions of Pdx1-Cre;LSL-KrasG12D mice.  Most interestingly, in vivo studies showed that miR-219-1-3p injection in xenografted pancreatic tumors in mice decreased both tumor growth and MUC4 mucin expression.  Altogether, these results identify miR-219-1-3p as a new neg. regulator of MUC4 oncomucin that possesses tumor-suppressor activity in PDAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2j-hTxJqNOrVg90H21EOLACvtfcHk0liBkt-a6Q30Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvV2jsbs%253D&md5=2fd7228df915a21743420b9a79901db1</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fonc.2014.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fonc.2014.11%26sid%3Dliteratum%253Aachs%26aulast%3DLahdaoui%26aufirst%3DF.%26aulast%3DDelpu%26aufirst%3DY.%26aulast%3DVincent%26aufirst%3DA.%26aulast%3DRenaud%26aufirst%3DF.%26aulast%3DMessager%26aufirst%3DM.%26aulast%3DDuchene%26aufirst%3DB.%26aulast%3DLeteurtre%26aufirst%3DE.%26aulast%3DMariette%26aufirst%3DC.%26aulast%3DTorrisani%26aufirst%3DJ.%26aulast%3DJonckheere%26aufirst%3DN.%26aulast%3Dvan%2BSeuningen%26aufirst%3DI.%26atitle%3DMir-219%25E2%2580%25931-3p%2520is%2520a%2520Negative%2520Regulator%2520of%2520the%2520Mucin%2520MUC4%2520Expression%2520and%2520is%2520a%2520Tumor%2520Suppressor%2520in%2520Pancreatic%2520Cancer%26jtitle%3DOncogene%26date%3D2015%26volume%3D34%26spage%3D780%26epage%3D788%26doi%3D10.1038%2Fonc.2014.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dokmanovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, W. J.</span></span> <span> </span><span class="NLM_article-title">Cardiotoxicity Of Erbb2-Targeted Therapies and its Impact on Drug Development, a Spotlight on Trastuzumab</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">755</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1337746</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1080%2F17425255.2017.1337746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=28571477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BC2sXps1ensLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=755-766&author=M.+Dokmanovicauthor=K.+E.+Kingauthor=N.+Mohanauthor=Y.+Endoauthor=W.+J.+Wu&title=Cardiotoxicity+Of+Erbb2-Targeted+Therapies+and+its+Impact+on+Drug+Development%2C+a+Spotlight+on+Trastuzumab&doi=10.1080%2F17425255.2017.1337746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab</span></div><div class="casAuthors">Dokmanovic, Milos; King, Kathryn E.; Mohan, Nishant; Endo, Yukinori; Wu, Wen Jin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">755-766</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Trastuzumab, a therapeutic monoclonal antibody directed against ErbB2, is often noted as a successful example of targeted therapy.  Trastuzumab improved outcomes for many patients with ErbB2-pos. breast and gastric cancers, however, cardiac side effects [e.g., left ventricular dysfunction and congestive heart failure (CHF)] were reported in the early phase clin. studies.  This finding, subsequently corroborated by multiple clin. studies, raised concerns that the obsd. cardiotoxicity induced by trastuzumab might adversely impact the clin. development of other therapeutics targeting ErbB family members.: In this review we summarize both basic research and clin. findings regarding trastuzumab-induced cardiotoxicity and assess if there has been an impact of trastuzumab-induced cardiotoxicity on the development of other agents targeting ErbB family members.: There are a no. of scientific gaps that are critically important to address for the continued success of HER2-targeted agents.  These include: 1) elucidating the mol. mechanisms contributing to cardiotoxicity; 2) developing relevant preclin. testing systems for predicting cardiotoxicity; 3) developing clin. strategies to identify patients at risk of cardiotoxicity; and 4) enhancing management of clin. symptoms of cardiotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorbY04GiyZBLVg90H21EOLACvtfcHk0liBkt-a6Q30Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXps1ensLw%253D&md5=0247a9ff192e22b5d92753c8b501c49e</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1337746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1337746%26sid%3Dliteratum%253Aachs%26aulast%3DDokmanovic%26aufirst%3DM.%26aulast%3DKing%26aufirst%3DK.%2BE.%26aulast%3DMohan%26aufirst%3DN.%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DW.%2BJ.%26atitle%3DCardiotoxicity%2520Of%2520Erbb2-Targeted%2520Therapies%2520and%2520its%2520Impact%2520on%2520Drug%2520Development%252C%2520a%2520Spotlight%2520on%2520Trastuzumab%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D755%26epage%3D766%26doi%3D10.1080%2F17425255.2017.1337746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedländer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapanen, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isola, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jovin, T. M.</span></span> <span> </span><span class="NLM_article-title">Decreased Accessibility and Lack of Activation of Erbb2 in JIMT-1, a Herceptin-Resistant, MUC4-Expressing Breast Cancer Cell Line</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">473</span>– <span class="NLM_lpage">482</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=15695389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1KqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=473-482&author=P.+Nagyauthor=E.+Friedl%C3%A4nderauthor=M.+Tannerauthor=A.+I.+Kapanenauthor=K.+L.+Carrawayauthor=J.+Isolaauthor=T.+M.+Jovin&title=Decreased+Accessibility+and+Lack+of+Activation+of+Erbb2+in+JIMT-1%2C+a+Herceptin-Resistant%2C+MUC4-Expressing+Breast+Cancer+Cell+Line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line</span></div><div class="casAuthors">Nagy, Peter; Friedlaender, Elza; Tanner, Minna; Kapanen, Anita I.; Carraway, Kermit L.; Isola, Jorma; Jovin, Thomas M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">473-482</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overexpression of erbB2 in breast tumors is assocd. with poor prognosis and is a target of receptor-oriented cancer therapy.  Trastuzumab (Herceptin), a monoclonal antibody against a membrane-proximal epitope in the extracellular region of erbB2, shows a therapeutic effect against a fraction of erbB2-amplified breast tumors.  Unfortunately, resistance to Herceptin is common, and its cause is as yet unclear.  Here the authors investigated the properties of erbB2 in a Herceptin-resistant cell line, JIMT-1, established from a breast cancer patient showing erbB2 gene amplification and primary resistance to Herceptin.  The expression profile of erbB proteins, Herceptin-induced erbB2 internalization, and down-regulation in JIMT-1 were similar to those in Herceptin-sensitive lines.  However, the mean no. of Herceptin Mab binding sites in JIMT-1 was 1/5 that of the expressed erbB2 mols., although 5% to 10% of the cells showed a ∼ 10-fold higher Herceptin binding than the main population.  Herceptin Fab and Mab 2C4, an antibody binding to an epitope in the ectodomain further removed from the membrane, bound more efficiently to JIMT-1 cells than Herceptin Mab, implying that erbB2 was partly masked.  The expression of MUC4, a membrane-assocd. mucin that according to reports contributes to the masking of membrane proteins, was higher in JIMT-1 than in Herceptin-sensitive lines, and its level was inversely correlated with the Herceptin binding capacity of single cells.  Knockdown of MUC4 expression by RNA interference increased the binding of Herceptin.  Western blotting showed a low level of proteolytic processing, shedding, and tyrosine phosphorylation of erbB2 in JIMT-1.  The latter finding may explain its Herceptin-resistant phenotype characterizing both the low and high Herceptin binding subpopulations.  The authors conclude that masking of erbB2 in JIMT-1 leads to diminished Herceptin binding and isolation of erbB2 from its normal interaction and activation partners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAgcvhORF8KLVg90H21EOLACvtfcHk0liBkt-a6Q30Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1KqsA%253D%253D&md5=72b05c3a22b40002676e2caf9a00c330</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagy%26aufirst%3DP.%26aulast%3DFriedl%25C3%25A4nder%26aufirst%3DE.%26aulast%3DTanner%26aufirst%3DM.%26aulast%3DKapanen%26aufirst%3DA.%2BI.%26aulast%3DCarraway%26aufirst%3DK.%2BL.%26aulast%3DIsola%26aufirst%3DJ.%26aulast%3DJovin%26aufirst%3DT.%2BM.%26atitle%3DDecreased%2520Accessibility%2520and%2520Lack%2520of%2520Activation%2520of%2520Erbb2%2520in%2520JIMT-1%252C%2520a%2520Herceptin-Resistant%252C%2520MUC4-Expressing%2520Breast%2520Cancer%2520Cell%2520Line%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D473%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rexer, B. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arteaga, C. L.</span></span> <span> </span><span class="NLM_article-title">Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications</span>. <i>Crit. Rev. Oncog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">16</span>, <span class="refDoi"> DOI: 10.1615/CritRevOncog.v17.i1.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1615%2FCritRevOncog.v17.i1.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=22471661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BC38rhvVyitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=1-16&author=B.+N.+Rexerauthor=C.+L.+Arteaga&title=Intrinsic+and+Acquired+Resistance+to+HER2-Targeted+Therapies+in+HER2+Gene-Amplified+Breast+Cancer%3A+Mechanisms+and+Clinical+Implications&doi=10.1615%2FCritRevOncog.v17.i1.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications</span></div><div class="casAuthors">Rexer Brent N; Arteaga Carlos L</div><div class="citationInfo"><span class="NLM_cas:title">Critical reviews in oncogenesis</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-16</span>
        ISSN:<span class="NLM_cas:issn">0893-9675</span>.
    </div><div class="casAbstract">Approximately 25% of human breast cancers overexpress the HER2 (ErbB2) proto-oncogene, which confers a more aggressive tumor phenotype and associates with a poor prognosis in patients with this disease.  Two approved therapies targeting HER2, the monoclonal antibody trastuzumab and the tyrosine kinase inhibitor lapatinib, are clinically active against this type of breast cancer.  However, a significant fraction of patients with HER2+ breast cancer treated with these agents eventually relapse or develop progressive disease.  This suggests that tumors acquire or possess intrinsic mechanisms of resistance that allow escape from HER2 inhibition.  This review focuses on mechanisms of intrinsic and/or acquired resistance to HER2-targeted therapies that have been identified in preclinical and clinical studies.  These mechanisms involve alterations to HER2 itself, coexpression or acquisition of bypass signaling through other receptor or intracellular signaling pathways, defects in mechanisms of cell cycle regulation or apoptosis, and host factors that may modulate drug response.  Emerging clinical evidence already suggests that combinations of therapies targeting HER2 as well as these resistance pathways will be effective in overcoming or preventing resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR-aUq9kTcyKsERNNga7KD-fW6udTcc2ebXNEbQBmST2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rhvVyitQ%253D%253D&md5=66e4d56a35c84d3ec3276e97e91b97cb</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1615%2FCritRevOncog.v17.i1.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1615%252FCritRevOncog.v17.i1.20%26sid%3Dliteratum%253Aachs%26aulast%3DRexer%26aufirst%3DB.%2BN.%26aulast%3DArteaga%26aufirst%3DC.%2BL.%26atitle%3DIntrinsic%2520and%2520Acquired%2520Resistance%2520to%2520HER2-Targeted%2520Therapies%2520in%2520HER2%2520Gene-Amplified%2520Breast%2520Cancer%253A%2520Mechanisms%2520and%2520Clinical%2520Implications%26jtitle%3DCrit.%2520Rev.%2520Oncog.%26date%3D2012%26volume%3D17%26spage%3D1%26epage%3D16%26doi%3D10.1615%2FCritRevOncog.v17.i1.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J. Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Portman, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nobis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastings, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latham, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miladinovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marriott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, Y. EI.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shearer, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timpson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolch, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Croucher, D. R.</span></span> <span> </span><span class="NLM_article-title">Targeting Promiscuous Heterodimerization Overcomes Innate Resistance to ERBB2 Dimerization Inhibitors in Breast Cancer</span>. <i>Breast Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">43</span>, <span class="refDoi"> DOI: 10.1186/s13058-019-1127-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=10.1186%2Fs13058-019-1127-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=30898150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;key=1%3ACAS%3A280%3ADC%252BB3cbmsl2ksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2019&pages=43&author=S.+P.+Kennedyauthor=J.+Z.+R.+Hanauthor=N.+Portmanauthor=M.+Nobisauthor=J.+F.+Hastingsauthor=K.+J.+Murphyauthor=S.+L.+Lathamauthor=A.+L.+Cadellauthor=D.+Miladinovicauthor=G.+R.+Marriottauthor=Y.+EI.+O%E2%80%99Donnellauthor=R.+F.+Shearerauthor=J.+T.+Williamsauthor=A.+G.+Munozauthor=T.+R.+Coxauthor=D.+N.+Watkinsauthor=D.+N.+Saundersauthor=P.+Timpsonauthor=E.+Limauthor=W.+Kolchauthor=D.+R.+Croucher&title=Targeting+Promiscuous+Heterodimerization+Overcomes+Innate+Resistance+to+ERBB2+Dimerization+Inhibitors+in+Breast+Cancer&doi=10.1186%2Fs13058-019-1127-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer</span></div><div class="casAuthors">Kennedy Sean P; Han Jeremy Z R; Portman Neil; Nobis Max; Hastings Jordan F; Murphy Kendelle J; Latham Sharissa L; Cadell Antonia L; Miladinovic Dushan; Marriott Gabriella R; O'Donnell Yolande E I; Shearer Robert F; Williams James T; Cox Thomas R; Watkins D Neil; Saunders Darren N; Timpson Paul; Lim Elgene; Croucher David R; Kennedy Sean P; Munoz Amaya Garcia; Kolch Walter; Portman Neil; Cox Thomas R; Watkins D Neil; Timpson Paul; Lim Elgene; Croucher David R; Williams James T; Saunders Darren N; Kolch Walter; Kolch Walter; Croucher David R</div><div class="citationInfo"><span class="NLM_cas:title">Breast cancer research : BCR</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The oncogenic receptor tyrosine kinase (RTK) ERBB2 is known to dimerize with other EGFR family members, particularly ERBB3, through which it potently activates PI3K signalling.  Antibody-mediated inhibition of this ERBB2/ERBB3/PI3K axis has been a cornerstone of treatment for ERBB2-amplified breast cancer patients for two decades.  However, the lack of response and the rapid onset of relapse in many patients now question the assumption that the ERBB2/ERBB3 heterodimer is the sole relevant effector target of these therapies.  METHODS:  Through a systematic protein-protein interaction screen, we have identified and validated alternative RTKs that interact with ERBB2.  Using quantitative readouts of signalling pathway activation and cell proliferation, we have examined their influence upon the mechanism of trastuzumab- and pertuzumab-mediated inhibition of cell growth in ERBB2-amplified breast cancer cell lines and a patient-derived xenograft model.  RESULTS:  We now demonstrate that inactivation of ERBB3/PI3K by these therapeutic antibodies is insufficient to inhibit the growth of ERBB2-amplified breast cancer cells.  Instead, we show extensive promiscuity between ERBB2 and an array of RTKs from outside of the EGFR family.  Paradoxically, pertuzumab also acts as an artificial ligand to promote ERBB2 activation and ERK signalling, through allosteric activation by a subset of these non-canonical RTKs.  However, this unexpected activation mechanism also increases the sensitivity of the receptor network to the ERBB2 kinase inhibitor lapatinib, which in combination with pertuzumab, displays a synergistic effect in single-agent resistant cell lines and PDX models.  CONCLUSIONS:  The interaction of ERBB2 with a number of non-canonical RTKs activates a compensatory signalling response following treatment with pertuzumab, although a counter-intuitive combination of ERBB2 antibody therapy and a kinase inhibitor can overcome this innate therapeutic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT6yC1eUZaTXpVVjGoY74BafW6udTcc2ebXNEbQBmST2bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbmsl2ksA%253D%253D&md5=c4ebdbf76c5d545ca3fe9234702931f7</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1186%2Fs13058-019-1127-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13058-019-1127-y%26sid%3Dliteratum%253Aachs%26aulast%3DKennedy%26aufirst%3DS.%2BP.%26aulast%3DHan%26aufirst%3DJ.%2BZ.%2BR.%26aulast%3DPortman%26aufirst%3DN.%26aulast%3DNobis%26aufirst%3DM.%26aulast%3DHastings%26aufirst%3DJ.%2BF.%26aulast%3DMurphy%26aufirst%3DK.%2BJ.%26aulast%3DLatham%26aufirst%3DS.%2BL.%26aulast%3DCadell%26aufirst%3DA.%2BL.%26aulast%3DMiladinovic%26aufirst%3DD.%26aulast%3DMarriott%26aufirst%3DG.%2BR.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DY.%2BEI.%26aulast%3DShearer%26aufirst%3DR.%2BF.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DMunoz%26aufirst%3DA.%2BG.%26aulast%3DCox%26aufirst%3DT.%2BR.%26aulast%3DWatkins%26aufirst%3DD.%2BN.%26aulast%3DSaunders%26aufirst%3DD.%2BN.%26aulast%3DTimpson%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DE.%26aulast%3DKolch%26aufirst%3DW.%26aulast%3DCroucher%26aufirst%3DD.%2BR.%26atitle%3DTargeting%2520Promiscuous%2520Heterodimerization%2520Overcomes%2520Innate%2520Resistance%2520to%2520ERBB2%2520Dimerization%2520Inhibitors%2520in%2520Breast%2520Cancer%26jtitle%3DBreast%2520Cancer%2520Res.%26date%3D2019%26volume%3D21%26spage%3D43%26doi%3D10.1186%2Fs13058-019-1127-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WIQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WIQ','PDB','4WIQ'); return false;">PDB: 4WIQ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AUT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1AUT','PDB','1AUT'); return false;">PDB: 1AUT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E8D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5E8D','PDB','5E8D'); return false;">PDB: 5E8D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WLW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3WLW','PDB','3WLW'); return false;">PDB: 3WLW</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i21"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02001">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_16826"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02001?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02001</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Multiple-sequence alignments of EGF domains, SEA domains, and combined EGF and SEA domains and resultant phylogenic trees (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02001/suppl_file/jm9b02001_si_001.pdf">jm9b02001_si_001.pdf (4.1 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02001&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02001%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02001" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679957df9ad53d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
